data_2k00_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k00 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.279 0.561 . . . . 1.49 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.64000000000000001 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.46999999999999997 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 1.27 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 1.0700000000000001 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 2.0 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.592 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.69999999999999996 110.557 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.671 -0.492 . . . . 1.3300000000000001 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 1.1799999999999999 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.52000000000000002 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.674 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.93999999999999995 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 1.1200000000000001 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 1.3 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.28999999999999998 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 1.0800000000000001 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' THR . . . . . 0.404 ' C ' ' H ' ' A' ' 335' ' ' GLU . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 1.1899999999999999 110.853 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 2.1800000000000002 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 333' ' ' THR . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.9299999999999999 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 1.1000000000000001 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.1699999999999999 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.8200000000000001 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 1.1100000000000001 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.674 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77000000000000002 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . 0.613 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.48 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 1.4099999999999999 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 2.0800000000000001 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.483 ' HG2' HG23 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 1.28 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 1.1399999999999999 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.6499999999999999 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65000000000000002 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52000000000000002 110.857 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 355' ' ' ASN . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.72 110.043 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 1.0900000000000001 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 1.1100000000000001 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 352' ' ' SER . 41.8 m-80 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.91000000000000003 110.78 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 1.1000000000000001 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 2.27 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.758 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 2.0600000000000001 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.5 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.403 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 1.1399999999999999 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 1.1200000000000001 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.3700000000000001 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.68999999999999995 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.664 ' HB3' ' HZ2' ' A' ' 364' ' ' LYS . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.6400000000000001 111.602 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.97 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.486 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.34000000000000002 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 1.1000000000000001 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.758 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.5 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.60999999999999999 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.3799999999999999 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 1.1699999999999999 110.26 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.1599999999999999 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.2999999999999998 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.69999999999999996 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.23 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.93999999999999995 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.6399999999999999 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.592 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 1.1100000000000001 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 1.0900000000000001 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 1.23 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.3899999999999999 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.32000000000000001 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.2799999999999998 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 1.0900000000000001 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.486 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 1.0600000000000001 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 2.0699999999999998 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 1.3100000000000001 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 388' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 1.0700000000000001 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 1.01 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.34999999999999998 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 1.3200000000000001 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.63 HG12 HD11 ' B' ' 379' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 1.21 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.98999999999999999 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 1.49 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 1.1799999999999999 110.53 -179.061 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . 0.453 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 121.281 0.562 . . . . 1.74 110.727 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.6699999999999999 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.2799999999999998 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.2 t-20 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.8300000000000001 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . 0.563 ' H ' ' ND2' ' B' ' 377' ' ' ASN . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.8799999999999999 113.511 -171.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.63 HD11 HG12 ' A' ' 396' ' ' ILE . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.1699999999999999 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 1.04 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.3599999999999999 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.783 0.325 . . . . 1.49 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.46999999999999997 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 1.27 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 1.0700000000000001 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 2.0 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.69999999999999996 110.869 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.598 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.0 -0.371 . . . . 1.3300000000000001 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 1.1799999999999999 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.52000000000000002 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.93999999999999995 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 1.1200000000000001 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 1.3 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.28999999999999998 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.799 HG23 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 1.0800000000000001 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 1.1899999999999999 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 2.1800000000000002 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.9299999999999999 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 1.1000000000000001 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.1699999999999999 111.52 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.638 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.8200000000000001 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77000000000000002 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.48 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 1.4099999999999999 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 2.0800000000000001 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 1.28 110.177 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.6499999999999999 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65000000000000002 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52000000000000002 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.72 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 1.1100000000000001 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.91000000000000003 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.1000000000000001 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 2.27 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 2.0600000000000001 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.541 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.5 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 110.638 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 110.436 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.3700000000000001 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.68999999999999995 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.6400000000000001 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.97 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.34000000000000002 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 1.1000000000000001 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.0700000000000001 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.5 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.60999999999999999 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.3799999999999999 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 1.1699999999999999 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.1599999999999999 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.2999999999999998 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.69999999999999996 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.23 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.638 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.93999999999999995 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.6399999999999999 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG13 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 1.0900000000000001 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 1.23 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.3899999999999999 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.32000000000000001 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.2799999999999998 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 1.0900000000000001 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 1.0600000000000001 111.662 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 2.0699999999999998 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.799 ' CD1' HG23 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 1.3100000000000001 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 1.0700000000000001 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 1.01 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.34999999999999998 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.172 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.543 HG12 HD12 ' B' ' 379' ' ' ILE . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 1.21 111.031 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.98999999999999999 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 1.49 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 1.1799999999999999 110.719 -178.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.74 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.6699999999999999 110.371 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.2799999999999998 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.778 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.8300000000000001 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.8799999999999999 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.778 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.1699999999999999 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 1.04 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.3599999999999999 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.134 0.493 . . . . 1.49 111.616 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.46999999999999997 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.547 HG11 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 1.0700000000000001 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 2.0 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.69999999999999996 110.927 -176.575 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.526 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.9 mp . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.795 -0.446 . . . . 1.3300000000000001 109.795 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 1.1799999999999999 111.092 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.52000000000000002 111.505 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.93999999999999995 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 1.1200000000000001 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 1.3 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.28999999999999998 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.576 HD11 HG11 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 1.0800000000000001 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 1.1899999999999999 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 2.1800000000000002 111.837 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.9299999999999999 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 1.1000000000000001 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.1699999999999999 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 110.461 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 1.1100000000000001 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77000000000000002 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . 0.525 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.48 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 1.4099999999999999 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 2.0800000000000001 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 1.28 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 1.1399999999999999 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.6499999999999999 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65000000000000002 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . 0.49 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52000000000000002 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.72 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 1.1100000000000001 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.91000000000000003 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 1.1000000000000001 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 2.27 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 2.0600000000000001 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.465 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.5 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 1.1399999999999999 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 1.1200000000000001 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.3700000000000001 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.68999999999999995 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.6400000000000001 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.97 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.34000000000000002 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 1.1000000000000001 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 1.0700000000000001 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.5 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.60999999999999999 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.3799999999999999 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 1.1699999999999999 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.1599999999999999 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.2999999999999998 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.69999999999999996 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.23 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.93999999999999995 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.6399999999999999 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 1.1100000000000001 110.732 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.547 ' HB ' HG11 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 1.0900000000000001 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.3899999999999999 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.32000000000000001 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.2799999999999998 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 1.0600000000000001 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 2.0699999999999998 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.463 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 1.3100000000000001 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.748 HG21 HD13 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 1.0700000000000001 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 1.01 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.34999999999999998 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 1.3200000000000001 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 392' ' ' ILE . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.98999999999999999 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 1.49 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 1.1799999999999999 111.977 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.349 0.595 . . . . 1.74 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.428 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.6699999999999999 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.2799999999999998 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.8300000000000001 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.8799999999999999 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.63 HD11 HG12 ' A' ' 396' ' ' ILE . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.1699999999999999 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 1.04 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.3599999999999999 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.674 0.273 . . . . 1.49 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.64000000000000001 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.46999999999999997 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 1.27 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 2.0 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.484 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.69999999999999996 110.927 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.891 0.377 . . . . 1.3300000000000001 110.374 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 1.1799999999999999 110.836 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.52000000000000002 111.616 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.805 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.75 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 1.1200000000000001 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 1.3 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.28999999999999998 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 1.0800000000000001 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 1.1899999999999999 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 2.1800000000000002 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.9299999999999999 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 1.1000000000000001 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.1699999999999999 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.8200000000000001 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.79 HG21 HG23 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 1.1100000000000001 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.805 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77000000000000002 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.48 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 1.4099999999999999 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 2.0800000000000001 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 1.28 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 1.1399999999999999 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.6499999999999999 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65000000000000002 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52000000000000002 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.72 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.5 HD21 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 1.0900000000000001 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 1.1100000000000001 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.91000000000000003 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 1.1000000000000001 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 2.27 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 2.0600000000000001 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.431 ' HB3' HD21 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.5 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 1.1399999999999999 110.616 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 1.1200000000000001 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3700000000000001 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.68999999999999995 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.6400000000000001 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.97 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.34000000000000002 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 1.1000000000000001 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.569 HD13 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 1.0700000000000001 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.5 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.60999999999999999 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.3799999999999999 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 1.1699999999999999 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.1599999999999999 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.2999999999999998 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.69999999999999996 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.23 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.569 ' HD2' HD13 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.93999999999999995 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.6399999999999999 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 1.1100000000000001 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 1.0900000000000001 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 1.23 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.531 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.3899999999999999 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.32000000000000001 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.2799999999999998 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.531 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 1.0900000000000001 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 1.0600000000000001 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 2.0699999999999998 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.3100000000000001 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.5 HG23 HD21 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 1.0700000000000001 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 1.01 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.34999999999999998 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 1.3200000000000001 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.558 HG12 HD13 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 1.21 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.98999999999999999 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 1.49 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 1.1799999999999999 110.821 -179.299 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.253 0.549 . . . . 1.74 109.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.6699999999999999 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.2799999999999998 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.8300000000000001 109.766 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.8799999999999999 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.558 HD13 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.1699999999999999 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 1.04 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.3599999999999999 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.764 -0.458 . . . . 1.49 109.764 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.487 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.64000000000000001 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.46999999999999997 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 1.27 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 1.0700000000000001 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 2.0 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.69999999999999996 110.766 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.341 -0.614 . . . . 1.3300000000000001 109.341 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 1.1799999999999999 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.52000000000000002 110.875 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 1.1200000000000001 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 1.3 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.28999999999999998 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 1.0800000000000001 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 1.1899999999999999 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 2.1800000000000002 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.9299999999999999 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 1.1000000000000001 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.455 ' HB2' HG12 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.1699999999999999 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.8200000000000001 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 1.1100000000000001 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77000000000000002 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.48 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 1.4099999999999999 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 2.0800000000000001 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 1.28 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 1.1399999999999999 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.6499999999999999 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65000000000000002 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52000000000000002 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.531 ' HB3' HD21 ' A' ' 355' ' ' ASN . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.72 109.327 171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 1.0900000000000001 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 1.1100000000000001 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 352' ' ' SER . 58.2 m-80 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.91000000000000003 111.178 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 1.1000000000000001 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 2.27 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 2.0600000000000001 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.687 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.5 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 1.1399999999999999 110.755 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 1.1200000000000001 110.793 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.3700000000000001 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.68999999999999995 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.6400000000000001 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.97 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.34000000000000002 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 1.1000000000000001 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 1.0700000000000001 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.5 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.60999999999999999 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.685 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.3799999999999999 110.787 -175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 1.1699999999999999 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.1599999999999999 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.2999999999999998 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.69999999999999996 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.23 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.572 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.93999999999999995 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.6399999999999999 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.412 ' HB ' HG11 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 1.0900000000000001 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.32000000000000001 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.2799999999999998 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 1.0900000000000001 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 1.0600000000000001 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 2.0699999999999998 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 1.3100000000000001 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.571 HG22 HD13 ' A' ' 396' ' ' ILE . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0700000000000001 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.01 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.34999999999999998 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 1.3200000000000001 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.679 HG12 HD12 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 1.21 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.98999999999999999 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 1.49 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 1.1799999999999999 111.191 -175.096 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 1.74 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.6699999999999999 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.2799999999999998 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.687 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.8300000000000001 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.8799999999999999 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.679 HD12 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.1699999999999999 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.685 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 1.04 109.032 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.3599999999999999 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.241 0.543 . . . . 1.49 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.64000000000000001 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.46999999999999997 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 1.27 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 1.0700000000000001 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 2.0 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.606 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 110.823 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.988 -0.375 . . . . 1.3300000000000001 109.988 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 1.1799999999999999 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.52000000000000002 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.93999999999999995 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 1.1200000000000001 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 1.3 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.28999999999999998 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.459 HD11 HG11 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 1.0800000000000001 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 1.1899999999999999 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 2.1800000000000002 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.9299999999999999 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 1.1000000000000001 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.1699999999999999 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.606 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.8200000000000001 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 1.1100000000000001 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77000000000000002 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.48 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 1.4099999999999999 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 2.0800000000000001 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 1.28 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 1.1399999999999999 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.6499999999999999 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65000000000000002 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52000000000000002 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.72 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 1.0900000000000001 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 1.1100000000000001 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.91000000000000003 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 1.1000000000000001 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 2.27 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.738 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 2.0600000000000001 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.601 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.5 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 1.1399999999999999 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 1.1200000000000001 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.3700000000000001 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.68999999999999995 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.6400000000000001 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.97 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.509 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.34000000000000002 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 1.1000000000000001 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 1.0700000000000001 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.738 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.5 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.60999999999999999 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.421 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.3799999999999999 111.205 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 1.1699999999999999 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.1599999999999999 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.2999999999999998 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.69999999999999996 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.23 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.93999999999999995 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.6399999999999999 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 1.1100000000000001 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 1.0900000000000001 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 1.23 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.3899999999999999 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.32000000000000001 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.2799999999999998 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 1.0900000000000001 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.509 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 1.0600000000000001 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 2.0699999999999998 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 1.3100000000000001 110.649 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.645 HG21 HD12 ' A' ' 396' ' ' ILE . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 1.0700000000000001 109.982 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 1.01 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.34999999999999998 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 1.3200000000000001 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.645 HD12 HG21 ' A' ' 392' ' ' ILE . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 1.21 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.98999999999999999 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.49 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 1.1799999999999999 111.434 -176.089 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . 0.403 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 83.0 m95 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.619 -0.512 . . . . 1.74 109.619 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.6699999999999999 110.774 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.2799999999999998 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.53 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.8300000000000001 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.8799999999999999 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.485 HD13 HG12 ' A' ' 396' ' ' ILE . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.1699999999999999 110.301 172.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.421 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 1.04 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.3599999999999999 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.807 0.337 . . . . 1.49 111.816 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.64000000000000001 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.46999999999999997 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 1.27 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.818 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 2.0 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.69999999999999996 110.971 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.818 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.945 -0.391 . . . . 1.3300000000000001 109.945 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 1.1799999999999999 111.205 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.52000000000000002 111.383 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.804 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.93999999999999995 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 1.1200000000000001 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 1.3 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.28999999999999998 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 1.0800000000000001 109.763 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 1.1899999999999999 110.597 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 2.1800000000000002 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.9299999999999999 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 1.1000000000000001 109.035 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.1699999999999999 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.8200000000000001 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 1.1100000000000001 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.804 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77000000000000002 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.48 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 1.4099999999999999 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 2.0800000000000001 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 1.28 109.563 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 1.1399999999999999 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.6499999999999999 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65000000000000002 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52000000000000002 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.72 109.275 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 1.0900000000000001 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.91000000000000003 111.799 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 1.1000000000000001 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 2.27 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.434 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 2.0600000000000001 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.442 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.5 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 1.1399999999999999 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 1.1200000000000001 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.3700000000000001 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.68999999999999995 113.355 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.6400000000000001 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.97 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.34000000000000002 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 1.1000000000000001 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 1.0700000000000001 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.43 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.5 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.60999999999999999 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.3799999999999999 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 1.1699999999999999 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.1599999999999999 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.2999999999999998 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.69999999999999996 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.23 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.93999999999999995 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.6399999999999999 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 1.1100000000000001 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 1.23 110.399 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.3899999999999999 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.32000000000000001 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.2799999999999998 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0900000000000001 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.6 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 1.0600000000000001 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 2.0699999999999998 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 1.3100000000000001 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 1.0700000000000001 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 1.3200000000000001 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 1.21 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.98999999999999999 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 1.49 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.1799999999999999 110.254 179.231 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.194 0.521 . . . . 1.74 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.6699999999999999 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.2799999999999998 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.481 HD22 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.8300000000000001 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.8799999999999999 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.481 HG13 HD22 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.1699999999999999 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 1.04 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . 0.427 ' O ' ' CD1' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.3599999999999999 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.947 -0.39 . . . . 1.49 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.436 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.64000000000000001 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.422 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.46999999999999997 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 1.27 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 2.0 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.69999999999999996 110.559 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.471 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.1 mp . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 1.1799999999999999 111.106 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.52000000000000002 111.235 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.93999999999999995 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 1.1200000000000001 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 1.3 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.28999999999999998 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.523 ' HB ' HD22 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 1.0800000000000001 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 1.1899999999999999 110.005 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.441 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 2.1800000000000002 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.9299999999999999 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 1.1000000000000001 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.1699999999999999 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.8200000000000001 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 1.1100000000000001 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77000000000000002 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.48 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 1.4099999999999999 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 2.0800000000000001 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.28 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 1.1399999999999999 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.6499999999999999 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65000000000000002 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52000000000000002 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.72 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 1.0900000000000001 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 1.1100000000000001 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.91000000000000003 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.487 HG23 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 1.1000000000000001 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 2.27 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 2.0600000000000001 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.631 ' HB3' HD22 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.5 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 1.1399999999999999 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.3700000000000001 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.68999999999999995 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.6400000000000001 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.97 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.59 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.34000000000000002 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 1.1000000000000001 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.5 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.60999999999999999 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.3799999999999999 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 1.1699999999999999 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.1599999999999999 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.2999999999999998 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.69999999999999996 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.23 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.93999999999999995 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.6399999999999999 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 1.1100000000000001 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 1.0900000000000001 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 1.23 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.3899999999999999 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.32000000000000001 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.2799999999999998 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 1.0900000000000001 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.59 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 1.0600000000000001 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 2.0699999999999998 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.523 HD22 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 1.0700000000000001 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.411 ' HB1' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 1.01 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.34999999999999998 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.3200000000000001 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 1.21 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.98999999999999999 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 1.49 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 1.1799999999999999 111.18 -176.066 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.946 -0.39 . . . . 1.74 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.6699999999999999 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2799999999999998 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.8300000000000001 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.8799999999999999 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 396' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.1699999999999999 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 1.04 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.3599999999999999 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.64 0.257 . . . . 1.49 110.647 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.714 ' HE1' HG22 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.64000000000000001 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.46999999999999997 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 1.27 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 1.0700000000000001 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 2.0 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.605 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.69999999999999996 110.793 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.571 -0.529 . . . . 1.3300000000000001 109.571 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 1.1799999999999999 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.52000000000000002 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.776 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.93999999999999995 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 1.1200000000000001 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 1.3 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.28999999999999998 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.48 ' HB ' HD21 ' A' ' 391' ' ' LEU . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 1.0800000000000001 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 1.1899999999999999 110.527 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 2.1800000000000002 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.9299999999999999 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 1.1000000000000001 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.1699999999999999 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.605 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.8200000000000001 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.714 HG22 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 1.1100000000000001 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.776 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77000000000000002 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.48 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 1.4099999999999999 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 2.0800000000000001 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 1.28 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 1.1399999999999999 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.6499999999999999 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65000000000000002 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52000000000000002 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.72 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 1.1100000000000001 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.91000000000000003 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 1.1000000000000001 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 2.27 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.741 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 2.0600000000000001 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.643 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.5 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 1.1399999999999999 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 1.1200000000000001 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.68999999999999995 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.6400000000000001 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.97 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.34000000000000002 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 1.1000000000000001 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 1.0700000000000001 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.5 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.60999999999999999 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.3799999999999999 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 1.1699999999999999 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.1599999999999999 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.2999999999999998 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.69999999999999996 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.23 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.93999999999999995 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.6399999999999999 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 1.1100000000000001 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.41 ' HB ' HG11 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 1.0900000000000001 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 1.23 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.3899999999999999 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.32000000000000001 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.2799999999999998 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.421 HD11 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 1.0900000000000001 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 1.0600000000000001 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 2.0699999999999998 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 396' ' ' ILE . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 1.0700000000000001 110.362 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 1.01 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.34999999999999998 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 1.3200000000000001 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 392' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 1.21 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.98999999999999999 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 1.49 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 1.1799999999999999 110.736 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.904 0.383 . . . . 1.74 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.6699999999999999 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.741 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.2799999999999998 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.8300000000000001 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.8799999999999999 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.1699999999999999 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 1.04 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.3599999999999999 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 110.214 -0.291 . . . . 1.49 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG22 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.64000000000000001 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.46999999999999997 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 1.27 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 1.0700000000000001 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 2.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.409 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.69999999999999996 111.055 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.978 0.418 . . . . 1.3300000000000001 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 342' ' ' GLU . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.52000000000000002 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.781 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.696 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 1.1200000000000001 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 1.3 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.28999999999999998 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 1.0800000000000001 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 1.1899999999999999 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 2.1800000000000002 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.9299999999999999 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 1.1000000000000001 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.1699999999999999 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.8200000000000001 110.207 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.781 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77000000000000002 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.48 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 1.4099999999999999 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 2.0800000000000001 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 1.28 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 1.1399999999999999 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.6499999999999999 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65000000000000002 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52000000000000002 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.72 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 1.0900000000000001 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 1.1100000000000001 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.91000000000000003 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.428 HG22 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 1.1000000000000001 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.522 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 2.27 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 2.0600000000000001 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.428 ' HE3' HG22 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.5 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 1.1399999999999999 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 1.1200000000000001 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 364' ' ' LYS . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.3700000000000001 109.535 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.68999999999999995 112.102 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 362' ' ' SER . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.6400000000000001 110.611 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.97 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.467 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.34000000000000002 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 1.1000000000000001 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 1.0700000000000001 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.5 109.505 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.522 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.60999999999999999 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.449 ' HB2' ' HH ' ' B' ' 380' ' ' TYR . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.3799999999999999 110.655 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 1.1699999999999999 111.006 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.1599999999999999 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.2999999999999998 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.69999999999999996 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.23 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.93999999999999995 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.6399999999999999 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 1.1100000000000001 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 1.23 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.3899999999999999 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.32000000000000001 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.2799999999999998 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 1.0900000000000001 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 1.0600000000000001 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 2.0699999999999998 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 1.3100000000000001 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 388' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 1.0700000000000001 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 1.01 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.34999999999999998 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.463 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 1.3200000000000001 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 1.21 111.44 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.98999999999999999 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 1.49 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 1.1799999999999999 111.285 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.109 0.48 . . . . 1.74 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.6699999999999999 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.2799999999999998 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.8300000000000001 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.8799999999999999 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.1699999999999999 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.449 ' HH ' ' HB2' ' A' ' 372' ' ' ASP . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 1.04 109.336 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . 0.445 ' HD1' ' N ' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.3599999999999999 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.877 0.37 . . . . 1.49 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.64000000000000001 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.46999999999999997 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 1.27 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 1.0700000000000001 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 2.0 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.431 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.69999999999999996 111.418 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.604 -0.517 . . . . 1.3300000000000001 109.604 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 1.1799999999999999 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.52000000000000002 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.93999999999999995 110.222 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.047 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 1.3 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.28999999999999998 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.493 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 1.0800000000000001 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 2.1800000000000002 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.9299999999999999 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 1.1000000000000001 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.1699999999999999 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.439 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.8200000000000001 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 1.1100000000000001 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77000000000000002 110.312 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.48 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 1.4099999999999999 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 2.0800000000000001 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 1.28 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.6499999999999999 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65000000000000002 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52000000000000002 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.72 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.453 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 1.0900000000000001 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 1.1100000000000001 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.91000000000000003 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 1.1000000000000001 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 2.27 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 2.0600000000000001 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.592 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.5 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 1.1399999999999999 110.3 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 1.1200000000000001 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.3700000000000001 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.68999999999999995 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.6400000000000001 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.97 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.34000000000000002 109.336 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 1.1000000000000001 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 1.0700000000000001 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.664 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.5 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.60999999999999999 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.3799999999999999 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 1.1699999999999999 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.1599999999999999 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.2999999999999998 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.69999999999999996 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.23 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.667 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.93999999999999995 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.6399999999999999 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 1.1100000000000001 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.618 ' HB ' HG11 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0900000000000001 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 1.23 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.3899999999999999 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.32000000000000001 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.439 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.2799999999999998 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 1.0900000000000001 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 1.0600000000000001 111.388 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 1.3100000000000001 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.453 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 1.0700000000000001 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 1.01 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.34999999999999998 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 1.3200000000000001 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 1.21 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.98999999999999999 110.75 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 1.49 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 1.1799999999999999 110.952 -177.794 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.74 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.484 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.6699999999999999 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.2799999999999998 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.538 HD22 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.8300000000000001 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.8799999999999999 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.1699999999999999 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 1.04 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.3599999999999999 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' SER . . . . . 0.43 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.594 0.235 . . . . 1.49 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.64000000000000001 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.46999999999999997 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 1.27 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 1.0700000000000001 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 2.0 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.69999999999999996 110.865 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.547 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.59 -0.522 . . . . 1.3300000000000001 109.59 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 1.1799999999999999 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.52000000000000002 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.93999999999999995 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 1.1200000000000001 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 1.3 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.28999999999999998 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HB ' HD23 ' A' ' 391' ' ' LEU . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 1.0800000000000001 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 1.1899999999999999 109.752 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 2.1800000000000002 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.9299999999999999 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 1.1000000000000001 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.1699999999999999 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.497 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.8200000000000001 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 1.1100000000000001 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77000000000000002 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.48 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 1.4099999999999999 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 2.0800000000000001 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 1.28 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 1.1399999999999999 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.6499999999999999 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65000000000000002 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52000000000000002 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.72 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 1.0900000000000001 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 1.1100000000000001 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.91000000000000003 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 1.1000000000000001 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.432 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 2.27 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 2.0600000000000001 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.739 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.5 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 1.1399999999999999 110.702 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 1.1200000000000001 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.3700000000000001 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.68999999999999995 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.6400000000000001 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.97 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.34000000000000002 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 1.1000000000000001 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 1.0700000000000001 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.476 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.5 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.60999999999999999 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.3799999999999999 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 1.1699999999999999 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.1599999999999999 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.2999999999999998 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.69999999999999996 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.23 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.625 ' HD2' HD13 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.93999999999999995 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.6399999999999999 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 1.1100000000000001 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 1.0900000000000001 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 1.23 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.3899999999999999 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.32000000000000001 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.457 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.2799999999999998 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 1.0900000000000001 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 1.0600000000000001 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 2.0699999999999998 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 1.3100000000000001 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.588 HG21 HD13 ' A' ' 396' ' ' ILE . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 1.0700000000000001 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 1.01 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.34999999999999998 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.496 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 1.3200000000000001 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.588 HD13 HG21 ' A' ' 392' ' ' ILE . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 1.21 110.9 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.98999999999999999 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 1.49 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 1.1799999999999999 110.773 -179.792 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.7 m95 . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.74 109.024 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.6699999999999999 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.2799999999999998 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.8300000000000001 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.8799999999999999 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 396' ' ' ILE . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.1699999999999999 111.14 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 1.04 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.3599999999999999 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.828 0.346 . . . . 1.49 111.148 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.653 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.64000000000000001 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.46999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 1.27 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 1.0700000000000001 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 2.0 109.79 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.518 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.69999999999999996 111.174 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.663 -0.495 . . . . 1.3300000000000001 109.663 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 1.1799999999999999 110.765 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.52000000000000002 111.974 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.403 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.93999999999999995 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 1.1200000000000001 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 1.3 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.28999999999999998 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.567 ' HB ' HD21 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 1.0800000000000001 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 2.1800000000000002 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.9299999999999999 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 1.1000000000000001 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.1699999999999999 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.518 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.8200000000000001 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 1.1100000000000001 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77000000000000002 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.48 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 1.4099999999999999 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 2.0800000000000001 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 1.28 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 1.1399999999999999 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . 0.461 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.6499999999999999 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65000000000000002 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52000000000000002 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.478 ' HB2' ' ND2' ' A' ' 355' ' ' ASN . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.72 108.883 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 1.0900000000000001 112.066 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.1100000000000001 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 352' ' ' SER . 37.3 m-80 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.91000000000000003 110.585 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.1000000000000001 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 2.27 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 2.0600000000000001 109.812 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.49 ' HB3' HD21 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.5 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 1.1200000000000001 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.3700000000000001 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.68999999999999995 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.6400000000000001 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.97 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.425 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.34000000000000002 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 1.1000000000000001 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 1.0700000000000001 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.5 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.681 ' HA3' ' HH ' ' B' ' 380' ' ' TYR . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.60999999999999999 112.408 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.705 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.3799999999999999 110.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 1.1699999999999999 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.1599999999999999 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.2999999999999998 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.69999999999999996 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.23 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.597 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.93999999999999995 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.6399999999999999 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 1.1100000000000001 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 1.0900000000000001 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.3899999999999999 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.32000000000000001 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.2799999999999998 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 1.0900000000000001 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 1.0600000000000001 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 2.0699999999999998 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.567 HD21 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 1.3100000000000001 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 1.0700000000000001 110.26 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 1.01 111.065 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.34999999999999998 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 1.3200000000000001 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.556 HG12 HD11 ' B' ' 379' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 1.21 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.98999999999999999 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 1.49 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 1.1799999999999999 110.741 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.74 111.745 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.454 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.6699999999999999 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.2799999999999998 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.624 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.8300000000000001 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.8799999999999999 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.624 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.1699999999999999 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.705 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 1.04 110.132 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.3599999999999999 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.922 -0.399 . . . . 1.49 109.922 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.64000000000000001 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 1.27 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 1.0700000000000001 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 2.0 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.3 mt-10 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.114 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.234 0.244 0 N-CA-C 109.953 -0.388 . . . . 1.3300000000000001 109.953 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 1.1799999999999999 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.52000000000000002 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.837 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.93999999999999995 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 1.1200000000000001 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.454 HD21 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 1.3 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.614 ' HB ' HD21 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 1.0800000000000001 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 1.1899999999999999 110.255 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.482 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.1800000000000002 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.9299999999999999 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 1.1000000000000001 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.1699999999999999 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 1.1100000000000001 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.837 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77000000000000002 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.48 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 1.4099999999999999 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 2.0800000000000001 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 1.28 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 1.1399999999999999 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.6499999999999999 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65000000000000002 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . 0.436 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52000000000000002 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.72 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 1.0900000000000001 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.91000000000000003 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 1.1000000000000001 110.752 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.4 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 2.27 109.678 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 2.0600000000000001 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.434 ' CE2' ' HB ' ' B' ' 375' ' ' VAL . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.5 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 1.1399999999999999 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.1200000000000001 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.3700000000000001 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.68999999999999995 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.6400000000000001 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.97 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.34000000000000002 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 1.1000000000000001 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 1.0700000000000001 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.60999999999999999 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.3799999999999999 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 1.1699999999999999 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.1599999999999999 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.2999999999999998 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.69999999999999996 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.23 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.678 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.93999999999999995 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.6399999999999999 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.553 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 1.1100000000000001 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 1.0900000000000001 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.23 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.563 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.3899999999999999 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.32000000000000001 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.2799999999999998 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0900000000000001 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 1.0600000000000001 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 2.0699999999999998 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 1.3100000000000001 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 396' ' ' ILE . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 1.0700000000000001 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 1.01 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.34999999999999998 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 1.3200000000000001 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.627 HG12 HD12 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 1.21 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.98999999999999999 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 1.49 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 1.1799999999999999 110.819 -178.916 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.74 110.602 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.6699999999999999 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.2799999999999998 111.074 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.524 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.8300000000000001 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.8799999999999999 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.627 HD12 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.1699999999999999 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 1.04 109.097 175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.3599999999999999 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.777 0.322 . . . . 1.49 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.64000000000000001 110.986 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.46999999999999997 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 1.27 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 1.0700000000000001 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 2.0 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.69999999999999996 111.068 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.945 -0.761 . . . . 1.3300000000000001 108.945 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 110.802 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.52000000000000002 111.621 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.93999999999999995 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 1.1200000000000001 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.552 HD21 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 1.3 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.28999999999999998 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.421 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 1.0800000000000001 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 1.1899999999999999 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.535 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 2.1800000000000002 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.401 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.9299999999999999 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 1.1000000000000001 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.1699999999999999 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.8200000000000001 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 1.1100000000000001 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77000000000000002 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.48 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 1.4099999999999999 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 2.0800000000000001 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 1.28 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 1.1399999999999999 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.6499999999999999 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65000000000000002 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52000000000000002 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.72 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.445 HD23 HG21 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 1.0900000000000001 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.91000000000000003 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 2.27 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 2.0600000000000001 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.498 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.5 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.617 ' HB1' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 1.1399999999999999 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 1.1200000000000001 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.3700000000000001 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.68999999999999995 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.6400000000000001 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.97 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.34000000000000002 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.617 ' HB ' ' HB1' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 1.1000000000000001 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 1.0700000000000001 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.5 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.60999999999999999 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.648 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.3799999999999999 110.855 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 1.1699999999999999 110.308 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.1599999999999999 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.2999999999999998 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.69999999999999996 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.23 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.93999999999999995 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.6399999999999999 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 1.1100000000000001 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 1.23 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.3899999999999999 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.32000000000000001 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 1.0900000000000001 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.49 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 1.0600000000000001 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 2.0699999999999998 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 1.3100000000000001 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.445 HG21 HD23 ' A' ' 353' ' ' LEU . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 1.0700000000000001 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . 0.498 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.34999999999999998 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 1.3200000000000001 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.57 HG12 HD11 ' B' ' 379' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 1.21 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.98999999999999999 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 1.49 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 1.1799999999999999 110.936 -178.079 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.175 0.512 . . . . 1.74 110.293 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.425 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.6699999999999999 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.2799999999999998 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.429 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.8300000000000001 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.8799999999999999 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.1699999999999999 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.648 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 1.04 109.105 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.3599999999999999 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.977 0.417 . . . . 1.49 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.64000000000000001 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 1.27 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 1.0700000000000001 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 2.0 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.69999999999999996 111.236 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.732 -0.47 . . . . 1.3300000000000001 109.732 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 1.1799999999999999 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.52000000000000002 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.93999999999999995 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 1.1200000000000001 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 1.3 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.28999999999999998 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 1.0800000000000001 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 1.1899999999999999 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 2.1800000000000002 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.9299999999999999 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 1.1000000000000001 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.1699999999999999 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.709 HG23 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 1.1100000000000001 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77000000000000002 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.48 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 1.4099999999999999 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 2.0800000000000001 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 1.28 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 1.1399999999999999 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.6499999999999999 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65000000000000002 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52000000000000002 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.72 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 1.1100000000000001 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.91000000000000003 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 1.1000000000000001 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 2.27 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 2.0600000000000001 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.545 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.5 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 1.1399999999999999 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 1.1200000000000001 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.3700000000000001 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.6400000000000001 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.97 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.418 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.34000000000000002 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 1.1000000000000001 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 1.0700000000000001 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.5 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.543 ' HA3' ' HH ' ' B' ' 380' ' ' TYR . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.60999999999999999 112.966 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.645 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.3799999999999999 111.027 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.1699999999999999 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.1599999999999999 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.2999999999999998 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.69999999999999996 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.23 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.568 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.93999999999999995 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.6399999999999999 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 1.1100000000000001 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.437 HG23 HG13 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 1.0900000000000001 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.591 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.3899999999999999 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.32000000000000001 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.2799999999999998 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . 0.591 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 1.0900000000000001 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 1.0600000000000001 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 2.0699999999999998 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 1.3100000000000001 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 1.0700000000000001 110.064 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 1.01 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.34999999999999998 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 1.3200000000000001 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 1.21 110.94 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.98999999999999999 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 1.49 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 1.1799999999999999 111.358 -175.505 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.8 m95 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 1.74 112.157 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.6699999999999999 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.2799999999999998 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.478 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.8300000000000001 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.8799999999999999 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 379' ' ' ILE . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.1699999999999999 111.551 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.645 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 1.04 110.069 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.3599999999999999 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.128 0.489 . . . . 1.49 109.706 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.4 ' HE2' HG21 ' A' ' 340' ' ' VAL . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.64000000000000001 110.668 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.46999999999999997 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 1.27 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 1.0700000000000001 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 2.0 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.69999999999999996 111.839 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.757 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.948 -0.39 . . . . 1.3300000000000001 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 1.1799999999999999 111.152 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.52000000000000002 111.744 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.885 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.93999999999999995 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 1.1200000000000001 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 1.3 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.28999999999999998 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 1.0800000000000001 110.053 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 1.1899999999999999 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 2.1800000000000002 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.43 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.9299999999999999 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 1.1000000000000001 109.338 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.1699999999999999 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.8200000000000001 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 1.1100000000000001 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.885 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77000000000000002 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . 0.443 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.48 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 1.4099999999999999 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 2.0800000000000001 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 1.28 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 1.1399999999999999 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.6499999999999999 110.067 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65000000000000002 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52000000000000002 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.72 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 1.0900000000000001 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 379' ' ' ILE . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 1.1100000000000001 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.91000000000000003 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.426 HG23 ' HE3' ' A' ' 359' ' ' TRP . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 110.016 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 2.27 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 2.0600000000000001 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.469 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.5 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 1.1399999999999999 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 1.1200000000000001 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.3700000000000001 109.627 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.68999999999999995 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.6400000000000001 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.97 111.345 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.61 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.34000000000000002 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 1.1000000000000001 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 1.0700000000000001 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.5 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.60999999999999999 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.894 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.3799999999999999 110.63 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 1.1699999999999999 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.1599999999999999 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.2999999999999998 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.69999999999999996 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.23 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.515 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.93999999999999995 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.6399999999999999 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 1.1100000000000001 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.425 ' HB ' HG13 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 1.0900000000000001 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 1.23 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.567 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.3899999999999999 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.32000000000000001 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.2799999999999998 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 1.0900000000000001 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.61 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 2.0699999999999998 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 1.3100000000000001 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.484 HG21 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 1.0700000000000001 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.01 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.34999999999999998 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 1.3200000000000001 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 1.21 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.98999999999999999 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 1.49 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.086 -177.275 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.74 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . 0.469 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.6699999999999999 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.2799999999999998 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.421 ' HB2' ' HZ3' ' A' ' 359' ' ' TRP . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.8300000000000001 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.8799999999999999 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 354' ' ' THR . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.1699999999999999 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.894 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 1.04 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . 0.419 ' HD2' ' HG1' ' A' ' 354' ' ' THR . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.3599999999999999 110.464 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.64 0.257 . . . . 1.49 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.64000000000000001 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.46999999999999997 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 1.27 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 1.0700000000000001 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 2.0 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' A' ' 380' ' ' VAL . 65.0 mt-10 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.69999999999999996 110.205 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.697 0.284 . . . . 1.3300000000000001 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 1.1799999999999999 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.52000000000000002 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . 0.651 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.93999999999999995 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 1.1200000000000001 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.423 HD22 HD12 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 1.3 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.28999999999999998 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . 0.484 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 1.0800000000000001 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 1.1899999999999999 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 2.1800000000000002 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.9299999999999999 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 1.1000000000000001 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.1699999999999999 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.451 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.8200000000000001 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 1.1100000000000001 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.651 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77000000000000002 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.48 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 1.4099999999999999 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 2.0800000000000001 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 1.28 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.1399999999999999 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.6499999999999999 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65000000000000002 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . 0.451 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52000000000000002 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 1.0900000000000001 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 1.1100000000000001 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.91000000000000003 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 1.1000000000000001 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 2.27 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.531 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 2.0600000000000001 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.495 ' HB3' HD22 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.5 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.644 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 1.1399999999999999 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 1.1200000000000001 111.197 -175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.3700000000000001 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . 0.625 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.68999999999999995 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.6400000000000001 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.97 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.34000000000000002 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 1.1000000000000001 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0700000000000001 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.5 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.60999999999999999 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.507 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.3799999999999999 110.314 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 1.1699999999999999 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.1599999999999999 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.2999999999999998 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.69999999999999996 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.23 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.46 ' HD2' HD11 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.93999999999999995 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.6399999999999999 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.421 HG11 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 1.1100000000000001 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 1.0900000000000001 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 1.23 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.3899999999999999 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.32000000000000001 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.2799999999999998 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 1.0900000000000001 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 111.761 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 2.0699999999999998 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 1.3100000000000001 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.651 HG22 HD11 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 1.0700000000000001 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 1.01 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.34999999999999998 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 1.3200000000000001 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.651 HD11 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 1.21 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.98999999999999999 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 1.1799999999999999 110.513 178.934 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . 0.531 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 . . . . . 0 CA--C 1.512 -0.51 0 CA-C-O 121.297 0.57 . . . . 1.74 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.6699999999999999 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.2799999999999998 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.8300000000000001 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.8799999999999999 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.409 HD12 HG12 ' A' ' 396' ' ' ILE . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.1699999999999999 111.244 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.507 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 1.04 109.783 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.3599999999999999 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.528 0.204 . . . . 1.49 110.722 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.64000000000000001 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.46999999999999997 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 1.27 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 1.0700000000000001 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 2.0 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.471 ' HG2' HG13 ' A' ' 380' ' ' VAL . 86.4 mt-10 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.69999999999999996 110.039 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.822 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.726 -0.472 . . . . 1.3300000000000001 109.726 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 1.1799999999999999 110.976 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.52000000000000002 111.654 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.93999999999999995 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 1.1200000000000001 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 1.3 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.28999999999999998 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 1.0800000000000001 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 1.1899999999999999 110.294 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 2.1800000000000002 112.059 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . 0.413 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.9299999999999999 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 1.1000000000000001 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.1699999999999999 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.8200000000000001 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 1.1100000000000001 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77000000000000002 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.48 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 1.4099999999999999 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 2.0800000000000001 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 1.28 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 1.1399999999999999 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.6499999999999999 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65000000000000002 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52000000000000002 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.72 108.931 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.413 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 1.0900000000000001 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.91000000000000003 110.825 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 1.1000000000000001 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . 0.43 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 2.27 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.904 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 2.0600000000000001 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.499 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.5 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 1.1399999999999999 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 1.1200000000000001 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.3700000000000001 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.68999999999999995 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.6400000000000001 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.97 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.476 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.34000000000000002 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 1.1000000000000001 111.546 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 1.0700000000000001 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.789 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.60999999999999999 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.3799999999999999 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 1.1699999999999999 111.53 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.1599999999999999 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.2999999999999998 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.69999999999999996 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.23 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.93999999999999995 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.6399999999999999 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.471 HG13 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 1.1100000000000001 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 1.0900000000000001 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 1.23 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.3899999999999999 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.32000000000000001 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.2799999999999998 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 1.0900000000000001 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.476 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 1.0600000000000001 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 2.0699999999999998 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 1.3100000000000001 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 1.0700000000000001 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 1.01 110.763 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.34999999999999998 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 1.3200000000000001 110.84 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.575 HG12 HD12 ' B' ' 379' ' ' ILE . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 1.21 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.98999999999999999 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 1.49 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 1.1799999999999999 110.831 -178.356 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.357 -0.609 . . . . 1.74 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.6699999999999999 111.04 -169.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.904 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.2799999999999998 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . 0.558 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.8300000000000001 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.8799999999999999 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.1699999999999999 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 1.04 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.3599999999999999 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.021 -0.363 . . . . 1.49 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.605 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.64000000000000001 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 1.27 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 1.0700000000000001 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 2.0 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.454 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.786 -0.45 . . . . 1.3300000000000001 109.786 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 1.1799999999999999 110.621 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.52000000000000002 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.93999999999999995 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 1.1200000000000001 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 1.3 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.28999999999999998 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 1.0800000000000001 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 1.1899999999999999 109.615 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 2.1800000000000002 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.9299999999999999 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 1.1000000000000001 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' MET . . . . . 0.501 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.1699999999999999 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.8200000000000001 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77000000000000002 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.48 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 1.4099999999999999 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 2.0800000000000001 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 1.28 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 1.1399999999999999 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' GLN . . . . . 0.416 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.6499999999999999 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65000000000000002 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52000000000000002 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.72 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 1.0900000000000001 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 1.1100000000000001 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.91000000000000003 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 1.1000000000000001 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 2.27 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ARG . . . . . 0.596 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 2.0600000000000001 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' TRP . . . . . 0.459 ' HB3' HD21 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.5 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.718 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 1.1399999999999999 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 1.1200000000000001 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.3700000000000001 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.68999999999999995 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.6400000000000001 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' SER . . . . . 0.493 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.97 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' PHE . . . . . 0.466 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.34000000000000002 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 1.1000000000000001 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' LEU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 1.0700000000000001 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' ASP . . . . . 0.541 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.5 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.60999999999999999 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ASP . . . . . 0.734 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.3799999999999999 111.684 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 1.1699999999999999 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.1599999999999999 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.2999999999999998 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.23 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' TYR . . . . . 0.598 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.93999999999999995 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.6399999999999999 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 1.1100000000000001 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' GLN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' THR . . . . . 0.493 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 1.0900000000000001 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 1.23 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.3899999999999999 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.32000000000000001 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.2799999999999998 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 1.0900000000000001 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ALA . . . . . 0.466 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 1.0600000000000001 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 2.0699999999999998 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 1.3100000000000001 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 1.0700000000000001 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 1.01 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.34999999999999998 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 334' ' ' LYS . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 1.3200000000000001 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' ILE . . . . . 0.524 HG12 HD13 ' B' ' 379' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 1.21 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.98999999999999999 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 1.49 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 1.1799999999999999 110.826 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.171 0.51 . . . . 1.74 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.6699999999999999 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 376' ' ' GLU . . . . . 0.596 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.2799999999999998 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.8799999999999999 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 379' ' ' ILE . . . . . 0.524 HD13 HG12 ' A' ' 396' ' ' ILE . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.1699999999999999 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 380' ' ' TYR . . . . . 0.734 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 1.04 110.996 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.3599999999999999 110.349 177.342 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . 0.448 ' HA3' HG21 ' A' ' 333' ' ' THR . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.131 -0.387 . . . . 4.6299999999999999 112.131 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.52 -8.85 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.624 0.25 . . . . 3.3500000000000001 111.196 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p -84.72 95.99 9.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.561 . . . . 1.49 110.97 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.64000000000000001 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.437 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.46999999999999997 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 1.27 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.555 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 1.0700000000000001 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 2.0 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.592 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 -90.53 127.44 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.69999999999999996 110.557 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -100.22 100.42 11.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.292 0.568 . . . . 2.21 110.117 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.3 mmm -110.84 171.0 7.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.502 -0.772 . . . . 2.1800000000000002 109.1 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.691 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.3 177.32 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.885 -0.413 . . . . 2.7400000000000002 109.885 175.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.7 -35.7 4.57 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.904 -0.878 . . . . 2.0600000000000001 110.904 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.445 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -155.54 157.71 37.29 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.139 -0.689 . . . . 2.1000000000000001 109.139 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -87.31 -6.17 58.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.935 0.398 . . . . 2.8799999999999999 110.647 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.4 tttt -76.3 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 2.5499999999999998 110.836 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp -73.27 130.99 41.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.077 -0.511 . . . . 1.3300000000000001 109.671 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 1.1799999999999999 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.52000000000000002 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.674 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.93999999999999995 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 1.1200000000000001 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.449 HD21 HD12 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 1.3 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.28999999999999998 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 1.0800000000000001 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.448 HG21 ' HA3' ' A' ' 309' ' ' GLY . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 1.1899999999999999 110.853 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 2.1800000000000002 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 333' ' ' THR . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.9299999999999999 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 1.1000000000000001 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.1699999999999999 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.8200000000000001 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.63 HG22 HG21 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 1.1100000000000001 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.674 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77000000000000002 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . 0.613 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.48 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.483 HG23 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 1.4099999999999999 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 2.0800000000000001 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.483 ' HG2' HG23 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.63 HG21 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 1.28 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 1.1399999999999999 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.6499999999999999 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65000000000000002 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52000000000000002 110.857 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.498 ' HB2' HD21 ' A' ' 355' ' ' ASN . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.72 110.043 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 1.0900000000000001 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 1.1100000000000001 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.498 HD21 ' HB2' ' A' ' 352' ' ' SER . 41.8 m-80 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.91000000000000003 110.78 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 1.1000000000000001 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 2.27 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.758 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 2.0600000000000001 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.438 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.5 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 1.1399999999999999 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 1.1200000000000001 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.3700000000000001 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.505 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.68999999999999995 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.664 ' HB3' ' HZ2' ' A' ' 364' ' ' LYS . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.6400000000000001 111.602 -178.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.97 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.486 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.34000000000000002 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 1.1000000000000001 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 366' ' ' PHE . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 1.0700000000000001 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.758 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.5 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.60999999999999999 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.3799999999999999 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 1.1699999999999999 110.26 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.1599999999999999 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.2999999999999998 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.69999999999999996 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.23 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.414 ' HE2' HD11 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.93999999999999995 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.6399999999999999 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.592 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 1.1100000000000001 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 1.0900000000000001 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 1.23 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.54 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.3899999999999999 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.32000000000000001 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.2799999999999998 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 1.0900000000000001 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.486 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 1.0600000000000001 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 2.0699999999999998 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.511 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 1.3100000000000001 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 388' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 1.0700000000000001 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.438 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 1.01 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.34999999999999998 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.511 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 1.3200000000000001 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.63 HG12 HD11 ' B' ' 379' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 1.21 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.98999999999999999 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 1.49 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.22 -27.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 1.1799999999999999 110.53 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 25.2 tp . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.379 -0.819 . . . . 2.0699999999999998 110.483 -175.97 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.293 -0.323 . . . . 13.23 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -116.43 106.76 13.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.035 -0.357 . . . . 14.94 110.035 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 44.5 p -84.95 157.3 20.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.681 0.277 . . . . 10.73 110.7 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -140.37 42.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.832 0.825 . . . . 10.01 109.288 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.35 -58.03 10.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.385 -1.28 . . . . 8.9399999999999995 111.938 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 12.7 p -90.73 142.11 28.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.838 0.351 . . . . 5.6600000000000001 110.686 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 90.7 -49.22 3.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.993 -0.622 . . . . 2.7799999999999998 112.551 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . 0.453 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 -95.67 119.24 33.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.281 0.562 . . . . 1.74 110.727 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.6699999999999999 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.2799999999999998 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.587 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.2 t-20 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.8300000000000001 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . 0.563 ' H ' ' ND2' ' B' ' 377' ' ' ASN . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.8799999999999999 113.511 -171.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.63 HD11 HG12 ' A' ' 396' ' ' ILE . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.1699999999999999 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 1.04 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.3599999999999999 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.697 -0.561 . . . . 4.6299999999999999 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.29 107.48 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.398 -0.593 . . . . 3.3500000000000001 109.398 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m -81.77 113.25 19.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 1.49 111.033 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.64000000000000001 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.46999999999999997 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 1.27 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 1.0700000000000001 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 2.0 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.494 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 -76.81 124.6 27.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.69999999999999996 110.869 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -90.27 103.96 16.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 2.21 109.554 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.5 mmm -112.19 -159.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 2.1800000000000002 110.244 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.716 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -111.99 167.3 10.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.209 -0.45 . . . . 2.7400000000000002 110.234 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.64 -20.23 48.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.93 -0.653 . . . . 2.0600000000000001 112.571 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -161.67 166.57 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.995 -0.372 . . . . 2.1000000000000001 109.995 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -97.81 -9.06 27.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.8 0.333 . . . . 2.8799999999999999 110.608 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.64 120.86 18.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 2.5499999999999998 110.04 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.598 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp -83.99 131.3 34.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.302 -0.408 . . . . 1.3300000000000001 110.0 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 1.1799999999999999 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.52000000000000002 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.93999999999999995 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.428 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 1.1200000000000001 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 1.3 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.28999999999999998 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.799 HG23 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 1.0800000000000001 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 1.1899999999999999 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 2.1800000000000002 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.9299999999999999 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 1.1000000000000001 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.1699999999999999 111.52 -175.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.638 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.8200000000000001 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.428 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77000000000000002 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.48 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 1.4099999999999999 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 2.0800000000000001 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 1.28 110.177 178.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 1.1399999999999999 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.6499999999999999 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65000000000000002 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52000000000000002 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.72 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 1.0900000000000001 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 1.1100000000000001 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.91000000000000003 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 1.1000000000000001 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 2.27 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 2.0600000000000001 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.541 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.5 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 110.638 -178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 1.1200000000000001 110.436 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.509 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.3700000000000001 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.68999999999999995 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.6400000000000001 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.97 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.34000000000000002 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 1.1000000000000001 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.592 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 1.0700000000000001 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.5 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.60999999999999999 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.3799999999999999 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 1.1699999999999999 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.1599999999999999 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.2999999999999998 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.69999999999999996 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.23 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.638 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.93999999999999995 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.6399999999999999 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.516 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 1.1100000000000001 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG13 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 1.0900000000000001 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 1.23 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.428 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.3899999999999999 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.32000000000000001 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.2799999999999998 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 1.0900000000000001 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 1.0600000000000001 111.662 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 2.0699999999999998 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.799 ' CD1' HG23 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 1.3100000000000001 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 1.0700000000000001 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 1.01 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.34999999999999998 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 1.3200000000000001 110.172 176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.543 HG12 HD12 ' B' ' 379' ' ' ILE . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 1.21 111.031 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.98999999999999999 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 1.49 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.21 -26.07 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 1.1799999999999999 110.719 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.415 HD23 HG23 ' B' ' 379' ' ' ILE . 98.1 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.535 -0.745 . . . . 2.0699999999999998 110.822 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.638 -0.585 . . . . 13.23 111.638 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -85.76 -76.72 0.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.812 -0.228 . . . . 14.94 110.847 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' SER . . . . . 0.601 ' H ' ' HD2' ' B' ' 370' ' ' LYS . 12.7 p -174.06 33.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 10.73 111.13 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.601 ' HD2' ' H ' ' B' ' 369' ' ' SER . 0.0 OUTLIER -149.41 108.62 3.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.654 -0.703 . . . . 10.01 109.881 -177.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . 0.663 ' O ' HG23 ' B' ' 375' ' ' VAL . 37.3 mt-10 -112.05 -88.82 0.52 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 8.9399999999999995 112.0 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 24.3 m -75.85 144.75 41.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.206 0.527 . . . . 5.6600000000000001 111.889 -174.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 87.98 -72.45 2.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.671 -0.695 . . . . 2.7799999999999998 111.953 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -110.43 104.68 13.46 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.74 109.338 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.663 HG23 ' O ' ' B' ' 371' ' ' GLU . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.6699999999999999 110.371 -171.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.2799999999999998 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.778 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.8300000000000001 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.8799999999999999 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.778 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.1699999999999999 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 1.04 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.3599999999999999 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.924 -0.471 . . . . 4.6299999999999999 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.1 t 72.33 -69.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.026 0.53 . . . . 3.3500000000000001 111.502 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p -80.71 102.75 10.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.134 0.493 . . . . 1.49 111.616 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.64000000000000001 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.46999999999999997 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 1.27 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.547 HG11 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 1.0700000000000001 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 2.0 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -90.1 127.4 36.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.69999999999999996 110.927 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.71 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.3 tptp -89.83 89.69 7.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 2.21 110.016 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 92.5 mmm -103.47 173.82 6.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.777 -0.647 . . . . 2.1800000000000002 110.067 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.708 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -67.15 166.96 12.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 2.7400000000000002 111.003 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.22 -42.72 1.86 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.963 -0.637 . . . . 2.0600000000000001 112.37 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.5 pttm -157.3 166.0 34.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.534 -0.173 . . . . 2.1000000000000001 110.534 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.71 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 37.1 p30 -84.4 -7.49 59.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 2.8799999999999999 111.117 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.4 ttmt -74.39 143.21 44.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.107 -0.497 . . . . 2.5499999999999998 110.342 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.526 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.9 mp -95.01 117.65 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 1.3300000000000001 109.795 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 1.1799999999999999 111.092 -174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.52000000000000002 111.505 177.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.93999999999999995 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 1.1200000000000001 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 1.3 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.28999999999999998 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.576 HD11 HG11 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 1.0800000000000001 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 1.1899999999999999 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 2.1800000000000002 111.837 -174.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.9299999999999999 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 1.1000000000000001 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.1699999999999999 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.8200000000000001 110.461 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.561 HG21 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 1.1100000000000001 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77000000000000002 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.525 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.48 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.418 HG23 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 1.4099999999999999 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 2.0800000000000001 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.418 ' HG2' HG23 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.561 HG22 HG21 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 1.28 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 1.1399999999999999 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.6499999999999999 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.409 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65000000000000002 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . 0.49 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52000000000000002 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.72 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.598 HD12 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 1.0900000000000001 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 1.1100000000000001 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.91000000000000003 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 1.1000000000000001 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 2.27 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 2.0600000000000001 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.465 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.5 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.749 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 1.1399999999999999 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 1.1200000000000001 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.3700000000000001 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.68999999999999995 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.6400000000000001 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.503 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.97 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.34000000000000002 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 1.1000000000000001 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 1.0700000000000001 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.56 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.5 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.60999999999999999 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.3799999999999999 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 1.1699999999999999 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.1599999999999999 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.2999999999999998 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.69999999999999996 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.23 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.467 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.93999999999999995 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.6399999999999999 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 1.1100000000000001 110.732 178.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.609 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.547 ' HB ' HG11 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 1.0900000000000001 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 1.23 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.498 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.3899999999999999 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.32000000000000001 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.2799999999999998 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 1.0900000000000001 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 1.0600000000000001 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 2.0699999999999998 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.463 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 1.3100000000000001 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.748 HG21 HD13 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 1.0700000000000001 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 1.01 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.34999999999999998 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.47 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 1.3200000000000001 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.748 HD13 HG21 ' A' ' 392' ' ' ILE . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 1.21 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.98999999999999999 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 1.49 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt -70.75 -58.59 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 1.1799999999999999 111.977 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.727 ' HG ' HG21 ' B' ' 379' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 120.224 -0.59 . . . . 2.0699999999999998 111.842 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.442 ' O ' ' HD2' ' B' ' 368' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.88 -0.488 . . . . 13.23 111.88 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' B' ' 368' ' ' ARG . 11.2 mmm-85 -124.95 -157.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 14.94 109.276 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 50.2 m 63.29 30.45 15.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.421 0.629 . . . . 10.73 111.353 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -170.43 78.1 0.08 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.105 . . . . 10.01 109.42 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.83 150.78 52.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.551 -0.749 . . . . 8.9399999999999995 110.709 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.7 t -177.29 150.76 0.74 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 5.6600000000000001 109.703 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 83.02 -61.58 4.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.209 -0.519 . . . . 2.7799999999999998 113.282 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -86.46 117.27 25.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.349 0.595 . . . . 1.74 111.728 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.428 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.6699999999999999 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.2799999999999998 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.8300000000000001 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.8799999999999999 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.727 HG21 ' HG ' ' A' ' 400' ' ' LEU . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.1699999999999999 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 1.04 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.3599999999999999 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.958 -0.457 . . . . 4.6299999999999999 111.958 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.48 -59.88 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.35 . . . . 3.3500000000000001 111.183 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m -92.12 119.02 31.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.141 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.561 ' HE1' HG23 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.64000000000000001 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.46999999999999997 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 1.27 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 1.0700000000000001 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 2.0 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.484 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 -79.41 123.12 27.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.69999999999999996 110.927 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.481 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.5 tptm -104.05 116.21 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.08 -0.509 . . . . 2.21 109.901 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 69.8 mtm -135.09 -173.23 3.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.341 -0.391 . . . . 2.1800000000000002 110.556 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.855 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.85 167.24 22.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 2.7400000000000002 110.859 178.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.51 -52.86 0.75 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.886 -0.674 . . . . 2.0600000000000001 112.181 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.71 168.84 19.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.292 -0.262 . . . . 2.1000000000000001 110.292 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.481 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 8.9 p30 -97.17 -3.45 40.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 2.8799999999999999 110.596 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -81.55 126.14 31.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 2.5499999999999998 109.981 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp -87.93 134.23 33.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 1.3300000000000001 110.374 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 1.1799999999999999 110.836 -176.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.52000000000000002 111.616 176.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.805 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.75 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 1.1200000000000001 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 1.3 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.28999999999999998 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 1.0800000000000001 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 1.1899999999999999 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.45 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 2.1800000000000002 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.9299999999999999 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 1.1000000000000001 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.1699999999999999 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.484 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.8200000000000001 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.79 HG21 HG23 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 1.1100000000000001 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.805 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77000000000000002 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.48 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 1.4099999999999999 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 2.0800000000000001 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.79 HG23 HG21 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 1.28 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 1.1399999999999999 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.6499999999999999 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65000000000000002 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52000000000000002 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.72 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.5 HD21 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 1.0900000000000001 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 1.1100000000000001 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.91000000000000003 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 1.1000000000000001 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 2.27 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 2.0600000000000001 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.431 ' HB3' HD21 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.5 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 1.1399999999999999 110.616 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.458 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 1.1200000000000001 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.3700000000000001 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.68999999999999995 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.6400000000000001 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.97 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.34000000000000002 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 1.1000000000000001 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.569 HD13 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 1.0700000000000001 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.5 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.60999999999999999 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.3799999999999999 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.462 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 1.1699999999999999 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.1599999999999999 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.2999999999999998 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.69999999999999996 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.23 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.569 ' HD2' HD13 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.93999999999999995 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.6399999999999999 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 1.1100000000000001 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 1.0900000000000001 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 1.23 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.531 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.3899999999999999 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.32000000000000001 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.2799999999999998 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.531 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.509 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 1.0900000000000001 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 1.0600000000000001 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 2.0699999999999998 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 1.3100000000000001 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.5 HG23 HD21 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 1.0700000000000001 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 1.01 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.408 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.34999999999999998 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.45 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 1.3200000000000001 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.558 HG12 HD13 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 1.21 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.98999999999999999 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 1.49 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt -72.25 -33.44 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 1.1799999999999999 110.821 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.488 -0.767 . . . . 2.0699999999999998 111.25 -179.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 112.065 -0.414 . . . . 13.23 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 56.4 64.19 1.76 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.447 0.641 . . . . 14.94 110.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 15.7 m -132.15 120.56 22.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.783 -0.644 . . . . 10.73 110.164 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 61.17 87.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.833 0.708 . . . . 10.01 110.582 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -55.67 -46.64 77.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 8.9399999999999995 111.125 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 14.9 m -94.62 68.76 3.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.948 0.88 . . . . 5.6600000000000001 109.8 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -110.46 23.45 20.26 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.524 -1.216 . . . . 2.7799999999999998 111.386 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -115.05 110.6 19.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.253 0.549 . . . . 1.74 109.971 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.6699999999999999 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.2799999999999998 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.8300000000000001 109.766 177.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.8799999999999999 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.558 HD13 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.1699999999999999 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 1.04 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.3599999999999999 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.956 -0.457 . . . . 4.6299999999999999 111.956 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.87 111.21 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.72 0.295 . . . . 3.3500000000000001 110.627 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m -87.5 110.62 20.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.764 -0.458 . . . . 1.49 109.764 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.487 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.64000000000000001 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.46999999999999997 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 1.27 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 1.0700000000000001 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.643 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 2.0 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.504 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 -76.26 126.73 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.69999999999999996 110.766 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 318' ' ' LYS . 24.0 tptp -109.55 101.87 10.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.303 0.573 . . . . 2.21 109.884 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.3 mtm -125.95 174.69 8.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.516 -0.766 . . . . 2.1800000000000002 109.637 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.774 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -64.08 160.24 18.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.153 0.501 . . . . 2.7400000000000002 110.862 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.88 -41.44 2.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.865 -0.683 . . . . 2.0600000000000001 112.0 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.448 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.7 pttm -161.26 163.93 30.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.416 0.627 . . . . 2.1000000000000001 110.552 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -83.55 -17.11 42.89 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.755 -1.111 . . . . 2.8799999999999999 111.097 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.448 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 83.8 tttt -70.42 123.11 20.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.477 . . . . 2.5499999999999998 110.838 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -77.74 110.2 12.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.341 -0.614 . . . . 1.3300000000000001 109.341 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 1.1799999999999999 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.52000000000000002 110.875 173.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.93999999999999995 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 1.1200000000000001 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 1.3 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.28999999999999998 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 1.0800000000000001 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 1.1899999999999999 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.429 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 2.1800000000000002 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.9299999999999999 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 1.1000000000000001 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.455 ' HB2' HG12 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.1699999999999999 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.504 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.8200000000000001 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.617 HG22 HG21 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 1.1100000000000001 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77000000000000002 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.48 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 1.4099999999999999 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 2.0800000000000001 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.617 HG21 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 1.28 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 1.1399999999999999 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.6499999999999999 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65000000000000002 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52000000000000002 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.531 ' HB3' HD21 ' A' ' 355' ' ' ASN . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.72 109.327 171.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.546 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 1.0900000000000001 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 1.1100000000000001 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.531 HD21 ' HB3' ' A' ' 352' ' ' SER . 58.2 m-80 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.91000000000000003 111.178 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 1.1000000000000001 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 2.27 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 2.0600000000000001 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.687 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.5 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 1.1399999999999999 110.755 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 1.1200000000000001 110.793 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.3700000000000001 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.68999999999999995 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.6400000000000001 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.97 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.585 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.34000000000000002 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 1.1000000000000001 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.576 HD22 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 1.0700000000000001 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.5 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.60999999999999999 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.685 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.3799999999999999 110.787 -175.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 1.1699999999999999 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.1599999999999999 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.2999999999999998 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.69999999999999996 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.23 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.572 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.93999999999999995 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.6399999999999999 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.566 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 1.1100000000000001 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.643 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.412 ' HB ' HG11 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 1.0900000000000001 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 1.23 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.483 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.3899999999999999 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.32000000000000001 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.2799999999999998 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 1.0900000000000001 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.585 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 1.0600000000000001 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 2.0699999999999998 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 1.3100000000000001 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.571 HG22 HD13 ' A' ' 396' ' ' ILE . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 1.0700000000000001 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.502 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.01 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.34999999999999998 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.429 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 1.3200000000000001 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.679 HG12 HD12 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 1.21 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.98999999999999999 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 1.49 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.6 -21.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 1.1799999999999999 111.191 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.933 -0.556 . . . . 2.0699999999999998 109.941 175.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.578 -0.609 . . . . 13.23 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . 0.411 ' HD3' ' HA ' ' B' ' 368' ' ' ARG . 8.1 mmt180 55.65 86.73 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.865 0.364 . . . . 14.94 111.42 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 11.8 m -52.91 119.45 4.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.841 -0.618 . . . . 10.73 111.562 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -97.59 109.6 22.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.398 -0.964 . . . . 10.01 108.398 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -83.91 89.33 7.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.826 -0.625 . . . . 8.9399999999999995 112.173 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 m -127.05 142.42 51.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.71 -0.677 . . . . 5.6600000000000001 109.195 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 105.99 -41.53 2.15 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.116 -0.794 . . . . 2.7799999999999998 111.116 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -128.68 131.87 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.355 -0.609 . . . . 1.74 109.355 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.6699999999999999 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.2799999999999998 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.687 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.8300000000000001 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.8799999999999999 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.679 HD12 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.1699999999999999 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.685 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 1.04 109.032 175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.3599999999999999 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.155 -0.378 . . . . 4.6299999999999999 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 14.3 p -116.44 -14.9 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.35 0.595 . . . . 3.3500000000000001 110.166 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m -77.47 86.94 3.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.944 -0.571 . . . . 1.49 110.882 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.421 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.64000000000000001 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.46999999999999997 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 1.27 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 1.0700000000000001 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.441 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 2.0 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.606 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 -89.44 135.73 33.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.69999999999999996 110.823 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -89.24 86.44 6.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.377 -0.601 . . . . 2.21 109.377 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 85.3 mtp -106.76 157.03 18.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.219 -0.446 . . . . 2.1800000000000002 110.415 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.85 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.36 161.55 30.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 2.7400000000000002 110.394 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -24.16 10.52 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.798 -0.921 . . . . 2.0600000000000001 110.798 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -167.79 169.12 11.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.676 -0.861 . . . . 2.1000000000000001 108.676 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -92.6 -4.48 53.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.01 0.433 . . . . 2.8799999999999999 110.984 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.729 ' HB2' ' HZ2' ' A' ' 324' ' ' LYS . 5.0 ttmp? -87.08 137.46 32.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.984 -0.553 . . . . 2.5499999999999998 110.491 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.441 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp -73.82 130.5 40.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.248 -0.433 . . . . 1.3300000000000001 109.988 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 1.1799999999999999 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.52000000000000002 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.93999999999999995 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 1.1200000000000001 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 1.3 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.28999999999999998 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.459 HD11 HG11 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 1.0800000000000001 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 1.1899999999999999 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 2.1800000000000002 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.9299999999999999 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.459 HG11 HD11 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 1.1000000000000001 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.1699999999999999 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.606 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.8200000000000001 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.504 HG22 HG23 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 1.1100000000000001 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77000000000000002 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.48 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 1.4099999999999999 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 2.0800000000000001 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.504 HG23 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 1.28 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 1.1399999999999999 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.6499999999999999 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65000000000000002 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52000000000000002 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.72 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 1.0900000000000001 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 1.1100000000000001 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.91000000000000003 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.42 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 1.1000000000000001 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 2.27 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.738 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 2.0600000000000001 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.601 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.5 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 1.1399999999999999 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.413 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 1.1200000000000001 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.41 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.3700000000000001 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.446 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.68999999999999995 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.6400000000000001 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.97 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.509 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.34000000000000002 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 1.1000000000000001 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 1.0700000000000001 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.738 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.504 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.5 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.60999999999999999 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.421 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.3799999999999999 111.205 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.504 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 1.1699999999999999 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.1599999999999999 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.2999999999999998 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.69999999999999996 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.23 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.528 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.93999999999999995 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.6399999999999999 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 1.1100000000000001 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 1.0900000000000001 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 1.23 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.514 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.3899999999999999 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.32000000000000001 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.2799999999999998 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.514 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 1.0900000000000001 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.509 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 1.0600000000000001 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 2.0699999999999998 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 1.3100000000000001 110.649 -177.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.645 HG21 HD12 ' A' ' 396' ' ' ILE . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 1.0700000000000001 109.982 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 1.01 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.34999999999999998 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 1.3200000000000001 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.645 HD12 HG21 ' A' ' 392' ' ' ILE . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 1.21 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.459 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.98999999999999999 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 1.49 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt -63.59 -42.15 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 1.1799999999999999 111.434 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.573 -0.727 . . . . 2.0699999999999998 110.571 -175.139 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 111.734 -0.546 . . . . 13.23 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 70.78 -62.71 0.44 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.254 0.622 . . . . 14.94 110.841 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.3 m -78.89 147.67 33.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.416 -0.356 . . . . 10.73 110.053 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.545 ' HE3' ' O ' ' B' ' 374' ' ' TRP . 0.0 OUTLIER -150.23 150.99 32.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.177 -0.305 . . . . 10.01 110.177 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -68.2 -1.67 6.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.66 0.985 . . . . 8.9399999999999995 113.66 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 4.2 m -70.86 142.95 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 5.6600000000000001 111.129 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -66.01 -28.91 74.05 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.042 -0.526 . . . . 2.7799999999999998 112.208 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . 0.545 ' O ' ' HE3' ' B' ' 370' ' ' LYS . 83.0 m95 -97.3 123.57 41.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.619 -0.512 . . . . 1.74 109.619 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.426 ' HA ' ' CE ' ' B' ' 370' ' ' LYS . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.6699999999999999 110.774 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.2799999999999998 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.53 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.8300000000000001 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.8799999999999999 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.485 HD13 HG12 ' A' ' 396' ' ' ILE . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.1699999999999999 110.301 172.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.421 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 1.04 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.3599999999999999 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.126 -0.39 . . . . 4.6299999999999999 112.126 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.416 ' CG2' HG21 ' A' ' 333' ' ' THR . 13.2 p -133.44 154.5 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.615 -0.513 . . . . 3.3500000000000001 109.615 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m -77.78 111.28 13.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.807 0.337 . . . . 1.49 111.816 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.64000000000000001 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.46999999999999997 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 1.27 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 1.0700000000000001 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.818 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 2.0 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.491 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 -75.82 123.12 25.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.69999999999999996 110.971 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.624 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -100.63 107.92 19.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.259 -0.645 . . . . 2.21 109.259 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 26.4 mtt -120.06 159.8 24.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.41 -0.359 . . . . 2.1800000000000002 110.587 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.643 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -59.86 157.96 11.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 2.7400000000000002 110.737 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.63 -28.54 14.52 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.75 -0.738 . . . . 2.0600000000000001 112.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.614 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.9 pttm -155.67 168.79 26.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.687 0.28 . . . . 2.1000000000000001 110.334 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.624 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.2 m-80 -101.28 -11.98 19.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 2.8799999999999999 110.158 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.614 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.7 tttt -70.8 138.15 50.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.277 -0.874 . . . . 2.5499999999999998 110.147 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.818 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp -102.43 143.38 32.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.945 -0.391 . . . . 1.3300000000000001 109.945 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 1.1799999999999999 111.205 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.52000000000000002 111.383 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.804 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.93999999999999995 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.507 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 1.1200000000000001 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 1.3 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.28999999999999998 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 1.0800000000000001 109.763 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 310' ' ' VAL . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 1.1899999999999999 110.597 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.453 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 2.1800000000000002 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.9299999999999999 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 1.1000000000000001 109.035 173.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.1699999999999999 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.491 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.8200000000000001 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.507 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 1.1100000000000001 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.804 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77000000000000002 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.48 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 1.4099999999999999 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 2.0800000000000001 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 1.28 109.563 176.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 1.1399999999999999 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.6499999999999999 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65000000000000002 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52000000000000002 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.72 109.275 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 1.0900000000000001 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 1.1100000000000001 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.91000000000000003 111.799 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 1.1000000000000001 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 2.27 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.434 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 2.0600000000000001 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.442 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.5 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.589 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 1.1399999999999999 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 1.1200000000000001 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.3700000000000001 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.68999999999999995 113.355 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.6400000000000001 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.97 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.6 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.34000000000000002 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.589 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 1.1000000000000001 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.533 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 1.0700000000000001 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.434 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.43 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.5 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.60999999999999999 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.3799999999999999 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.43 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 1.1699999999999999 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.1599999999999999 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.2999999999999998 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.69999999999999996 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.23 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.93999999999999995 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.6399999999999999 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 1.1100000000000001 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 1.0900000000000001 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 1.23 110.399 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.469 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.3899999999999999 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.32000000000000001 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.2799999999999998 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 1.0900000000000001 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.6 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 1.0600000000000001 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 2.0699999999999998 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.415 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 1.3100000000000001 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 1.0700000000000001 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 1.01 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.453 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 1.3200000000000001 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 1.21 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.98999999999999999 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 1.49 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.19 -30.67 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 1.1799999999999999 110.254 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.448 HD22 HG22 ' B' ' 379' ' ' ILE . 93.7 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.402 -0.809 . . . . 2.0699999999999998 110.65 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.795 -0.522 . . . . 13.23 111.795 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 62.14 17.38 9.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.615 0.598 . . . . 14.94 112.615 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 6.9 m -94.57 100.67 12.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.984 -0.376 . . . . 10.73 109.984 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' B' ' 370' ' ' LYS . 13.3 ptmm? -55.08 131.68 45.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.977 -0.556 . . . . 10.01 110.486 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.04 144.37 28.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.945 -0.571 . . . . 8.9399999999999995 111.49 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.2 t -114.8 41.46 2.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.564 1.173 . . . . 5.6600000000000001 108.891 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -77.8 -54.5 4.52 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 113.256 -1.793 . . . . 2.7799999999999998 111.623 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -95.86 111.23 23.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.194 0.521 . . . . 1.74 110.339 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.6699999999999999 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.2799999999999998 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.481 HD22 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.8300000000000001 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.8799999999999999 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.481 HG13 HD22 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.1699999999999999 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.504 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 1.04 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . 0.427 ' O ' ' CD1' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.3599999999999999 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.047 -0.421 . . . . 4.6299999999999999 112.047 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.442 ' HB ' HG22 ' A' ' 333' ' ' THR . 6.9 p -102.28 126.9 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.049 0.452 . . . . 3.3500000000000001 110.561 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m -103.75 126.46 50.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.261 -0.427 . . . . 1.49 109.947 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.436 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.64000000000000001 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.422 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.46999999999999997 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 1.27 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.464 HG13 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 1.0700000000000001 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 2.0 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.3 116.29 16.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.69999999999999996 110.559 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.476 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 26.5 tptp -106.35 107.82 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.615 -0.513 . . . . 2.21 109.615 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 45.4 mtt -118.36 -170.41 1.88 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.781 -0.645 . . . . 2.1800000000000002 110.252 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.849 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.67 177.55 8.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 2.7400000000000002 110.327 176.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 89.37 -47.13 3.26 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.924 -0.655 . . . . 2.0600000000000001 113.022 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -143.76 156.79 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 2.1000000000000001 111.074 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.457 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -91.43 4.08 53.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.784 -0.644 . . . . 2.8799999999999999 111.144 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -86.27 124.09 32.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.278 -0.419 . . . . 2.5499999999999998 110.544 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.476 ' HG ' ' HD3' ' A' ' 318' ' ' LYS . 6.1 mp -83.93 124.51 31.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.234 -0.654 . . . . 1.3300000000000001 109.234 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 1.1799999999999999 111.106 -174.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.52000000000000002 111.235 175.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.93999999999999995 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.418 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 1.1200000000000001 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 1.3 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.28999999999999998 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.523 ' HB ' HD22 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 1.0800000000000001 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.442 HG22 ' HB ' ' A' ' 310' ' ' VAL . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 1.1899999999999999 110.005 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.441 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 2.1800000000000002 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.9299999999999999 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 1.1000000000000001 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.1699999999999999 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.8200000000000001 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.436 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 1.1100000000000001 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77000000000000002 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.418 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.48 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 1.4099999999999999 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 2.0800000000000001 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 1.28 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 1.1399999999999999 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.6499999999999999 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65000000000000002 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52000000000000002 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.72 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.633 HD12 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 1.0900000000000001 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 1.1100000000000001 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.91000000000000003 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.487 HG23 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 1.1000000000000001 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 2.27 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 2.0600000000000001 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.631 ' HB3' HD22 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.5 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 1.1399999999999999 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.452 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 1.1200000000000001 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.3700000000000001 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.68999999999999995 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.6400000000000001 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.97 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.59 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.34000000000000002 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 1.1000000000000001 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 1.0700000000000001 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.5 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.60999999999999999 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.3799999999999999 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.532 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 1.1699999999999999 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.1599999999999999 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.2999999999999998 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.69999999999999996 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.23 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.93999999999999995 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.6399999999999999 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 1.1100000000000001 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.464 ' HB ' HG13 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 1.0900000000000001 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 1.23 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.55 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.3899999999999999 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.32000000000000001 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.2799999999999998 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 1.0900000000000001 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.59 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 1.0600000000000001 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 2.0699999999999998 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.523 HD22 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 1.3100000000000001 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.573 HG21 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 1.0700000000000001 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.411 ' HB1' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 1.01 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.34999999999999998 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.441 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 1.3200000000000001 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.633 HG13 HD12 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 1.21 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.98999999999999999 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 1.49 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.41 -26.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 1.1799999999999999 111.18 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 396' ' ' ILE . 2.2 mm? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.719 -0.658 . . . . 2.0699999999999998 109.965 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.422 ' O ' ' HE3' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.969 -0.452 . . . . 13.23 111.969 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -105.21 9.63 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.766 0.284 . . . . 14.94 111.766 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 8.5 t -124.0 91.62 3.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.252 0.549 . . . . 10.73 111.525 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' B' ' 367' ' ' GLY . 0.0 OUTLIER -135.79 34.55 2.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.841 0.829 . . . . 10.01 109.333 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 105.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.141 -1.391 . . . . 8.9399999999999995 110.116 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 11.2 m -117.96 145.64 44.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 5.6600000000000001 111.025 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.05 0.8 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.102 -0.571 . . . . 2.7799999999999998 111.955 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -119.76 142.03 48.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.946 -0.39 . . . . 1.74 109.946 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.6699999999999999 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.2799999999999998 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.8300000000000001 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.8799999999999999 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.46 HD12 HG12 ' A' ' 396' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.1699999999999999 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 1.04 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.3599999999999999 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 CA-C-O 120.007 -0.329 . . . . 4.6299999999999999 112.38 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.427 HG11 HG21 ' A' ' 333' ' ' THR . 17.4 m 34.33 70.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.562 1.145 . . . . 3.3500000000000001 113.886 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m -103.92 127.28 51.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.256 -0.429 . . . . 1.49 110.647 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.714 ' HE1' HG22 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.64000000000000001 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.46999999999999997 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 1.27 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 1.0700000000000001 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.577 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 2.0 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.605 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 -80.76 115.7 20.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.69999999999999996 110.793 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.6 tptp -90.54 97.03 10.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.259 0.552 . . . . 2.21 109.786 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 80.0 mmm -110.45 169.95 8.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.602 -0.726 . . . . 2.1800000000000002 109.384 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.508 ' HE2' ' N ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -70.5 169.7 13.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.756 0.312 . . . . 2.7400000000000002 110.566 177.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.79 6.29 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 2.0600000000000001 112.297 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.404 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -161.48 162.18 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 2.1000000000000001 110.464 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.558 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 31.7 p30 -83.02 -14.56 53.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 2.8799999999999999 111.167 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.8 ttmt -77.45 122.73 25.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 2.5499999999999998 110.887 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp -76.25 133.62 40.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.849 -0.614 . . . . 1.3300000000000001 109.571 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 1.1799999999999999 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.52000000000000002 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.776 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.93999999999999995 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 1.1200000000000001 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.405 HD22 HD12 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 1.3 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.28999999999999998 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.48 ' HB ' HD21 ' A' ' 391' ' ' LEU . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 1.0800000000000001 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.427 HG21 HG11 ' A' ' 310' ' ' VAL . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 1.1899999999999999 110.527 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 2.1800000000000002 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.9299999999999999 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.415 HG13 HD11 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 1.1000000000000001 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.1699999999999999 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.605 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.8200000000000001 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.714 HG22 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 1.1100000000000001 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.776 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77000000000000002 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.48 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' THR . . . . . 0.405 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 1.4099999999999999 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 2.0800000000000001 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 1.28 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 1.1399999999999999 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.6499999999999999 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65000000000000002 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52000000000000002 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.72 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 1.0900000000000001 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 1.1100000000000001 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.91000000000000003 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 1.1000000000000001 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 2.27 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.741 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 2.0600000000000001 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.643 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.5 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 1.1399999999999999 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HB1' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 1.1200000000000001 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.3700000000000001 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.68999999999999995 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.6400000000000001 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.97 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.34000000000000002 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 1.1000000000000001 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.643 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 1.0700000000000001 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.506 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.5 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.60999999999999999 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.3799999999999999 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.432 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 1.1699999999999999 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.1599999999999999 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.2999999999999998 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.69999999999999996 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.23 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.581 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.93999999999999995 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.6399999999999999 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.556 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 1.1100000000000001 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.41 ' HB ' HG11 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 1.0900000000000001 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 1.23 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.3899999999999999 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . 0.421 ' HA2' HD11 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.32000000000000001 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.2799999999999998 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.421 HD11 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 1.0900000000000001 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 1.0600000000000001 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 2.0699999999999998 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.48 HD21 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 1.3100000000000001 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.64 HG22 HD12 ' A' ' 396' ' ' ILE . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 1.0700000000000001 110.362 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 1.01 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.34999999999999998 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 1.3200000000000001 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.64 HD12 HG22 ' A' ' 392' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 1.21 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.98999999999999999 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 1.49 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt -75.34 -35.27 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 1.1799999999999999 110.736 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.413 HD22 HG22 ' B' ' 379' ' ' ILE . 96.4 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.57 -0.729 . . . . 2.0699999999999998 110.853 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.743 -0.543 . . . . 13.23 111.743 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.12 73.16 0.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.218 0.532 . . . . 14.94 111.313 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 10.9 t -112.04 100.79 9.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.853 -0.612 . . . . 10.73 110.467 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -125.33 80.54 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.177 -1.416 . . . . 10.01 107.177 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -87.16 109.54 19.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.608 -0.724 . . . . 8.9399999999999995 110.546 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 43.0 m -80.45 113.33 18.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 5.6600000000000001 110.638 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -74.34 -48.61 13.88 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.233 -0.747 . . . . 2.7799999999999998 111.233 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -104.58 130.82 52.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.904 0.383 . . . . 1.74 110.232 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.6699999999999999 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.741 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.2799999999999998 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.8300000000000001 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.8799999999999999 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.603 HD13 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.1699999999999999 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 1.04 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.3599999999999999 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.48 -0.248 . . . . 4.6299999999999999 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.09 110.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.789 0.295 . . . . 3.3500000000000001 110.452 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m -97.36 122.27 40.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.426 -0.352 . . . . 1.49 110.214 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG22 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.64000000000000001 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.438 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.46999999999999997 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 1.27 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 1.0700000000000001 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 2.0 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.409 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 -80.06 119.43 22.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.69999999999999996 111.055 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.701 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -98.77 92.52 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.621 -0.511 . . . . 2.21 109.621 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.1 mmt -104.67 176.82 5.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.688 -0.687 . . . . 2.1800000000000002 110.615 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.912 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.1 OUTLIER -72.22 158.76 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 2.7400000000000002 110.703 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.25 -42.29 1.97 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.731 -0.747 . . . . 2.0600000000000001 113.009 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.503 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.6 pttm -152.76 163.85 38.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.627 0.727 . . . . 2.1000000000000001 110.937 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.701 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 23.6 p-10 -95.78 4.8 52.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.567 -1.197 . . . . 2.8799999999999999 110.407 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.503 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 64.1 tttm -92.21 123.82 35.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.127 -0.694 . . . . 2.5499999999999998 109.127 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.47 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp -88.87 139.27 30.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 1.3300000000000001 110.829 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 1.1799999999999999 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 342' ' ' GLU . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.52000000000000002 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.781 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.696 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 1.1200000000000001 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 1.3 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.28999999999999998 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 1.0800000000000001 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 1.1899999999999999 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 2.1800000000000002 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.9299999999999999 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 1.1000000000000001 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.1699999999999999 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.8200000000000001 110.207 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.696 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 1.1100000000000001 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.781 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77000000000000002 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.48 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 1.4099999999999999 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 2.0800000000000001 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.491 HG21 HG23 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 1.28 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 1.1399999999999999 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.6499999999999999 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65000000000000002 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52000000000000002 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.72 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 1.0900000000000001 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 1.1100000000000001 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.91000000000000003 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.428 HG22 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 1.1000000000000001 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.522 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 2.27 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 2.0600000000000001 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.428 ' HE3' HG22 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.5 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.603 ' HB1' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 1.1399999999999999 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 1.1200000000000001 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.416 ' C ' ' H ' ' A' ' 364' ' ' LYS . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.3700000000000001 109.535 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.4 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.68999999999999995 112.102 177.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.416 ' H ' ' C ' ' A' ' 362' ' ' SER . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.6400000000000001 110.611 -176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.97 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.467 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.34000000000000002 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.619 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 1.1000000000000001 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 1.0700000000000001 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.5 109.505 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.522 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.60999999999999999 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.449 ' HB2' ' HH ' ' B' ' 380' ' ' TYR . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.3799999999999999 110.655 -170.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 1.1699999999999999 111.006 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.1599999999999999 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.2999999999999998 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.69999999999999996 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.23 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.619 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.93999999999999995 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.6399999999999999 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 1.1100000000000001 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 1.0900000000000001 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 1.23 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.535 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.3899999999999999 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.32000000000000001 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.458 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.2799999999999998 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 1.0900000000000001 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.467 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 1.0600000000000001 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 2.0699999999999998 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 1.3100000000000001 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.408 HG13 ' O ' ' A' ' 388' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 1.0700000000000001 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 1.01 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.34999999999999998 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.463 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 1.3200000000000001 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 1.21 111.44 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.98999999999999999 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 1.49 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt -70.18 -37.5 71.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 1.1799999999999999 111.285 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.666 -0.683 . . . . 2.0699999999999998 110.426 178.104 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.764 -0.134 . . . . 13.23 112.764 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -113.7 122.68 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.282 -0.266 . . . . 14.94 110.282 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 14.4 m -64.08 119.51 10.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.085 0.469 . . . . 10.73 110.221 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -158.01 41.17 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.888 0.852 . . . . 10.01 109.654 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -81.79 139.69 34.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.406 -1.27 . . . . 8.9399999999999995 110.099 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.3 t 71.19 152.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.761 0.663 . . . . 5.6600000000000001 110.531 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 86.54 -65.57 3.78 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.853 -0.689 . . . . 2.7799999999999998 112.143 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -142.76 142.9 32.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 1.74 110.945 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.6699999999999999 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.2799999999999998 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.8300000000000001 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.8799999999999999 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.1699999999999999 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.449 ' HH ' ' HB2' ' A' ' 372' ' ' ASP . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 1.04 109.336 173.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . 0.445 ' HD1' ' N ' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.3599999999999999 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.745 -0.542 . . . . 4.6299999999999999 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.05 97.54 7.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 3.3500000000000001 110.219 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m -84.07 108.94 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.669 . . . . 1.49 110.748 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.64000000000000001 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.46999999999999997 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 1.27 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 1.0700000000000001 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 2.0 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.431 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 -98.87 122.66 42.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.69999999999999996 111.418 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.543 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.5 tptm -80.2 93.76 5.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.211 -0.663 . . . . 2.21 109.211 170.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 78.9 mtp -98.98 158.05 15.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.103 -0.499 . . . . 2.1800000000000002 110.802 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.55 158.78 20.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 2.7400000000000002 111.011 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.2 -40.66 2.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.752 -0.737 . . . . 2.0600000000000001 112.524 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.616 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.9 pttm -143.99 166.47 24.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.536 0.684 . . . . 2.1000000000000001 111.026 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.543 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 18.6 p-10 -97.89 24.63 6.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.788 -1.096 . . . . 2.8799999999999999 110.379 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.616 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.9 tttp -111.1 133.52 53.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.552 -0.749 . . . . 2.5499999999999998 109.964 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp -90.47 120.36 31.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.604 -0.517 . . . . 1.3300000000000001 109.604 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 1.1799999999999999 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.52000000000000002 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.93999999999999995 110.222 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 1.1200000000000001 110.047 176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 1.3 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.28999999999999998 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.493 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 1.0800000000000001 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 1.1899999999999999 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 2.1800000000000002 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.9299999999999999 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 1.1000000000000001 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.1699999999999999 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.439 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.8200000000000001 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.535 HG21 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 1.1100000000000001 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77000000000000002 110.312 178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.48 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 1.4099999999999999 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 2.0800000000000001 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.535 HG22 HG21 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 1.28 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 1.1399999999999999 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.6499999999999999 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65000000000000002 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52000000000000002 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.72 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.453 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 1.0900000000000001 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 1.1100000000000001 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.91000000000000003 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 1.1000000000000001 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 2.27 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 2.0600000000000001 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.592 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.5 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 1.1399999999999999 110.3 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.439 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 1.1200000000000001 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.3700000000000001 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.565 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.68999999999999995 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.6400000000000001 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.44 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.97 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.34000000000000002 109.336 179.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 1.1000000000000001 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 1.0700000000000001 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.451 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.664 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.5 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.60999999999999999 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.3799999999999999 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.664 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 1.1699999999999999 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.1599999999999999 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.2999999999999998 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.69999999999999996 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.23 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.667 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.93999999999999995 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.6399999999999999 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 1.1100000000000001 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.618 ' HB ' HG11 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 1.0900000000000001 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.565 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 1.23 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.3899999999999999 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.32000000000000001 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.439 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.2799999999999998 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 1.0900000000000001 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 1.0600000000000001 111.388 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 2.0699999999999998 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 1.3100000000000001 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.453 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 1.0700000000000001 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 1.01 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.412 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.34999999999999998 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 1.3200000000000001 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 1.21 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . 0.487 ' HA ' HD23 ' A' ' 400' ' ' LEU . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.98999999999999999 110.75 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 1.49 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.39 -32.09 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 1.1799999999999999 110.952 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.487 HD23 ' HA ' ' A' ' 397' ' ' ASP . 2.2 mm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.619 -0.705 . . . . 2.0699999999999998 110.505 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 111.815 -0.514 . . . . 13.23 111.815 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -145.5 -26.52 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.941 0.371 . . . . 14.94 111.838 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.7 m -91.35 71.7 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.925 -0.31 . . . . 10.73 111.074 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? 36.14 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.362 1.039 . . . . 10.01 112.222 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.88 98.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.055 -0.975 . . . . 8.9399999999999995 112.041 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 45.9 m -100.68 96.9 7.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.358 0.599 . . . . 5.6600000000000001 109.875 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -100.63 18.63 54.82 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.227 -0.897 . . . . 2.7799999999999998 111.289 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -116.56 104.55 11.52 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.74 110.407 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.484 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.6699999999999999 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.2799999999999998 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.538 HD22 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.8300000000000001 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.8799999999999999 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.538 HG13 HD22 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.1699999999999999 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 1.04 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.3599999999999999 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.324 -0.31 . . . . 4.6299999999999999 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.482 HG11 HG21 ' A' ' 333' ' ' THR . 46.3 t 68.95 84.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.273 0.559 . . . . 3.3500000000000001 110.963 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' SER . . . . . 0.43 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m -105.19 148.9 26.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.764 -0.653 . . . . 1.49 111.141 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.64000000000000001 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.46999999999999997 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 1.27 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 1.0700000000000001 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.578 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 2.0 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.465 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 -75.6 118.51 18.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.69999999999999996 110.865 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -88.45 103.63 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.39 -0.596 . . . . 2.21 109.39 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.4 mmt -118.82 167.39 11.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.462 -0.79 . . . . 2.1800000000000002 109.745 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.647 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -76.51 -176.97 3.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.385 -0.598 . . . . 2.7400000000000002 109.385 171.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.45 -25.65 19.65 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.483 -0.865 . . . . 2.0600000000000001 111.383 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.694 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.6 pttm -167.23 -177.9 3.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.647 -0.501 . . . . 2.1000000000000001 109.647 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.15 2.44 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.064 0.459 . . . . 2.8799999999999999 110.586 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.694 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.6 ttmt -86.91 123.15 31.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 2.5499999999999998 110.056 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.547 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp -78.67 120.06 22.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.59 -0.522 . . . . 1.3300000000000001 109.59 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 1.1799999999999999 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.52000000000000002 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.93999999999999995 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 1.1200000000000001 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 1.3 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.28999999999999998 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 310' ' ' VAL . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 1.0800000000000001 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.482 HG21 HG11 ' A' ' 310' ' ' VAL . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 1.1899999999999999 109.752 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 2.1800000000000002 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.9299999999999999 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 1.1000000000000001 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.1699999999999999 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.497 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.8200000000000001 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.616 HG23 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 1.1100000000000001 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.419 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77000000000000002 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.48 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 1.4099999999999999 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . 0.419 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 2.0800000000000001 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.616 HG22 HG23 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 1.28 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 1.1399999999999999 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.6499999999999999 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65000000000000002 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52000000000000002 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.72 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.452 HD23 HG22 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 1.0900000000000001 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 1.1100000000000001 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.91000000000000003 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 1.1000000000000001 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.432 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 2.27 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.437 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 2.0600000000000001 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.739 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.5 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 1.1399999999999999 110.702 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 1.1200000000000001 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.3700000000000001 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.68999999999999995 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.6400000000000001 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.97 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.34000000000000002 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 1.1000000000000001 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 1.0700000000000001 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.437 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.476 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.5 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.422 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.60999999999999999 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.3799999999999999 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.476 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 1.1699999999999999 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.1599999999999999 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.2999999999999998 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.69999999999999996 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.23 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.625 ' HD2' HD13 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.93999999999999995 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.6399999999999999 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.446 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 1.1100000000000001 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.578 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 1.0900000000000001 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 1.23 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.48 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.3899999999999999 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.32000000000000001 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.457 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.2799999999999998 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 1.0900000000000001 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.48 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 1.0600000000000001 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 2.0699999999999998 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.43 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 1.3100000000000001 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.588 HG21 HD13 ' A' ' 396' ' ' ILE . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 1.0700000000000001 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 1.01 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.34999999999999998 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.496 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 1.3200000000000001 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.588 HD13 HG21 ' A' ' 392' ' ' ILE . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 1.21 110.9 176.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.98999999999999999 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 1.49 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt -70.7 -34.64 57.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 1.1799999999999999 110.773 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.424 HD21 HG21 ' B' ' 379' ' ' ILE . 85.9 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.542 -0.742 . . . . 2.0699999999999998 110.953 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.661 -0.575 . . . . 13.23 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -152.03 -60.24 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.926 0.393 . . . . 14.94 110.106 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.8 p -145.12 41.05 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.769 -0.65 . . . . 10.73 110.542 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -119.96 103.58 9.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 10.01 110.795 -178.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.66 -55.37 24.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.213 -0.449 . . . . 8.9399999999999995 110.748 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 27.6 m -98.24 169.17 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.138 0.494 . . . . 5.6600000000000001 110.544 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 85.06 -64.59 4.2 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.359 -0.696 . . . . 2.7799999999999998 111.359 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -115.63 99.6 7.45 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.74 109.024 172.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.6699999999999999 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.2799999999999998 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.8300000000000001 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.8799999999999999 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 396' ' ' ILE . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.1699999999999999 111.14 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 1.04 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.3599999999999999 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.535 -0.226 . . . . 4.6299999999999999 112.535 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.28 88.83 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.529 -0.545 . . . . 3.3500000000000001 109.529 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m -97.52 122.48 40.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.869 -0.605 . . . . 1.49 111.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.653 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.64000000000000001 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.46999999999999997 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 1.27 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 1.0700000000000001 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 2.0 109.79 178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.518 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 -76.98 117.93 19.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.69999999999999996 111.174 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.459 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -92.51 95.59 9.72 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.582 -0.525 . . . . 2.21 109.582 173.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.4 mmt -98.1 160.78 14.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.665 . . . . 2.1800000000000002 110.356 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.952 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -72.9 159.68 33.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 2.7400000000000002 111.051 -178.356 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.05 -37.11 3.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.902 -0.666 . . . . 2.0600000000000001 112.346 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.504 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.6 pttm -144.14 156.87 44.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.729 0.299 . . . . 2.1000000000000001 110.313 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.459 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -88.73 8.04 30.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.096 -0.502 . . . . 2.8799999999999999 111.05 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 60.8 tttp -88.93 130.83 35.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.063 -0.517 . . . . 2.5499999999999998 110.47 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.53 134.34 35.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 1.3300000000000001 109.663 176.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 1.1799999999999999 110.765 -176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.52000000000000002 111.974 177.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.403 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.93999999999999995 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.631 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 1.1200000000000001 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 1.3 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.28999999999999998 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.567 ' HB ' HD21 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 1.0800000000000001 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 1.1899999999999999 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 2.1800000000000002 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.9299999999999999 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 1.1000000000000001 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.1699999999999999 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.518 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.8200000000000001 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.653 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 1.1100000000000001 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77000000000000002 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.48 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 1.4099999999999999 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 2.0800000000000001 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 339' ' ' ARG . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 1.28 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 1.1399999999999999 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . 0.461 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.6499999999999999 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65000000000000002 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52000000000000002 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.478 ' HB2' ' ND2' ' A' ' 355' ' ' ASN . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.72 108.883 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 1.0900000000000001 112.066 -175.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 1.1100000000000001 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.478 ' ND2' ' HB2' ' A' ' 352' ' ' SER . 37.3 m-80 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.91000000000000003 110.585 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 1.1000000000000001 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 2.27 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 2.0600000000000001 109.812 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.49 ' HB3' HD21 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.5 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.426 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 1.1399999999999999 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 1.1200000000000001 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.441 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.3700000000000001 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.441 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.68999999999999995 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.6400000000000001 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.97 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.425 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.34000000000000002 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.426 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 1.1000000000000001 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.597 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 1.0700000000000001 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.5 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.681 ' HA3' ' HH ' ' B' ' 380' ' ' TYR . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.60999999999999999 112.408 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.705 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.3799999999999999 110.409 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 1.1699999999999999 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.1599999999999999 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.2999999999999998 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.69999999999999996 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.23 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.597 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.93999999999999995 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.6399999999999999 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.5 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 1.1100000000000001 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 1.0900000000000001 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 1.23 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.3899999999999999 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.32000000000000001 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.2799999999999998 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 1.0900000000000001 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.521 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 1.0600000000000001 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 2.0699999999999998 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.567 HD21 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 1.3100000000000001 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 1.0700000000000001 110.26 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 1.01 111.065 179.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . 0.448 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.34999999999999998 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.482 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 1.3200000000000001 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.556 HG12 HD11 ' B' ' 379' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 1.21 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.98999999999999999 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 1.49 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt -66.8 -30.93 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 1.1799999999999999 110.741 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.523 -0.751 . . . . 2.0699999999999998 110.918 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.444 -0.662 . . . . 13.23 111.444 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -114.4 131.62 56.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.384 -0.599 . . . . 14.94 109.384 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.4 m -118.23 90.97 3.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.359 . . . . 10.73 110.323 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -169.49 48.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 10.01 109.379 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.34 90.63 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.212 -0.904 . . . . 8.9399999999999995 111.27 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.2 m -84.32 117.72 23.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.823 -0.626 . . . . 5.6600000000000001 110.807 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 169.67 65.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.512 -0.852 . . . . 2.7799999999999998 112.605 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 62.61 94.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.74 111.745 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.454 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.6699999999999999 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.2799999999999998 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.624 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.8300000000000001 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.8799999999999999 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.624 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.1699999999999999 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.705 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 1.04 110.132 178.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.3599999999999999 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.654 -0.579 . . . . 4.6299999999999999 111.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 10.4 m -60.08 96.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.501 0.667 . . . . 3.3500000000000001 111.284 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m -103.91 114.76 29.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 1.49 109.922 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.64000000000000001 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.46999999999999997 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 1.27 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 1.0700000000000001 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 2.0 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.513 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.3 mt-10 -80.98 120.4 24.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.69999999999999996 111.114 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 20.8 tptm -93.18 91.62 7.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.458 -0.571 . . . . 2.21 109.458 172.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 52.9 mtt -104.93 158.57 16.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.84 -0.618 . . . . 2.1800000000000002 110.388 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.88 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.53 158.33 21.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 2.7400000000000002 110.914 177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -31.37 6.17 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.685 -0.689 . . . . 2.0600000000000001 111.468 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.496 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.2 pttm -159.53 -177.53 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.972 -0.381 . . . . 2.1000000000000001 109.972 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.594 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 0.0 OUTLIER -104.88 -16.54 14.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.079 0.466 . . . . 2.8799999999999999 110.489 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.5 ttmt -73.66 134.46 43.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 2.5499999999999998 111.06 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -86.73 142.14 28.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 1.3300000000000001 109.953 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 1.1799999999999999 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.52000000000000002 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.837 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.93999999999999995 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 1.1200000000000001 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.454 HD21 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 1.3 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.614 ' HB ' HD21 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 1.0800000000000001 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 1.1899999999999999 110.255 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.482 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 2.1800000000000002 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.9299999999999999 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.425 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 1.1000000000000001 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.1699999999999999 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.513 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.8200000000000001 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 1.1100000000000001 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.837 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77000000000000002 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.48 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 1.4099999999999999 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 2.0800000000000001 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.486 HG23 HG23 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 1.28 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 1.1399999999999999 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.6499999999999999 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65000000000000002 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . 0.436 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52000000000000002 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.72 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.552 HD23 HG21 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 1.0900000000000001 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 1.1100000000000001 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.91000000000000003 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.405 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 1.1000000000000001 110.752 -178.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.4 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 2.27 109.678 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 2.0600000000000001 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.434 ' CE2' ' HB ' ' B' ' 375' ' ' VAL . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.5 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.534 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 1.1399999999999999 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 1.1200000000000001 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.3700000000000001 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.68999999999999995 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.6400000000000001 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.97 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.457 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.34000000000000002 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 1.1000000000000001 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.678 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 1.0700000000000001 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.4 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.5 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.60999999999999999 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.3799999999999999 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.539 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 1.1699999999999999 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.1599999999999999 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.2999999999999998 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.69999999999999996 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.23 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.678 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.93999999999999995 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.6399999999999999 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.553 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 1.1100000000000001 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 1.0900000000000001 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 1.23 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.563 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.3899999999999999 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.32000000000000001 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.2799999999999998 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 1.0900000000000001 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.457 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 1.0600000000000001 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 2.0699999999999998 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.614 HD21 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 1.3100000000000001 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 396' ' ' ILE . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 1.0700000000000001 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 1.01 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.34999999999999998 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 1.3200000000000001 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.627 HG12 HD12 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 1.21 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.98999999999999999 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 1.49 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.3 -29.56 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 1.1799999999999999 110.819 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.515 -0.755 . . . . 2.0699999999999998 110.78 -175.574 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.128 -0.389 . . . . 13.23 112.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -145.16 -54.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.157 -0.312 . . . . 14.94 110.157 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.9 m -97.96 19.54 13.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.041 0.924 . . . . 10.73 109.551 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.417 ' O ' ' HA3' ' B' ' 367' ' ' GLY . 30.4 ttpt 170.25 118.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.338 -1.755 . . . . 10.01 107.705 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -54.7 -61.83 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.289 0.368 . . . . 8.9399999999999995 111.397 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 2.0 m 62.39 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.813 0.696 . . . . 5.6600000000000001 110.639 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 121.32 -146.13 17.22 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.232 -0.985 . . . . 2.7799999999999998 111.812 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 63.58 86.21 0.12 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.74 110.602 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.434 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.6699999999999999 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.2799999999999998 111.074 -176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.524 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.8300000000000001 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.8799999999999999 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.627 HD12 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.1699999999999999 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.405 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 1.04 109.097 175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.3599999999999999 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.91 -0.476 . . . . 4.6299999999999999 111.91 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.413 ' HB ' ' CE2' ' A' ' 312' ' ' PHE . 61.3 t -105.23 138.14 31.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 110.338 -0.245 . . . . 3.3500000000000001 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m -81.47 107.55 14.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.777 0.322 . . . . 1.49 110.169 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.413 ' CE2' ' HB ' ' A' ' 310' ' ' VAL . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.64000000000000001 110.986 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.46999999999999997 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 1.27 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 1.0700000000000001 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.61 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 2.0 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.468 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 -85.81 116.45 24.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.69999999999999996 111.068 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.502 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 22.9 tptm -85.75 93.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 2.21 109.509 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 29.9 mtt -107.99 177.05 4.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.876 -0.602 . . . . 2.1800000000000002 110.708 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.809 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -74.07 162.46 28.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.903 -0.589 . . . . 2.7400000000000002 110.575 178.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 113.3 -45.79 1.27 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 2.0600000000000001 112.819 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -148.86 174.11 12.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.772 0.32 . . . . 2.1000000000000001 110.729 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -81.31 -19.58 42.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 2.8799999999999999 110.622 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.05 136.32 37.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.521 . . . . 2.5499999999999998 111.537 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp -82.67 129.43 34.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.945 -0.761 . . . . 1.3300000000000001 108.945 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 1.1799999999999999 110.802 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.52000000000000002 111.621 177.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.468 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.93999999999999995 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 1.1200000000000001 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.552 HD21 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 1.3 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.28999999999999998 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.421 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 1.0800000000000001 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 1.1899999999999999 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.535 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 2.1800000000000002 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.401 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.9299999999999999 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 1.1000000000000001 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.1699999999999999 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.455 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.8200000000000001 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.424 HG23 HG21 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 1.1100000000000001 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77000000000000002 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.48 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 1.4099999999999999 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 2.0800000000000001 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.424 HG21 HG23 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 1.28 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 1.1399999999999999 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.6499999999999999 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65000000000000002 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52000000000000002 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.72 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.445 HD23 HG21 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 1.0900000000000001 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 1.1100000000000001 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.91000000000000003 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 1.1000000000000001 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 2.27 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.411 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 2.0600000000000001 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.498 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.5 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.617 ' HB1' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 1.1399999999999999 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 1.1200000000000001 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.433 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.3700000000000001 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.68999999999999995 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . 0.433 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.6400000000000001 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.97 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.49 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.34000000000000002 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.617 ' HB ' ' HB1' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 1.1000000000000001 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 1.0700000000000001 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.411 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.531 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.5 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.60999999999999999 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.648 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.3799999999999999 110.855 -174.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 1.1699999999999999 110.308 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . 0.531 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.1599999999999999 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.2999999999999998 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.69999999999999996 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.23 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.93999999999999995 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.6399999999999999 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.471 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 1.1100000000000001 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 1.0900000000000001 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 1.23 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.3899999999999999 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.32000000000000001 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.2799999999999998 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.552 HD13 HD21 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 1.0900000000000001 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.49 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 1.0600000000000001 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 2.0699999999999998 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 1.3100000000000001 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.445 HG21 HD23 ' A' ' 353' ' ' LEU . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 1.0700000000000001 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . 0.498 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 1.01 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.34999999999999998 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 1.3200000000000001 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.57 HG12 HD11 ' B' ' 379' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 1.21 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.98999999999999999 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 1.49 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.18 -42.8 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 1.1799999999999999 110.936 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.262 -0.881 . . . . 2.0699999999999998 110.776 -175.482 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.848 -0.501 . . . . 13.23 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.41 -0.93 2.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 14.94 110.083 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -177.72 3.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.4 -0.963 . . . . 10.73 108.4 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.22 94.18 5.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.638 -0.505 . . . . 10.01 109.638 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.9 166.3 19.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 8.9399999999999995 111.209 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.9 t -101.86 147.82 26.06 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.101 -0.703 . . . . 5.6600000000000001 109.101 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 113.16 -72.6 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.154 -0.779 . . . . 2.7799999999999998 111.154 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -114.78 107.87 16.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.175 0.512 . . . . 1.74 110.293 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.425 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.6699999999999999 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.2799999999999998 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.429 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.8300000000000001 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.8799999999999999 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.57 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.1699999999999999 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.648 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 1.04 109.105 173.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.3599999999999999 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.921 -0.472 . . . . 4.6299999999999999 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.55 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.09 0.556 . . . . 3.3500000000000001 111.043 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t -74.19 119.38 18.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.09 -0.505 . . . . 1.49 110.277 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.64000000000000001 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.46999999999999997 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 1.27 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 1.0700000000000001 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 2.0 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.466 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 -74.18 124.68 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.69999999999999996 111.236 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.664 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 24.6 tptp -108.79 103.49 12.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.534 -0.543 . . . . 2.21 109.534 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.2 mtm -121.02 173.73 7.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.684 -0.689 . . . . 2.1800000000000002 109.748 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.683 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.61 158.84 20.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.173 -0.467 . . . . 2.7400000000000002 110.33 176.681 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.5 -49.39 0.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.584 -0.817 . . . . 2.0600000000000001 112.557 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -153.76 157.61 39.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 2.1000000000000001 110.774 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.664 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 33.8 m-80 -84.32 -1.96 56.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.991 -0.549 . . . . 2.8799999999999999 111.186 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.46 128.38 34.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.936 -0.394 . . . . 2.5499999999999998 109.936 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp -87.49 142.13 28.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.732 -0.47 . . . . 1.3300000000000001 109.732 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 1.1799999999999999 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.52000000000000002 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.466 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.93999999999999995 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.425 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 1.1200000000000001 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 1.3 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.28999999999999998 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.466 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 1.0800000000000001 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 1.1899999999999999 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.463 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 2.1800000000000002 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.9299999999999999 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.451 HG11 HD11 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 1.1000000000000001 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.1699999999999999 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.465 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.8200000000000001 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.709 HG23 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 1.1100000000000001 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77000000000000002 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.48 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 1.4099999999999999 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 2.0800000000000001 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.709 HG22 HG23 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 1.28 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 1.1399999999999999 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.6499999999999999 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65000000000000002 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . 0.422 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52000000000000002 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.72 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 1.0900000000000001 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 1.1100000000000001 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.91000000000000003 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 1.1000000000000001 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 2.27 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.537 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 2.0600000000000001 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.545 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.5 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.477 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 1.1399999999999999 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 1.1200000000000001 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.3700000000000001 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.68999999999999995 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.6400000000000001 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.97 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.418 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.34000000000000002 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 1.1000000000000001 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 1.0700000000000001 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.5 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.543 ' HA3' ' HH ' ' B' ' 380' ' ' TYR . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.60999999999999999 112.966 176.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.645 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.3799999999999999 111.027 -175.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 1.1699999999999999 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.1599999999999999 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.2999999999999998 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.69999999999999996 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.23 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.568 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.93999999999999995 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.6399999999999999 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.521 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 1.1100000000000001 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.437 HG23 HG13 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 1.0900000000000001 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 1.23 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.591 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.3899999999999999 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.32000000000000001 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.2799999999999998 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . 0.591 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 1.0900000000000001 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 1.0600000000000001 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 2.0699999999999998 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 1.3100000000000001 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 1.0700000000000001 110.064 177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 1.01 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.34999999999999998 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 1.3200000000000001 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 1.21 110.94 178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.98999999999999999 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 1.49 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt -81.51 -37.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 1.1799999999999999 111.358 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.435 -0.793 . . . . 2.0699999999999998 110.708 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.791 -0.524 . . . . 13.23 111.791 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -116.27 -55.16 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 14.94 110.146 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 58.7 p -118.6 13.8 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.628 0.727 . . . . 10.73 110.663 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -153.56 111.74 3.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.458 -1.246 . . . . 10.01 109.148 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.4 160.78 14.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.843 0.354 . . . . 8.9399999999999995 110.96 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.0 m -95.9 157.66 15.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.914 -0.585 . . . . 5.6600000000000001 109.923 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.44 44.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.623 -0.799 . . . . 2.7799999999999998 111.729 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -122.15 140.34 52.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.425 0.631 . . . . 1.74 112.157 -172.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.6699999999999999 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.2799999999999998 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.478 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.8300000000000001 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.8799999999999999 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 379' ' ' ILE . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.1699999999999999 111.551 175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.645 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 1.04 110.069 177.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.3599999999999999 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.974 -0.45 . . . . 4.6299999999999999 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 8.7 t 57.42 41.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.614 0.721 . . . . 3.3500000000000001 110.633 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m -101.83 87.05 3.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.94 -0.573 . . . . 1.49 109.706 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.4 ' HE2' HG21 ' A' ' 340' ' ' VAL . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.64000000000000001 110.668 -177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.46999999999999997 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 1.27 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 1.0700000000000001 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.757 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 2.0 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.534 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 -77.82 122.09 24.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.69999999999999996 111.839 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.404 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -105.25 101.61 11.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.677 -0.692 . . . . 2.21 109.322 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 62.1 mtp -128.29 172.67 10.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.251 -0.431 . . . . 2.1800000000000002 110.097 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 158.93 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 2.7400000000000002 111.271 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.25 -29.7 10.7 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.818 -0.706 . . . . 2.0600000000000001 112.264 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -163.29 174.36 12.15 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.047 -0.353 . . . . 2.1000000000000001 110.047 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.404 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.1 m-80 -103.11 -15.46 16.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.715 0.293 . . . . 2.8799999999999999 110.635 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -64.44 121.0 13.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 2.5499999999999998 110.893 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.757 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp -83.13 119.63 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.115 -0.493 . . . . 1.3300000000000001 109.948 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 1.1799999999999999 111.152 -175.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.52000000000000002 111.744 176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.885 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.93999999999999995 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 1.1200000000000001 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 1.3 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.28999999999999998 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 1.0800000000000001 110.053 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 1.1899999999999999 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 2.1800000000000002 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.43 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.9299999999999999 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 1.1000000000000001 109.338 177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.437 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.1699999999999999 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.534 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.8200000000000001 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.607 HG22 HG21 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 1.1100000000000001 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.885 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77000000000000002 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.443 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.48 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 1.4099999999999999 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 2.0800000000000001 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.607 HG21 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 1.28 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 1.1399999999999999 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.6499999999999999 110.067 -176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65000000000000002 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52000000000000002 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.72 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.484 HD22 HG21 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 1.0900000000000001 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' B' ' 379' ' ' ILE . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 1.1100000000000001 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.91000000000000003 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.426 HG23 ' HE3' ' A' ' 359' ' ' TRP . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 110.016 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.43 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 2.27 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.52 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 2.0600000000000001 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.469 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.5 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 1.1399999999999999 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 1.1200000000000001 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.3700000000000001 109.627 177.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.68999999999999995 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.6400000000000001 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.97 111.345 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.61 ' HE1' ' HB3' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.34000000000000002 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 1.1000000000000001 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 1.0700000000000001 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.52 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . 0.466 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.5 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . 0.43 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.60999999999999999 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.894 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.3799999999999999 110.63 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . 0.466 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 1.1699999999999999 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.1599999999999999 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.2999999999999998 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.69999999999999996 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.23 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.515 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.93999999999999995 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.6399999999999999 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 1.1100000000000001 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.425 ' HB ' HG13 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 1.0900000000000001 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 1.23 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.567 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.3899999999999999 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.32000000000000001 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.2799999999999998 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 1.0900000000000001 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.61 ' HB3' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 1.0600000000000001 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 2.0699999999999998 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 1.3100000000000001 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.484 HG21 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 1.0700000000000001 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 1.01 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.34999999999999998 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 1.3200000000000001 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 1.21 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.98999999999999999 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 1.49 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt -76.27 -32.64 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 1.1799999999999999 111.086 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.44 HD22 HG22 ' B' ' 379' ' ' ILE . 92.9 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.828 -0.606 . . . . 2.0699999999999998 111.515 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.429 -0.668 . . . . 13.23 111.429 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -77.96 88.63 4.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 14.94 109.242 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 34.7 t -155.62 109.22 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.816 0.341 . . . . 10.73 110.711 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.771 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -91.3 107.62 19.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.05 -1.092 . . . . 10.01 108.05 168.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -55.5 109.68 0.59 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 8.9399999999999995 113.313 -167.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 t -129.82 138.89 51.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.315 -0.857 . . . . 5.6600000000000001 109.134 171.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -176.27 -162.48 27.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.692 -0.766 . . . . 2.7799999999999998 111.841 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -106.51 127.84 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.74 112.318 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . 0.469 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.6699999999999999 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.2799999999999998 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.421 ' HB2' ' HZ3' ' A' ' 359' ' ' TRP . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.8300000000000001 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.8799999999999999 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 354' ' ' THR . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.1699999999999999 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.894 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 1.04 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . 0.419 ' HD2' ' HG1' ' A' ' 354' ' ' THR . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.3599999999999999 110.464 176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.125 -0.39 . . . . 4.6299999999999999 112.125 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.87 95.24 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.902 0.858 . . . . 3.3500000000000001 110.176 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m -93.1 131.87 37.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.435 -0.802 . . . . 1.49 110.88 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.54 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.64000000000000001 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.46999999999999997 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 1.27 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 1.0700000000000001 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 2.0 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.421 ' HG2' HG11 ' A' ' 380' ' ' VAL . 65.0 mt-10 -84.32 112.22 20.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.69999999999999996 110.205 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.683 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 27.1 tptp -85.97 100.99 12.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 2.21 110.34 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 34.8 mtt -97.17 166.58 11.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.676 -0.693 . . . . 2.1800000000000002 110.193 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.815 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -77.82 175.44 9.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.227 -0.442 . . . . 2.7400000000000002 110.283 178.324 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.87 -41.07 2.93 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.697 -0.763 . . . . 2.0600000000000001 112.186 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.467 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.0 pttm -143.31 167.11 22.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 2.1000000000000001 110.31 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.683 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 90.2 m-20 -95.09 -9.71 32.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.933 -0.576 . . . . 2.8799999999999999 110.609 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.467 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.5 ttmt -77.76 121.47 24.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.5499999999999998 110.449 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.8 147.87 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 1.3300000000000001 110.336 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 1.1799999999999999 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.52000000000000002 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . 0.651 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.93999999999999995 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 1.1200000000000001 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.423 HD22 HD12 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 1.3 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.28999999999999998 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . 0.484 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 1.0800000000000001 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 1.1899999999999999 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 2.1800000000000002 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.9299999999999999 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . 0.484 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 1.1000000000000001 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.1699999999999999 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.451 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.8200000000000001 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.544 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 1.1100000000000001 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.651 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77000000000000002 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.48 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 1.4099999999999999 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 2.0800000000000001 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 1.28 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 1.1399999999999999 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.6499999999999999 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65000000000000002 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . 0.451 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52000000000000002 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.72 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.41 HD21 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 1.0900000000000001 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 1.1100000000000001 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.91000000000000003 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 1.1000000000000001 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 2.27 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.531 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 2.0600000000000001 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.495 ' HB3' HD22 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.5 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.644 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 1.1399999999999999 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 1.1200000000000001 111.197 -175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' SER . . . . . 0.625 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.3700000000000001 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . 0.625 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.68999999999999995 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.6400000000000001 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.97 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.34000000000000002 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 1.1000000000000001 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 1.0700000000000001 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.417 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.5 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.60999999999999999 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.507 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.3799999999999999 110.314 -177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 1.1699999999999999 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.1599999999999999 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.2999999999999998 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.69999999999999996 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.23 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.46 ' HD2' HD11 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.93999999999999995 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.6399999999999999 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.421 HG11 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 1.1100000000000001 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 1.0900000000000001 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 1.23 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.3899999999999999 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.32000000000000001 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.2799999999999998 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 1.0900000000000001 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 1.0600000000000001 111.761 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 2.0699999999999998 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 1.3100000000000001 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.651 HG22 HD11 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 1.0700000000000001 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 1.01 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.34999999999999998 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 1.3200000000000001 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.651 HD11 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 1.21 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.98999999999999999 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 1.49 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt -68.81 -38.23 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 1.1799999999999999 110.513 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.444 HD22 HG21 ' B' ' 379' ' ' ILE . 84.8 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.699 -0.667 . . . . 2.0699999999999998 110.926 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.919 0 N-CA-C 111.843 -0.503 . . . . 13.23 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -68.96 -37.69 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.326 0.584 . . . . 14.94 109.886 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.23 175.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.261 -1.014 . . . . 10.73 108.261 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -75.75 79.32 2.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.921 -0.77 . . . . 10.01 108.921 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.2 64.97 8.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.915 -1.039 . . . . 8.9399999999999995 110.425 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 362' ' ' SER . 9.9 m -147.28 128.05 14.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.407 -0.815 . . . . 5.6600000000000001 110.044 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -80.22 177.45 54.32 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.215 -0.993 . . . . 2.7799999999999998 111.135 174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . 0.531 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 -123.29 129.26 51.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.297 0.57 . . . . 1.74 111.155 -171.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.6699999999999999 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.2799999999999998 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.8300000000000001 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.8799999999999999 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.444 HG21 HD22 ' A' ' 400' ' ' LEU . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.1699999999999999 111.244 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.507 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 1.04 109.783 176.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.3599999999999999 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.69 -0.564 . . . . 4.6299999999999999 111.69 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.457 HG21 HG22 ' A' ' 333' ' ' THR . 19.5 t 52.9 67.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.623 0.725 . . . . 3.3500000000000001 109.731 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m -103.46 129.31 50.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.31 -0.859 . . . . 1.49 110.722 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.64000000000000001 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.46999999999999997 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 1.27 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.406 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 1.0700000000000001 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.822 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 2.0 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.471 ' HG2' HG13 ' A' ' 380' ' ' VAL . 86.4 mt-10 -78.62 109.51 12.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.69999999999999996 110.039 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -81.37 98.98 8.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.448 -0.575 . . . . 2.21 109.448 175.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 32.5 mtt -104.59 171.85 7.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.528 -0.76 . . . . 2.1800000000000002 110.316 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.851 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.23 162.05 28.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.786 -0.643 . . . . 2.7400000000000002 110.171 177.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.28 -35.38 4.87 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.519 -0.848 . . . . 2.0600000000000001 112.563 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . 0.453 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.1 pttm -153.01 167.93 27.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.745 0.307 . . . . 2.1000000000000001 110.592 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -87.13 -11.98 48.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 2.8799999999999999 111.232 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . 0.453 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 38.5 ttmt -83.16 139.62 33.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.473 -0.331 . . . . 2.5499999999999998 110.507 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.822 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp -89.74 141.83 28.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 1.3300000000000001 109.726 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 1.1799999999999999 110.976 -175.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.52000000000000002 111.654 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.93999999999999995 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 1.1200000000000001 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 1.3 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.28999999999999998 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 1.0800000000000001 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.457 HG22 HG21 ' A' ' 310' ' ' VAL . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 1.1899999999999999 110.294 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 2.1800000000000002 112.059 -173.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . 0.413 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.9299999999999999 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 1.1000000000000001 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.1699999999999999 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.8200000000000001 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 1.1100000000000001 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77000000000000002 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.48 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 1.4099999999999999 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 2.0800000000000001 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . 0.434 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 1.28 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 1.1399999999999999 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.6499999999999999 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65000000000000002 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52000000000000002 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.72 108.931 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.413 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 1.0900000000000001 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 1.1100000000000001 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.91000000000000003 110.825 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 1.1000000000000001 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.43 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 2.27 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.904 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 2.0600000000000001 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.499 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.5 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 1.1399999999999999 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 1.1200000000000001 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.3700000000000001 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.68999999999999995 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.6400000000000001 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.97 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.476 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.34000000000000002 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 1.1000000000000001 111.546 -178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.499 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 1.0700000000000001 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.43 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.5 110.789 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.60999999999999999 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.3799999999999999 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 1.1699999999999999 111.53 -176.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.1599999999999999 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.2999999999999998 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.69999999999999996 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.23 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.48 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.93999999999999995 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.6399999999999999 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.471 HG13 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 1.1100000000000001 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 1.0900000000000001 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 1.23 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.3899999999999999 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.32000000000000001 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.2799999999999998 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 1.0900000000000001 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.476 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 1.0600000000000001 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 2.0699999999999998 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 1.3100000000000001 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 1.0700000000000001 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 1.01 110.763 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.34999999999999998 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 1.3200000000000001 110.84 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.575 HG12 HD12 ' B' ' 379' ' ' ILE . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 1.21 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.98999999999999999 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 1.49 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.12 -36.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 1.1799999999999999 110.831 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.428 HD11 HG21 ' B' ' 379' ' ' ILE . 29.8 tp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.739 -0.648 . . . . 2.0699999999999998 110.437 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.947 -0.461 . . . . 13.23 111.947 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -106.03 -1.32 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.699 0.285 . . . . 14.94 111.02 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.5 m -106.75 44.79 1.02 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.054 0.454 . . . . 10.73 110.964 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.894 ' HE3' ' HB2' ' B' ' 376' ' ' GLU . 60.9 mttm -121.44 148.73 44.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 10.01 109.969 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.45 157.79 37.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.52 . . . . 8.9399999999999995 111.477 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.5 p -80.91 123.44 28.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.252 -0.431 . . . . 5.6600000000000001 110.294 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 123.33 -43.6 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.289 -0.724 . . . . 2.7799999999999998 111.289 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -124.47 103.95 8.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.357 -0.609 . . . . 1.74 109.357 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.6699999999999999 111.04 -169.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.904 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.2799999999999998 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . 0.558 ' C ' HD21 ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.8300000000000001 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.8799999999999999 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.575 HD12 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.1699999999999999 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 1.04 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.3599999999999999 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.647 -0.581 . . . . 4.6299999999999999 111.647 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . 0.849 HG12 HG21 ' A' ' 333' ' ' THR . 15.4 m -62.66 101.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.608 0.718 . . . . 3.3500000000000001 111.372 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m -104.26 126.26 51.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.748 -0.66 . . . . 1.49 110.021 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.605 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.64000000000000001 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.46999999999999997 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 1.27 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 1.0700000000000001 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.598 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 2.0 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 -77.76 122.16 25.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.454 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' LYS . . . . . 0.711 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.6 tptm -90.69 101.14 13.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.096 0.474 . . . . 2.21 110.039 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.3 mmt -100.28 157.11 16.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 2.1800000000000002 110.098 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LYS . . . . . 0.478 ' N ' ' HE3' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.29 162.64 29.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.922 -0.581 . . . . 2.7400000000000002 110.62 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.74 -32.49 7.46 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 2.0600000000000001 112.166 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -153.73 157.98 40.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.318 -0.623 . . . . 2.1000000000000001 109.318 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.711 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 55.1 m-80 -86.48 -14.31 43.51 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.003 -0.279 . . . . 2.8799999999999999 111.246 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -68.05 125.1 25.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 2.5499999999999998 110.16 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.34 150.32 26.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.786 -0.45 . . . . 1.3300000000000001 109.786 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 1.1799999999999999 110.621 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.52000000000000002 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.93999999999999995 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' LEU . . . . . 0.555 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 1.1200000000000001 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' LEU . . . . . 0.419 HD21 HD12 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 1.3 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.28999999999999998 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 1.0800000000000001 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' THR . . . . . 0.849 HG21 HG12 ' A' ' 310' ' ' VAL . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 1.1899999999999999 109.615 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 2.1800000000000002 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.9299999999999999 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 1.1000000000000001 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' MET . . . . . 0.501 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.1699999999999999 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.8200000000000001 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' VAL . . . . . 0.605 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 1.1100000000000001 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77000000000000002 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.48 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 1.4099999999999999 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 2.0800000000000001 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.425 HG23 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 1.28 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 1.1399999999999999 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' GLN . . . . . 0.416 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.6499999999999999 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65000000000000002 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52000000000000002 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.72 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' LEU . . . . . 0.589 HD22 HG21 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 1.0900000000000001 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 1.1100000000000001 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.91000000000000003 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 1.1000000000000001 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 2.27 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.596 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 2.0600000000000001 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' TRP . . . . . 0.459 ' HB3' HD21 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.5 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.718 ' HB2' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 1.1399999999999999 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 1.1200000000000001 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.3700000000000001 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.68999999999999995 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.6400000000000001 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' SER . . . . . 0.493 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.97 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' PHE . . . . . 0.466 ' HE1' ' HB1' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.34000000000000002 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' THR . . . . . 0.718 ' HB ' ' HB2' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 1.1000000000000001 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' LEU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 1.0700000000000001 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' ASP . . . . . 0.541 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.5 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.60999999999999999 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ASP . . . . . 0.734 ' H ' ' HH ' ' B' ' 380' ' ' TYR . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.3799999999999999 111.684 -173.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 1.1699999999999999 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.1599999999999999 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.2999999999999998 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.23 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' TYR . . . . . 0.598 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.93999999999999995 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.6399999999999999 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 1.1100000000000001 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLN . . . . . 0.598 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' THR . . . . . 0.493 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 1.0900000000000001 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 1.23 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.3899999999999999 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.32000000000000001 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . 0.454 ' HA ' ' HB2' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.2799999999999998 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.419 HD12 HD21 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 1.0900000000000001 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ALA . . . . . 0.466 ' HB1' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 1.0600000000000001 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 2.0699999999999998 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 1.3100000000000001 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ILE . . . . . 0.589 HG21 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 1.0700000000000001 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 1.01 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.34999999999999998 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' TYR . . . . . 0.466 ' CD2' ' HA ' ' A' ' 334' ' ' LYS . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 1.3200000000000001 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' ILE . . . . . 0.524 HG12 HD13 ' B' ' 379' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 1.21 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.98999999999999999 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 1.49 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt -74.53 -20.92 17.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 1.1799999999999999 110.826 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' LEU . . . . . 0.642 HD23 HG21 ' B' ' 379' ' ' ILE . 97.6 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.285 -0.864 . . . . 2.0699999999999998 111.488 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.765 -0.534 . . . . 13.23 111.765 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.15 179.94 7.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.018 -0.364 . . . . 14.94 110.018 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.2 m -98.5 94.19 6.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.201 -0.666 . . . . 10.73 109.201 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' LYS . . . . . 0.519 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -62.88 139.74 58.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.679 -0.489 . . . . 10.01 109.679 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' GLU . . . . . 0.535 ' HB3' ' HB2' ' B' ' 374' ' ' TRP . 7.4 mp0 -45.72 -61.27 1.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.978 0.799 . . . . 8.9399999999999995 112.431 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 103.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.767 0.667 . . . . 5.6600000000000001 111.361 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 98.39 -39.67 2.69 Favored Glycine 0 C--N 1.316 -0.531 0 C-N-CA 120.689 -0.767 . . . . 2.7799999999999998 111.265 -176.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' TRP . . . . . 0.535 ' HB2' ' HB3' ' B' ' 371' ' ' GLU . 94.3 m95 -92.05 121.24 33.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.171 0.51 . . . . 1.74 109.944 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.6699999999999999 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' GLU . . . . . 0.596 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.2799999999999998 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.8799999999999999 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 379' ' ' ILE . . . . . 0.642 HG21 HD23 ' A' ' 400' ' ' LEU . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.1699999999999999 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 380' ' ' TYR . . . . . 0.734 ' HH ' ' H ' ' A' ' 372' ' ' ASP . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 1.04 110.996 -177.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.3599999999999999 110.349 177.342 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.279 0.561 . . . . 1.06 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.52 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.41 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 0.3 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 1.44 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.7 110.557 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.671 -0.492 . . . . 0.69 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 0.51 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.46 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.712 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.78 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 0.37 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 0.57 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.29 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 0.36 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 0.38 110.853 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 1.61 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.1 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.32 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.08 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.55 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 0.31 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.712 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.06 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.92 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 1.5 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.58 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.65 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' TRP . . . . . 0.402 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52 110.857 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.043 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.31 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.83 110.78 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 396' ' ' ILE . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 0.38 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 1.75 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.778 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 1.75 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.467 ' HB3' HD23 ' A' ' 368' ' ' LEU . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.4 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 0.31 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 0.38 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.66 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.08 111.602 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.32 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.3 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 359' ' ' TRP . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 0.33 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.778 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.44 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.58 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.38 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE2' ' HD1' ' A' ' 351' ' ' TRP . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 0.79 110.26 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.09 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.3 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.7 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.06 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.423 ' HE2' HD13 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.47 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.06 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.33 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 0.42 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 0.55 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.27 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.28 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.29 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.28 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 1.99 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.509 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 396' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.435 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.29 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.35 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 0.7 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 392' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 0.45 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.99 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.81 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 0.72 110.53 -179.061 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 374' ' ' TRP . . . . . 0.467 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 121.281 0.562 . . . . 1.42 110.727 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.07 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.28 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.928 HD22 HG12 ' B' ' 379' ' ' ILE . 55.8 t30 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.83 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.88 113.511 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.928 HG12 HD22 ' B' ' 377' ' ' ASN . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.17 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 380' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 0.58 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.2 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.783 0.325 . . . . 1.06 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.52 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.41 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 0.72 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 0.3 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.624 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 1.44 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.7 110.869 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.624 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.0 -0.371 . . . . 0.69 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 0.51 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.46 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.861 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.78 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 0.37 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 0.57 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.29 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.721 HG21 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 0.36 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 0.38 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 1.61 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.1 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 0.32 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 347' ' ' VAL . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.08 111.52 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.654 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.55 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 0.31 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.861 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.06 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 0.92 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 1.5 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 338' ' ' MET . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.177 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.35 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.65 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.27 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 0.31 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.44 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.83 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.38 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 1.75 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 1.75 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.566 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.4 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 0.31 110.638 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.38 110.436 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.66 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.08 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.32 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.3 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 0.34 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 0.33 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.44 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.58 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.38 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.79 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.09 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.3 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.7 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.654 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.47 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.06 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 0.33 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG12 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 0.42 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 0.55 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.39 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.27 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.28 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.29 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 0.28 111.662 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.99 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.721 ' CD1' HG21 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 0.63 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 0.21 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.29 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.35 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 391' ' ' LEU . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.7 110.172 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 0.45 111.031 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.99 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 0.81 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 0.72 110.719 -178.539 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.42 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.07 110.371 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.28 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.789 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.83 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.88 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.789 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.17 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 0.58 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.2 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.134 0.493 . . . . 1.06 111.616 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.52 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.41 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.72 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.3 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 1.44 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.927 -176.575 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.9 mp . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.795 -0.446 . . . . 0.69 109.795 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.51 111.092 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.417 ' HB2' ' HG3' ' A' ' 342' ' ' GLU . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.46 111.505 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.78 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 0.37 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 0.57 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.29 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.584 HD13 HG13 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 0.36 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 0.38 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 1.61 111.837 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.1 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 0.32 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.08 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.4 ' HD3' ' CZ ' ' A' ' 378' ' ' TYR . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.55 110.461 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 0.31 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.06 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.92 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 1.5 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.58 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 0.35 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.65 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' TRP . . . . . 0.497 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.27 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 0.31 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 0.44 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.83 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.38 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 1.75 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 1.75 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.491 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.4 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 0.31 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.38 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.66 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.08 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.32 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.667 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.3 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.772 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 359' ' ' TRP . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 0.33 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.6 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.38 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 0.79 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.09 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.3 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.7 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.06 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.47 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 379' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.06 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 365' ' ' SER . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.732 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.551 ' HB ' HG12 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.39 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.27 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.28 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.29 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.667 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.28 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 1.99 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 0.63 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 0.21 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.35 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.48 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.7 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 353' ' ' LEU . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.99 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.81 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.72 111.977 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.349 0.595 . . . . 1.42 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.07 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.28 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.83 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.88 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 396' ' ' ILE . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.17 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.2 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.674 0.273 . . . . 1.06 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.556 ' HE1' HG21 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.52 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.41 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 0.72 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 0.3 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 1.44 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.7 110.927 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.891 0.377 . . . . 0.69 110.374 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 0.51 110.836 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.46 111.616 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.846 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 0.37 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 0.57 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.29 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 0.36 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 0.38 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 1.61 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.1 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 0.32 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.08 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.31 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.846 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.06 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 0.92 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 1.5 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 0.58 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 0.35 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.65 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.27 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.52 HD22 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 0.31 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.44 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.83 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 1.75 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 1.75 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.458 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.4 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.31 110.616 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 0.38 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.66 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.08 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.32 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.3 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 0.34 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.33 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.44 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.58 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.38 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 0.79 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.3 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.7 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.06 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.583 ' HD2' HD12 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.47 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.06 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 0.33 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 0.42 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 0.55 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.542 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.39 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.27 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.28 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.28 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 1.99 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.52 HG23 HD22 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.21 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.29 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.35 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.7 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.493 HG12 HD11 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.45 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.99 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 0.81 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 0.72 110.821 -179.299 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.253 0.549 . . . . 1.42 109.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.07 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.28 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.422 ' OD1' HG12 ' B' ' 379' ' ' ILE . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.83 109.766 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.88 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.493 HD11 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.17 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.58 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.2 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.764 -0.458 . . . . 1.06 109.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.485 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.52 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.41 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 0.72 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 0.3 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 1.44 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.7 110.766 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.341 -0.614 . . . . 0.69 109.341 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.51 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.46 110.875 173.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 0.57 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.29 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.36 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 0.38 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 1.61 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.1 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 0.32 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.47 ' HB2' HG13 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.08 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.55 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 0.31 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.06 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 0.92 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 1.5 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 0.58 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 0.35 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.65 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.27 109.327 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.581 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 0.31 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 0.44 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.83 111.178 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 0.38 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 1.75 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 1.75 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.689 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.4 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 0.31 110.755 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 389' ' ' ALA . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 0.38 110.793 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.66 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.08 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.32 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.3 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 0.34 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.33 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.58 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.38 110.787 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.79 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.09 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.3 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.7 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.06 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.585 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.47 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 0.33 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.416 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 0.42 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.27 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.28 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 0.29 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 0.28 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 0.63 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.581 HG23 HD22 ' A' ' 353' ' ' LEU . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 0.21 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.29 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 0.7 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.568 HG12 HD11 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 0.45 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.99 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 0.81 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 0.72 111.191 -175.096 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 1.42 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.07 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.28 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.83 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.88 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.568 HD11 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.17 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 0.58 109.032 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.2 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.241 0.543 . . . . 1.06 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.419 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.52 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.41 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.72 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 0.3 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 1.44 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.624 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.7 110.823 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.988 -0.375 . . . . 0.69 109.988 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 0.51 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.46 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.78 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 0.37 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.57 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.29 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 0.36 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 0.38 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 1.61 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.1 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 0.32 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.08 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.624 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.55 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.06 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 0.92 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 1.5 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 0.58 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 0.35 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.65 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.27 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 0.31 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 0.44 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.83 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 370' ' ' PHE . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 1.75 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.76 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 1.75 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.4 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 0.31 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.422 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.66 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.08 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.32 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.528 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.3 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.34 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.33 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.76 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.58 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.38 111.205 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 0.79 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.09 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.3 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.7 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.06 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.47 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.06 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 0.33 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 0.42 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.55 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.39 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.27 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.28 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.29 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.528 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 0.28 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 1.99 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.405 HD23 ' HB ' ' A' ' 332' ' ' ILE . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.63 110.649 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.21 109.982 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.29 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.35 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.7 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 377' ' ' ASN . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.99 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 0.72 111.434 -176.089 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 374' ' ' TRP . . . . . 0.417 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 83.0 m95 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.619 -0.512 . . . . 1.42 109.619 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.07 110.774 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.28 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.541 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.83 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.88 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.17 110.301 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 380' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 0.58 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.2 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.807 0.337 . . . . 1.06 111.816 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.52 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.41 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 0.72 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 0.3 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 1.44 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.507 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.7 110.971 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.842 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.945 -0.391 . . . . 0.69 109.945 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 0.51 111.205 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.46 111.383 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.78 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 0.37 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 0.57 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.29 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.407 HD13 HG13 ' A' ' 337' ' ' VAL . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 0.36 109.763 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 0.38 110.597 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 1.61 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.1 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 332' ' ' ILE . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 0.32 109.035 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.08 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.507 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.55 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.31 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.06 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 0.92 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 1.5 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 340' ' ' VAL . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 0.58 109.563 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.35 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.65 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.27 109.275 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.31 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.83 111.799 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.75 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 1.75 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.4 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 0.31 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 0.38 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 383' ' ' THR . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.66 113.355 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.08 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.32 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.3 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 0.34 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 0.33 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.467 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.58 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.38 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 0.79 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.09 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.7 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.06 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.548 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.47 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.06 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 0.33 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.42 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 0.55 110.399 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.39 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.27 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.28 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.29 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.28 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.99 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 0.63 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 0.21 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.29 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.7 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 0.45 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.99 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 0.81 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.72 110.254 179.231 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.194 0.521 . . . . 1.42 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.07 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.28 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.528 HD21 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.83 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.88 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.528 HG13 HD21 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.17 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 380' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 0.58 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 381' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.2 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.947 -0.39 . . . . 1.06 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.446 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.52 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.432 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.41 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 0.72 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 0.3 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 1.44 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.7 110.559 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.1 mp . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.234 -0.654 . . . . 0.69 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 0.51 111.106 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.46 111.235 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.78 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.37 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 0.57 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.29 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 0.36 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 0.38 110.005 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 1.61 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.1 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 0.32 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.08 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.55 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.446 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 0.31 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.06 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.92 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 1.5 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 0.58 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.65 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.27 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.66 HD13 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 0.31 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.44 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.83 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.486 HG21 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 0.38 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 1.75 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 1.75 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.4 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 0.31 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 0.38 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.66 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.08 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.32 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.609 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.3 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 0.34 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.33 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.44 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.58 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.38 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 0.79 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.09 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.3 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.7 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.06 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.47 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.33 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.461 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 0.42 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 0.55 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.39 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.27 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.28 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 0.29 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.609 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 0.28 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 1.99 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.532 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 0.63 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 0.21 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 0.29 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.35 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.7 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.66 HG13 HD13 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.45 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.99 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 0.81 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.72 111.18 -176.066 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.946 -0.39 . . . . 1.42 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.07 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.28 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.83 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.88 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.17 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 0.58 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.2 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.64 0.257 . . . . 1.06 110.647 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.71 ' HE1' HG21 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.52 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.41 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.72 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 0.3 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 1.44 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.7 110.793 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.554 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.571 -0.529 . . . . 0.69 109.571 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 0.51 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.46 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.795 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.78 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 0.37 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 0.57 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.29 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 395' ' ' TYR . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.527 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 1.61 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.1 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.427 HG13 HD13 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 0.32 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.08 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.55 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.71 HG21 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 0.31 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.795 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.06 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 344' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 0.92 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 1.5 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 0.58 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.65 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.27 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.31 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.83 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.38 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 1.75 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.767 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 1.75 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.668 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.4 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 0.31 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 0.38 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.66 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.08 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.32 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.514 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.3 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 0.34 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 0.33 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.58 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.38 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 0.79 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.09 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.3 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.7 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.47 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 0.33 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.411 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 0.42 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 0.55 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 385' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.27 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.28 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.436 HD12 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 0.28 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 1.99 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 0.63 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 0.21 110.362 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 0.29 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.35 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.483 ' CE2' HG22 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 0.7 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.484 HG12 HD11 ' B' ' 379' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 0.45 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.99 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 0.81 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 0.72 110.736 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.904 0.383 . . . . 1.42 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.07 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.28 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.83 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.88 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.484 HD11 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.17 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 0.58 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.2 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 110.214 -0.291 . . . . 1.06 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.52 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' PHE . . . . . 0.447 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.41 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 0.72 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 1.44 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.7 111.055 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.978 0.418 . . . . 0.69 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 0.51 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.46 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.78 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.37 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 0.57 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.29 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 0.36 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 0.38 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.1 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 0.32 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.08 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.55 110.207 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 0.31 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.793 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.06 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 0.92 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 1.5 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 0.58 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 0.35 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.65 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.27 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 0.31 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.44 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.83 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.429 HG21 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 0.38 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 1.75 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 1.75 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.429 ' HE3' HG21 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.4 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 0.31 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.535 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.66 112.102 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.08 110.611 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.32 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.3 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 0.34 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 0.33 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.505 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.532 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.58 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.38 110.655 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 0.79 111.006 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.09 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.7 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.06 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.47 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.06 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.33 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 0.42 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 0.55 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.538 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.39 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.27 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.28 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.29 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 0.28 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 1.99 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 0.63 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 0.21 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.29 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.35 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.7 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.45 111.44 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.99 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.81 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 0.72 111.285 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.109 0.48 . . . . 1.42 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.07 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.28 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.83 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.88 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.481 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 0.58 109.336 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 381' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.2 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.877 0.37 . . . . 1.06 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.52 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.41 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 0.72 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 1.44 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.7 111.418 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.604 -0.517 . . . . 0.69 109.604 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 0.51 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.46 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 341' ' ' ASP . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.78 110.222 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.047 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.57 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.29 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 0.36 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 0.38 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 1.61 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.1 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 0.32 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.08 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.459 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 0.31 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 328' ' ' ARG . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77 110.312 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.06 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 0.92 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 1.5 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.58 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.35 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.65 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 0.31 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.83 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 0.38 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 1.75 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 1.75 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.622 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.4 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 0.31 110.3 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.38 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.0 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.573 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.66 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.08 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.32 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.3 109.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 0.34 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.33 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.58 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.38 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.698 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 0.79 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.09 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.3 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.7 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.06 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.47 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.06 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 0.55 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.39 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.27 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.28 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.29 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 0.28 111.388 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 1.99 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.512 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.462 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 0.21 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.29 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.35 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.7 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 0.45 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.99 110.75 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.81 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 0.72 110.952 -177.794 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.42 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.476 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.07 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.28 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.581 HD21 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.83 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.88 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.581 HG13 HD21 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.17 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 0.58 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.2 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 311' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.594 0.235 . . . . 1.06 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.52 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.41 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 0.72 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 0.3 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 1.44 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.7 110.865 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.59 -0.522 . . . . 0.69 109.59 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.46 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.78 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 0.37 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 0.57 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.29 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HB ' HD23 ' A' ' 391' ' ' LEU . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 0.36 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 0.38 109.752 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.503 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 1.61 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.1 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 0.32 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.08 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.55 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.06 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 0.92 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 1.5 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 0.58 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 0.35 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.27 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 0.31 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 0.44 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.83 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 0.38 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.458 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 1.75 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.482 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.768 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.4 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 0.31 110.702 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 0.38 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.66 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.08 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.32 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.3 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 0.34 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 0.33 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.58 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.38 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 0.79 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.09 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.7 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.06 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.635 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.47 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 0.33 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.519 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.42 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.55 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.39 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.27 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.28 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.28 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 1.99 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 0.63 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 353' ' ' LEU . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 0.21 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 0.29 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.35 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.503 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 0.7 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 0.45 110.9 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.99 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.81 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.72 110.773 -179.792 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.7 m95 . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.42 109.024 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.07 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.28 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.83 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.88 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.17 111.14 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.58 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.2 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.828 0.346 . . . . 1.06 111.148 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.672 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.52 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.41 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 0.72 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 0.3 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 1.44 109.79 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.7 111.174 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.663 -0.495 . . . . 0.69 109.663 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.765 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.46 111.974 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.78 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 0.37 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.29 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 0.36 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.38 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 1.61 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 353' ' ' LEU . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.1 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 0.32 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.08 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.55 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.31 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.06 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 0.92 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 1.5 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 340' ' ' VAL . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 0.58 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 0.35 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 349' ' ' GLN . . . . . 0.523 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.65 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.27 108.883 171.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 399' ' ' ILE . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 0.31 112.066 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.83 110.585 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.38 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 1.75 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 1.75 109.812 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.4 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 0.31 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.66 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.08 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.32 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.462 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.3 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 0.34 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 0.33 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.58 112.408 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.38 110.409 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 0.79 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.09 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.3 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.7 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.06 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.613 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.47 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.06 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.33 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 0.42 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 0.55 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.39 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.27 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.28 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 0.29 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 0.28 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 1.99 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.578 HD23 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 0.63 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 396' ' ' ILE . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 0.21 110.26 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.065 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.35 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 0.7 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 392' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.45 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.99 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.81 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 0.72 110.741 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.42 111.745 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.452 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.07 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.28 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.83 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.88 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.629 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.17 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.58 110.132 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.2 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.922 -0.399 . . . . 1.06 109.922 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.52 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.41 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 0.72 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.3 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 1.44 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.529 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 83.3 mt-10 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.7 111.114 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.234 0.244 0 N-CA-C 109.953 -0.388 . . . . 0.69 109.953 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 0.51 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.46 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.865 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 0.37 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.466 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.57 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.29 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 0.36 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 0.38 110.255 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 1.61 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.1 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 0.32 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.08 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.55 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 0.31 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.865 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.06 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 0.92 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 1.5 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 0.58 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 0.35 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.65 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' TRP . . . . . 0.447 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.27 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.31 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.44 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.83 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 0.38 110.752 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 1.75 109.678 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 1.75 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.456 ' HB3' HD23 ' A' ' 368' ' ' LEU . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.4 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 0.31 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.38 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.66 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.08 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.32 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.3 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 0.34 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 0.33 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.44 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.58 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.38 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 0.79 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.09 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.3 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.7 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.06 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.7 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.47 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.06 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 0.33 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 0.42 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.55 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.573 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.39 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.27 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.28 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.573 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.29 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.481 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 0.28 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 1.99 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.63 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.57 HG23 HD22 ' A' ' 353' ' ' LEU . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 0.21 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.29 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.35 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 0.7 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.496 HG12 HD11 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.45 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.99 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 0.81 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 0.72 110.819 -178.916 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.42 110.602 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.07 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.28 111.074 -176.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.535 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.83 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.88 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.17 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 0.58 109.097 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.2 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.777 0.322 . . . . 1.06 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.408 ' HE1' HG21 ' A' ' 340' ' ' VAL . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.52 110.986 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.41 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.72 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 0.3 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.632 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 1.44 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.502 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.7 111.068 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.632 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.945 -0.761 . . . . 0.69 108.945 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.802 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.46 111.621 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.502 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.78 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.37 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.29 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.433 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 0.36 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 0.38 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.544 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 1.61 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.405 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.1 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 0.32 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.08 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.469 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.55 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 0.31 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.06 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.92 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 1.5 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 0.58 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 0.35 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.65 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.27 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.31 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.83 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.38 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 1.75 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 1.75 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.4 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.31 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.38 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.66 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.08 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.32 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.3 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 0.34 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 0.33 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.58 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.38 110.855 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 0.79 110.308 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.09 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.3 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.7 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.06 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.47 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.06 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 0.33 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 0.42 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 0.55 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.39 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.27 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.28 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.29 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.523 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 0.28 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 1.99 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.508 HG22 HD12 ' A' ' 396' ' ' ILE . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 0.21 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.29 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.35 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 0.7 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 392' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 0.45 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.99 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 0.81 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.72 110.936 -178.079 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.175 0.512 . . . . 1.42 110.293 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.427 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.07 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.28 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.439 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.83 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.88 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.17 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 0.58 109.105 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.2 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.977 0.417 . . . . 1.06 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.52 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.41 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 0.72 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 0.3 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 1.44 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.7 111.236 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.732 -0.47 . . . . 0.69 109.732 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 0.51 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.46 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.78 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 0.37 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.57 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.29 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 0.36 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 0.38 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 1.61 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.1 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.32 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.08 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.55 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 0.31 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.06 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 0.92 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 1.5 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 0.58 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.35 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.65 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' TRP . . . . . 0.413 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.27 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 0.31 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 0.44 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.83 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 0.38 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 1.75 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.572 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.4 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 0.31 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 0.38 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.66 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.08 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.32 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.3 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 0.34 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.58 112.966 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.38 111.027 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 0.79 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.09 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.7 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.06 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.47 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.06 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 0.33 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 0.42 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.55 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.39 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.27 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.28 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 0.29 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.434 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 0.28 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 1.99 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 0.63 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 396' ' ' ILE . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 0.21 110.064 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.35 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 0.7 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 392' ' ' ILE . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 0.45 110.94 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.99 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 0.72 111.358 -175.505 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 374' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 358' ' ' ARG . 66.8 m95 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 1.42 112.157 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.07 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.28 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.487 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.83 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.88 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.17 111.551 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 0.58 110.069 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.2 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.128 0.489 . . . . 1.06 109.706 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.52 110.668 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.41 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 0.72 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 0.3 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 1.44 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.7 111.839 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.948 -0.39 . . . . 0.69 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 0.51 111.152 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.46 111.744 176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.916 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.78 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 0.37 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 0.57 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.29 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 337' ' ' VAL . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 0.36 110.053 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 0.38 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 1.61 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.434 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.1 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 332' ' ' ILE . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.338 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.08 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.55 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 0.31 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.916 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.06 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 0.92 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 1.5 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 0.58 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' GLN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.65 110.067 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.27 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.502 HD22 HG23 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.31 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.83 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 0.38 110.016 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 1.75 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 1.75 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.472 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.4 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 0.38 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 365' ' ' SER . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.0 109.627 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.66 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.08 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.444 ' H ' ' HB2' ' A' ' 362' ' ' SER . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.32 111.345 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.3 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 0.34 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.33 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.58 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.38 110.63 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 0.79 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.09 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.3 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.7 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.06 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.47 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.06 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.33 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 0.42 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 383' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 0.55 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.27 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.479 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.28 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.29 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.28 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 1.99 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 0.63 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.502 HG23 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 0.21 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.29 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.35 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.7 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 0.45 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.99 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 0.81 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.72 111.086 -177.275 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.42 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.472 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.07 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.28 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.443 HD21 HG13 ' B' ' 379' ' ' ILE . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.83 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.88 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.49 ' O ' HG13 ' B' ' 379' ' ' ILE . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.17 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 380' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 354' ' ' THR . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 0.58 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.2 110.464 176.834 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.64 0.257 . . . . 1.06 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.537 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.52 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.41 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 0.72 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.3 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 1.44 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 380' ' ' VAL . 65.0 mt-10 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.7 110.205 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.697 0.284 . . . . 0.69 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 0.51 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.46 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' ARG . . . . . 0.678 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.78 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 0.37 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 0.57 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.29 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 0.36 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 0.38 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 1.61 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.1 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 0.32 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.08 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.435 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.55 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.06 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.92 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 1.5 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 0.58 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.35 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.65 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' TRP . . . . . 0.435 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.31 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 0.44 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.83 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 0.38 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.75 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.538 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 1.75 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.4 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 0.31 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 0.38 111.197 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 362' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.66 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.08 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.32 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.3 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 0.34 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.58 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.38 110.314 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 0.79 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.09 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.3 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.7 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.06 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.473 ' HD2' HD12 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.47 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 379' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.06 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 0.33 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 0.42 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 0.55 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 384' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.39 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.27 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.28 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.445 HD13 HD23 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.29 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.761 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 1.99 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.63 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 0.21 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 0.29 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.35 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.7 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.45 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.99 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.81 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.72 110.513 178.934 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 374' ' ' TRP . . . . . 0.538 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 . . . . . 0 CA--C 1.512 -0.51 0 CA-C-O 121.297 0.57 . . . . 1.42 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.07 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.28 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.83 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.88 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.17 111.244 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 0.58 109.783 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.2 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.528 0.204 . . . . 1.06 110.722 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.52 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.41 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 0.72 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 0.3 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.85 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 1.44 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.47 ' HG2' HG12 ' A' ' 380' ' ' VAL . 86.4 mt-10 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.039 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.85 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.726 -0.472 . . . . 0.69 109.726 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.51 110.976 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.46 111.654 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.78 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 0.37 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.57 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.29 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.36 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 0.38 110.294 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 1.61 112.059 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLU . . . . . 0.417 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.1 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 0.32 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.08 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.55 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.06 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.92 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 1.5 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' GLU . . . . . 0.495 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 0.58 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.65 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.27 108.931 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 0.31 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.83 110.825 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 0.38 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LYS . . . . . 0.433 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 1.75 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.924 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 1.75 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.4 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 0.31 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 0.38 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.66 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.32 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.3 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 0.34 111.546 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.33 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.789 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.58 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.38 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 373' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.79 111.53 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.09 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.3 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.7 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.06 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.47 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.06 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.33 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.42 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.55 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.27 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.28 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.29 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.513 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 0.28 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 1.99 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 0.63 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 0.21 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' ALA . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.29 110.763 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.35 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 0.7 110.84 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' B' ' 377' ' ' ASN . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.45 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.99 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 0.81 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 0.72 110.831 -178.356 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.357 -0.609 . . . . 1.42 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 375' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 359' ' ' TRP . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.07 111.04 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.28 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 377' ' ' ASN . . . . . 0.572 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.83 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.88 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.474 HD11 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.17 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 380' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 0.58 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.2 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.021 -0.363 . . . . 1.06 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.52 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.41 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 0.72 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 327' ' ' PRO . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 0.3 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 1.44 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.454 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.786 -0.45 . . . . 0.69 109.786 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 0.51 110.621 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.46 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.78 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 0.37 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 0.57 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.29 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 0.36 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 0.38 109.615 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 1.61 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.1 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 0.32 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.08 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.55 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 0.31 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' GLU . . . . . 0.565 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.06 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 1.5 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 0.58 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 0.35 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' GLN . . . . . 0.479 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.65 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.27 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 0.31 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 0.44 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.83 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 0.38 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 1.75 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 1.75 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' TRP . . . . . 0.489 ' HB3' HD23 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.4 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.31 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 0.38 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.66 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.08 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 365' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.32 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' PHE . . . . . 0.498 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.3 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 0.34 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.44 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.58 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.38 111.684 -173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 0.79 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.09 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.3 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.06 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 378' ' ' TYR . . . . . 0.611 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.47 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.06 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 0.33 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 0.42 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.55 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.39 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.27 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLU . . . . . 0.451 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.28 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 388' ' ' ILE . . . . . 0.437 HD13 HD23 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 0.29 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ALA . . . . . 0.498 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 0.28 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 1.99 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 0.63 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 392' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 0.21 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 0.29 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.35 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 395' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 334' ' ' LYS . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.7 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 396' ' ' ILE . . . . . 0.485 HD12 HG22 ' A' ' 392' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.45 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.99 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 0.81 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.72 110.826 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.171 0.51 . . . . 1.42 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.07 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 376' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.28 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.83 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.88 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 379' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 396' ' ' ILE . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.17 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 0.58 110.996 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.2 110.349 177.342 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 333' ' ' THR . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.131 -0.387 . . . . 4.12 112.131 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.52 -8.85 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.624 0.25 . . . . 2.92 111.196 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p -84.72 95.99 9.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.561 . . . . 1.06 110.97 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.52 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.41 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 0.3 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 1.44 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 -90.53 127.44 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.7 110.557 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -100.22 100.42 11.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.292 0.568 . . . . 1.74 110.117 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.3 mmm -110.84 171.0 7.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.502 -0.772 . . . . 1.68 109.1 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.759 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.3 177.32 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.885 -0.413 . . . . 2.3 109.885 175.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.7 -35.7 4.57 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.904 -0.878 . . . . 1.93 110.904 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -155.54 157.71 37.29 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.139 -0.689 . . . . 1.68 109.139 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -87.31 -6.17 58.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.935 0.398 . . . . 2.79 110.647 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.4 tttt -76.3 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 2.01 110.836 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp -73.27 130.99 41.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.077 -0.511 . . . . 0.69 109.671 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 0.51 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.46 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.712 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.78 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 0.37 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 0.57 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.29 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 0.36 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.469 HG22 ' HA3' ' A' ' 309' ' ' GLY . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 0.38 110.853 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 1.61 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.1 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.32 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.08 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.55 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 0.31 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.712 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.06 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.92 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 1.5 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.58 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.65 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' TRP . . . . . 0.402 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52 110.857 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.043 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.31 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.83 110.78 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 396' ' ' ILE . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 0.38 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 1.75 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.778 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 1.75 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.467 ' HB3' HD23 ' A' ' 368' ' ' LEU . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.4 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 0.31 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 0.38 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.66 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.08 111.602 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.32 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.3 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 359' ' ' TRP . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 0.33 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.778 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.44 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.58 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.38 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE2' ' HD1' ' A' ' 351' ' ' TRP . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 0.79 110.26 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.09 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.3 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.7 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.06 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.423 ' HE2' HD13 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.47 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.06 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.33 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 0.42 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 0.55 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.27 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.28 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.29 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.28 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 1.99 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.509 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 396' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.435 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.29 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.35 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 0.7 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 392' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 0.45 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.99 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.81 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.22 -27.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 0.72 110.53 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 25.2 tp . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.379 -0.819 . . . . 1.56 110.483 -175.97 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.293 -0.323 . . . . 12.98 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -116.43 106.76 13.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.035 -0.357 . . . . 14.53 110.035 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 44.5 p -84.95 157.3 20.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.681 0.277 . . . . 10.62 110.7 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -140.37 42.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.832 0.825 . . . . 9.78 109.288 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.35 -58.03 10.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.385 -1.28 . . . . 8.94 111.938 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 12.7 p -90.73 142.11 28.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.838 0.351 . . . . 5.29 110.686 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 90.7 -49.22 3.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.993 -0.622 . . . . 2.37 112.551 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.467 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 -95.67 119.24 33.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.281 0.562 . . . . 1.42 110.727 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.07 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.28 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.928 HD22 HG12 ' B' ' 379' ' ' ILE . 55.8 t30 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.83 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.88 113.511 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.928 HG12 HD22 ' B' ' 377' ' ' ASN . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.17 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 380' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 0.58 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.2 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.697 -0.561 . . . . 4.12 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.29 107.48 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.398 -0.593 . . . . 2.92 109.398 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m -81.77 113.25 19.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 1.06 111.033 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.52 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.41 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 0.72 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 0.3 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.624 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 1.44 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 -76.81 124.6 27.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.7 110.869 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -90.27 103.96 16.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 1.74 109.554 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.5 mmm -112.19 -159.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 1.68 110.244 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.761 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -111.99 167.3 10.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.209 -0.45 . . . . 2.3 110.234 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.64 -20.23 48.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.93 -0.653 . . . . 1.93 112.571 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -161.67 166.57 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.995 -0.372 . . . . 1.68 109.995 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -97.81 -9.06 27.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.8 0.333 . . . . 2.79 110.608 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.64 120.86 18.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 2.01 110.04 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.624 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp -83.99 131.3 34.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.302 -0.408 . . . . 0.69 110.0 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 0.51 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.46 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.861 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.78 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 0.37 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 0.57 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.29 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.721 HG21 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 0.36 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 0.38 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 1.61 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.1 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 0.32 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 347' ' ' VAL . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.08 111.52 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.654 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.55 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 0.31 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.861 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.06 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 0.92 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 1.5 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 338' ' ' MET . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.177 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.35 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.65 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.27 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 0.31 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.44 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.83 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.38 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 1.75 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 1.75 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.566 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.4 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 0.31 110.638 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.38 110.436 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.66 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.08 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.32 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.3 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 0.34 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 0.33 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.44 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.58 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.38 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.79 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.09 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.3 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.7 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.654 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.47 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.06 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 0.33 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG12 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 0.42 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 0.55 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.39 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.27 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.28 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.29 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 0.28 111.662 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.99 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.721 ' CD1' HG21 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 0.63 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 0.21 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.29 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.35 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 391' ' ' LEU . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.7 110.172 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 0.45 111.031 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.99 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 0.81 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.21 -26.07 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 0.72 110.719 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.4 HD21 HG23 ' B' ' 379' ' ' ILE . 98.1 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.535 -0.745 . . . . 1.56 110.822 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.638 -0.585 . . . . 12.98 111.638 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -85.76 -76.72 0.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.812 -0.228 . . . . 14.53 110.847 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' B' ' 370' ' ' LYS . 12.7 p -174.06 33.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 10.62 111.13 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.683 ' HD2' ' H ' ' B' ' 369' ' ' SER . 0.0 OUTLIER -149.41 108.62 3.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.654 -0.703 . . . . 9.78 109.881 -177.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 371' ' ' GLU . . . . . 0.636 ' O ' HG22 ' B' ' 375' ' ' VAL . 37.3 mt-10 -112.05 -88.82 0.52 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 8.94 112.0 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 24.3 m -75.85 144.75 41.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.206 0.527 . . . . 5.29 111.889 -174.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 87.98 -72.45 2.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.671 -0.695 . . . . 2.37 111.953 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -110.43 104.68 13.46 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.42 109.338 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 371' ' ' GLU . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.07 110.371 -171.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.28 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.789 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.83 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.88 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.789 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.17 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 0.58 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.2 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.924 -0.471 . . . . 4.12 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.1 t 72.33 -69.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.026 0.53 . . . . 2.92 111.502 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p -80.71 102.75 10.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.134 0.493 . . . . 1.06 111.616 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.52 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.41 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.72 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.3 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 1.44 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -90.1 127.4 36.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.927 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.726 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.3 tptp -89.83 89.69 7.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 1.74 110.016 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 92.5 mmm -103.47 173.82 6.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.777 -0.647 . . . . 1.68 110.067 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -67.15 166.96 12.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 2.3 111.003 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.22 -42.72 1.86 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.963 -0.637 . . . . 1.93 112.37 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.5 pttm -157.3 166.0 34.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.534 -0.173 . . . . 1.68 110.534 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 37.1 p30 -84.4 -7.49 59.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 2.79 111.117 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.4 ttmt -74.39 143.21 44.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.107 -0.497 . . . . 2.01 110.342 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.9 mp -95.01 117.65 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 0.69 109.795 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.51 111.092 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.417 ' HB2' ' HG3' ' A' ' 342' ' ' GLU . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.46 111.505 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.78 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 0.37 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 0.57 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.29 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.584 HD13 HG13 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 0.36 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 0.38 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 1.61 111.837 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.1 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 0.32 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.08 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.4 ' HD3' ' CZ ' ' A' ' 378' ' ' TYR . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.55 110.461 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 0.31 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.06 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.92 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 1.5 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.58 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 0.35 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.65 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' TRP . . . . . 0.497 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.27 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 0.31 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 0.44 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.83 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.38 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 1.75 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 1.75 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.491 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.4 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 0.31 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.38 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.66 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.08 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.32 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.667 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.3 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.772 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 359' ' ' TRP . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 0.33 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.6 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.38 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 0.79 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.09 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.3 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.7 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.06 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.47 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 379' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.06 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 365' ' ' SER . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.732 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.551 ' HB ' HG12 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.39 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.27 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.28 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.29 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.667 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.28 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 1.99 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 0.63 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 0.21 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.35 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.48 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.7 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 353' ' ' LEU . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.99 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.81 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt -70.75 -58.59 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.72 111.977 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' B' ' 379' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 120.224 -0.59 . . . . 1.56 111.842 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' B' ' 368' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.88 -0.488 . . . . 12.98 111.88 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' B' ' 368' ' ' ARG . 11.2 mmm-85 -124.95 -157.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 14.53 109.276 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 50.2 m 63.29 30.45 15.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.421 0.629 . . . . 10.62 111.353 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -170.43 78.1 0.08 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.105 . . . . 9.78 109.42 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.83 150.78 52.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.551 -0.749 . . . . 8.94 110.709 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.7 t -177.29 150.76 0.74 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 5.29 109.703 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 83.02 -61.58 4.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.209 -0.519 . . . . 2.37 113.282 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -86.46 117.27 25.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.349 0.595 . . . . 1.42 111.728 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.07 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.28 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.83 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.88 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.75 HG23 ' HG ' ' A' ' 400' ' ' LEU . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.17 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.2 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.958 -0.457 . . . . 4.12 111.958 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.48 -59.88 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.35 . . . . 2.92 111.183 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m -92.12 119.02 31.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.223 -0.444 . . . . 1.06 111.141 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.556 ' HE1' HG21 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.52 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.41 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 0.72 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 0.3 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 1.44 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 -79.41 123.12 27.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.7 110.927 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.5 tptm -104.05 116.21 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.08 -0.509 . . . . 1.74 109.901 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 69.8 mtm -135.09 -173.23 3.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.556 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.92 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.85 167.24 22.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 2.3 110.859 178.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.51 -52.86 0.75 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.886 -0.674 . . . . 1.93 112.181 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.71 168.84 19.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.292 -0.262 . . . . 1.68 110.292 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 8.9 p30 -97.17 -3.45 40.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 2.79 110.596 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -81.55 126.14 31.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 2.01 109.981 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp -87.93 134.23 33.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.69 110.374 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 0.51 110.836 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.46 111.616 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.846 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 0.37 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 0.57 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.29 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 0.36 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 0.38 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 1.61 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.1 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 0.32 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.08 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.31 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.846 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.06 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 0.92 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 1.5 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 0.58 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 0.35 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.65 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.27 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.52 HD22 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 0.31 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.44 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.83 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 1.75 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 1.75 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.458 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.4 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.31 110.616 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 0.38 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.66 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.08 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.32 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.3 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 0.34 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.33 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.44 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.58 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.38 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 0.79 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.3 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.7 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.06 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.583 ' HD2' HD12 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.47 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.06 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 0.33 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 0.42 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 0.55 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.542 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.39 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.27 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.28 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.28 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 1.99 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.52 HG23 HD22 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.21 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.29 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.35 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.7 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.493 HG12 HD11 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.45 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.99 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 0.81 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt -72.25 -33.44 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 0.72 110.821 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.488 -0.767 . . . . 1.56 111.25 -179.687 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 112.065 -0.414 . . . . 12.98 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 56.4 64.19 1.76 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.447 0.641 . . . . 14.53 110.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 15.7 m -132.15 120.56 22.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.783 -0.644 . . . . 10.62 110.164 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 61.17 87.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.833 0.708 . . . . 9.78 110.582 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -55.67 -46.64 77.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 8.94 111.125 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 14.9 m -94.62 68.76 3.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.948 0.88 . . . . 5.29 109.8 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -110.46 23.45 20.26 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.524 -1.216 . . . . 2.37 111.386 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -115.05 110.6 19.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.253 0.549 . . . . 1.42 109.971 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.07 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.28 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.422 ' OD1' HG12 ' B' ' 379' ' ' ILE . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.83 109.766 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.88 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.493 HD11 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.17 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.58 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.2 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.956 -0.457 . . . . 4.12 111.956 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.87 111.21 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.72 0.295 . . . . 2.92 110.627 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m -87.5 110.62 20.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.764 -0.458 . . . . 1.06 109.764 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.485 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.52 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.41 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 0.72 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 0.3 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 1.44 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 -76.26 126.73 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.7 110.766 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 24.0 tptp -109.55 101.87 10.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.303 0.573 . . . . 1.74 109.884 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.3 mtm -125.95 174.69 8.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.516 -0.766 . . . . 1.68 109.637 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.849 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -64.08 160.24 18.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.153 0.501 . . . . 2.3 110.862 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.88 -41.44 2.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.865 -0.683 . . . . 1.93 112.0 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.7 pttm -161.26 163.93 30.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.416 0.627 . . . . 1.68 110.552 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.433 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 20.2 p-10 -83.55 -17.11 42.89 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.755 -1.111 . . . . 2.79 111.097 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 83.8 tttt -70.42 123.11 20.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.477 . . . . 2.01 110.838 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -77.74 110.2 12.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.341 -0.614 . . . . 0.69 109.341 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.51 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.46 110.875 173.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 0.57 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.29 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.36 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 0.38 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 1.61 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.1 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 0.32 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.47 ' HB2' HG13 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.08 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.55 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 0.31 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.06 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 0.92 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 1.5 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 0.58 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 0.35 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.65 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.27 109.327 171.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.581 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 0.31 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 0.44 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.83 111.178 -177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 0.38 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 1.75 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 1.75 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.689 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.4 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 0.31 110.755 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 389' ' ' ALA . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 0.38 110.793 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.66 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.08 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.32 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.3 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 0.34 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.33 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.58 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.38 110.787 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.79 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.09 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.3 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.7 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.06 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.585 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.47 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 0.33 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.416 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 0.42 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.27 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.28 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 0.29 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 0.28 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 0.63 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.581 HG23 HD22 ' A' ' 353' ' ' LEU . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 0.21 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.29 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 0.7 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.568 HG12 HD11 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 0.45 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.99 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 0.81 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.6 -21.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 0.72 111.191 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 396' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.933 -0.556 . . . . 1.56 109.941 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.578 -0.609 . . . . 12.98 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 368' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' B' ' 368' ' ' ARG . 8.1 mmt180 55.65 86.73 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.865 0.364 . . . . 14.53 111.42 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 11.8 m -52.91 119.45 4.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.841 -0.618 . . . . 10.62 111.562 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -97.59 109.6 22.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.398 -0.964 . . . . 9.78 108.398 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -83.91 89.33 7.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.826 -0.625 . . . . 8.94 112.173 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 m -127.05 142.42 51.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.71 -0.677 . . . . 5.29 109.195 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 105.99 -41.53 2.15 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.116 -0.794 . . . . 2.37 111.116 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -128.68 131.87 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.355 -0.609 . . . . 1.42 109.355 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.07 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.28 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.83 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.88 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.568 HD11 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.17 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 0.58 109.032 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.2 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.155 -0.378 . . . . 4.12 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 14.3 p -116.44 -14.9 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.35 0.595 . . . . 2.92 110.166 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m -77.47 86.94 3.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.944 -0.571 . . . . 1.06 110.882 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.419 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.52 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.41 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.72 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 0.3 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 1.44 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.624 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 -89.44 135.73 33.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.7 110.823 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -89.24 86.44 6.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.377 -0.601 . . . . 1.74 109.377 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 85.3 mtp -106.76 157.03 18.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.415 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.933 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.36 161.55 30.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.394 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -24.16 10.52 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.798 -0.921 . . . . 1.93 110.798 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -167.79 169.12 11.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.676 -0.861 . . . . 1.68 108.676 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -92.6 -4.48 53.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.01 0.433 . . . . 2.79 110.984 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.494 ' NZ ' ' HB2' ' A' ' 324' ' ' LYS . 5.0 ttmp? -87.08 137.46 32.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.984 -0.553 . . . . 2.01 110.491 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp -73.82 130.5 40.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.248 -0.433 . . . . 0.69 109.988 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 0.51 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.46 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.78 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 0.37 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.57 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.29 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 0.36 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 0.38 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 1.61 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.1 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 0.32 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.08 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.624 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.55 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.06 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 0.92 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 1.5 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 0.58 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 0.35 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.65 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.27 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 0.31 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 0.44 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.83 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 370' ' ' PHE . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 1.75 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.76 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 1.75 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.4 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 0.31 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.422 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.66 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.08 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.32 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.528 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.3 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.34 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.33 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.76 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.58 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.38 111.205 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 0.79 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.09 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.3 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.7 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.06 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.47 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.06 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 0.33 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 0.42 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.55 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.39 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.27 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.28 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.29 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.528 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 0.28 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 1.99 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.405 HD23 ' HB ' ' A' ' 332' ' ' ILE . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.63 110.649 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.21 109.982 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.29 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.35 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.7 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 377' ' ' ASN . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.99 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt -63.59 -42.15 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 0.72 111.434 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.573 -0.727 . . . . 1.56 110.571 -175.139 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 111.734 -0.546 . . . . 12.98 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 70.78 -62.71 0.44 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.254 0.622 . . . . 14.53 110.841 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.3 m -78.89 147.67 33.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.416 -0.356 . . . . 10.62 110.053 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' B' ' 374' ' ' TRP . 0.0 OUTLIER -150.23 150.99 32.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.177 -0.305 . . . . 9.78 110.177 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -68.2 -1.67 6.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.66 0.985 . . . . 8.94 113.66 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 4.2 m -70.86 142.95 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 5.29 111.129 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -66.01 -28.91 74.05 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.042 -0.526 . . . . 2.37 112.208 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.552 ' O ' ' HE3' ' B' ' 370' ' ' LYS . 83.0 m95 -97.3 123.57 41.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.619 -0.512 . . . . 1.42 109.619 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.459 ' HA ' ' HE3' ' B' ' 370' ' ' LYS . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.07 110.774 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.28 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.541 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.83 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.88 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.17 110.301 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 380' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 0.58 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.2 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.126 -0.39 . . . . 4.12 112.126 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 333' ' ' THR . 13.2 p -133.44 154.5 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.615 -0.513 . . . . 2.92 109.615 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m -77.78 111.28 13.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.807 0.337 . . . . 1.06 111.816 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.52 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.41 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 0.72 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 0.3 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 1.44 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.507 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 -75.82 123.12 25.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.7 110.971 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -100.63 107.92 19.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.259 -0.645 . . . . 1.74 109.259 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 26.4 mtt -120.06 159.8 24.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.41 -0.359 . . . . 1.68 110.587 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -59.86 157.96 11.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 2.3 110.737 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.63 -28.54 14.52 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.75 -0.738 . . . . 1.93 112.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.9 pttm -155.67 168.79 26.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.687 0.28 . . . . 1.68 110.334 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.654 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.2 m-80 -101.28 -11.98 19.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 2.79 110.158 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.7 tttt -70.8 138.15 50.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.277 -0.874 . . . . 2.01 110.147 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.842 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp -102.43 143.38 32.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.945 -0.391 . . . . 0.69 109.945 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 0.51 111.205 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.46 111.383 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.78 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 0.37 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 0.57 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.29 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.407 HD13 HG13 ' A' ' 337' ' ' VAL . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 0.36 109.763 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.427 HG22 ' CG2' ' A' ' 310' ' ' VAL . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 0.38 110.597 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 1.61 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.1 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 332' ' ' ILE . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 0.32 109.035 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.08 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.507 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.55 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.31 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.06 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 0.92 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 1.5 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 340' ' ' VAL . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 0.58 109.563 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.35 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.65 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.27 109.275 173.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.31 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.83 111.799 -174.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.75 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 1.75 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.4 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 0.31 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 0.38 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 383' ' ' THR . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.66 113.355 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.08 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.32 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.3 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 0.34 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 0.33 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.467 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.58 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.38 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 0.79 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.09 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.7 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.06 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.548 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.47 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.06 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 0.33 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.42 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 0.55 110.399 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.39 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.27 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.28 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.29 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.28 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.99 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 0.63 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 0.21 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.29 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.7 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 0.45 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.99 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 0.81 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.19 -30.67 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.72 110.254 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.456 HD21 HG23 ' B' ' 379' ' ' ILE . 93.7 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.402 -0.809 . . . . 1.56 110.65 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.795 -0.522 . . . . 12.98 111.795 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 62.14 17.38 9.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.615 0.598 . . . . 14.53 112.615 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 6.9 m -94.57 100.67 12.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.984 -0.376 . . . . 10.62 109.984 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 370' ' ' LYS . 13.3 ptmm? -55.08 131.68 45.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.977 -0.556 . . . . 9.78 110.486 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.04 144.37 28.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.945 -0.571 . . . . 8.94 111.49 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.2 t -114.8 41.46 2.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.564 1.173 . . . . 5.29 108.891 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -77.8 -54.5 4.52 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 113.256 -1.793 . . . . 2.37 111.623 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -95.86 111.23 23.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.194 0.521 . . . . 1.42 110.339 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.07 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.28 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.528 HD21 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.83 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.88 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.528 HG13 HD21 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.17 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 380' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 0.58 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 381' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.2 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.047 -0.421 . . . . 4.12 112.047 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 333' ' ' THR . 6.9 p -102.28 126.9 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.049 0.452 . . . . 2.92 110.561 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m -103.75 126.46 50.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.261 -0.427 . . . . 1.06 109.947 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.446 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.52 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.432 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.41 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 0.72 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 0.3 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 1.44 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.3 116.29 16.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.7 110.559 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 26.5 tptp -106.35 107.82 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.615 -0.513 . . . . 1.74 109.615 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 45.4 mtt -118.36 -170.41 1.88 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.781 -0.645 . . . . 1.68 110.252 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.921 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.67 177.55 8.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 2.3 110.327 176.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 89.37 -47.13 3.26 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.924 -0.655 . . . . 1.93 113.022 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -143.76 156.79 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 1.68 111.074 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.478 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -91.43 4.08 53.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.784 -0.644 . . . . 2.79 111.144 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -86.27 124.09 32.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.278 -0.419 . . . . 2.01 110.544 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.1 mp -83.93 124.51 31.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.234 -0.654 . . . . 0.69 109.234 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 0.51 111.106 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.46 111.235 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.78 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.37 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 0.57 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.29 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 0.36 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.452 HG22 ' HB ' ' A' ' 310' ' ' VAL . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 0.38 110.005 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 1.61 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.1 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 0.32 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.08 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.55 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.446 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 0.31 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.06 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.92 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 1.5 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 0.58 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.65 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.27 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.66 HD13 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 0.31 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.44 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.83 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.486 HG21 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 0.38 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 1.75 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 1.75 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.4 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 0.31 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 0.38 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.66 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.08 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.32 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.609 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.3 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 0.34 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.33 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.44 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.58 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.38 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 0.79 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.09 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.3 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.7 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.06 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.47 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.33 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.461 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 0.42 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 0.55 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.39 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.27 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.28 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 0.29 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.609 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 0.28 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 1.99 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.532 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 0.63 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 0.21 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 0.29 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.35 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.7 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.66 HG13 HD13 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.45 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.99 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 0.81 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.41 -26.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.72 111.18 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 396' ' ' ILE . 2.2 mm? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.719 -0.658 . . . . 1.56 109.965 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.438 ' O ' ' HE3' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.969 -0.452 . . . . 12.98 111.969 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -105.21 9.63 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.766 0.284 . . . . 14.53 111.766 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 8.5 t -124.0 91.62 3.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.252 0.549 . . . . 10.62 111.525 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' B' ' 367' ' ' GLY . 0.0 OUTLIER -135.79 34.55 2.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.841 0.829 . . . . 9.78 109.333 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 105.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.141 -1.391 . . . . 8.94 110.116 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 11.2 m -117.96 145.64 44.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 5.29 111.025 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.05 0.8 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.102 -0.571 . . . . 2.37 111.955 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -119.76 142.03 48.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.946 -0.39 . . . . 1.42 109.946 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.07 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.28 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.83 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.88 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.17 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 0.58 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.2 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 CA-C-O 120.007 -0.329 . . . . 4.12 112.38 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 333' ' ' THR . 17.4 m 34.33 70.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.562 1.145 . . . . 2.92 113.886 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m -103.92 127.28 51.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.647 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.71 ' HE1' HG21 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.52 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.41 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.72 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 0.3 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 1.44 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 -80.76 115.7 20.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.7 110.793 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.6 tptp -90.54 97.03 10.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.259 0.552 . . . . 1.74 109.786 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 80.0 mmm -110.45 169.95 8.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.602 -0.726 . . . . 1.68 109.384 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.511 ' N ' ' HE2' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -70.5 169.7 13.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.756 0.312 . . . . 2.3 110.566 177.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.79 6.29 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 1.93 112.297 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -161.48 162.18 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 1.68 110.464 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.583 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 31.7 p30 -83.02 -14.56 53.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 2.79 111.167 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.8 ttmt -77.45 122.73 25.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 2.01 110.887 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.554 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp -76.25 133.62 40.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.849 -0.614 . . . . 0.69 109.571 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 0.51 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.46 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.795 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.78 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 0.37 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 0.57 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.29 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 395' ' ' TYR . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 310' ' ' VAL . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.527 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 1.61 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.1 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.427 HG13 HD13 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 0.32 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.08 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.55 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.71 HG21 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 0.31 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.795 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.06 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 0.92 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 1.5 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 0.58 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.65 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.27 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.31 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.83 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.38 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 1.75 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.767 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 1.75 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.668 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.4 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 0.31 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 0.38 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.66 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.08 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.32 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.514 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.3 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 0.34 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 0.33 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.58 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.38 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 0.79 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.09 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.3 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.7 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.47 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 0.33 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.411 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 0.42 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 0.55 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.27 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.28 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.436 HD12 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 0.28 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 1.99 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 0.63 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 0.21 110.362 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 0.29 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.35 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.483 ' CE2' HG22 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 0.7 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.484 HG12 HD11 ' B' ' 379' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 0.45 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.99 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 0.81 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt -75.34 -35.27 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 0.72 110.736 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.411 HD21 HG23 ' B' ' 379' ' ' ILE . 96.4 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.57 -0.729 . . . . 1.56 110.853 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.743 -0.543 . . . . 12.98 111.743 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.12 73.16 0.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.218 0.532 . . . . 14.53 111.313 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 10.9 t -112.04 100.79 9.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.853 -0.612 . . . . 10.62 110.467 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -125.33 80.54 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.177 -1.416 . . . . 9.78 107.177 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -87.16 109.54 19.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.608 -0.724 . . . . 8.94 110.546 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 43.0 m -80.45 113.33 18.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 5.29 110.638 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -74.34 -48.61 13.88 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.233 -0.747 . . . . 2.37 111.233 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -104.58 130.82 52.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.904 0.383 . . . . 1.42 110.232 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.07 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.28 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.83 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.88 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.484 HD11 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.17 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 0.58 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.2 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.48 -0.248 . . . . 4.12 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.09 110.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.789 0.295 . . . . 2.92 110.452 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m -97.36 122.27 40.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.426 -0.352 . . . . 1.06 110.214 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.52 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.447 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.41 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 0.72 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 1.44 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 -80.06 119.43 22.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.7 111.055 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -98.77 92.52 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.621 -0.511 . . . . 1.74 109.621 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.1 mmt -104.67 176.82 5.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.688 -0.687 . . . . 1.68 110.615 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.99 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.1 OUTLIER -72.22 158.76 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 2.3 110.703 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.25 -42.29 1.97 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.731 -0.747 . . . . 1.93 113.009 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.6 pttm -152.76 163.85 38.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.627 0.727 . . . . 1.68 110.937 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.723 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 23.6 p-10 -95.78 4.8 52.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.567 -1.197 . . . . 2.79 110.407 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 64.1 tttm -92.21 123.82 35.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.127 -0.694 . . . . 2.01 109.127 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp -88.87 139.27 30.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.69 110.829 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 0.51 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.46 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.78 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.37 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 0.57 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.29 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 0.36 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 0.38 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.1 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 0.32 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.08 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.55 110.207 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 0.31 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.793 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.06 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 0.92 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 1.5 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 0.58 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 0.35 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.65 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.27 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 0.31 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.44 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.83 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.429 HG21 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 0.38 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 1.75 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 1.75 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.429 ' HE3' HG21 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.4 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 0.31 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.535 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.66 112.102 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.08 110.611 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.32 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.3 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 0.34 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 0.33 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.505 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.532 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.58 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.38 110.655 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 0.79 111.006 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.09 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.7 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.06 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.47 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.06 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.33 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 0.42 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 0.55 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.538 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.39 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.27 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.28 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.29 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 0.28 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 1.99 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 0.63 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 0.21 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.29 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.35 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.7 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.45 111.44 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.99 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.81 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt -70.18 -37.5 71.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 0.72 111.285 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 396' ' ' ILE . 1.6 mm? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.666 -0.683 . . . . 1.56 110.426 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.764 -0.134 . . . . 12.98 112.764 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -113.7 122.68 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.282 -0.266 . . . . 14.53 110.282 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 14.4 m -64.08 119.51 10.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.085 0.469 . . . . 10.62 110.221 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -158.01 41.17 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.888 0.852 . . . . 9.78 109.654 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -81.79 139.69 34.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.406 -1.27 . . . . 8.94 110.099 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.3 t 71.19 152.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.761 0.663 . . . . 5.29 110.531 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 86.54 -65.57 3.78 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.853 -0.689 . . . . 2.37 112.143 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -142.76 142.9 32.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 1.42 110.945 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.07 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.28 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.83 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.88 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.481 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 0.58 109.336 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 381' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.2 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.745 -0.542 . . . . 4.12 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.05 97.54 7.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 2.92 110.219 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m -84.07 108.94 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.669 . . . . 1.06 110.748 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.52 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.41 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 0.72 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 1.44 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 -98.87 122.66 42.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.7 111.418 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.5 tptm -80.2 93.76 5.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.211 -0.663 . . . . 1.74 109.211 170.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 78.9 mtp -98.98 158.05 15.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.103 -0.499 . . . . 1.68 110.802 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.791 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.55 158.78 20.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 2.3 111.011 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.2 -40.66 2.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.752 -0.737 . . . . 1.93 112.524 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.9 pttm -143.99 166.47 24.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.536 0.684 . . . . 1.68 111.026 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.582 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 18.6 p-10 -97.89 24.63 6.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.788 -1.096 . . . . 2.79 110.379 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.624 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.9 tttp -111.1 133.52 53.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.552 -0.749 . . . . 2.01 109.964 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp -90.47 120.36 31.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.604 -0.517 . . . . 0.69 109.604 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 0.51 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.46 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 341' ' ' ASP . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.78 110.222 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.047 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.57 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.29 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 0.36 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 0.38 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 1.61 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.1 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 0.32 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.08 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.459 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 0.31 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 328' ' ' ARG . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77 110.312 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.06 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 0.92 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 1.5 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.58 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.35 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.65 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 0.31 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.83 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 0.38 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 1.75 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 1.75 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.622 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.4 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 0.31 110.3 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.38 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.0 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.573 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.66 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.08 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.32 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.3 109.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 0.34 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.33 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.58 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.38 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.698 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 0.79 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.09 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.3 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.7 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.06 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.47 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.06 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 0.55 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.39 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.27 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.28 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.29 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 0.28 111.388 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 1.99 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.512 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.462 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 0.21 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.29 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.35 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.7 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 0.45 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 400' ' ' LEU . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.99 110.75 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.81 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.39 -32.09 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 0.72 110.952 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 397' ' ' ASP . 2.2 mm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.619 -0.705 . . . . 1.56 110.505 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 111.815 -0.514 . . . . 12.98 111.815 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -145.5 -26.52 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.941 0.371 . . . . 14.53 111.838 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.7 m -91.35 71.7 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.925 -0.31 . . . . 10.62 111.074 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? 36.14 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.362 1.039 . . . . 9.78 112.222 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.88 98.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.055 -0.975 . . . . 8.94 112.041 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 45.9 m -100.68 96.9 7.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.358 0.599 . . . . 5.29 109.875 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -100.63 18.63 54.82 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.227 -0.897 . . . . 2.37 111.289 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -116.56 104.55 11.52 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.42 110.407 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.476 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.07 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.28 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.581 HD21 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.83 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.88 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.581 HG13 HD21 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.17 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 0.58 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.2 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.324 -0.31 . . . . 4.12 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 333' ' ' THR . 46.3 t 68.95 84.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.273 0.559 . . . . 2.92 110.963 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m -105.19 148.9 26.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.764 -0.653 . . . . 1.06 111.141 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.52 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.41 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 0.72 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 0.3 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 1.44 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 -75.6 118.51 18.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.7 110.865 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -88.45 103.63 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.39 -0.596 . . . . 1.74 109.39 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.4 mmt -118.82 167.39 11.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.462 -0.79 . . . . 1.68 109.745 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -76.51 -176.97 3.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.385 -0.598 . . . . 2.3 109.385 171.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.45 -25.65 19.65 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.483 -0.865 . . . . 1.93 111.383 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.6 pttm -167.23 -177.9 3.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.647 -0.501 . . . . 1.68 109.647 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.15 2.44 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.064 0.459 . . . . 2.79 110.586 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.707 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.6 ttmt -86.91 123.15 31.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 2.01 110.056 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp -78.67 120.06 22.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.59 -0.522 . . . . 0.69 109.59 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.46 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.78 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 0.37 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 0.57 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.29 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 310' ' ' VAL . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 0.36 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 310' ' ' VAL . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 0.38 109.752 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.503 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 1.61 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.1 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 0.32 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.08 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.55 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.06 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 0.92 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 1.5 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 0.58 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 0.35 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.27 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 0.31 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 0.44 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.83 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 0.38 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.458 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 1.75 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.482 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.768 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.4 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 0.31 110.702 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 0.38 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.66 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.08 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.32 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.3 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 0.34 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 0.33 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.58 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.38 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 0.79 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.09 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.7 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.06 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.635 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.47 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 0.33 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.519 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.42 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.55 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.39 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.27 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.28 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.28 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 1.99 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 0.63 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 353' ' ' LEU . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 0.21 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 0.29 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.35 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.503 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 0.7 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 0.45 110.9 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.99 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.81 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt -70.7 -34.64 57.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.72 110.773 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.427 HD21 HG23 ' B' ' 379' ' ' ILE . 85.9 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.542 -0.742 . . . . 1.56 110.953 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.661 -0.575 . . . . 12.98 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -152.03 -60.24 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.926 0.393 . . . . 14.53 110.106 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.8 p -145.12 41.05 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.769 -0.65 . . . . 10.62 110.542 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.41 ' HE2' ' HD1' ' B' ' 374' ' ' TRP . 27.8 mtpp -119.96 103.58 9.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 9.78 110.795 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.66 -55.37 24.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.213 -0.449 . . . . 8.94 110.748 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 27.6 m -98.24 169.17 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.138 0.494 . . . . 5.29 110.544 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 85.06 -64.59 4.2 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.359 -0.696 . . . . 2.37 111.359 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.41 ' HD1' ' HE2' ' B' ' 370' ' ' LYS . 66.7 m95 -115.63 99.6 7.45 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.42 109.024 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.07 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.28 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.83 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.88 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.427 HG23 HD21 ' A' ' 400' ' ' LEU . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.17 111.14 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.58 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.2 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.535 -0.226 . . . . 4.12 112.535 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.28 88.83 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.529 -0.545 . . . . 2.92 109.529 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m -97.52 122.48 40.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.869 -0.605 . . . . 1.06 111.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.672 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.52 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.41 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 0.72 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 0.3 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 1.44 109.79 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 -76.98 117.93 19.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.7 111.174 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -92.51 95.59 9.72 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.582 -0.525 . . . . 1.74 109.582 173.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.4 mmt -98.1 160.78 14.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.665 . . . . 1.68 110.356 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 1.013 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -72.9 159.68 33.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 2.3 111.051 -178.356 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.05 -37.11 3.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.902 -0.666 . . . . 1.93 112.346 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.6 pttm -144.14 156.87 44.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.729 0.299 . . . . 1.68 110.313 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.483 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -88.73 8.04 30.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.096 -0.502 . . . . 2.79 111.05 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 60.8 tttp -88.93 130.83 35.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.063 -0.517 . . . . 2.01 110.47 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.2 mp -92.53 134.34 35.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.69 109.663 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.765 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.46 111.974 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.78 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 0.37 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.29 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 0.36 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.38 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 1.61 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 353' ' ' LEU . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.1 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 0.32 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.08 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.55 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.31 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.06 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 0.92 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 1.5 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 340' ' ' VAL . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 0.58 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 0.35 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' GLN . . . . . 0.523 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.65 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.27 108.883 171.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 399' ' ' ILE . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 0.31 112.066 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.83 110.585 -178.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.38 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 1.75 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 1.75 109.812 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.4 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 0.31 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.66 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.08 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.32 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.462 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.3 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 0.34 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 0.33 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.58 112.408 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.38 110.409 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 0.79 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.09 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.3 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.7 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.06 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.613 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.47 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.06 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.33 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 0.42 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 0.55 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.39 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.27 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.28 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 0.29 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 0.28 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 1.99 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.578 HD23 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 0.63 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 396' ' ' ILE . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 0.21 110.26 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.065 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.35 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 0.7 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 392' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.45 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.99 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.81 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt -66.8 -30.93 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 0.72 110.741 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.523 -0.751 . . . . 1.56 110.918 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.444 -0.662 . . . . 12.98 111.444 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -114.4 131.62 56.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.384 -0.599 . . . . 14.53 109.384 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.4 m -118.23 90.97 3.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.359 . . . . 10.62 110.323 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -169.49 48.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 9.78 109.379 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.34 90.63 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.212 -0.904 . . . . 8.94 111.27 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.2 m -84.32 117.72 23.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.823 -0.626 . . . . 5.29 110.807 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 169.67 65.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.512 -0.852 . . . . 2.37 112.605 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 62.61 94.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.42 111.745 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.452 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.07 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.28 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.83 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.88 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.629 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.17 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.58 110.132 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.2 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.433 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.654 -0.579 . . . . 4.12 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 333' ' ' THR . 10.4 m -60.08 96.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.501 0.667 . . . . 2.92 111.284 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m -103.91 114.76 29.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 1.06 109.922 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.52 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.41 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 0.72 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.3 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 1.44 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.529 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 83.3 mt-10 -80.98 120.4 24.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.7 111.114 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 20.8 tptm -93.18 91.62 7.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 172.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 52.9 mtt -104.93 158.57 16.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.84 -0.618 . . . . 1.68 110.388 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.955 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.53 158.33 21.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 2.3 110.914 177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -31.37 6.17 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.685 -0.689 . . . . 1.93 111.468 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.2 pttm -159.53 -177.53 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.972 -0.381 . . . . 1.68 109.972 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.634 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 0.0 OUTLIER -104.88 -16.54 14.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.079 0.466 . . . . 2.79 110.489 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.5 ttmt -73.66 134.46 43.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 2.01 111.06 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -86.73 142.14 28.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 0.69 109.953 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 0.51 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.46 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.865 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 0.37 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.466 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.57 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.29 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 0.36 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 310' ' ' VAL . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 0.38 110.255 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 1.61 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.1 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 0.32 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.08 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.55 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 0.31 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.865 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.06 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 0.92 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 1.5 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 0.58 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 0.35 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.65 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' TRP . . . . . 0.447 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.27 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.31 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.44 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.83 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 0.38 110.752 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 1.75 109.678 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 1.75 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.456 ' HB3' HD23 ' A' ' 368' ' ' LEU . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.4 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 0.31 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.38 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.66 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.08 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.32 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.3 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 0.34 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 0.33 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.44 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.58 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.38 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 0.79 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.09 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.3 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.7 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.06 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.7 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.47 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.06 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 0.33 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 0.42 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.55 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.573 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.39 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.27 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.28 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.573 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.29 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.481 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 0.28 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 1.99 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.63 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.57 HG23 HD22 ' A' ' 353' ' ' LEU . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 0.21 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.29 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.35 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 0.7 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.496 HG12 HD11 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.45 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.99 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 0.81 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.3 -29.56 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 0.72 110.819 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.515 -0.755 . . . . 1.56 110.78 -175.574 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.128 -0.389 . . . . 12.98 112.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -145.16 -54.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.157 -0.312 . . . . 14.53 110.157 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.9 m -97.96 19.54 13.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.041 0.924 . . . . 10.62 109.551 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.427 ' O ' ' HA3' ' B' ' 367' ' ' GLY . 30.4 ttpt 170.25 118.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.338 -1.755 . . . . 9.78 107.705 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -54.7 -61.83 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.289 0.368 . . . . 8.94 111.397 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 2.0 m 62.39 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.813 0.696 . . . . 5.29 110.639 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 121.32 -146.13 17.22 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.232 -0.985 . . . . 2.37 111.812 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 63.58 86.21 0.12 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.42 110.602 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.07 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.28 111.074 -176.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.535 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.83 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.88 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.17 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 0.58 109.097 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.2 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.91 -0.476 . . . . 4.12 111.91 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 312' ' ' PHE . 61.3 t -105.23 138.14 31.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 110.338 -0.245 . . . . 2.92 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m -81.47 107.55 14.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.777 0.322 . . . . 1.06 110.169 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 310' ' ' VAL . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.52 110.986 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.41 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.72 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 0.3 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.632 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 1.44 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.502 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 -85.81 116.45 24.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.7 111.068 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 22.9 tptm -85.75 93.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 1.74 109.509 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 29.9 mtt -107.99 177.05 4.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.876 -0.602 . . . . 1.68 110.708 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.899 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -74.07 162.46 28.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.903 -0.589 . . . . 2.3 110.575 178.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 113.3 -45.79 1.27 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 1.93 112.819 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -148.86 174.11 12.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.772 0.32 . . . . 1.68 110.729 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -81.31 -19.58 42.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 2.79 110.622 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.05 136.32 37.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.521 . . . . 2.01 111.537 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.632 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp -82.67 129.43 34.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.945 -0.761 . . . . 0.69 108.945 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.802 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.46 111.621 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.502 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.78 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.37 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.29 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.433 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 0.36 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 0.38 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.544 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 1.61 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.405 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.1 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 0.32 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.08 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.469 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.55 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 0.31 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.06 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.92 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 1.5 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 0.58 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 0.35 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.65 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.27 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.31 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.83 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.38 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 1.75 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 1.75 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.4 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.31 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.38 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.66 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.08 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.32 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.3 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 0.34 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 0.33 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.58 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.38 110.855 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 0.79 110.308 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.09 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.3 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.7 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.06 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.47 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.06 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 0.33 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 0.42 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 0.55 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.39 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.27 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.28 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.29 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.523 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 0.28 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 1.99 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.508 HG22 HD12 ' A' ' 396' ' ' ILE . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 0.21 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.29 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.35 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 0.7 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 392' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 0.45 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.99 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 0.81 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.18 -42.8 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.72 110.936 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.262 -0.881 . . . . 1.56 110.776 -175.482 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.848 -0.501 . . . . 12.98 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 368' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' B' ' 368' ' ' ARG . 0.3 OUTLIER -136.41 -0.93 2.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 14.53 110.083 177.234 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -177.72 3.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.4 -0.963 . . . . 10.62 108.4 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.22 94.18 5.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.638 -0.505 . . . . 9.78 109.638 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.9 166.3 19.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 8.94 111.209 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.9 t -101.86 147.82 26.06 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.101 -0.703 . . . . 5.29 109.101 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 113.16 -72.6 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.154 -0.779 . . . . 2.37 111.154 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -114.78 107.87 16.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.175 0.512 . . . . 1.42 110.293 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.427 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.07 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.28 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.439 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.83 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.88 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.17 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 0.58 109.105 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.2 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.921 -0.472 . . . . 4.12 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.55 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.09 0.556 . . . . 2.92 111.043 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t -74.19 119.38 18.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.09 -0.505 . . . . 1.06 110.277 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.52 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.41 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 0.72 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 0.3 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 1.44 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 -74.18 124.68 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.7 111.236 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.691 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 24.6 tptp -108.79 103.49 12.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.534 -0.543 . . . . 1.74 109.534 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.2 mtm -121.02 173.73 7.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.684 -0.689 . . . . 1.68 109.748 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.754 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.61 158.84 20.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.33 176.681 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.5 -49.39 0.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.584 -0.817 . . . . 1.93 112.557 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -153.76 157.61 39.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.68 110.774 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.691 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 33.8 m-80 -84.32 -1.96 56.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.991 -0.549 . . . . 2.79 111.186 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.46 128.38 34.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.936 -0.394 . . . . 2.01 109.936 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp -87.49 142.13 28.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.732 -0.47 . . . . 0.69 109.732 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 0.51 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.46 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.78 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 0.37 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.57 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.29 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 0.36 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 0.38 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 1.61 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.1 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.32 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.08 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.55 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 0.31 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.06 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 0.92 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 1.5 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 0.58 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.35 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.65 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' TRP . . . . . 0.413 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.27 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 0.31 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 0.44 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.83 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 0.38 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 1.75 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.572 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.4 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 0.31 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 0.38 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.66 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.08 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.32 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.3 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 0.34 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.58 112.966 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.38 111.027 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 0.79 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.09 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.7 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.06 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.47 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.06 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 0.33 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 0.42 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.55 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.39 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.27 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.28 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 0.29 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.434 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 0.28 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 1.99 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 0.63 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 396' ' ' ILE . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 0.21 110.064 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.35 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 0.7 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 392' ' ' ILE . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 0.45 110.94 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.99 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt -81.51 -37.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 0.72 111.358 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.435 -0.793 . . . . 1.56 110.708 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.791 -0.524 . . . . 12.98 111.791 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -116.27 -55.16 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 14.53 110.146 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 58.7 p -118.6 13.8 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.628 0.727 . . . . 10.62 110.663 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -153.56 111.74 3.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.458 -1.246 . . . . 9.78 109.148 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.4 160.78 14.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.843 0.354 . . . . 8.94 110.96 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.0 m -95.9 157.66 15.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.914 -0.585 . . . . 5.29 109.923 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.44 44.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.623 -0.799 . . . . 2.37 111.729 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 358' ' ' ARG . 66.8 m95 -122.15 140.34 52.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.425 0.631 . . . . 1.42 112.157 -172.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.07 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.28 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.487 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.83 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.88 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.17 111.551 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 0.58 110.069 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.2 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.974 -0.45 . . . . 4.12 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 8.7 t 57.42 41.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.614 0.721 . . . . 2.92 110.633 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m -101.83 87.05 3.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.94 -0.573 . . . . 1.06 109.706 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.52 110.668 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.41 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 0.72 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 0.3 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 1.44 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 -77.82 122.09 24.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.7 111.839 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -105.25 101.61 11.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.677 -0.692 . . . . 1.74 109.322 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 62.1 mtp -128.29 172.67 10.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.251 -0.431 . . . . 1.68 110.097 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 158.93 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 2.3 111.271 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.25 -29.7 10.7 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.818 -0.706 . . . . 1.93 112.264 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -163.29 174.36 12.15 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.047 -0.353 . . . . 1.68 110.047 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.1 m-80 -103.11 -15.46 16.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.715 0.293 . . . . 2.79 110.635 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -64.44 121.0 13.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 2.01 110.893 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp -83.13 119.63 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.115 -0.493 . . . . 0.69 109.948 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 0.51 111.152 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.46 111.744 176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.916 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.78 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 0.37 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 0.57 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.29 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 337' ' ' VAL . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 0.36 110.053 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 0.38 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 1.61 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.434 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.1 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 332' ' ' ILE . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.338 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.08 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.55 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 0.31 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.916 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.06 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 0.92 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 1.5 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 0.58 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' GLN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.65 110.067 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.27 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.502 HD22 HG23 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.31 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.83 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 0.38 110.016 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 1.75 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 1.75 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.472 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.4 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 0.38 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 365' ' ' SER . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.0 109.627 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.66 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.08 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.444 ' H ' ' HB2' ' A' ' 362' ' ' SER . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.32 111.345 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.3 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 0.34 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.33 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.58 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.38 110.63 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 0.79 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.09 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.3 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.7 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.06 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.47 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.06 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.33 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 0.42 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 383' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 0.55 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.27 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.479 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.28 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.29 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.28 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 1.99 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 0.63 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.502 HG23 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 0.21 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.29 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.35 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.7 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 0.45 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.99 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 0.81 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt -76.27 -32.64 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.72 111.086 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.454 HD21 HG23 ' B' ' 379' ' ' ILE . 92.9 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.828 -0.606 . . . . 1.56 111.515 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.429 -0.668 . . . . 12.98 111.429 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -77.96 88.63 4.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 14.53 109.242 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 34.7 t -155.62 109.22 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.816 0.341 . . . . 10.62 110.711 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.83 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -91.3 107.62 19.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.05 -1.092 . . . . 9.78 108.05 168.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -55.5 109.68 0.59 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 8.94 113.313 -167.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 t -129.82 138.89 51.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.315 -0.857 . . . . 5.29 109.134 171.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -176.27 -162.48 27.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.692 -0.766 . . . . 2.37 111.841 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -106.51 127.84 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.42 112.318 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.472 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.07 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.28 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.443 HD21 HG13 ' B' ' 379' ' ' ILE . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.83 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.88 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.49 ' O ' HG13 ' B' ' 379' ' ' ILE . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.17 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 380' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 354' ' ' THR . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 0.58 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.2 110.464 176.834 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.653 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.125 -0.39 . . . . 4.12 112.125 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.87 95.24 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.902 0.858 . . . . 2.92 110.176 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m -93.1 131.87 37.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.435 -0.802 . . . . 1.06 110.88 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.537 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.52 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.41 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 0.72 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.3 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 1.44 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 380' ' ' VAL . 65.0 mt-10 -84.32 112.22 20.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.7 110.205 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.702 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 27.1 tptp -85.97 100.99 12.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 1.74 110.34 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 34.8 mtt -97.17 166.58 11.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.676 -0.693 . . . . 1.68 110.193 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.877 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -77.82 175.44 9.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.283 178.324 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.87 -41.07 2.93 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.697 -0.763 . . . . 1.93 112.186 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.0 pttm -143.31 167.11 22.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 1.68 110.31 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.702 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 90.2 m-20 -95.09 -9.71 32.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.933 -0.576 . . . . 2.79 110.609 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.5 ttmt -77.76 121.47 24.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.01 110.449 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.8 147.87 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.69 110.336 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 0.51 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.46 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ARG . . . . . 0.678 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.78 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 0.37 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 0.57 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.29 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 0.36 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 0.38 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 1.61 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.1 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 0.32 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.08 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.435 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.55 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.06 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.92 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 1.5 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 0.58 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.35 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.65 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' TRP . . . . . 0.435 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.31 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 0.44 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.83 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 0.38 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.75 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.538 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 1.75 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.4 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 0.31 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 0.38 111.197 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 362' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.66 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.08 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.32 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.3 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 0.34 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.58 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.38 110.314 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 0.79 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.09 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.3 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.7 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.06 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.473 ' HD2' HD12 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.47 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 379' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.06 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 0.33 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 0.42 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 0.55 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.39 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.27 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.28 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.445 HD13 HD23 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.29 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.761 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 1.99 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.63 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 0.21 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 0.29 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.35 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.653 ' HH ' ' N ' ' A' ' 309' ' ' GLY . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.7 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.45 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.99 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.81 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt -68.81 -38.23 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.72 110.513 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.439 HD21 HG23 ' B' ' 379' ' ' ILE . 84.8 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.699 -0.667 . . . . 1.56 110.926 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.919 0 N-CA-C 111.843 -0.503 . . . . 12.98 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -68.96 -37.69 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.326 0.584 . . . . 14.53 109.886 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.23 175.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.261 -1.014 . . . . 10.62 108.261 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -75.75 79.32 2.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.921 -0.77 . . . . 9.78 108.921 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.2 64.97 8.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.915 -1.039 . . . . 8.94 110.425 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 372' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 362' ' ' SER . 9.9 m -147.28 128.05 14.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.407 -0.815 . . . . 5.29 110.044 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -80.22 177.45 54.32 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.215 -0.993 . . . . 2.37 111.135 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.538 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 -123.29 129.26 51.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.297 0.57 . . . . 1.42 111.155 -171.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.07 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.28 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.83 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.88 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.439 HG23 HD21 ' A' ' 400' ' ' LEU . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.17 111.244 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 0.58 109.783 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.2 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.69 -0.564 . . . . 4.12 111.69 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 333' ' ' THR . 19.5 t 52.9 67.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.623 0.725 . . . . 2.92 109.731 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m -103.46 129.31 50.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.31 -0.859 . . . . 1.06 110.722 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.52 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.41 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 0.72 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 0.3 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.85 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 1.44 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.47 ' HG2' HG12 ' A' ' 380' ' ' VAL . 86.4 mt-10 -78.62 109.51 12.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.039 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.419 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 26.3 tptp -81.37 98.98 8.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 32.5 mtt -104.59 171.85 7.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.528 -0.76 . . . . 1.68 110.316 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.93 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.23 162.05 28.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.786 -0.643 . . . . 2.3 110.171 177.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.28 -35.38 4.87 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.519 -0.848 . . . . 1.93 112.563 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.1 pttm -153.01 167.93 27.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.745 0.307 . . . . 1.68 110.592 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -87.13 -11.98 48.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 2.79 111.232 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 38.5 ttmt -83.16 139.62 33.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.473 -0.331 . . . . 2.01 110.507 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.85 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp -89.74 141.83 28.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.69 109.726 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.51 110.976 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.46 111.654 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.78 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 0.37 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.57 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.29 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.36 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 310' ' ' VAL . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 0.38 110.294 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 1.61 112.059 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLU . . . . . 0.417 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.1 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 0.32 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.08 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.55 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.06 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.92 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 1.5 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' GLU . . . . . 0.495 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 0.58 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.65 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.27 108.931 173.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 0.31 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.83 110.825 -177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 0.38 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.433 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 1.75 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.924 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 1.75 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.4 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 0.31 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 0.38 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.66 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.32 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.3 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 0.34 111.546 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.33 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.789 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.58 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.38 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 373' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.79 111.53 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.09 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.3 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.7 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.06 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.47 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.06 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.33 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.42 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.55 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.27 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.28 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.29 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.513 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 0.28 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 1.99 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 0.63 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 0.21 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ALA . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.29 110.763 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.35 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 0.7 110.84 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' B' ' 377' ' ' ASN . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.45 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.99 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 0.81 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.12 -36.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 0.72 110.831 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.413 HD13 HG23 ' B' ' 379' ' ' ILE . 29.8 tp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.739 -0.648 . . . . 1.56 110.437 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.947 -0.461 . . . . 12.98 111.947 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -106.03 -1.32 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.699 0.285 . . . . 14.53 111.02 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.5 m -106.75 44.79 1.02 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.054 0.454 . . . . 10.62 110.964 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.884 ' HE3' ' HB2' ' B' ' 376' ' ' GLU . 60.9 mttm -121.44 148.73 44.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 9.78 109.969 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.45 157.79 37.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.52 . . . . 8.94 111.477 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.5 p -80.91 123.44 28.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.252 -0.431 . . . . 5.29 110.294 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 123.33 -43.6 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.289 -0.724 . . . . 2.37 111.289 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -124.47 103.95 8.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.357 -0.609 . . . . 1.42 109.357 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 375' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 359' ' ' TRP . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.07 111.04 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.28 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 377' ' ' ASN . . . . . 0.572 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.83 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.88 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.474 HD11 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.17 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 380' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 0.58 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.2 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLY . . . . . 0.691 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.647 -0.581 . . . . 4.12 111.647 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' VAL . . . . . 0.865 HG12 HG22 ' A' ' 333' ' ' THR . 15.4 m -62.66 101.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.608 0.718 . . . . 2.92 111.372 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m -104.26 126.26 51.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.748 -0.66 . . . . 1.06 110.021 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.52 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.41 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 0.72 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 327' ' ' PRO . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 0.3 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 1.44 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 -77.76 122.16 25.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.454 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' LYS . . . . . 0.727 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.6 tptm -90.69 101.14 13.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.096 0.474 . . . . 1.74 110.039 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.3 mmt -100.28 157.11 16.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 1.68 110.098 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LYS . . . . . 0.48 ' HE3' ' N ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.29 162.64 29.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.922 -0.581 . . . . 2.3 110.62 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.74 -32.49 7.46 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 1.93 112.166 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -153.73 157.98 40.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.318 -0.623 . . . . 1.68 109.318 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.727 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 55.1 m-80 -86.48 -14.31 43.51 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.003 -0.279 . . . . 2.79 111.246 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -68.05 125.1 25.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 2.01 110.16 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.34 150.32 26.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.786 -0.45 . . . . 0.69 109.786 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 0.51 110.621 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.46 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.78 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 0.37 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 0.57 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.29 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 0.36 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' THR . . . . . 0.865 HG22 HG12 ' A' ' 310' ' ' VAL . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 0.38 109.615 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 1.61 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.1 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 0.32 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.08 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.55 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 0.31 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' GLU . . . . . 0.565 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.06 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 1.5 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 0.58 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 0.35 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' GLN . . . . . 0.479 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.65 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.27 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 0.31 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 0.44 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.83 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 0.38 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 1.75 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 1.75 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' TRP . . . . . 0.489 ' HB3' HD23 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.4 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.31 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 0.38 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.66 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.08 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.32 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' PHE . . . . . 0.498 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.3 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 0.34 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.44 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.58 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.38 111.684 -173.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 0.79 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.09 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.3 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.06 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' TYR . . . . . 0.611 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.47 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.06 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 0.33 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 0.42 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.55 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.39 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.27 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . 0.451 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.28 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.437 HD13 HD23 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 0.29 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ALA . . . . . 0.498 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 0.28 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 1.99 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 0.63 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 0.21 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 0.29 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.35 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' TYR . . . . . 0.691 ' HH ' ' N ' ' A' ' 309' ' ' GLY . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.7 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' ILE . . . . . 0.485 HD12 HG22 ' A' ' 392' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.45 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.99 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 0.81 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt -74.53 -20.92 17.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.72 110.826 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' LEU . . . . . 0.674 HD21 HG23 ' B' ' 379' ' ' ILE . 97.6 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.285 -0.864 . . . . 1.56 111.488 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.765 -0.534 . . . . 12.98 111.765 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.15 179.94 7.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.018 -0.364 . . . . 14.53 110.018 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.2 m -98.5 94.19 6.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.201 -0.666 . . . . 10.62 109.201 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 370' ' ' LYS . . . . . 0.565 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -62.88 139.74 58.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.679 -0.489 . . . . 9.78 109.679 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 371' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' B' ' 374' ' ' TRP . 7.4 mp0 -45.72 -61.27 1.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.978 0.799 . . . . 8.94 112.431 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 103.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.767 0.667 . . . . 5.29 111.361 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 373' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 98.39 -39.67 2.69 Favored Glycine 0 C--N 1.316 -0.531 0 C-N-CA 120.689 -0.767 . . . . 2.37 111.265 -176.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 374' ' ' TRP . . . . . 0.555 ' HB2' ' HB3' ' B' ' 371' ' ' GLU . 94.3 m95 -92.05 121.24 33.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.171 0.51 . . . . 1.42 109.944 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.07 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 376' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.28 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.83 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.88 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 379' ' ' ILE . . . . . 0.674 HG23 HD21 ' A' ' 400' ' ' LEU . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.17 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 0.58 110.996 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.2 110.349 177.342 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--O 1.236 0.345 0 CA-C-O 121.279 0.561 . . . . 1.06 110.97 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.52 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.41 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 0.3 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 1.44 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.7 110.557 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.671 -0.492 . . . . 0.69 109.671 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 0.51 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.46 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.712 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.78 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 0.37 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 0.57 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.29 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 0.36 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 0.38 110.853 -178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 1.61 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.1 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.32 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.08 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.55 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 0.31 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.712 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.06 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.92 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 1.5 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.58 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.65 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . 0.402 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52 110.857 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.554 ' HB2' HD22 ' A' ' 355' ' ' ASN . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.043 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.31 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 352' ' ' SER . 41.8 m-80 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.83 110.78 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 396' ' ' ILE . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 0.38 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 1.75 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.778 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 1.75 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.467 ' HB3' HD23 ' A' ' 368' ' ' LEU . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.4 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.412 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 0.31 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 0.38 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.66 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.08 111.602 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.32 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.3 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 359' ' ' TRP . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 0.33 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.778 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.44 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.58 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.38 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE2' ' HD1' ' A' ' 351' ' ' TRP . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 0.79 110.26 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.09 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.3 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.7 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.06 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.423 ' HE2' HD13 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.47 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.06 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.33 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 0.42 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 0.55 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.27 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.28 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.29 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.28 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 1.99 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.509 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 396' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.435 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.29 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.35 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 0.7 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 392' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 0.45 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.99 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.81 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 0.72 110.53 -179.061 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . 0.467 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 . . . . . 0 CA--C 1.522 -0.132 0 CA-C-O 121.281 0.562 . . . . 1.42 110.727 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.07 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.28 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.606 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.2 t-20 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.83 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . 0.543 ' H ' ' ND2' ' B' ' 377' ' ' ASN . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.88 113.511 -171.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.606 HG12 ' OD1' ' B' ' 377' ' ' ASN . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.17 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 0.58 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.2 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 120.783 0.325 . . . . 1.06 111.033 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.52 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.41 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 0.72 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 0.3 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.624 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 1.44 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 . . . . . 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.7 110.869 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.624 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 110.0 -0.371 . . . . 0.69 110.0 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 0.51 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.46 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.861 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.78 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 0.37 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 0.57 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.29 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.721 HG21 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 0.36 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 0.38 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 1.61 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.1 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 0.32 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 347' ' ' VAL . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.08 111.52 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.654 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.55 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 0.31 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.861 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.06 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 0.92 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 1.5 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 338' ' ' MET . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.177 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.35 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.65 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.27 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 0.31 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.44 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.83 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.38 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 1.75 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 1.75 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.566 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.4 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 0.31 110.638 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.38 110.436 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.66 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.08 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.32 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.3 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 0.34 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 0.33 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.44 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.58 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.38 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.79 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.09 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.3 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.7 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.654 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.47 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.06 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 0.33 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG12 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 0.42 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 0.55 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.39 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.27 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.28 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.29 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 0.28 111.662 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.99 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.721 ' CD1' HG21 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 0.63 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 0.21 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.29 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.35 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 391' ' ' LEU . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.7 110.172 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 0.45 111.031 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.99 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 0.81 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 0.72 110.719 -178.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 . . . . . 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.42 109.338 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.07 110.371 -171.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.28 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.789 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.83 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.88 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.789 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.17 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 0.58 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.2 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.134 0.493 . . . . 1.06 111.616 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.52 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.41 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.72 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.3 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 1.44 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.927 -176.575 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.9 mp . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 109.795 -0.446 . . . . 0.69 109.795 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.51 111.092 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.417 ' HB2' ' HG3' ' A' ' 342' ' ' GLU . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.46 111.505 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.78 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 0.37 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 0.57 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.29 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.584 HD13 HG13 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 0.36 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 0.38 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 1.61 111.837 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.1 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 0.32 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.08 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.4 ' HD3' ' CZ ' ' A' ' 378' ' ' TYR . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.55 110.461 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 0.31 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.06 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.92 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 1.5 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.58 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 0.35 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.65 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . 0.497 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.27 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 0.31 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 0.44 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.83 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.38 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 1.75 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 1.75 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.491 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.4 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 0.31 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.38 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.66 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.08 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.32 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.667 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.3 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.772 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 359' ' ' TRP . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 0.33 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.6 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.38 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 0.79 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.09 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.3 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.7 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.06 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.47 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.06 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 365' ' ' SER . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.732 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.551 ' HB ' HG12 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.39 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.27 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.28 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.29 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.667 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.28 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 1.99 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 0.63 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 0.21 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.35 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.48 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.7 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 353' ' ' LEU . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.99 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.81 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.72 111.977 -173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 . . . . . 0 C--O 1.234 0.264 0 CA-C-O 121.349 0.595 . . . . 1.42 111.728 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.07 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.28 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.83 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.88 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.577 HD11 HG12 ' A' ' 396' ' ' ILE . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.17 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.2 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.454 -0.267 0 CA-C-O 120.674 0.273 . . . . 1.06 111.141 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.556 ' HE1' HG21 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.52 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.41 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 0.72 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 0.3 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 1.44 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.7 110.927 -178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp . . . . . 0 N--CA 1.454 -0.259 0 CA-C-O 120.891 0.377 . . . . 0.69 110.374 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 0.51 110.836 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.46 111.616 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.846 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 0.37 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 0.57 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.29 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 0.36 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 0.38 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 1.61 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.1 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 0.32 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.08 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.31 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.846 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.06 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 0.92 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 1.5 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 0.58 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 0.35 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.65 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.27 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.52 HD22 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 0.31 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.44 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.83 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 1.75 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 1.75 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.458 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.4 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.31 110.616 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 0.38 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.66 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.08 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.32 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.3 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 0.34 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.33 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.44 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.58 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.38 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 0.79 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.3 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.7 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.06 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.583 ' HD2' HD12 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.47 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.06 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 0.33 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 0.42 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 0.55 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.542 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.39 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.27 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.28 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.28 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 1.99 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.52 HG23 HD22 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.21 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.29 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.35 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.7 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.493 HG12 HD11 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.45 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.99 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 0.81 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 0.72 110.821 -179.299 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.253 0.549 . . . . 1.42 109.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.07 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.28 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.422 ' OD1' HG12 ' B' ' 379' ' ' ILE . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.83 109.766 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.88 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.493 HD11 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.17 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.58 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.2 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 109.764 -0.458 . . . . 1.06 109.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.485 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.52 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.41 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 0.72 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 0.3 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 1.44 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 . . . . . 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.7 110.766 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.341 -0.614 . . . . 0.69 109.341 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.51 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.46 110.875 173.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 0.57 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.29 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.36 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 0.38 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 1.61 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.1 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 0.32 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.47 ' HB2' HG13 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.08 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.55 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 0.31 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.06 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 0.92 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 1.5 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 0.58 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 0.35 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.65 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.582 ' HB3' HD22 ' A' ' 355' ' ' ASN . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.27 109.327 171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.581 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 0.31 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 0.44 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 352' ' ' SER . 58.2 m-80 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.83 111.178 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 0.38 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 1.75 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 1.75 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.689 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.4 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 0.31 110.755 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 389' ' ' ALA . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 0.38 110.793 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.66 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.08 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.32 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.3 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 0.34 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.33 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.58 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.38 110.787 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.79 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.09 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.3 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.7 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.06 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.585 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.47 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 0.33 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.416 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 0.42 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.27 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.28 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 0.29 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 0.28 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 0.63 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.581 HG23 HD22 ' A' ' 353' ' ' LEU . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 0.21 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.29 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 0.7 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.568 HG12 HD11 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 0.45 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.99 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 0.81 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 0.72 111.191 -175.096 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.355 -0.609 . . . . 1.42 109.355 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.07 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.28 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.83 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.88 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.568 HD11 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.17 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 0.58 109.032 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.2 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.241 0.543 . . . . 1.06 110.882 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.419 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.52 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.41 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.72 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 0.3 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 1.44 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.624 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.7 110.823 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 109.988 -0.375 . . . . 0.69 109.988 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 0.51 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.46 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.78 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 0.37 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.57 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.29 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 0.36 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 0.38 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 1.61 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.1 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 0.32 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.08 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.624 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.55 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.06 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 0.92 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 1.5 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 0.58 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 0.35 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.65 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.27 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 0.31 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 0.44 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.83 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 370' ' ' PHE . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 1.75 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.76 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 1.75 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.4 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 0.31 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.422 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.66 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.08 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.32 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.528 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.3 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.34 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.33 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.76 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.58 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.38 111.205 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 0.79 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.09 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.3 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.7 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.06 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.47 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.06 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 0.33 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 0.42 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.55 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.39 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.27 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.28 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.29 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.528 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 0.28 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 1.99 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.405 HD23 ' HB ' ' A' ' 332' ' ' ILE . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.63 110.649 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.21 109.982 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.29 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.35 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.7 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 377' ' ' ASN . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.99 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 0.72 111.434 -176.089 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . 0.417 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 83.0 m95 . . . . . 0 N--CA 1.451 -0.417 0 N-CA-C 109.619 -0.512 . . . . 1.42 109.619 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.07 110.774 -177.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.28 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.541 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.83 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.88 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.17 110.301 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 0.58 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.2 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.807 0.337 . . . . 1.06 111.816 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.52 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.41 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 0.72 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 0.3 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 1.44 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.507 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 . . . . . 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.7 110.971 -178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.842 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.945 -0.391 . . . . 0.69 109.945 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 0.51 111.205 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.46 111.383 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.78 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 0.37 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 0.57 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.29 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.407 HD13 HG13 ' A' ' 337' ' ' VAL . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 0.36 109.763 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 0.38 110.597 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 1.61 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.1 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 332' ' ' ILE . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 0.32 109.035 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.08 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.507 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.55 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.31 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.06 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 0.92 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 1.5 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 340' ' ' VAL . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 0.58 109.563 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.35 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.65 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 355' ' ' ASN . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.27 109.275 173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.31 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.422 HD22 ' HB3' ' A' ' 352' ' ' SER . 49.9 m-80 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.83 111.799 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.75 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 1.75 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.4 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 0.31 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 0.38 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 383' ' ' THR . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.66 113.355 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.08 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.32 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.3 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 0.34 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 0.33 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.467 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.58 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.38 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 0.79 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.09 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.7 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.06 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.548 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.47 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.06 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 0.33 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.42 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 0.55 110.399 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.39 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.27 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.28 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.29 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.28 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.99 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 0.63 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 0.21 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.29 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.7 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 0.45 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.99 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 0.81 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.72 110.254 179.231 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 . . . . . 0 CA--C 1.515 -0.4 0 CA-C-O 121.194 0.521 . . . . 1.42 110.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.07 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.28 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.528 HD21 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.83 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.88 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.528 HG13 HD21 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.17 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 0.58 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.2 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.947 -0.39 . . . . 1.06 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.446 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.52 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.432 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.41 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 0.72 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 0.3 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 1.44 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.7 110.559 -179.59 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.1 mp . . . . . 0 N--CA 1.453 -0.308 0 N-CA-C 109.234 -0.654 . . . . 0.69 109.234 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 0.51 111.106 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.46 111.235 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.78 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.37 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 0.57 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.29 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 0.36 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 0.38 110.005 175.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 1.61 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.1 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 0.32 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.08 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.55 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.446 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 0.31 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.06 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.92 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 1.5 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 0.58 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.65 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.27 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.66 HD13 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 0.31 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.44 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.83 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.486 HG21 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 0.38 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 1.75 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 1.75 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.4 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 0.31 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 0.38 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.66 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.08 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.32 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.609 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.3 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 0.34 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.33 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.44 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.58 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.38 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 0.79 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.09 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.3 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.7 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.06 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.47 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.33 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.461 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 0.42 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 0.55 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.39 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.27 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.28 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 0.29 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.609 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 0.28 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 1.99 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.532 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 0.63 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 0.21 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 0.29 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.35 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.7 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.66 HG13 HD13 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.45 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.99 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 0.81 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.72 111.18 -176.066 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 . . . . . 0 CA--C 1.514 -0.404 0 N-CA-C 109.946 -0.39 . . . . 1.42 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.07 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.28 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.83 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.88 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.17 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 0.58 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.2 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m . . . . . 0 N--CA 1.454 -0.229 0 CA-C-O 120.64 0.257 . . . . 1.06 110.647 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.71 ' HE1' HG21 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.52 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.41 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.72 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 0.3 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 1.44 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.7 110.793 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.554 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.571 -0.529 . . . . 0.69 109.571 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 0.51 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.46 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.795 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.78 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 0.37 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 0.57 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.29 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 395' ' ' TYR . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.527 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 1.61 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.1 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.427 HG13 HD13 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 0.32 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.08 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.55 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.71 HG21 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 0.31 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.795 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.06 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 0.92 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 1.5 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 0.58 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.65 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.27 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.31 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.83 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.38 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 1.75 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.767 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 1.75 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.668 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.4 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 0.31 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 0.38 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.66 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.08 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.32 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.514 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.3 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 0.34 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 0.33 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.58 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.38 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 0.79 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.09 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.3 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.7 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.47 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 0.33 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.411 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 0.42 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 0.55 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.27 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.28 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.436 HD12 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 0.28 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 1.99 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 0.63 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 0.21 110.362 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 0.29 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.35 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.483 ' CE2' HG22 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 0.7 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.484 HG12 HD11 ' B' ' 379' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 0.45 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.99 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 0.81 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 0.72 110.736 -179.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 . . . . . 0 N--CA 1.45 -0.451 0 CA-C-O 120.904 0.383 . . . . 1.42 110.232 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.07 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.28 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.83 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.88 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.484 HD11 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.17 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 0.58 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.2 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.454 -0.255 0 N-CA-C 110.214 -0.291 . . . . 1.06 110.214 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.52 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . 0.447 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.41 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 0.72 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 1.44 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.7 111.055 179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp . . . . . 0 N--CA 1.45 -0.446 0 CA-C-O 120.978 0.418 . . . . 0.69 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 0.51 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.46 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.78 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.37 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 0.57 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.29 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 0.36 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 0.38 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.1 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 0.32 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.08 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.55 110.207 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 0.31 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.793 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.06 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 0.92 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 1.5 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 0.58 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 0.35 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.65 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.27 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 0.31 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.44 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.83 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.429 HG21 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 0.38 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 1.75 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 1.75 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.429 ' HE3' HG21 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.4 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 0.31 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.535 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.66 112.102 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.08 110.611 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.32 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.3 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 0.34 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 0.33 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.505 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.532 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.58 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.38 110.655 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 0.79 111.006 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.09 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.7 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.06 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.47 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.06 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.33 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 0.42 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 0.55 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.538 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.39 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.27 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.28 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.29 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 0.28 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 1.99 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 0.63 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 0.21 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.29 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.35 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.7 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.45 111.44 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.99 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.81 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 0.72 111.285 -176.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 121.109 0.48 . . . . 1.42 110.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.07 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.28 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.83 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.88 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.481 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 0.58 109.336 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.2 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 120.877 0.37 . . . . 1.06 110.748 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.52 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.41 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 0.72 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 1.44 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 . . . . . 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.7 111.418 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.604 -0.517 . . . . 0.69 109.604 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 0.51 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.46 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 341' ' ' ASP . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.78 110.222 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.047 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.57 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.29 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 0.36 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 0.38 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 1.61 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.1 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 0.32 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.08 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.459 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 0.31 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 328' ' ' ARG . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77 110.312 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.06 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 0.92 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 1.5 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.58 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.35 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.65 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 0.31 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.83 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 0.38 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 1.75 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 1.75 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.622 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.4 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 0.31 110.3 178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.38 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.0 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.573 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.66 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.08 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.32 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.3 109.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 0.34 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.33 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.58 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.38 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.698 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 0.79 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.09 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.3 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.7 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.06 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.47 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.06 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 0.55 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.39 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.27 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.28 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.29 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 0.28 111.388 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 1.99 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.512 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.462 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 0.21 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.29 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.35 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.7 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 0.45 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.99 110.75 -177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.81 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 0.72 110.952 -177.794 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 . . . . . 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.42 110.407 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.476 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.07 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.28 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.581 HD21 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.83 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.88 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.581 HG13 HD21 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.17 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 0.58 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.2 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.594 0.235 . . . . 1.06 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.52 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.41 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 0.72 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 0.3 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 1.44 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 . . . . . 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.7 110.865 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 109.59 -0.522 . . . . 0.69 109.59 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.46 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.78 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 0.37 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 0.57 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.29 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.4 ' HB ' HD23 ' A' ' 391' ' ' LEU . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 0.36 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 0.38 109.752 178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.503 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 1.61 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.1 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 0.32 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.08 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.55 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.06 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 0.92 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 1.5 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 0.58 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 0.35 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.27 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 0.31 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 0.44 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.83 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 0.38 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.458 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 1.75 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.482 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.768 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.4 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 0.31 110.702 178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 0.38 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.66 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.08 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.32 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.3 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 0.34 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 0.33 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.58 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.38 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 0.79 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.09 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.7 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.06 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.635 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.47 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 0.33 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.519 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.42 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.55 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.39 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.27 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.28 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.28 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 1.99 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 0.63 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 353' ' ' LEU . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 0.21 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 0.29 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.35 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.503 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 0.7 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 0.45 110.9 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.99 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.81 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.72 110.773 -179.792 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.7 m95 . . . . . 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.42 109.024 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.07 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.28 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.83 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.88 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.17 111.14 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.58 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.2 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.828 0.346 . . . . 1.06 111.148 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.672 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.52 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.41 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 0.72 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 0.3 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 1.44 109.79 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.7 111.174 -177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.2 mp . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.663 -0.495 . . . . 0.69 109.663 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.765 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.46 111.974 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.78 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 0.37 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.29 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 0.36 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.38 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 1.61 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 353' ' ' LEU . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.1 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 0.32 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.08 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.55 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.31 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.06 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 0.92 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 1.5 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 340' ' ' VAL . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 0.58 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 0.35 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . 0.523 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.65 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.48 ' HB2' ' ND2' ' A' ' 355' ' ' ASN . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.27 108.883 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 399' ' ' ILE . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 0.31 112.066 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 352' ' ' SER . 37.3 m-80 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.83 110.585 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.38 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 1.75 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 1.75 109.812 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.4 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 0.31 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.66 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.08 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.32 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.462 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.3 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 0.34 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 0.33 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.58 112.408 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.38 110.409 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 0.79 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.09 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.3 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.7 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.06 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.613 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.47 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.06 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.33 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 0.42 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 0.55 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.39 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.27 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.28 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 0.29 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 0.28 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 1.99 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.578 HD23 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 0.63 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 396' ' ' ILE . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 0.21 110.26 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.065 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.35 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 0.7 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 392' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.45 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.99 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.81 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 0.72 110.741 179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 . . . . . 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.42 111.745 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.452 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.07 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.28 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.83 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.88 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.629 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.17 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.58 110.132 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.2 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 N--CA 1.45 -0.474 0 N-CA-C 109.922 -0.399 . . . . 1.06 109.922 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.52 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.41 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 0.72 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.3 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 1.44 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.529 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 83.3 mt-10 . . . . . 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.7 111.114 -178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp . . . . . 0 C--O 1.234 0.244 0 N-CA-C 109.953 -0.388 . . . . 0.69 109.953 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 0.51 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.46 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.865 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 0.37 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.466 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.57 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.29 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 0.36 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 0.38 110.255 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 1.61 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.1 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 0.32 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.08 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.55 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 0.31 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.865 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.06 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 0.92 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 1.5 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 0.58 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 0.35 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.65 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . 0.447 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.27 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.31 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.44 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.83 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 0.38 110.752 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 1.75 109.678 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 1.75 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.456 ' HB3' HD23 ' A' ' 368' ' ' LEU . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.4 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 0.31 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.38 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.66 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.08 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.32 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.3 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 0.34 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 0.33 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.44 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.58 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.38 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 0.79 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.09 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.3 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.7 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.06 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.7 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.47 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.06 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 0.33 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 0.42 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.55 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.573 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.39 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.27 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.28 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.573 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.29 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.481 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 0.28 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 1.99 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.63 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.57 HG23 HD22 ' A' ' 353' ' ' LEU . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 0.21 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.29 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.35 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 0.7 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.496 HG12 HD11 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.45 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.99 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 0.81 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt . . . . . 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 0.72 110.819 -178.916 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 . . . . . 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.42 110.602 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.07 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.28 111.074 -176.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.535 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.83 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.88 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.17 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 0.58 109.097 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.2 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m . . . . . 0 N--CA 1.451 -0.388 0 CA-C-O 120.777 0.322 . . . . 1.06 110.169 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.408 ' HE1' HG21 ' A' ' 340' ' ' VAL . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.52 110.986 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.41 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.72 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 0.3 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.632 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 1.44 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.502 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.7 111.068 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.632 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 108.945 -0.761 . . . . 0.69 108.945 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.802 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.46 111.621 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.502 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.78 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.37 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.29 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.433 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 0.36 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 0.38 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.544 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 1.61 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.405 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.1 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 0.32 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.08 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.469 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.55 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 0.31 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.06 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.92 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 1.5 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 0.58 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 0.35 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.65 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.27 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.31 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.83 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.38 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 1.75 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 1.75 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.4 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.31 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.38 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.66 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.08 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.32 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.3 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 0.34 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 0.33 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.58 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.38 110.855 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 0.79 110.308 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.09 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.3 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.7 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.06 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.47 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.06 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 0.33 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 0.42 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 0.55 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.39 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.27 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.28 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.29 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.523 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 0.28 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 1.99 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.508 HG22 HD12 ' A' ' 396' ' ' ILE . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 0.21 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.29 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.35 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 0.7 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 392' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 0.45 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.99 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 0.81 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.72 110.936 -178.079 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 . . . . . 0 CA--C 1.516 -0.335 0 CA-C-O 121.175 0.512 . . . . 1.42 110.293 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.427 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.07 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.28 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.439 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.83 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.88 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.17 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 0.58 109.105 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.2 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 N--CA 1.453 -0.292 0 CA-C-O 120.977 0.417 . . . . 1.06 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.52 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.41 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 0.72 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 0.3 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 1.44 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.7 111.236 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp . . . . . 0 N--CA 1.453 -0.312 0 N-CA-C 109.732 -0.47 . . . . 0.69 109.732 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 0.51 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.46 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.78 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 0.37 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.57 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.29 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 0.36 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 0.38 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 1.61 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.1 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.32 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.08 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.55 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 0.31 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.06 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 0.92 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 1.5 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 0.58 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.35 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.65 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . 0.413 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.27 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 0.31 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 0.44 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.83 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 0.38 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 1.75 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.572 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.4 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 0.31 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 0.38 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.66 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.08 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.32 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.3 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 0.34 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.58 112.966 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.38 111.027 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 0.79 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.09 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.7 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.06 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.47 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.06 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 0.33 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 0.42 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.55 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.39 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.27 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.28 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 0.29 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.434 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 0.28 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 1.99 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 0.63 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 396' ' ' ILE . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 0.21 110.064 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.35 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 0.7 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 392' ' ' ILE . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 0.45 110.94 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.99 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 0.72 111.358 -175.505 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 358' ' ' ARG . 66.8 m95 . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.425 0.631 . . . . 1.42 112.157 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.07 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.28 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.487 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.83 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.88 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.17 111.551 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 0.58 110.069 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.2 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m . . . . . 0 N--CA 1.451 -0.422 0 CA-C-O 121.128 0.489 . . . . 1.06 109.706 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.52 110.668 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.41 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 0.72 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 0.3 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 1.44 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.7 111.839 -175.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 109.948 -0.39 . . . . 0.69 109.948 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 0.51 111.152 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.46 111.744 176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.916 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.78 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 0.37 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 0.57 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.29 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 337' ' ' VAL . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 0.36 110.053 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 0.38 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 1.61 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.434 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.1 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 332' ' ' ILE . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.338 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.08 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.55 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 0.31 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.916 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.06 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 0.92 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 1.5 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 0.58 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.65 110.067 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.27 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.502 HD22 HG23 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.31 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.83 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 0.38 110.016 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 1.75 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 1.75 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.472 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.4 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 0.38 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 365' ' ' SER . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.0 109.627 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.66 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.08 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.444 ' H ' ' HB2' ' A' ' 362' ' ' SER . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.32 111.345 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.3 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 0.34 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.33 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.58 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.38 110.63 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 0.79 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.09 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.3 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.7 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.06 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.47 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.06 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.33 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 0.42 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 0.55 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.27 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.479 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.28 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.29 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.28 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 1.99 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 0.63 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.502 HG23 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 0.21 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.29 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.35 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.7 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 0.45 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.99 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 0.81 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.72 111.086 -177.275 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.42 112.318 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.472 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.07 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.28 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.443 HD21 HG13 ' B' ' 379' ' ' ILE . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.83 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.88 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.49 ' O ' HG13 ' B' ' 379' ' ' ILE . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.17 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 354' ' ' THR . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 0.58 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.2 110.464 176.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 120.64 0.257 . . . . 1.06 110.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.537 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.52 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.41 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 0.72 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.3 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 1.44 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 380' ' ' VAL . 65.0 mt-10 . . . . . 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.7 110.205 179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 C--O 1.235 0.317 0 CA-C-O 120.697 0.284 . . . . 0.69 110.336 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 0.51 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.46 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . 0.678 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.78 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 0.37 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 0.57 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.29 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 0.36 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 0.38 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 1.61 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.1 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 0.32 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.08 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.435 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.55 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.06 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.92 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 1.5 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 0.58 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.35 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.65 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . 0.435 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.31 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 0.44 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.83 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 0.38 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.75 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.538 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 1.75 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.4 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 0.31 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 0.38 111.197 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.66 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.08 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.32 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.3 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 0.34 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.58 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.38 110.314 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 0.79 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.09 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.3 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.7 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.06 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.473 ' HD2' HD12 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.47 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.06 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 0.33 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 0.42 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 0.55 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.39 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.27 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.28 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.445 HD13 HD23 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.29 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.761 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 1.99 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.63 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 0.21 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 0.29 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.35 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.7 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.45 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.99 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.81 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.72 110.513 178.934 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . 0.538 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 . . . . . 0 CA--C 1.512 -0.51 0 CA-C-O 121.297 0.57 . . . . 1.42 111.155 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.07 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.28 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.83 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.88 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.17 111.244 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 0.58 109.783 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.2 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 120.528 0.204 . . . . 1.06 110.722 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.52 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.41 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 0.72 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 0.3 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.85 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 1.44 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.47 ' HG2' HG12 ' A' ' 380' ' ' VAL . 86.4 mt-10 . . . . . 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.039 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.85 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp . . . . . 0 N--CA 1.452 -0.359 0 N-CA-C 109.726 -0.472 . . . . 0.69 109.726 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.51 110.976 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.46 111.654 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.78 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 0.37 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.57 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.29 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.36 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 0.38 110.294 179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 1.61 112.059 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . 0.417 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.1 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 0.32 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.08 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.55 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.06 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.92 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 1.5 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . 0.495 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 0.58 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.65 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . 0.45 ' HB3' HD22 ' A' ' 355' ' ' ASN . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.27 108.931 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 0.31 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . 0.45 HD22 ' HB3' ' A' ' 352' ' ' SER . 45.4 m-80 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.83 110.825 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 0.38 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . 0.433 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 1.75 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.924 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 1.75 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.4 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 0.31 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 0.38 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.66 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.32 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.3 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 0.34 111.546 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.33 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.789 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.58 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.38 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.79 111.53 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.09 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.3 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.7 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.06 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.47 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.06 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.33 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.42 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.55 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.27 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.28 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.29 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.513 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 0.28 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 1.99 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 0.63 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 0.21 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.29 110.763 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.35 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 0.7 110.84 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' B' ' 377' ' ' ASN . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.45 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.99 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 0.81 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 0.72 110.831 -178.356 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 109.357 -0.609 . . . . 1.42 109.357 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 359' ' ' TRP . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.07 111.04 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.28 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . 0.572 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.83 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.88 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.474 HD11 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.17 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 0.58 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.2 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m . . . . . 0 N--CA 1.45 -0.465 0 N-CA-C 110.021 -0.363 . . . . 1.06 110.021 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.52 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.41 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 0.72 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 327' ' ' PRO . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 0.3 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 1.44 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.454 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 109.786 -0.45 . . . . 0.69 109.786 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 0.51 110.621 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.46 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.78 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 0.37 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 0.57 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.29 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 0.36 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 0.38 109.615 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 1.61 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.1 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 0.32 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.08 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.55 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 0.31 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' GLU . . . . . 0.565 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.06 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 1.5 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 0.58 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 0.35 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' GLN . . . . . 0.479 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.65 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.27 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 0.31 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 0.44 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.83 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 0.38 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 1.75 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 1.75 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' TRP . . . . . 0.489 ' HB3' HD23 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.4 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.31 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 0.38 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.66 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.08 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.32 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' PHE . . . . . 0.498 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.3 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 0.34 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.44 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.58 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.38 111.684 -173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 0.79 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.09 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.3 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.06 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' TYR . . . . . 0.611 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.47 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.06 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 0.33 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 0.42 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.55 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.39 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.27 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLU . . . . . 0.451 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.28 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' ILE . . . . . 0.437 HD13 HD23 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 0.29 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ALA . . . . . 0.498 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 0.28 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 1.99 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 0.63 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 0.21 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 0.29 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.35 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' TYR . . . . . 0.473 ' CD2' ' HA ' ' A' ' 334' ' ' LYS . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.7 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' ILE . . . . . 0.485 HD12 HG22 ' A' ' 392' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.45 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.99 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 0.81 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.72 110.826 -177.284 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.3 m95 . . . . . 0 CA--C 1.515 -0.372 0 CA-C-O 121.171 0.51 . . . . 1.42 109.944 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.07 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 376' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.28 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.83 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.88 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 379' ' ' ILE . . . . . 0.454 HD11 HG12 ' A' ' 396' ' ' ILE . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.17 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 0.58 110.996 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.2 110.349 177.342 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 333' ' ' THR . . . . . . . . 0 N--CA 1.482 1.753 0 N-CA-C 112.131 -0.387 . . . . 4.12 112.131 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 18.1 m -121.52 -8.85 9.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.624 0.25 . . . . 2.92 111.196 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 3.3 p -84.72 95.99 9.1 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.279 0.561 . . . . 1.06 110.97 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -120.12 136.56 54.56 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.52 110.095 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.453 ' CG ' HG12 ' A' ' 388' ' ' ILE . 88.4 m-85 -106.99 135.94 47.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.891 0.377 . . . . 0.41 110.809 178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.3 tp -82.23 104.56 12.64 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.897 -0.592 . . . . 0.72 110.079 178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.572 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -117.87 163.95 14.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.035 -0.53 . . . . 0.3 110.467 -178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 56.6 mtpt -124.98 115.74 21.05 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.954 0.406 . . . . 1.44 110.257 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 380' ' ' VAL . 38.6 mt-10 -90.53 127.44 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.817 -0.629 . . . . 0.7 110.557 -176.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -100.22 100.42 11.24 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.292 0.568 . . . . 1.74 110.117 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.3 mmm -110.84 171.0 7.73 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.502 -0.772 . . . . 1.68 109.1 178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.759 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.3 177.32 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.885 -0.413 . . . . 2.3 109.885 175.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 99.7 -35.7 4.57 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.904 -0.878 . . . . 1.93 110.904 -177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.446 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -155.54 157.71 37.29 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.139 -0.689 . . . . 1.68 109.139 175.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -87.31 -6.17 58.62 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.935 0.398 . . . . 2.79 110.647 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.4 tttt -76.3 126.17 30.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.731 -0.668 . . . . 2.01 110.836 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 8.1 mp -73.27 130.99 41.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.077 -0.511 . . . . 0.69 109.671 175.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.89 119.45 68.35 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.107 -0.497 . . . . 0.51 111.238 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.99 121.39 9.06 Favored 'Trans proline' 0 C--O 1.236 0.38 0 C-N-CA 122.56 2.174 . . . . 0.46 111.492 174.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.712 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.6 tpp180 -126.15 142.89 51.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.081 -0.509 . . . . 0.78 109.925 -177.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 72.0 mt -92.33 104.23 16.59 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.592 -0.522 . . . . 0.37 109.592 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.464 HD23 HD13 ' A' ' 388' ' ' ILE . 38.4 tp -83.28 102.22 11.8 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.949 -0.568 . . . . 0.57 109.721 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -85.76 112.57 3.72 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.718 -0.673 . . . . 0.29 111.891 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 44.0 mm -106.61 108.84 26.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.44 -0.578 . . . . 0.36 109.44 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.469 HG22 ' HA3' ' A' ' 309' ' ' GLY . 72.7 p -116.48 170.29 8.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.882 0.372 . . . . 0.38 110.853 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 22.6 pttp -71.45 8.2 1.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.798 -0.637 . . . . 1.61 112.121 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -144.12 -26.28 0.53 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.412 0.523 . . . . 1.79 112.412 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.0 p -160.28 170.1 21.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.274 0.559 . . . . 1.1 112.214 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 97.3 t -123.53 114.06 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.467 -0.788 . . . . 0.32 109.482 175.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -112.8 141.25 46.82 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.201 0.524 . . . . 1.08 111.755 -175.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -97.89 102.91 14.78 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.82 -0.627 . . . . 1.55 110.119 173.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 347' ' ' VAL . 60.7 t -99.48 138.31 24.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 115.902 -0.59 . . . . 0.31 109.994 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.712 ' HA ' HH11 ' A' ' 328' ' ' ARG . 14.6 t70 -69.94 139.28 52.86 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.819 -0.437 . . . . 0.77 109.819 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -34.15 73.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.459 -0.337 . . . . 1.51 111.592 -172.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 341' ' ' ASP . 14.4 pttm -104.88 -37.77 6.89 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.641 0.257 . . . . 3.06 111.376 -174.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.515 HG22 ' HG2' ' A' ' 346' ' ' GLU . 14.0 m -80.14 -26.12 39.54 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.969 0.414 . . . . 0.92 110.552 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 64.58 23.57 12.87 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.586 -0.734 . . . . 1.5 111.777 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.515 ' HG2' HG22 ' A' ' 344' ' ' THR . 80.6 mm-40 -103.17 150.47 23.64 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.648 0.261 . . . . 2.46 110.631 178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.65 HG22 HG22 ' A' ' 340' ' ' VAL . 45.4 t -85.45 116.66 29.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.17 -0.468 . . . . 0.58 109.973 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 59.6 mt -86.03 -45.54 16.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.14 -0.482 . . . . 0.35 110.935 -177.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -150.58 141.05 22.46 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.979 -0.555 . . . . 1.65 109.985 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.17 137.83 44.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.553 0.216 . . . . 0.65 110.419 -177.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . 0.402 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 8.9 m-90 -121.1 151.81 39.42 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.388 -0.369 . . . . 0.52 110.857 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.554 ' HB2' HD22 ' A' ' 355' ' ' ASN . 11.1 m -83.69 152.53 24.69 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.043 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 83.3 mt -69.41 -25.16 64.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.22 0.533 . . . . 0.31 110.517 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 25.8 p -71.7 -5.21 32.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.6 -0.727 . . . . 0.44 111.896 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.554 HD22 ' HB2' ' A' ' 352' ' ' SER . 41.8 m-80 -104.72 16.55 25.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.127 0.489 . . . . 0.83 110.78 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.551 HD12 HD11 ' A' ' 396' ' ' ILE . 62.2 mt -93.79 111.29 24.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.636 . . . . 0.38 110.35 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -84.66 -41.96 15.81 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.319 0.581 . . . . 1.75 109.611 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.778 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.0 ptp180 -168.94 175.69 5.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.144 -0.934 . . . . 1.75 109.611 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.467 ' HB3' HD23 ' A' ' 368' ' ' LEU . 25.4 p90 -153.43 153.13 31.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.5 -0.318 . . . . 0.4 110.226 173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -113.58 111.68 22.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.044 -0.525 . . . . 0.31 110.715 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -97.72 101.03 12.44 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.426 -0.806 . . . . 0.38 111.065 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.4 ' HB2' ' O ' ' A' ' 365' ' ' SER . 35.8 m -115.5 152.55 47.21 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.908 -0.587 . . . . 1.0 109.457 175.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.514 ' O ' ' HA ' ' A' ' 383' ' ' THR . 33.7 Cg_endo -64.37 -19.36 65.39 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.748 2.299 . . . . 0.66 113.865 -174.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 5.1 ttpm? -110.99 -27.02 8.96 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.571 -0.451 . . . . 2.08 111.602 -178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 362' ' ' SER . 44.0 m -148.42 145.74 28.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.138 0.494 . . . . 1.32 111.375 -176.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.499 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -121.09 136.5 54.97 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.693 -0.685 . . . . 0.3 109.907 -178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 98.8 m -124.12 130.44 52.55 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.426 -0.352 . . . . 0.34 111.094 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.467 HD23 ' HB3' ' A' ' 359' ' ' TRP . 27.5 mt -106.59 119.68 39.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.024 -0.535 . . . . 0.33 110.345 174.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.778 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.9 OUTLIER -95.26 105.88 17.87 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.5 . . . . 1.52 110.16 178.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -92.6 10.24 31.27 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.051 0.453 . . . . 0.44 110.841 -179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.89 -122.61 19.96 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.634 -0.712 . . . . 0.58 112.768 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -102.1 30.08 4.69 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.842 0.353 . . . . 2.38 110.865 -175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.402 ' CE2' ' HD1' ' A' ' 351' ' ' TRP . 64.1 t80 -86.51 -26.26 24.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.021 0.438 . . . . 0.79 110.26 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -156.17 178.06 10.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.726 -0.67 . . . . 1.09 109.37 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 -84.67 112.04 20.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.857 0.36 . . . . 2.3 110.159 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 87.02 -162.81 34.17 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.677 -0.773 . . . . 0.7 112.162 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -121.17 -168.56 1.69 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.875 0.369 . . . . 1.06 110.3 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.423 ' HE2' HD13 ' A' ' 330' ' ' LEU . 27.9 t80 -122.06 103.36 8.75 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.316 -0.402 . . . . 0.47 110.011 178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 23.6 m -113.89 126.36 55.09 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.172 -0.467 . . . . 1.06 110.95 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 317' ' ' GLU . 6.9 m -133.21 149.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.043 -0.526 . . . . 0.33 111.341 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -89.42 130.54 35.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.027 -0.533 . . . . 1.47 110.016 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.9 t -176.85 145.59 0.51 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.246 -0.434 . . . . 0.42 110.047 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 27.6 p -85.6 -4.86 59.28 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.05 0.452 . . . . 0.55 110.864 178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.546 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.0 mt-10 -97.55 20.87 11.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.023 -0.535 . . . . 1.39 110.573 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -53.77 -49.54 57.74 Favored Glycine 0 CA--C 1.521 0.446 0 CA-C-N 116.088 -0.505 . . . . 0.27 113.71 -176.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.45 -34.91 78.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.932 0.366 . . . . 2.28 110.684 -179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -60.77 -41.16 94.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.549 -0.296 . . . . 2.27 110.64 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.546 HG13 ' O ' ' A' ' 384' ' ' GLU . 56.7 mt -61.83 -52.34 61.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.096 0.474 . . . . 0.29 110.037 176.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.499 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -54.16 -49.57 68.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.389 -0.823 . . . . 0.28 111.331 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -60.51 -37.61 81.7 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.603 -0.726 . . . . 1.99 111.104 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.509 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.8 tp -73.04 -42.27 63.31 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.537 -0.301 . . . . 0.63 110.68 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.688 HG22 HD12 ' A' ' 396' ' ' ILE . 66.6 mt -61.02 -48.99 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 N-CA-C 109.888 -0.412 . . . . 0.21 109.888 176.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.435 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -61.95 -29.58 70.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.29 110.651 178.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.3 -47.5 57.81 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.139 -0.553 . . . . 0.35 112.224 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.509 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 28.5 m-85 -66.99 -40.04 87.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.067 0.461 . . . . 0.7 110.435 177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.688 HD12 HG22 ' A' ' 392' ' ' ILE . 35.8 mt -63.23 -35.01 70.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.677 -0.692 . . . . 0.45 110.636 177.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -61.01 -29.58 69.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 0.99 111.28 176.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 67.4 mt -73.9 -33.3 36.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.045 0.45 . . . . 0.81 110.721 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.5 mt -89.22 -27.44 5.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.336 0.589 . . . . 0.72 110.53 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 25.2 tp . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.379 -0.819 . . . . 1.56 110.483 -175.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 112.293 -0.323 . . . . 12.98 112.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 17.3 tpp180 -116.43 106.76 13.97 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.035 -0.357 . . . . 14.53 110.035 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 44.5 p -84.95 157.3 20.86 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.681 0.277 . . . . 10.62 110.7 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -140.37 42.82 1.9 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.832 0.825 . . . . 9.78 109.288 176.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -57.35 -58.03 10.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.385 -1.28 . . . . 8.94 111.938 -176.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 12.7 p -90.73 142.11 28.1 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.838 0.351 . . . . 5.29 110.686 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 90.7 -49.22 3.11 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.993 -0.622 . . . . 2.37 112.551 177.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.467 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 93.0 m95 -95.67 119.24 33.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.281 0.562 . . . . 1.42 110.727 -177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.2 t -109.06 122.89 64.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.556 -0.747 . . . . 1.07 110.009 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -93.91 106.54 18.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.922 -0.581 . . . . 2.28 110.819 -174.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.606 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.2 t-20 -89.89 157.9 17.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.204 -0.453 . . . . 1.83 110.215 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . 0.543 ' H ' ' ND2' ' B' ' 377' ' ' ASN . 34.8 mt-10 -121.23 16.82 11.51 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 113.511 0.93 . . . . 1.88 113.511 -171.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.606 HG12 ' OD1' ' B' ' 377' ' ' ASN . 17.6 pt -108.32 14.15 8.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 118.92 -1.112 . . . . 1.17 112.187 176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . 0.467 ' HA ' ' O ' ' A' ' 354' ' ' THR . 65.8 t80 -75.97 95.87 3.66 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.597 -0.52 . . . . 0.58 109.597 175.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.645 -0.693 . . . . 3.2 112.208 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.697 -0.561 . . . . 4.12 111.697 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.29 107.48 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 109.398 -0.593 . . . . 2.92 109.398 177.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.3 m -81.77 113.25 19.61 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.545 -0.752 . . . . 1.06 111.033 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 -98.64 123.0 42.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.181 -0.463 . . . . 0.52 110.57 176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -108.8 132.73 53.7 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.639 -0.71 . . . . 0.41 109.85 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 47.5 tp -86.62 89.37 7.9 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.487 -0.561 . . . . 0.72 109.487 177.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.6 m -103.66 168.68 2.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.598 -0.728 . . . . 0.3 110.233 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.624 ' HE3' ' HB2' ' A' ' 325' ' ' LEU . 27.7 mtpp -126.83 117.59 22.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.877 0.37 . . . . 1.44 110.435 178.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.525 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 73.6 mt-10 -76.81 124.6 27.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 0.7 110.869 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -90.27 103.96 16.58 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.554 -0.536 . . . . 1.74 109.554 175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 84.5 mmm -112.19 -159.62 0.69 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 1.68 110.244 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.761 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -111.99 167.3 10.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.209 -0.45 . . . . 2.3 110.234 -179.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.64 -20.23 48.06 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.93 -0.653 . . . . 1.93 112.571 176.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -161.67 166.57 26.56 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.995 -0.372 . . . . 1.68 109.995 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 46.6 m-80 -97.81 -9.06 27.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.8 0.333 . . . . 2.79 110.608 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -72.64 120.86 18.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 2.01 110.04 175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.624 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.0 mp -83.99 131.3 34.84 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.302 -0.408 . . . . 0.69 110.0 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 26.0 t -74.24 120.5 81.71 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.978 -0.556 . . . . 0.51 111.176 -175.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -61.75 119.51 6.67 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 122.62 2.214 . . . . 0.46 111.491 174.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.861 HH11 ' HA ' ' A' ' 341' ' ' ASP . 14.3 tpp180 -124.2 137.94 54.47 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.067 -0.515 . . . . 0.78 110.456 -177.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.5 mt -92.85 98.4 11.36 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.46 -0.571 . . . . 0.37 109.46 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 31.2 tp -78.85 102.65 8.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.863 -0.608 . . . . 0.57 109.551 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.45 107.89 3.6 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.953 -0.642 . . . . 0.29 112.282 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.721 HG21 ' CD1' ' A' ' 391' ' ' LEU . 30.9 mm -96.22 116.22 37.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 110.316 -0.253 . . . . 0.36 110.316 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 65.0 p -105.82 -175.23 2.74 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.969 -0.382 . . . . 0.38 109.969 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -79.68 3.68 18.46 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.38 -0.373 . . . . 1.61 111.163 179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -140.74 -31.25 0.62 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.633 0.605 . . . . 1.79 112.633 -171.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 20.5 p -149.43 160.94 43.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.451 0.643 . . . . 1.1 112.496 -173.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.444 HG13 HD13 ' A' ' 332' ' ' ILE . 94.2 t -109.5 111.49 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.149 -0.932 . . . . 0.32 108.935 173.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 347' ' ' VAL . 19.8 ptp -109.74 139.07 45.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.234 0.54 . . . . 1.08 111.52 -175.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.654 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 44.8 mtm180 -94.94 98.43 10.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.787 -0.642 . . . . 1.55 110.335 174.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.2 t -90.11 130.15 39.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.21 -0.45 . . . . 0.31 110.125 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.861 ' HA ' HH11 ' A' ' 328' ' ' ARG . 29.8 t70 -70.01 134.82 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.082 -0.34 . . . . 0.77 110.082 179.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -65.9 -40.87 91.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.083 -0.508 . . . . 1.51 111.009 -176.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -86.47 -47.56 9.18 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.118 0.485 . . . . 3.06 111.295 -173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.9 m -85.16 -22.08 28.95 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.042 -0.526 . . . . 0.92 111.307 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 63.8 20.78 12.39 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.914 -0.585 . . . . 1.5 111.86 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -98.51 150.83 21.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.345 -0.389 . . . . 2.46 110.741 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 338' ' ' MET . 49.3 t -82.06 109.37 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.318 -0.401 . . . . 0.58 110.177 178.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 71.7 mt -74.51 -54.73 13.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.166 -0.47 . . . . 0.35 110.862 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -144.74 145.08 31.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.256 -0.429 . . . . 1.65 109.989 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -131.98 130.16 41.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.343 -0.39 . . . . 0.65 110.481 -175.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 -116.14 136.83 52.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.362 -0.381 . . . . 0.52 110.806 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 47.7 t -75.14 145.17 42.38 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.634 -0.506 . . . . 1.27 109.634 174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 95.3 mt -61.55 -27.27 68.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.207 0.527 . . . . 0.31 110.415 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 77.2 p -73.93 -7.62 53.04 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.514 -0.767 . . . . 0.44 111.62 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -108.14 9.25 28.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.107 0.48 . . . . 0.83 110.564 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 67.3 mt -92.16 132.44 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.829 -0.623 . . . . 0.38 109.749 177.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -99.38 -69.7 0.76 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 1.75 110.247 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 6.9 ptp180 -137.34 154.04 50.12 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.895 -0.593 . . . . 1.75 110.192 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.566 ' HB3' HD23 ' A' ' 368' ' ' LEU . 43.5 p90 -133.74 145.31 49.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.117 0.484 . . . . 0.4 110.574 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.411 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.11 118.24 35.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.511 -0.768 . . . . 0.31 110.638 -178.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -95.19 119.64 34.05 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.504 -0.771 . . . . 0.38 110.436 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.1 m -141.63 146.17 40.4 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.103 -0.499 . . . . 1.0 109.719 177.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.39 -14.56 43.05 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.899 2.399 . . . . 0.66 113.714 -175.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -102.92 -36.04 8.37 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.889 -0.324 . . . . 2.08 111.145 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.512 ' O ' ' HB2' ' A' ' 362' ' ' SER . 21.0 m -153.42 144.85 23.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.819 0.343 . . . . 1.32 110.878 -177.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -107.64 141.02 39.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.959 -0.756 . . . . 0.3 108.959 177.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 23.3 m -129.32 122.32 29.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.852 0.358 . . . . 0.34 111.596 -176.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 40.4 mt -100.03 137.52 38.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.984 -0.553 . . . . 0.33 110.289 174.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -121.85 134.45 54.88 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.073 0.463 . . . . 1.52 110.421 175.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -118.56 4.46 11.7 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.659 -0.701 . . . . 0.44 110.163 -178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 57.12 -125.2 38.27 Favored Glycine 0 N--CA 1.449 -0.464 0 CA-C-N 115.848 -0.615 . . . . 0.58 112.893 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -78.44 65.68 3.81 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.477 0.656 . . . . 2.38 110.627 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -138.66 -47.27 0.5 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.865 -0.607 . . . . 0.79 110.538 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -136.02 178.58 6.94 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.513 -0.312 . . . . 1.09 110.254 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.24 113.44 25.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.049 0.452 . . . . 2.3 110.815 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.6 -162.31 29.08 Favored Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.668 -0.777 . . . . 0.7 111.697 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -116.98 -172.29 2.18 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.654 ' CE1' ' HD3' ' A' ' 339' ' ' ARG . 54.2 t80 -121.74 91.33 3.49 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.221 -0.445 . . . . 0.47 109.923 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -102.4 118.6 37.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.886 -0.597 . . . . 1.06 110.748 -178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.53 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 8.8 m -127.87 136.43 60.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.272 -0.422 . . . . 0.33 110.835 177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -80.43 123.96 28.5 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.028 0.442 . . . . 1.47 109.96 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.454 ' HB ' HG12 ' A' ' 315' ' ' VAL . 8.3 t -161.32 148.39 14.83 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.413 -0.812 . . . . 0.42 109.468 -177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 9.4 p -92.41 1.55 57.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 120.773 0.321 . . . . 0.55 111.214 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.436 ' O ' HG13 ' A' ' 388' ' ' ILE . 44.7 mt-10 -121.35 35.29 4.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.06 0.457 . . . . 1.39 111.299 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -65.88 -29.9 76.0 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.98 -0.629 . . . . 0.27 112.567 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -63.46 -41.88 98.62 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.788 0.328 . . . . 2.28 110.718 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -63.5 -44.12 95.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.129 -0.487 . . . . 2.27 111.214 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 384' ' ' GLU . 33.7 mt -57.74 -47.76 85.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.29 110.647 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.443 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.42 -45.11 94.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.799 -0.637 . . . . 0.28 111.662 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -63.51 -47.92 79.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 1.99 110.832 -178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.721 ' CD1' HG21 ' A' ' 332' ' ' ILE . 0.6 OUTLIER -63.77 -43.72 95.54 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.958 -0.564 . . . . 0.63 111.541 -176.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 78.1 mt -58.0 -45.5 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 C-N-CA 120.236 -0.586 . . . . 0.21 110.12 -179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -65.96 -25.6 67.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.95 -0.568 . . . . 0.29 110.733 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.51 -49.89 41.28 Favored Glycine 0 N--CA 1.452 -0.283 0 CA-C-N 116.06 -0.518 . . . . 0.35 112.582 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.444 ' CE2' HD21 ' A' ' 391' ' ' LEU . 5.6 m-85 -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.101 0.477 . . . . 0.7 110.172 176.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 29.1 mt -61.96 -35.47 68.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.686 -0.688 . . . . 0.45 111.031 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -60.77 -29.89 69.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.904 -0.589 . . . . 0.99 111.139 177.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.0 mt -75.27 -39.6 42.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.143 0.497 . . . . 0.81 110.424 178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.0 mt -70.21 -26.07 28.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.71 -0.677 . . . . 0.72 110.719 -178.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.4 HD21 HG23 ' B' ' 379' ' ' ILE . 98.1 mt . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.535 -0.745 . . . . 1.56 110.822 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.638 -0.585 . . . . 12.98 111.638 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.2 mmm180 -85.76 -76.72 0.32 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 122.812 -0.228 . . . . 14.53 110.847 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . 0.683 ' H ' ' HD2' ' B' ' 370' ' ' LYS . 12.7 p -174.06 33.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.278 0.561 . . . . 10.62 111.13 -176.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.683 ' HD2' ' H ' ' B' ' 369' ' ' SER . 0.0 OUTLIER -149.41 108.62 3.93 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.654 -0.703 . . . . 9.78 109.881 -177.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . 0.636 ' O ' HG22 ' B' ' 375' ' ' VAL . 37.3 mt-10 -112.05 -88.82 0.52 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.874 -0.603 . . . . 8.94 112.0 -172.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 24.3 m -75.85 144.75 41.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.206 0.527 . . . . 5.29 111.889 -174.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 87.98 -72.45 2.43 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.671 -0.695 . . . . 2.37 111.953 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -110.43 104.68 13.46 Favored 'General case' 0 CA--C 1.511 -0.543 0 N-CA-C 109.338 -0.616 . . . . 1.42 109.338 175.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.636 HG22 ' O ' ' B' ' 371' ' ' GLU . 19.1 t -103.09 105.57 18.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.171 -0.922 . . . . 1.07 110.371 -171.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -100.5 137.09 39.38 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.372 -0.603 . . . . 2.28 109.372 176.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.789 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.4 OUTLIER -111.35 179.64 3.98 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.877 -0.601 . . . . 1.83 110.802 -169.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -112.01 11.29 20.55 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 113.553 0.946 . . . . 1.88 113.553 -168.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.789 HG12 ' OD1' ' B' ' 377' ' ' ASN . 19.1 pt -118.19 22.22 5.75 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 120.314 -0.554 . . . . 1.17 112.343 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -79.48 104.35 10.02 Favored 'General case' 0 C--N 1.321 -0.645 0 C-N-CA 120.083 -0.647 . . . . 0.58 109.267 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.732 -0.651 . . . . 3.2 110.831 -178.214 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.707 0 N-CA-C 111.924 -0.471 . . . . 4.12 111.924 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.1 t 72.33 -69.04 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 123.026 0.53 . . . . 2.92 111.502 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 1.9 p -80.71 102.75 10.1 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.134 0.493 . . . . 1.06 111.616 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -125.99 128.68 47.84 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.703 -0.681 . . . . 0.52 110.339 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -107.05 129.31 54.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.188 -0.46 . . . . 0.41 110.172 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -80.71 102.24 9.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.72 109.811 177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.551 HG12 ' HB ' ' A' ' 382' ' ' THR . 35.8 m -107.96 169.62 2.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.882 -0.599 . . . . 0.3 110.432 -178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.628 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.9 mtpp -128.24 114.25 16.7 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.362 -0.381 . . . . 1.44 110.365 179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -90.1 127.4 36.08 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.02 -0.536 . . . . 0.7 110.927 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.726 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.3 tptp -89.83 89.69 7.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.16 0.505 . . . . 1.74 110.016 175.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 92.5 mmm -103.47 173.82 6.14 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.777 -0.647 . . . . 1.68 110.067 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -67.15 166.96 12.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.25 -0.432 . . . . 2.3 111.003 178.35 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.22 -42.72 1.86 Allowed Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.963 -0.637 . . . . 1.93 112.37 176.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.5 pttm -157.3 166.0 34.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.534 -0.173 . . . . 1.68 110.534 -177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.726 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 37.1 p30 -84.4 -7.49 59.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.81 0.338 . . . . 2.79 111.117 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.459 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.4 ttmt -74.39 143.21 44.91 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.107 -0.497 . . . . 2.01 110.342 176.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.551 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.9 mp -95.01 117.65 30.5 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.987 -0.552 . . . . 0.69 109.795 177.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 41.6 t -68.59 125.16 91.47 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.701 -0.681 . . . . 0.51 111.092 -174.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.417 ' HB2' ' HG3' ' A' ' 342' ' ' GLU . 18.4 Cg_exo -66.43 130.34 23.54 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.659 2.239 . . . . 0.46 111.505 177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -139.04 154.6 48.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.725 -0.472 . . . . 0.78 109.725 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 96.6 mt -100.52 106.83 18.39 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.958 -0.386 . . . . 0.37 109.958 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.417 HD23 HD13 ' A' ' 388' ' ' ILE . 21.4 tp -84.95 101.62 12.5 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.393 -0.595 . . . . 0.57 109.393 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.09 111.26 3.94 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.995 -0.621 . . . . 0.29 112.312 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.584 HD13 HG13 ' A' ' 337' ' ' VAL . 27.6 mm -96.44 113.29 30.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.602 -0.518 . . . . 0.36 109.602 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.5 p -109.01 -173.89 2.38 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.074 -0.343 . . . . 0.38 110.074 178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.405 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 20.6 pttp -72.24 -23.07 61.17 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.837 0.31 . . . . 1.61 111.837 -174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.16 -12.69 6.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.838 0.681 . . . . 1.79 112.838 -172.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -155.81 169.45 24.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.661 0.743 . . . . 1.1 112.93 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 332' ' ' ILE . 87.9 t -121.62 111.98 33.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.812 -1.086 . . . . 0.32 108.968 175.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 23.8 ptp -109.69 138.7 45.68 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.095 0.474 . . . . 1.08 111.509 -174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.4 ' HD3' ' CZ ' ' A' ' 378' ' ' TYR . 58.4 mtm180 -91.67 101.06 13.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.953 -0.567 . . . . 1.55 110.461 175.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 347' ' ' VAL . 93.8 t -97.09 133.29 39.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.279 -0.637 . . . . 0.31 109.279 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -65.17 143.42 57.87 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.548 -0.461 . . . . 0.77 110.903 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 5.8 tm-20 -58.09 -50.17 74.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.449 -0.796 . . . . 1.51 111.257 -176.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -100.7 -44.2 5.89 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 111.796 0.295 . . . . 3.06 111.796 -172.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.444 HG22 ' HG2' ' A' ' 346' ' ' GLU . 1.4 m -74.95 -20.48 59.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.92 110.749 -176.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 62.38 23.81 14.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.838 -0.619 . . . . 1.5 111.291 178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.444 ' HG2' HG22 ' A' ' 344' ' ' THR . 61.7 mm-40 -92.57 142.59 27.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.337 -0.392 . . . . 2.46 110.761 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.576 HG22 HG22 ' A' ' 340' ' ' VAL . 47.8 t -85.1 106.46 15.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.307 -0.406 . . . . 0.58 109.959 177.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.6 mt -78.2 -50.3 19.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.963 -0.562 . . . . 0.35 111.053 -176.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -149.92 139.64 21.73 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.19 -0.459 . . . . 1.65 110.239 -177.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.4 tt0 -119.53 130.76 55.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.188 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . 0.497 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 5.7 m-90 -108.95 120.81 43.65 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.822 -0.436 . . . . 0.52 109.822 174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 m -72.65 144.71 47.68 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.468 -0.567 . . . . 1.27 109.468 174.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.617 HD13 HG13 ' A' ' 396' ' ' ILE . 79.3 mt -62.14 -20.13 63.77 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 121.075 0.464 . . . . 0.31 111.073 -177.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.5 p -78.1 -10.83 59.8 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.687 -0.688 . . . . 0.44 111.281 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -106.87 8.13 30.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.109 0.481 . . . . 0.83 110.37 -176.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -90.7 143.12 11.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.742 -0.663 . . . . 0.38 109.831 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -105.99 -52.13 2.86 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.006 0.432 . . . . 1.75 110.595 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -163.34 151.23 13.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.893 -0.594 . . . . 1.75 109.674 -178.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.491 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.7 p90 -131.75 156.6 45.67 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.963 0.411 . . . . 0.4 111.168 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.772 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -120.25 110.8 17.01 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.488 -0.778 . . . . 0.31 110.313 178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -90.63 112.91 24.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.38 110.952 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 365' ' ' SER . 17.2 m -131.65 146.59 62.5 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.461 -0.57 . . . . 1.0 109.461 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.67 7.18 2.84 Favored 'Trans proline' 0 CA--C 1.528 0.2 0 C-N-CA 122.73 2.287 . . . . 0.66 113.147 -176.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -129.35 -16.93 3.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.027 0.442 . . . . 2.08 110.899 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 362' ' ' SER . 13.1 t -166.17 140.75 4.46 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.222 -0.445 . . . . 1.32 109.893 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.667 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.7 t80 -108.35 123.78 49.35 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.238 -0.653 . . . . 0.3 109.238 177.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.772 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 26.8 m -110.05 124.91 52.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.25 -0.432 . . . . 0.34 110.998 -177.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.491 HD23 ' HB3' ' A' ' 359' ' ' TRP . 37.8 mt -109.43 142.44 40.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.339 -0.391 . . . . 0.33 111.002 176.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -127.18 128.39 46.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.942 -0.572 . . . . 1.52 109.69 173.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.6 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.0 m-85 -115.38 3.34 14.14 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.335 -0.393 . . . . 0.44 110.934 -176.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.74 -99.94 0.15 Allowed Glycine 0 CA--C 1.518 0.244 0 CA-C-N 115.939 -0.573 . . . . 0.58 113.927 174.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -92.28 5.57 50.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.308 0.575 . . . . 2.38 111.153 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.6 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 76.8 t80 -85.74 -39.9 16.68 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.018 -0.426 . . . . 0.79 110.53 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -159.9 155.86 26.31 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.458 -0.337 . . . . 1.09 110.169 176.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -82.81 135.5 34.94 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.206 -0.452 . . . . 2.3 111.132 -177.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 91.97 155.07 31.48 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.705 -0.68 . . . . 0.7 111.999 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -85.23 176.53 8.29 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.855 -0.424 . . . . 1.06 109.855 178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.481 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 61.8 t80 -128.98 96.38 4.33 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.805 -0.443 . . . . 0.47 109.805 177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 3.2 t -113.3 118.63 35.16 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.996 0.427 . . . . 1.06 110.256 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 365' ' ' SER . 16.0 m -118.84 149.5 21.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.031 -0.531 . . . . 0.33 110.732 178.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.628 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.0 tt0 -74.32 123.64 24.96 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.746 -0.464 . . . . 1.47 109.746 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.551 ' HB ' HG12 ' A' ' 315' ' ' VAL . 2.9 t -163.14 135.14 5.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.285 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 11.3 p -88.16 -0.04 56.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.821 -0.627 . . . . 0.55 110.149 176.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.502 ' O ' HG13 ' A' ' 388' ' ' ILE . 36.3 mt-10 -111.46 19.13 18.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.421 -0.809 . . . . 1.39 110.269 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.6 -39.25 74.46 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.85 -0.614 . . . . 0.27 113.125 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.18 -41.95 99.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.169 0.509 . . . . 2.28 110.247 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 64.6 mt-30 -65.84 -40.76 92.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.478 -0.783 . . . . 2.27 110.376 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 384' ' ' GLU . 64.2 mt -59.87 -53.15 52.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.872 -0.604 . . . . 0.29 110.538 179.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.667 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.57 -42.47 92.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.28 111.172 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -69.93 -25.07 63.49 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.742 -0.663 . . . . 1.99 110.592 -177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.478 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.9 tp -79.59 -42.02 25.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.361 -0.382 . . . . 0.63 110.035 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.567 HG22 HD12 ' A' ' 396' ' ' ILE . 74.2 mt -60.25 -51.06 77.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.136 -0.483 . . . . 0.21 110.018 176.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.9 -29.57 70.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.071 -0.513 . . . . 0.29 110.694 178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.34 -50.46 62.38 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.032 -0.531 . . . . 0.35 112.478 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.48 ' O ' HG13 ' A' ' 399' ' ' ILE . 30.0 m-85 -69.85 -40.36 75.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.818 0.342 . . . . 0.7 110.855 179.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.617 HG13 HD13 ' A' ' 353' ' ' LEU . 19.5 mt -57.23 -38.82 63.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.118 -0.492 . . . . 0.45 110.875 176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -61.55 -21.86 64.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.926 -0.579 . . . . 0.99 111.129 178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 47.2 mt -90.19 -30.15 5.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.81 110.78 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 395' ' ' TYR . 59.7 mt -70.75 -58.59 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.3 -0.409 . . . . 0.72 111.977 -173.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.75 ' HG ' HG23 ' B' ' 379' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.978 0 C-N-CA 120.224 -0.59 . . . . 1.56 111.842 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.451 ' O ' ' HD2' ' B' ' 368' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.88 -0.488 . . . . 12.98 111.88 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . 0.456 HH11 ' HD3' ' B' ' 368' ' ' ARG . 11.2 mmm-85 -124.95 -157.17 0.76 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.276 -0.638 . . . . 14.53 109.276 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 50.2 m 63.29 30.45 15.7 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 121.421 0.629 . . . . 10.62 111.353 176.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -170.43 78.1 0.08 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.77 -1.105 . . . . 9.78 109.42 176.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -131.83 150.78 52.05 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.551 -0.749 . . . . 8.94 110.709 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.7 t -177.29 150.76 0.74 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.886 -0.597 . . . . 5.29 109.703 -177.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 83.02 -61.58 4.76 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.209 -0.519 . . . . 2.37 113.282 176.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -86.46 117.27 25.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.349 0.595 . . . . 1.42 111.728 -174.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 31.8 t -121.33 117.91 54.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.0 -1.0 . . . . 1.07 109.313 178.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.44 144.28 26.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.373 0.606 . . . . 2.28 111.184 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -98.04 154.54 17.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.099 -0.955 . . . . 1.83 110.53 179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -97.56 13.51 29.77 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.543 0.571 . . . . 1.88 112.543 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.75 HG23 ' HG ' ' A' ' 400' ' ' LEU . 4.7 pt -123.76 60.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.939 -0.573 . . . . 1.17 111.441 173.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -103.7 106.81 17.43 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.883 -0.784 . . . . 0.58 108.883 173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 C--O 1.247 0.958 0 CA-C-O 118.396 -0.812 . . . . 3.2 111.04 -175.726 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.724 0 N-CA-C 111.958 -0.457 . . . . 4.12 111.958 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 88.4 t -104.48 -59.88 3.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 120.836 0.35 . . . . 2.92 111.183 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.8 m -92.12 119.02 31.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.223 -0.444 . . . . 1.06 111.141 -175.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.556 ' HE1' HG21 ' A' ' 340' ' ' VAL . 74.1 m-85 -122.52 125.96 46.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.001 0.429 . . . . 0.52 110.84 178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.82 132.78 53.84 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.028 -0.533 . . . . 0.41 110.284 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.67 91.65 8.82 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.073 0.463 . . . . 0.72 109.784 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 27.1 m -100.79 167.24 2.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.987 -0.552 . . . . 0.3 110.718 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 21.6 mtpp -115.37 111.85 21.46 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.917 -0.401 . . . . 1.44 109.917 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 55.3 mt-10 -79.41 123.12 27.22 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.763 0.316 . . . . 0.7 110.927 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.499 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.5 tptm -104.05 116.21 31.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.08 -0.509 . . . . 1.74 109.901 176.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 69.8 mtm -135.09 -173.23 3.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.341 -0.391 . . . . 1.68 110.556 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.92 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.85 167.24 22.24 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.955 -0.566 . . . . 2.3 110.859 178.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.51 -52.86 0.75 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.886 -0.674 . . . . 1.93 112.181 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 58.5 pttt -144.71 168.84 19.23 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.292 -0.262 . . . . 1.68 110.292 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.499 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 8.9 p30 -97.17 -3.45 40.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.932 0.396 . . . . 2.79 110.596 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -81.55 126.14 31.35 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 2.01 109.981 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.4 mp -87.93 134.23 33.76 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.69 110.374 -179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.404 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 44.7 t -88.9 129.34 48.8 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.826 -0.625 . . . . 0.51 110.836 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 17.9 Cg_exo -66.53 118.86 5.87 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.732 2.288 . . . . 0.46 111.616 176.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.846 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.3 tpp180 -122.7 138.33 54.64 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.149 -0.478 . . . . 0.78 110.354 -178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.775 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.6 mt -88.24 99.84 12.53 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.493 -0.558 . . . . 0.37 109.493 175.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -82.74 104.83 13.27 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.941 -0.572 . . . . 0.57 109.826 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.17 109.44 3.8 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.94 -0.648 . . . . 0.29 111.993 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 41.3 mm -100.53 117.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 110.033 -0.358 . . . . 0.36 110.033 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 70.2 p -115.81 -178.54 3.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.543 -0.299 . . . . 0.38 110.525 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.6 pttp -74.47 9.64 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.266 -0.424 . . . . 1.61 111.778 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -156.04 -30.48 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.73 0.641 . . . . 1.79 112.73 -174.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 68.9 m -131.12 164.36 25.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.633 0.73 . . . . 1.1 112.825 -173.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.11 103.46 9.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 114.67 -1.15 . . . . 0.32 108.805 175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.8 ptp -107.28 141.01 39.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.113 0.483 . . . . 1.08 111.821 -172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.502 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -99.27 100.66 11.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.812 -0.631 . . . . 1.55 110.243 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 347' ' ' VAL . 48.0 t -92.06 132.54 36.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.31 110.352 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.846 ' HA ' HH11 ' A' ' 328' ' ' ARG . 28.4 t70 -68.49 128.87 38.16 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.533 -0.543 . . . . 0.77 109.533 177.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -65.31 -35.75 81.97 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.973 0.415 . . . . 1.51 110.7 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -84.12 -53.23 5.67 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.582 . . . . 3.06 111.605 -177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -85.84 -19.06 31.19 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.198 0.444 . . . . 0.92 112.198 -171.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 68.16 15.67 9.39 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.854 0.461 . . . . 1.5 112.059 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 -93.78 140.78 29.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.491 -0.322 . . . . 2.46 110.387 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.814 HG22 HG22 ' A' ' 340' ' ' VAL . 61.6 t -81.04 106.16 11.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.958 0.408 . . . . 0.58 109.983 177.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.69 -44.72 59.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.562 -0.744 . . . . 0.35 111.217 -174.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -149.16 140.34 23.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.997 -0.547 . . . . 1.65 109.683 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -130.5 126.9 38.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.035 0.445 . . . . 0.65 111.155 -175.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -107.44 176.35 5.18 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.953 -0.567 . . . . 0.52 109.861 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 8.9 m -124.9 150.84 46.11 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.434 -0.58 . . . . 1.27 109.434 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.52 HD22 HG23 ' A' ' 392' ' ' ILE . 72.4 mt -61.9 -28.81 69.78 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.296 0.569 . . . . 0.31 110.561 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 67.2 p -72.14 -16.05 61.99 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 0.44 111.611 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -101.8 5.94 41.39 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.189 -0.46 . . . . 0.83 111.088 -175.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.95 128.61 40.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.368 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -84.32 -54.64 4.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.366 0.603 . . . . 1.75 109.5 178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 -163.76 168.35 19.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 1.75 109.135 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.458 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.1 p90 -141.99 151.01 42.1 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.4 111.054 177.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -114.15 118.68 34.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.533 -0.758 . . . . 0.31 110.616 179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.67 121.95 44.03 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.466 -0.788 . . . . 0.38 110.656 -178.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.449 ' HB3' ' HD2' ' A' ' 363' ' ' PRO . 49.2 m -141.87 159.36 59.75 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 116.201 -0.454 . . . . 1.0 109.96 177.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 362' ' ' SER . 46.1 Cg_endo -69.4 -12.09 32.79 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.692 2.262 . . . . 0.66 113.367 -178.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -113.09 -35.1 5.49 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.77 -0.372 . . . . 2.08 111.678 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.2 m -144.33 149.56 36.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.166 0.508 . . . . 1.32 111.791 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -123.95 126.59 46.6 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.401 -0.818 . . . . 0.3 109.098 177.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 31.2 m -118.5 131.23 56.25 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.755 0.312 . . . . 0.34 111.349 -175.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.583 HD12 ' HD2' ' A' ' 378' ' ' TYR . 66.7 mt -108.74 122.25 46.75 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.999 -0.546 . . . . 0.33 110.582 176.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.91 124.51 46.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.87 -0.605 . . . . 1.52 110.034 177.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.501 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.7 m-85 -113.47 -15.23 12.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.989 0.423 . . . . 0.44 110.912 178.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 75.55 -113.97 4.1 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.988 -0.625 . . . . 0.58 112.962 176.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -83.96 5.88 23.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.351 0.596 . . . . 2.38 111.296 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.501 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 41.4 t80 -85.39 -19.91 30.67 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.986 0.422 . . . . 0.79 109.991 -178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -164.47 153.13 12.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.283 -0.417 . . . . 1.09 110.149 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -80.68 146.69 30.98 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 108.861 -0.792 . . . . 2.3 108.861 173.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 72.6 -175.64 43.58 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.541 -0.838 . . . . 0.7 111.344 -174.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -123.26 -175.94 3.31 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.817 0.341 . . . . 1.06 110.627 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.583 ' HD2' HD12 ' A' ' 368' ' ' LEU . 33.3 t80 -121.22 99.55 6.55 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.628 -0.508 . . . . 0.47 109.628 178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -114.55 119.1 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.906 -0.588 . . . . 1.06 111.001 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 19.5 m -117.04 144.14 25.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.876 -0.602 . . . . 0.33 110.41 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -90.68 126.99 36.15 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.425 -0.583 . . . . 1.47 109.425 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.0 t -174.51 146.3 1.02 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.953 -0.567 . . . . 0.42 110.459 -175.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 41.5 p -82.1 -15.65 52.71 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.336 0.588 . . . . 0.55 110.084 175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.542 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 37.4 mt-10 -91.48 10.07 29.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 1.39 111.004 -174.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.11 -44.35 83.61 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 116.163 -0.472 . . . . 0.27 113.022 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 39.9 tt0 -64.1 -37.24 86.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.997 0.427 . . . . 2.28 110.635 179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.542 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.3 mp0 -67.9 -40.49 83.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 2.27 110.4 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 384' ' ' GLU . 66.1 mt -63.05 -45.54 98.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.29 110.336 177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . . . . . . . . . . . -56.04 -46.99 78.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.691 -0.686 . . . . 0.28 111.458 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -66.3 -33.03 74.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.075 -0.511 . . . . 1.99 110.822 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 45.5 tp -68.23 -44.84 74.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.331 -0.395 . . . . 0.63 110.434 -179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.52 HG23 HD22 ' A' ' 353' ' ' LEU . 72.2 mt -60.02 -48.48 87.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.942 0.401 . . . . 0.21 109.982 176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.23 -31.98 71.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.756 -0.656 . . . . 0.29 110.885 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -62.53 -50.97 59.57 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.288 -0.482 . . . . 0.35 112.203 178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.461 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 42.7 m-85 -65.07 -40.5 94.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.88 0.371 . . . . 0.7 110.325 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.493 HG12 HD11 ' B' ' 379' ' ' ILE . 32.1 mt -58.4 -44.91 89.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.686 -0.688 . . . . 0.45 110.973 177.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -59.49 -30.68 68.73 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.99 111.021 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 394' ' ' GLY . 78.0 mt -73.43 -37.46 50.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.892 0.377 . . . . 0.81 110.793 178.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.1 mt -72.25 -33.44 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.319 -0.401 . . . . 0.72 110.821 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.488 -0.767 . . . . 1.56 111.25 -179.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 112.065 -0.414 . . . . 12.98 112.065 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.0 tpp180 56.4 64.19 1.76 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.447 0.641 . . . . 14.53 110.213 -178.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 15.7 m -132.15 120.56 22.44 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.783 -0.644 . . . . 10.62 110.164 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp 61.17 87.36 0.09 Allowed 'General case' 0 N--CA 1.47 0.573 0 O-C-N 123.833 0.708 . . . . 9.78 110.582 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -55.67 -46.64 77.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 8.94 111.125 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 14.9 m -94.62 68.76 3.44 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.948 0.88 . . . . 5.29 109.8 172.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -110.46 23.45 20.26 Favored Glycine 0 C--N 1.306 -1.11 0 CA-C-N 114.524 -1.216 . . . . 2.37 111.386 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -115.05 110.6 19.82 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.253 0.549 . . . . 1.42 109.971 -174.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.2 t -97.69 125.17 50.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 115.544 -0.753 . . . . 1.07 109.687 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -77.03 144.27 38.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.609 -0.723 . . . . 2.28 110.836 -176.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.422 ' OD1' HG12 ' B' ' 379' ' ' ILE . 44.3 t30 -109.6 130.01 55.54 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.962 -0.563 . . . . 1.83 109.766 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -108.28 23.01 15.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.005 0.431 . . . . 1.88 112.016 -174.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.493 HD11 HG12 ' A' ' 396' ' ' ILE . 16.7 pt -126.76 26.19 2.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.06 -0.518 . . . . 1.17 110.465 169.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -82.35 123.01 28.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.076 -0.511 . . . . 0.58 109.901 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.367 -0.825 . . . . 3.2 110.831 -179.575 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.956 -0.457 . . . . 4.12 111.956 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.87 111.21 30.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.72 0.295 . . . . 2.92 110.627 -176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 15.1 m -87.5 110.62 20.46 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.764 -0.458 . . . . 1.06 109.764 176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.485 ' HE1' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -89.97 122.5 33.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.951 0.405 . . . . 0.52 111.633 -176.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -112.49 134.46 54.01 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.715 -0.675 . . . . 0.41 109.978 174.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 45.8 tp -85.58 99.93 11.6 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 0.72 110.135 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 31.3 m -109.65 162.02 7.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.808 -0.633 . . . . 0.3 110.487 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.665 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 28.2 mtpp -118.04 104.61 11.03 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.822 0.344 . . . . 1.44 110.551 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 82.2 mt-10 -76.26 126.73 31.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.976 -0.556 . . . . 0.7 110.766 -178.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.433 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 24.0 tptp -109.55 101.87 10.77 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.303 0.573 . . . . 1.74 109.884 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.3 mtm -125.95 174.69 8.23 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.516 -0.766 . . . . 1.68 109.637 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.849 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -64.08 160.24 18.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.153 0.501 . . . . 2.3 110.862 177.242 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.88 -41.44 2.14 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.865 -0.683 . . . . 1.93 112.0 177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 22.7 pttm -161.26 163.93 30.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.416 0.627 . . . . 1.68 110.552 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.433 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 20.2 p-10 -83.55 -17.11 42.89 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 114.755 -1.111 . . . . 2.79 111.097 -177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 83.8 tttt -70.42 123.11 20.96 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.152 -0.477 . . . . 2.01 110.838 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.61 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -77.74 110.2 12.39 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.341 -0.614 . . . . 0.69 109.341 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.4 t -70.12 118.28 62.25 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.618 -0.719 . . . . 0.51 112.1 -170.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.427 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 17.0 Cg_exo -67.49 113.91 3.09 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.487 2.125 . . . . 0.46 110.875 173.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.471 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 21.3 tpp180 -117.13 146.88 42.88 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.545 -176.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.495 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 96.3 mt -86.4 92.69 8.91 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.243 -0.651 . . . . 0.37 109.243 172.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 29.3 tp -80.61 100.03 8.43 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.054 -0.521 . . . . 0.57 109.683 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -90.97 108.28 3.56 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.896 -0.669 . . . . 0.29 112.18 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 34.7 mm -90.74 134.02 30.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.658 -0.497 . . . . 0.36 109.658 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 8.4 p -131.47 178.95 6.34 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.431 -0.35 . . . . 0.38 110.443 179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.438 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.9 pttm -66.95 -22.76 65.92 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.356 0.502 . . . . 1.61 112.356 -173.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.53 -4.87 2.58 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.748 0.647 . . . . 1.79 112.748 -175.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 71.1 m -149.09 166.64 28.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.729 0.776 . . . . 1.1 112.849 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.4 t -125.99 117.47 48.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 114.754 -1.112 . . . . 0.32 108.759 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.47 ' HB2' HG13 ' A' ' 347' ' ' VAL . 24.6 ptp -114.64 134.34 55.14 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.959 0.409 . . . . 1.08 111.58 -175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.516 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.3 mtm180 -93.84 101.64 13.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.097 -0.501 . . . . 1.55 109.915 175.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 347' ' ' VAL . 48.4 t -94.44 135.14 29.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 110.155 -0.313 . . . . 0.31 110.155 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -65.47 129.37 39.5 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.545 -0.539 . . . . 0.77 109.545 177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -62.18 -38.85 90.66 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.028 -0.533 . . . . 1.51 111.357 -173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -100.59 -35.92 9.34 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.003 0.43 . . . . 3.06 111.422 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.6 m -88.49 -17.92 29.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.361 -0.381 . . . . 0.92 111.307 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 63.69 24.42 13.87 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 116.101 -0.499 . . . . 1.5 112.145 175.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -105.17 139.36 39.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.545 0.212 . . . . 2.46 110.535 177.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.632 HG22 HG22 ' A' ' 340' ' ' VAL . 46.8 t -74.34 109.4 7.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.476 -0.564 . . . . 0.58 109.476 176.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 58.1 mt -78.71 -51.48 17.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.077 -0.511 . . . . 0.35 111.109 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -142.76 126.02 16.54 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.223 -0.288 . . . . 1.65 110.223 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -116.77 120.62 39.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.368 -0.378 . . . . 0.65 110.307 -177.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -110.94 123.62 50.51 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.525 -0.307 . . . . 0.52 110.983 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.582 ' HB3' HD22 ' A' ' 355' ' ' ASN . 42.4 t -66.36 141.75 57.86 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.327 -0.619 . . . . 1.27 109.327 171.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.581 HD22 HG23 ' A' ' 392' ' ' ILE . 82.7 mt -59.93 -22.94 63.09 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.399 0.619 . . . . 0.31 110.76 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 80.6 p -67.59 -20.79 65.42 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.121 -0.945 . . . . 0.44 111.834 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.582 HD22 ' HB3' ' A' ' 352' ' ' SER . 58.2 m-80 -92.54 -1.74 56.71 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.83 111.178 -177.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 63.7 mt -81.52 150.03 4.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.168 -0.469 . . . . 0.38 109.753 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -117.48 -46.07 2.69 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.082 0.467 . . . . 1.75 110.809 176.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 3.3 ptp180 -158.25 152.96 24.83 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.26 -0.427 . . . . 1.75 109.851 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.689 ' HZ3' ' HB3' ' B' ' 377' ' ' ASN . 31.0 p90 -141.31 142.92 33.82 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.238 0.542 . . . . 0.4 110.916 178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -102.34 111.61 23.97 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.371 -0.832 . . . . 0.31 110.755 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.443 ' HB2' ' CB ' ' A' ' 389' ' ' ALA . . . -95.46 111.42 23.32 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.48 -0.782 . . . . 0.38 110.793 -178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 32.2 m -141.47 148.03 48.78 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 109.53 -0.544 . . . . 1.0 109.53 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -71.23 -3.21 12.47 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.603 2.202 . . . . 0.66 112.918 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -111.08 -35.21 5.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.265 -0.425 . . . . 2.08 110.637 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 67.3 p -149.84 141.61 23.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.086 0.47 . . . . 1.32 111.082 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 85.8 t80 -119.73 121.55 39.45 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.958 -0.756 . . . . 0.3 108.958 175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 99.4 m -119.43 118.91 32.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.91 0.386 . . . . 0.34 111.666 -176.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.603 HD23 ' HB3' ' A' ' 359' ' ' TRP . 52.4 mt -93.62 136.16 34.17 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.018 -0.537 . . . . 0.33 110.651 175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -122.0 137.1 54.93 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.226 -0.443 . . . . 1.52 109.83 173.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.591 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 88.8 m-85 -117.56 11.18 13.71 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.515 -176.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 66.08 -102.58 0.73 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.839 -0.618 . . . . 0.58 113.115 175.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -105.52 11.5 32.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.983 0.42 . . . . 2.38 110.787 -175.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.3 t80 -85.32 -29.47 24.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.176 -0.465 . . . . 0.79 110.94 -176.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -157.27 151.7 25.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.882 0.372 . . . . 1.09 110.85 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -85.17 121.21 27.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.784 -0.644 . . . . 2.3 109.951 175.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.48 140.76 11.38 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.654 -0.784 . . . . 0.7 111.802 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -79.68 178.08 8.42 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 1.06 110.812 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.585 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.0 t80 -121.85 87.23 2.72 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.81 -0.632 . . . . 0.47 109.363 174.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.8 m -97.9 119.15 36.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.709 -0.678 . . . . 1.06 110.752 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.577 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 18.7 m -121.55 142.11 39.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 116.021 -0.536 . . . . 0.33 110.935 178.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.665 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.8 tt0 -80.98 117.71 21.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.842 -0.799 . . . . 1.47 108.842 174.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.416 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -155.2 141.92 18.93 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.967 0.413 . . . . 0.42 110.914 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 8.4 p -87.85 -8.4 55.92 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.739 -0.664 . . . . 0.55 110.699 177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.487 ' O ' HG13 ' A' ' 388' ' ' ILE . 42.4 mt-10 -112.11 22.43 14.81 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.758 -0.655 . . . . 1.39 110.904 -176.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.54 -36.8 72.25 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 116.143 -0.48 . . . . 0.27 112.755 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -63.3 -48.94 75.98 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.804 0.335 . . . . 2.28 110.179 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -61.2 -43.98 98.01 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.106 -0.497 . . . . 2.27 111.109 178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 384' ' ' GLU . 76.6 mt -57.54 -50.83 75.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.032 0.444 . . . . 0.29 110.557 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -63.72 -41.48 98.06 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.848 -0.614 . . . . 0.28 111.42 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -67.17 -31.57 72.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.889 -0.596 . . . . 1.99 110.419 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 21.1 tp -71.88 -45.62 60.7 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.172 -0.467 . . . . 0.63 110.048 177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.581 HG23 HD22 ' A' ' 353' ' ' LEU . 75.3 mt -59.93 -52.99 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 CA-C-N 116.257 -0.429 . . . . 0.21 110.502 177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.532 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -63.58 -25.45 68.24 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 0.29 110.919 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -70.73 -47.0 42.88 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.2 -0.524 . . . . 0.35 112.412 177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.438 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -70.45 -35.64 73.46 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.076 0.465 . . . . 0.7 110.286 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.568 HG12 HD11 ' B' ' 379' ' ' ILE . 10.7 mt -59.7 -40.9 83.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.457 -0.792 . . . . 0.45 111.314 177.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -55.07 -39.77 69.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.008 0.432 . . . . 0.99 110.635 178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 58.8 mt -64.45 -35.4 74.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.769 -0.651 . . . . 0.81 111.121 -179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 27.0 mt -72.6 -21.03 19.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.136 -0.484 . . . . 0.72 111.191 -175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.408 HD22 ' O ' ' A' ' 396' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.933 -0.556 . . . . 1.56 109.941 175.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.657 0 N-CA-C 111.578 -0.609 . . . . 12.98 111.578 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' B' ' 368' ' ' ARG . 8.1 mmt180 55.65 86.73 0.06 Allowed 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.865 0.364 . . . . 14.53 111.42 -177.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 11.8 m -52.91 119.45 4.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.841 -0.618 . . . . 10.62 111.562 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 37.0 mtmt -97.59 109.6 22.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.398 -0.964 . . . . 9.78 108.398 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -83.91 89.33 7.2 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.826 -0.625 . . . . 8.94 112.173 -167.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 m -127.05 142.42 51.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.71 -0.677 . . . . 5.29 109.195 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 105.99 -41.53 2.15 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 111.116 -0.794 . . . . 2.37 111.116 -176.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -128.68 131.87 48.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.355 -0.609 . . . . 1.42 109.355 174.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 6.9 p -131.52 123.01 51.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.193 0.52 . . . . 1.07 110.62 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -87.74 135.41 33.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.153 -0.93 . . . . 2.28 110.287 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.689 ' HB3' ' HZ3' ' A' ' 359' ' ' TRP . 34.2 p-10 -90.68 170.93 9.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.804 0.335 . . . . 1.83 110.571 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -128.46 28.41 5.44 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 111.995 0.369 . . . . 1.88 111.995 177.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.568 HD11 HG12 ' A' ' 396' ' ' ILE . 19.6 pt -123.29 26.28 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 120.685 -0.406 . . . . 1.17 111.602 170.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -85.49 98.65 10.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.032 -0.729 . . . . 0.58 109.032 175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.273 -0.87 . . . . 3.2 110.911 -176.184 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.155 -0.378 . . . . 4.12 112.155 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 14.3 p -116.44 -14.9 10.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.35 0.595 . . . . 2.92 110.166 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 25.6 m -77.47 86.94 3.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.944 -0.571 . . . . 1.06 110.882 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.419 ' HE1' HG21 ' A' ' 340' ' ' VAL . 58.5 m-85 -131.37 122.9 27.13 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.502 -0.772 . . . . 0.52 109.479 177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -107.46 117.43 34.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.216 -0.447 . . . . 0.41 110.622 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 53.8 tp -70.26 101.3 1.86 Allowed 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.981 -0.554 . . . . 0.72 109.579 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.1 m -108.05 165.6 4.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.779 -0.646 . . . . 0.3 110.056 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 29.2 mtpt -119.12 110.06 16.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.836 0.35 . . . . 1.44 110.223 178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.624 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 40.1 mt-10 -89.44 135.73 33.43 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.663 -0.699 . . . . 0.7 110.823 -176.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 42.9 tptt -89.24 86.44 6.85 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.377 -0.601 . . . . 1.74 109.377 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 85.3 mtp -106.76 157.03 18.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.219 -0.446 . . . . 1.68 110.415 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.933 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.36 161.55 30.34 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.184 -0.462 . . . . 2.3 110.394 178.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -24.16 10.52 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.798 -0.921 . . . . 1.93 110.798 -176.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -167.79 169.12 11.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.676 -0.861 . . . . 1.68 108.676 176.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -92.6 -4.48 53.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.01 0.433 . . . . 2.79 110.984 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.494 ' NZ ' ' HB2' ' A' ' 324' ' ' LYS . 5.0 ttmp? -87.08 137.46 32.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.984 -0.553 . . . . 2.01 110.491 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.482 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.6 mp -73.82 130.5 40.06 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.248 -0.433 . . . . 0.69 109.988 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 31.2 t -84.5 123.46 74.61 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.944 -0.571 . . . . 0.51 110.959 -175.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -67.81 117.71 5.09 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.583 2.189 . . . . 0.46 111.279 174.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -125.06 152.59 44.12 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.834 -0.432 . . . . 0.78 109.834 -178.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 85.7 mt -95.69 102.32 14.11 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.847 0.356 . . . . 0.37 110.245 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.5 tp -82.52 105.59 13.69 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.67 -0.493 . . . . 0.57 109.67 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.42 115.64 5.09 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.986 -0.626 . . . . 0.29 112.055 -177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.475 HD13 HG13 ' A' ' 337' ' ' VAL . 21.7 mm -101.86 114.04 40.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.702 -0.481 . . . . 0.36 109.702 -179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 69.5 p -110.85 -177.45 3.22 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.356 -0.238 . . . . 0.38 110.356 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -78.49 4.28 13.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.749 -0.205 . . . . 1.61 111.492 -175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -145.4 -26.62 0.47 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.519 0.563 . . . . 1.79 112.519 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 17.9 p -146.51 153.87 40.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.607 0.718 . . . . 1.1 112.784 -174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.475 HG13 HD13 ' A' ' 332' ' ' ILE . 91.5 t -109.44 115.2 48.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.004 -0.998 . . . . 0.32 108.728 173.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.7 ptp -114.99 142.18 46.98 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.021 0.439 . . . . 1.08 111.506 -174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.624 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.2 mtm180 -96.91 101.66 13.29 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.966 -0.561 . . . . 1.55 109.951 176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 347' ' ' VAL . 61.8 t -94.09 130.6 42.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.258 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -64.92 128.52 36.09 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.746 -0.464 . . . . 0.77 109.746 177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -63.83 -38.87 92.7 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.162 0.506 . . . . 1.51 110.46 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -86.8 -51.06 6.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.796 -0.638 . . . . 3.06 111.612 -174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.32 -16.9 30.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.022 -0.536 . . . . 0.92 111.612 -172.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm 66.02 21.3 11.28 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.964 -0.562 . . . . 1.5 111.679 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -89.55 140.26 29.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.489 -0.323 . . . . 2.46 110.411 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.519 HG22 HG22 ' A' ' 340' ' ' VAL . 57.8 t -83.26 101.54 8.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.721 -0.474 . . . . 0.58 109.721 176.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.0 mt -75.72 -34.43 28.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.933 -0.576 . . . . 0.35 111.482 -173.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -156.82 144.56 19.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.301 -0.409 . . . . 1.65 110.035 -175.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -135.25 126.89 28.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.787 0.327 . . . . 0.65 110.775 -175.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -115.62 122.17 44.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.446 -0.343 . . . . 0.52 111.065 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.0 t -68.16 145.77 54.04 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.633 -0.506 . . . . 1.27 109.633 174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 89.3 mt -61.59 -26.42 67.96 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.283 0.563 . . . . 0.31 110.258 178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.1 p -73.84 -8.48 56.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.58 -0.736 . . . . 0.44 111.264 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -104.97 0.31 27.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.99 -0.55 . . . . 0.83 110.343 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 370' ' ' PHE . 59.8 mt -83.4 133.92 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.113 -0.494 . . . . 0.38 110.176 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 369' ' ' ASP . 68.2 tttt -97.86 -61.29 1.41 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.209 -0.45 . . . . 1.75 110.299 178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.76 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.6 ptp180 -152.78 159.23 43.09 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.736 -0.665 . . . . 1.75 110.043 -178.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.629 ' HB3' HD23 ' A' ' 368' ' ' LEU . 40.8 p90 -143.95 151.67 40.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.993 0.425 . . . . 0.4 110.751 175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -116.75 129.26 56.0 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.637 -0.711 . . . . 0.31 110.605 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.447 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -113.6 122.66 47.89 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.38 111.66 -175.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.422 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 90.3 p -141.61 160.33 56.95 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 172.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.458 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.9 Cg_endo -76.13 14.72 1.07 Allowed 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.508 2.139 . . . . 0.66 112.572 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -131.99 -35.38 1.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.483 -0.326 . . . . 2.08 111.403 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 40.6 m -149.36 146.1 27.33 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.331 0.586 . . . . 1.32 111.591 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.528 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 79.4 t80 -118.53 124.77 48.34 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.828 -0.624 . . . . 0.3 109.399 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 91.0 m -116.51 118.89 33.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.776 0.322 . . . . 0.34 111.403 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.629 HD23 ' HB3' ' A' ' 359' ' ' TRP . 39.3 mt -97.73 134.96 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.061 -0.518 . . . . 0.33 110.097 172.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.76 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.5 t0 -125.01 124.26 41.61 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.71 -0.478 . . . . 1.52 109.71 175.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.544 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.1 m-85 -109.2 5.41 23.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.455 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.37 -106.54 1.17 Allowed Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.474 -0.784 . . . . 0.58 113.492 175.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -91.89 8.8 35.69 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.732 0.301 . . . . 2.38 111.205 -174.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.544 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 80.4 t80 -86.69 -31.73 20.88 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.924 -0.31 . . . . 0.79 110.712 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -153.1 170.97 19.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.617 0.246 . . . . 1.09 110.408 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -89.12 139.52 30.38 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.05 0.452 . . . . 2.3 110.986 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 73.53 -166.26 54.66 Favored Glycine 0 N--CA 1.449 -0.472 0 CA-C-N 115.658 -0.701 . . . . 0.7 112.679 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -116.48 177.23 4.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.756 -0.461 . . . . 1.06 109.756 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.543 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 44.1 t80 -121.9 91.48 3.52 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.655 -0.498 . . . . 0.47 109.655 176.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 40.5 m -108.24 119.14 38.64 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.0 -0.545 . . . . 1.06 110.956 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.48 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.1 m -118.53 146.31 23.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.86 -0.609 . . . . 0.33 111.034 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -84.46 118.01 24.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.037 -0.528 . . . . 1.47 109.834 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.2 t -167.67 142.02 3.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.987 0.423 . . . . 0.42 111.123 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 68.3 p -80.45 -14.68 58.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.381 0.61 . . . . 0.55 110.071 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.519 ' O ' HG13 ' A' ' 388' ' ' ILE . 46.1 mt-10 -90.0 10.77 22.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.544 -0.753 . . . . 1.39 111.024 -176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.84 -35.56 68.73 Favored Glycine 0 CA--C 1.518 0.24 0 C-N-CA 121.097 -0.573 . . . . 0.27 112.375 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -66.11 -30.19 70.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.098 0.475 . . . . 2.28 110.592 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 -79.7 -41.54 26.56 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 2.27 110.869 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 384' ' ' GLU . 52.7 mt -59.0 -50.01 81.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.271 -0.422 . . . . 0.29 110.789 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.528 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.29 -43.0 87.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.76 -0.654 . . . . 0.28 111.329 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -64.87 -33.2 75.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.781 -0.645 . . . . 1.99 110.525 -179.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.405 HD23 ' HB ' ' A' ' 332' ' ' ILE . 20.3 tp -73.64 -43.64 58.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.078 -0.51 . . . . 0.63 110.649 -177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.65 -49.25 85.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 120.967 0.413 . . . . 0.21 109.982 176.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -64.07 -26.18 68.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.073 -0.512 . . . . 0.29 110.627 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 397' ' ' ASP . . . -73.56 -39.72 48.92 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.35 112.511 178.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -72.76 -36.34 67.67 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.7 110.211 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' B' ' 377' ' ' ASN . 73.3 mt -65.15 -30.62 50.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.051 -0.522 . . . . 0.45 110.065 174.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 394' ' ' GLY . 24.6 t70 -59.86 -26.08 65.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.334 -0.394 . . . . 0.99 110.771 175.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.2 mt -80.58 -57.84 4.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.126 -0.488 . . . . 0.81 110.526 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 56.9 mt -63.59 -42.15 95.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.681 -0.69 . . . . 0.72 111.434 -176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 29.2 tp . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.573 -0.727 . . . . 1.56 110.571 -175.139 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.618 0 N-CA-C 111.734 -0.546 . . . . 12.98 111.734 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 70.78 -62.71 0.44 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.254 0.622 . . . . 14.53 110.841 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.3 m -78.89 147.67 33.01 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.416 -0.356 . . . . 10.62 110.053 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.552 ' HE3' ' O ' ' B' ' 374' ' ' TRP . 0.0 OUTLIER -150.23 150.99 32.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.177 -0.305 . . . . 9.78 110.177 178.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 11.9 mp0 -68.2 -1.67 6.57 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 113.66 0.985 . . . . 8.94 113.66 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 4.2 m -70.86 142.95 51.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 5.29 111.129 -175.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -66.01 -28.91 74.05 Favored Glycine 0 C--N 1.331 0.256 0 CA-C-N 116.042 -0.526 . . . . 2.37 112.208 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.552 ' O ' ' HE3' ' B' ' 370' ' ' LYS . 83.0 m95 -97.3 123.57 41.16 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.619 -0.512 . . . . 1.42 109.619 174.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.459 ' HA ' ' HE3' ' B' ' 370' ' ' LYS . 4.2 p -129.69 120.74 51.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.448 0.642 . . . . 1.07 110.774 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 1.3 mp0 -104.96 159.92 15.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.388 -0.824 . . . . 2.28 110.619 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.541 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -107.12 165.64 11.21 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.12 -0.326 . . . . 1.83 110.12 171.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -110.99 24.49 12.86 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.135 0.493 . . . . 1.88 111.128 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 9.8 pt -108.94 17.82 6.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.879 -0.6 . . . . 1.17 110.301 172.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . 0.403 ' HB2' ' O ' ' A' ' 356' ' ' ILE . 78.3 t80 -80.5 100.27 8.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.18 -0.674 . . . . 0.58 109.18 175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.49 -0.767 . . . . 3.2 110.565 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.126 -0.39 . . . . 4.12 112.126 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.427 ' CG2' HG22 ' A' ' 333' ' ' THR . 13.2 p -133.44 154.5 39.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.615 -0.513 . . . . 2.92 109.615 178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 7.4 m -77.78 111.28 13.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.807 0.337 . . . . 1.06 111.816 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -112.51 125.16 53.94 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.2 -0.455 . . . . 0.52 110.692 175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -108.57 127.23 53.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.217 -0.447 . . . . 0.41 110.253 175.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 56.3 tp -81.17 99.44 8.55 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 0.72 109.94 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 32.9 m -111.6 171.68 3.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.822 -0.626 . . . . 0.3 110.194 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.842 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 51.0 mtpt -125.89 115.21 19.6 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.572 -0.286 . . . . 1.44 110.47 177.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.507 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 57.9 mt-10 -75.82 123.12 25.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.128 -0.487 . . . . 0.7 110.971 -178.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.654 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -100.63 107.92 19.68 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.259 -0.645 . . . . 1.74 109.259 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 26.4 mtt -120.06 159.8 24.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.41 -0.359 . . . . 1.68 110.587 -178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.714 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -59.86 157.96 11.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 2.3 110.737 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.63 -28.54 14.52 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.75 -0.738 . . . . 1.93 112.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.623 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.9 pttm -155.67 168.79 26.01 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.687 0.28 . . . . 1.68 110.334 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.654 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.2 m-80 -101.28 -11.98 19.05 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.183 0.516 . . . . 2.79 110.158 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.623 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 86.7 tttt -70.8 138.15 50.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.277 -0.874 . . . . 2.01 110.147 176.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.842 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.3 mp -102.43 143.38 32.23 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.945 -0.391 . . . . 0.69 109.945 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 36.3 t -96.62 127.14 40.68 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 116.425 -0.352 . . . . 0.51 111.205 -175.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 32.1 Cg_exo -61.4 121.96 10.38 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.658 2.239 . . . . 0.46 111.383 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.828 HH11 ' HA ' ' A' ' 341' ' ' ASP . 17.1 tpp180 -130.82 137.73 49.55 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.172 -0.467 . . . . 0.78 110.486 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.537 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.9 mt -88.8 99.98 12.8 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.487 -0.56 . . . . 0.37 109.487 174.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 22.4 tp -83.42 103.67 12.97 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.998 -0.546 . . . . 0.57 109.773 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -89.35 107.72 3.42 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.97 -0.634 . . . . 0.29 112.167 -177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.407 HD13 HG13 ' A' ' 337' ' ' VAL . 40.1 mm -96.74 109.31 22.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.763 -0.458 . . . . 0.36 109.763 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.427 HG22 ' CG2' ' A' ' 310' ' ' VAL . 42.1 p -111.37 176.74 4.9 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.821 0.343 . . . . 0.38 110.597 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.464 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 22.5 pttp -67.72 -8.1 32.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.734 -0.666 . . . . 1.61 112.338 -178.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -137.33 -25.1 1.05 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.815 0.672 . . . . 1.79 112.815 -174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 14.2 p -149.07 156.15 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.71 0.767 . . . . 1.1 112.865 -174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.407 HG13 HD13 ' A' ' 332' ' ' ILE . 98.4 t -110.06 114.28 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 114.73 -1.123 . . . . 0.32 109.035 173.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 22.9 ptp -110.0 140.21 44.27 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.013 0.435 . . . . 1.08 111.574 -174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.507 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 47.2 mtm180 -95.74 99.92 11.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.937 -0.574 . . . . 1.55 109.988 174.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.537 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 62.4 t -97.57 135.27 32.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.249 -0.432 . . . . 0.31 110.555 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.828 ' HA ' HH11 ' A' ' 328' ' ' ARG . 38.8 t70 -69.46 138.35 53.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.505 -0.316 . . . . 0.77 110.307 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.11 -37.95 72.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.993 0.425 . . . . 1.51 110.201 -175.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -87.44 -53.85 4.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.467 -0.333 . . . . 3.06 111.846 -174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.5 m -86.8 -14.62 41.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.717 0.294 . . . . 0.92 111.428 -173.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 65.23 20.93 12.02 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.845 -0.616 . . . . 1.5 111.957 177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -87.89 152.33 22.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.731 0.301 . . . . 2.46 110.855 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.407 HG22 HG22 ' A' ' 340' ' ' VAL . 48.9 t -89.54 111.72 23.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.563 -0.532 . . . . 0.58 109.563 176.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.3 mt -77.53 -43.82 29.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.049 0.452 . . . . 0.35 110.827 -177.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -158.5 144.07 16.65 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.873 -0.603 . . . . 1.65 109.651 -176.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -133.39 116.49 16.12 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.814 0.34 . . . . 0.65 110.511 -175.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.9 m-90 -103.42 122.25 44.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.399 -0.364 . . . . 0.52 110.706 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.422 ' HB3' HD22 ' A' ' 355' ' ' ASN . 22.9 t -66.61 146.11 54.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.275 -0.639 . . . . 1.27 109.275 173.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.56 -24.19 60.2 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.984 0.421 . . . . 0.31 111.485 -176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 74.0 p -67.01 -18.55 65.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.106 -0.497 . . . . 0.44 111.657 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.422 HD22 ' HB3' ' A' ' 352' ' ' SER . 49.9 m-80 -93.44 -2.15 54.89 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 111.799 0.296 . . . . 0.83 111.799 -174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 60.0 mt -86.77 132.12 33.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.933 -0.395 . . . . 0.38 109.933 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -96.87 -54.12 3.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.156 0.503 . . . . 1.75 110.319 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.467 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 2.0 ptp180 -153.25 150.45 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.71 -0.677 . . . . 1.75 109.996 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.434 ' HZ3' ' HB2' ' B' ' 377' ' ' ASN . 42.9 p90 -132.3 152.23 51.48 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.931 0.396 . . . . 0.4 110.68 177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.591 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -117.36 113.17 21.73 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.724 -0.671 . . . . 0.31 110.318 179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -94.78 99.85 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.451 -0.795 . . . . 0.38 110.972 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 365' ' ' SER . 14.9 m -114.98 153.63 47.08 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 109.668 -0.493 . . . . 1.0 109.668 177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 383' ' ' THR . 56.9 Cg_endo -71.8 -5.44 17.07 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.641 2.227 . . . . 0.66 113.355 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -119.6 -36.83 3.24 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.546 0.213 . . . . 2.08 111.526 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.504 ' O ' ' HB2' ' A' ' 362' ' ' SER . 55.9 m -141.51 139.78 33.34 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.988 0.423 . . . . 1.32 110.856 -177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.622 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 74.9 t80 -107.8 131.23 54.69 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.072 -0.714 . . . . 0.3 109.072 177.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 7.3 m -118.53 129.01 55.11 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.576 -0.284 . . . . 0.34 111.301 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.548 HD12 ' HD2' ' A' ' 378' ' ' TYR . 57.9 mt -112.92 135.6 53.5 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.343 -0.39 . . . . 0.33 110.854 175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.467 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -122.48 132.38 54.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 1.52 109.882 174.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.464 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 89.0 m-85 -115.61 6.97 14.69 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.953 -176.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 63.61 -119.85 18.18 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.989 -0.624 . . . . 0.58 112.866 177.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -92.82 21.05 5.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.914 0.388 . . . . 2.38 111.289 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.464 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 88.2 t80 -86.64 -43.81 12.35 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.208 -0.451 . . . . 0.79 110.157 178.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -149.49 157.34 43.19 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.366 -0.379 . . . . 1.09 110.145 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -81.49 143.56 31.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.215 -0.448 . . . . 2.3 110.739 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.08 39.4 Favored Glycine 0 N--CA 1.449 -0.5 0 CA-C-N 115.875 -0.602 . . . . 0.7 112.127 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -101.01 177.92 4.81 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.774 -0.454 . . . . 1.06 109.774 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.548 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.5 t80 -121.98 105.17 10.07 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.739 -0.467 . . . . 0.47 109.739 176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 45.6 t -110.12 121.11 44.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.784 -0.644 . . . . 1.06 110.966 -177.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.47 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 15.7 m -123.66 142.76 39.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.783 -0.644 . . . . 0.33 110.125 175.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.15 129.62 35.72 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.584 -0.525 . . . . 1.47 109.584 178.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.9 t -170.86 145.12 2.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.102 0.477 . . . . 0.42 110.758 -177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 14.8 p -89.84 2.82 54.5 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.242 0.544 . . . . 0.55 110.399 176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 388' ' ' ILE . 40.4 mt-10 -108.03 17.08 22.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.775 -0.648 . . . . 1.39 110.546 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -52.68 -41.2 56.99 Favored Glycine 0 C--N 1.333 0.393 0 CA-C-N 115.943 -0.572 . . . . 0.27 113.405 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -63.31 -44.47 94.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.986 0.422 . . . . 2.28 110.676 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 47.6 mt-30 -66.16 -37.37 85.5 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.76 -0.655 . . . . 2.27 110.873 -176.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 384' ' ' GLU . 61.3 mt -61.51 -51.51 72.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.29 110.158 177.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.622 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.01 -44.64 97.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.632 -0.713 . . . . 0.28 111.061 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -58.28 -41.1 83.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.663 -0.699 . . . . 1.99 110.822 179.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.414 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 25.1 tp -71.1 -41.51 70.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.912 -0.585 . . . . 0.63 110.855 -177.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 388' ' ' ILE . 76.5 mt -59.57 -50.19 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 N-CA-C 110.112 -0.329 . . . . 0.21 110.112 177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.2 -30.6 70.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.29 110.753 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.74 -42.47 70.84 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.907 -0.588 . . . . 0.35 112.548 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.464 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 23.8 m-85 -72.63 -38.55 67.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.0 0.429 . . . . 0.7 110.481 177.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 37.1 mt -59.15 -39.04 77.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.78 -0.646 . . . . 0.45 110.525 175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -60.0 -33.02 71.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.957 -0.565 . . . . 0.99 111.374 178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 60.7 mt -69.02 -38.62 78.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.949 0.404 . . . . 0.81 110.65 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.19 -30.67 36.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.085 -0.507 . . . . 0.72 110.254 179.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.456 HD21 HG23 ' B' ' 379' ' ' ILE . 93.7 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.402 -0.809 . . . . 1.56 110.65 178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.795 -0.522 . . . . 12.98 111.795 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 62.14 17.38 9.12 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.615 0.598 . . . . 14.53 112.615 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 6.9 m -94.57 100.67 12.6 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.984 -0.376 . . . . 10.62 109.984 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.404 ' HE2' ' HB2' ' B' ' 370' ' ' LYS . 13.3 ptmm? -55.08 131.68 45.57 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.977 -0.556 . . . . 9.78 110.486 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.04 144.37 28.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.945 -0.571 . . . . 8.94 111.49 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.2 t -114.8 41.46 2.36 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-O 122.564 1.173 . . . . 5.29 108.891 172.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -77.8 -54.5 4.52 Favored Glycine 0 C--N 1.304 -1.213 0 CA-C-N 113.256 -1.793 . . . . 2.37 111.623 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -95.86 111.23 23.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.194 0.521 . . . . 1.42 110.339 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 33.5 t -113.96 127.34 71.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.502 -0.772 . . . . 1.07 108.99 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -102.42 142.03 34.29 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.52 0.676 . . . . 2.28 111.561 -173.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.528 HD21 HG13 ' B' ' 379' ' ' ILE . 39.8 t30 -89.24 137.82 31.98 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.803 -1.09 . . . . 1.83 110.792 -175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -100.62 10.87 40.6 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.606 -0.27 . . . . 1.88 111.705 -175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.528 HG13 HD21 ' B' ' 377' ' ' ASN . 26.6 pt -124.71 25.17 3.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 C-N-CA 120.22 -0.592 . . . . 1.17 111.809 176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . 0.51 ' HA ' ' O ' ' A' ' 354' ' ' THR . 58.4 t80 -76.33 98.27 4.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.307 -0.627 . . . . 0.58 109.307 174.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' B' ' 381' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.949 -0.568 . . . . 3.2 111.966 -175.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 112.047 -0.421 . . . . 4.12 112.047 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 333' ' ' THR . 6.9 p -102.28 126.9 56.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.049 0.452 . . . . 2.92 110.561 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 20.7 m -103.75 126.46 50.9 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.261 -0.427 . . . . 1.06 109.947 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.446 ' HE1' HG21 ' A' ' 340' ' ' VAL . 96.5 m-85 -96.84 128.04 43.41 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.055 0.455 . . . . 0.52 111.115 -177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.432 ' CG ' HG12 ' A' ' 388' ' ' ILE . 98.1 m-85 -109.72 128.74 55.48 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.693 -0.685 . . . . 0.41 109.705 174.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 61.8 tp -78.01 97.41 5.36 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.944 0.402 . . . . 0.72 110.076 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.461 HG12 ' HB ' ' A' ' 382' ' ' THR . 34.9 m -107.1 153.26 8.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.058 -0.519 . . . . 0.3 110.56 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 59.4 mtpt -114.37 108.66 17.2 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.298 -0.41 . . . . 1.44 110.489 178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -76.3 116.29 16.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.877 -0.602 . . . . 0.7 110.559 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.49 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 26.5 tptp -106.35 107.82 19.02 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.615 -0.513 . . . . 1.74 109.615 174.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 45.4 mtt -118.36 -170.41 1.88 Allowed 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.781 -0.645 . . . . 1.68 110.252 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.921 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -81.67 177.55 8.85 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.683 -0.689 . . . . 2.3 110.327 176.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 89.37 -47.13 3.26 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.924 -0.655 . . . . 1.93 113.022 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 55.4 pttt -143.76 156.79 44.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.976 0.417 . . . . 1.68 111.074 -176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.478 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -91.43 4.08 53.37 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.784 -0.644 . . . . 2.79 111.144 -178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -86.27 124.09 32.26 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.278 -0.419 . . . . 2.01 110.544 177.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.1 mp -83.93 124.51 31.08 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.234 -0.654 . . . . 0.69 109.234 176.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 20.1 t -85.86 119.19 71.71 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.32 -0.4 . . . . 0.51 111.106 -174.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 16.9 Cg_exo -67.91 122.39 9.5 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.601 2.201 . . . . 0.46 111.235 175.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -127.23 141.63 51.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.044 -0.525 . . . . 0.78 110.129 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.412 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.8 mt -90.36 95.43 10.18 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.256 -0.646 . . . . 0.37 109.256 174.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 23.1 tp -78.02 102.73 7.56 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.013 -0.54 . . . . 0.57 109.649 -178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.02 115.73 4.96 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.906 -0.664 . . . . 0.29 112.175 -177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.532 ' HB ' HD23 ' A' ' 391' ' ' LEU . 32.6 mm -100.69 117.71 46.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 110.048 -0.353 . . . . 0.36 110.048 178.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.452 HG22 ' HB ' ' A' ' 310' ' ' VAL . 38.8 p -108.76 -170.83 1.73 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 110.005 -0.368 . . . . 0.38 110.005 175.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.455 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.9 pttm -73.44 -21.48 60.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.114 0.412 . . . . 1.61 112.114 -173.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.62 -13.41 4.26 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 112.947 0.721 . . . . 1.79 112.947 -171.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 7.9 p -152.62 165.79 34.11 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.857 0.688 . . . . 1.1 112.857 -174.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 98.8 t -118.77 119.43 61.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 114.958 -1.019 . . . . 0.32 109.464 176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.7 ptp -114.38 136.47 52.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.053 0.454 . . . . 1.08 111.533 -176.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 48.8 mtm180 -92.13 97.95 11.23 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.087 -0.506 . . . . 1.55 110.023 174.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.446 HG21 ' HE1' ' A' ' 312' ' ' PHE . 69.4 t -91.52 132.63 35.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.603 -0.517 . . . . 0.31 109.603 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.19 134.18 48.92 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.669 -0.413 . . . . 0.77 110.458 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . 0.412 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 7.8 tm-20 -62.56 -30.82 71.6 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.127 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 24.0 ttpp -101.11 -53.66 2.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.96 0.41 . . . . 3.06 111.268 -176.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.3 m -77.33 -21.65 53.09 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.97 -0.559 . . . . 0.92 111.707 -172.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 67.1 17.88 10.44 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 122.872 0.469 . . . . 1.5 112.01 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -97.44 151.68 19.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.7 0.286 . . . . 2.46 110.733 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 53.6 t -82.44 108.49 15.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.062 -0.517 . . . . 0.58 109.892 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -79.46 -34.69 16.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.84 -0.618 . . . . 0.35 110.888 -177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -167.49 144.09 4.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.264 -0.425 . . . . 1.65 110.271 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -133.33 139.54 46.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.562 -0.29 . . . . 0.65 110.343 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 13.4 m-90 -118.12 133.89 55.49 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.165 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 32.6 t -71.48 143.21 50.1 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.968 -0.753 . . . . 1.27 108.968 171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.66 HD13 HG13 ' A' ' 396' ' ' ILE . 93.3 mt -62.32 -22.08 65.77 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.761 0.315 . . . . 0.31 111.496 -176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 36.7 p -69.67 -16.94 63.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.973 0.416 . . . . 0.44 111.371 178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -85.39 -13.75 48.45 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.812 0.339 . . . . 0.83 110.786 -175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.486 HG21 ' HE3' ' A' ' 359' ' ' TRP . 69.5 mt -72.04 138.53 21.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.927 -0.579 . . . . 0.38 110.131 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -102.67 -36.73 8.21 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.462 0.649 . . . . 1.75 109.464 175.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 358' ' ' ARG . 4.2 ptp180 -175.97 164.12 2.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.961 -1.018 . . . . 1.75 109.575 -179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.66 ' HB3' HD23 ' A' ' 368' ' ' LEU . 34.0 p90 -142.19 155.64 45.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.054 0.454 . . . . 0.4 111.077 176.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.71 22.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.333 -0.849 . . . . 0.31 109.608 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -103.36 131.32 50.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.935 -0.575 . . . . 0.38 110.877 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 70.0 p -141.56 158.16 63.81 Favored Pre-proline 0 C--N 1.32 -0.716 0 N-CA-C 109.07 -0.715 . . . . 1.0 109.07 175.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.81 -6.33 18.9 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 121.853 1.702 . . . . 0.66 111.896 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -104.3 -32.29 9.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.864 -0.607 . . . . 2.08 111.081 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 24.7 p -158.34 169.59 24.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.961 0.41 . . . . 1.32 111.581 -174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.609 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.0 t80 -133.82 138.39 45.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.512 -0.551 . . . . 0.3 109.512 176.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 92.4 m -135.59 123.72 22.98 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.85 0.357 . . . . 0.34 111.62 -178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.66 HD23 ' HB3' ' A' ' 359' ' ' TRP . 56.3 mt -104.17 144.25 31.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.856 -0.611 . . . . 0.33 110.786 176.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -122.38 137.66 54.79 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.391 -0.596 . . . . 1.52 109.391 170.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 91.0 m-85 -114.47 5.87 15.73 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.334 -0.393 . . . . 0.44 110.604 -177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.16 -109.46 2.46 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.864 -0.607 . . . . 0.58 113.49 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -87.78 5.65 39.06 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.804 0.335 . . . . 2.38 111.166 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 69.0 t80 -85.64 -35.52 20.89 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.566 -0.531 . . . . 0.79 109.566 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -162.46 142.8 9.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.905 -0.589 . . . . 1.09 109.971 176.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -84.04 141.82 30.9 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.701 -0.481 . . . . 2.3 109.701 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 100.51 176.93 29.94 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.35 -1.1 . . . . 0.7 110.35 -172.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -121.92 178.25 4.96 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 117.268 0.534 . . . . 1.06 111.053 -177.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.576 ' O ' ' HA ' ' A' ' 367' ' ' THR . 78.1 t80 -120.99 88.03 2.86 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.539 -0.755 . . . . 0.47 109.08 176.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 70.0 m -103.16 121.52 42.82 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.618 -0.719 . . . . 1.06 110.869 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 16.6 m -127.83 144.48 37.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.713 -0.676 . . . . 0.33 110.3 177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -81.64 122.06 27.14 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.134 -0.691 . . . . 1.47 109.134 177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.461 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.5 t -157.24 142.78 17.39 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.036 0.446 . . . . 0.42 111.096 -175.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.8 p -85.44 -12.58 51.63 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.683 -0.689 . . . . 0.55 110.484 177.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.557 ' O ' HG13 ' A' ' 388' ' ' ILE . 38.3 mt-10 -108.89 20.77 18.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.78 -0.646 . . . . 1.39 110.622 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.59 -41.27 73.16 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.979 -0.555 . . . . 0.27 113.38 -177.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.469 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 7.9 tp10 -66.37 -38.59 87.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.147 0.499 . . . . 2.28 110.229 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -69.43 -37.28 77.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.767 -0.651 . . . . 2.27 110.808 -178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.557 HG13 ' O ' ' A' ' 384' ' ' GLU . 62.5 mt -57.15 -51.49 68.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.114 0.483 . . . . 0.29 110.054 177.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.609 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.66 -42.7 97.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.494 -0.775 . . . . 0.28 111.438 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -66.35 -33.56 76.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 1.99 110.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.532 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.7 tp -71.44 -43.31 66.94 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.454 -0.339 . . . . 0.63 110.17 178.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.507 HG22 HD12 ' A' ' 396' ' ' ILE . 77.1 mt -59.99 -51.75 69.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.194 -0.457 . . . . 0.21 110.375 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.412 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.36 -31.05 71.64 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 116.267 -0.424 . . . . 0.29 110.7 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -64.84 -52.48 41.88 Favored Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.874 -0.603 . . . . 0.35 112.296 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.455 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 24.4 m-85 -66.44 -40.22 89.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.843 0.354 . . . . 0.7 110.802 178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.66 HG13 HD13 ' A' ' 353' ' ' LEU . 8.0 mt -55.94 -43.7 75.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.698 -0.683 . . . . 0.45 111.565 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.05 -32.36 66.13 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.957 0.408 . . . . 0.99 111.401 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 51.8 mt -70.67 -29.43 38.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.192 -0.458 . . . . 0.81 110.738 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 43.1 mt -71.41 -26.12 26.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 0.72 111.18 -176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 396' ' ' ILE . 2.2 mm? . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.719 -0.658 . . . . 1.56 109.965 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.438 ' O ' ' HE3' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.481 1.643 0 N-CA-C 111.969 -0.452 . . . . 12.98 111.969 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -105.21 9.63 34.0 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 111.766 0.284 . . . . 14.53 111.766 -178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 8.5 t -124.0 91.62 3.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.252 0.549 . . . . 10.62 111.525 -177.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.438 ' HE3' ' O ' ' B' ' 367' ' ' GLY . 0.0 OUTLIER -135.79 34.55 2.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.841 0.829 . . . . 9.78 109.333 174.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -63.79 105.41 0.82 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.141 -1.391 . . . . 8.94 110.116 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 11.2 m -117.96 145.64 44.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.933 0.396 . . . . 5.29 111.025 -174.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 112.17 -50.05 0.8 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 121.102 -0.571 . . . . 2.37 111.955 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -119.76 142.03 48.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.946 -0.39 . . . . 1.42 109.946 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 47.6 t -106.83 123.34 61.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 CA-C-N 115.858 -0.61 . . . . 1.07 109.575 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -91.85 137.46 32.35 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 2.28 109.641 -176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -101.54 157.78 16.56 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.028 0.442 . . . . 1.83 111.18 -178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -97.27 4.85 50.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.759 -0.655 . . . . 1.88 112.106 -175.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.468 ' O ' HG13 ' B' ' 379' ' ' ILE . 16.6 pt -129.13 84.21 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.664 -0.698 . . . . 1.17 111.744 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -116.96 129.52 56.09 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.058 -0.719 . . . . 0.58 109.058 175.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.625 -0.703 . . . . 3.2 111.26 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 CA-C-O 120.007 -0.329 . . . . 4.12 112.38 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 333' ' ' THR . 17.4 m 34.33 70.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.562 1.145 . . . . 2.92 113.886 178.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 42.1 m -103.92 127.28 51.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.256 -0.429 . . . . 1.06 110.647 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.71 ' HE1' HG21 ' A' ' 340' ' ' VAL . 93.3 m-85 -105.41 123.35 47.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.966 0.413 . . . . 0.52 110.668 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -107.84 136.63 47.24 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.41 110.173 178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -83.27 100.33 10.55 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.16 0.505 . . . . 0.72 109.766 177.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.8 m -111.87 164.56 7.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.699 -0.682 . . . . 0.3 110.452 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 45.6 mtpt -117.74 107.62 14.39 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.37 -0.377 . . . . 1.44 110.457 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.622 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 63.9 mt-10 -80.76 115.7 20.39 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.388 -0.369 . . . . 0.7 110.793 -178.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.6 tptp -90.54 97.03 10.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.259 0.552 . . . . 1.74 109.786 174.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 80.0 mmm -110.45 169.95 8.41 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.602 -0.726 . . . . 1.68 109.384 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.511 ' N ' ' HE2' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -70.5 169.7 13.6 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.756 0.312 . . . . 2.3 110.566 177.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 103.29 -33.79 6.29 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.714 -0.755 . . . . 1.93 112.297 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.4 pttm -161.48 162.18 30.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.7 0.286 . . . . 1.68 110.464 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.583 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 31.7 p30 -83.02 -14.56 53.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.326 -0.397 . . . . 2.79 111.167 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.8 ttmt -77.45 122.73 25.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.228 -0.442 . . . . 2.01 110.887 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.554 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.5 mp -76.25 133.62 40.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.849 -0.614 . . . . 0.69 109.571 176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 23.5 t -86.23 127.44 61.45 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 116.376 -0.374 . . . . 0.51 111.062 -174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.56 121.64 9.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.646 2.23 . . . . 0.46 111.271 174.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.795 HH11 ' HA ' ' A' ' 341' ' ' ASP . 12.5 tpp180 -130.12 140.62 50.77 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.303 -0.408 . . . . 0.78 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 79.7 mt -90.75 100.55 13.38 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.484 -0.562 . . . . 0.37 109.484 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 388' ' ' ILE . 26.3 tp -83.21 101.9 11.54 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.662 -0.496 . . . . 0.57 109.662 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.11 107.5 3.52 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.854 -0.688 . . . . 0.29 111.993 -177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.483 HG22 ' CE2' ' A' ' 395' ' ' TYR . 24.0 mm -95.75 111.17 25.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.696 -0.483 . . . . 0.36 109.696 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 310' ' ' VAL . 64.9 p -113.38 175.27 5.52 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.198 -0.455 . . . . 0.38 110.527 -178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.7 ptmt -67.3 -14.4 62.89 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.642 0.608 . . . . 1.61 112.642 -175.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.28 -16.06 3.59 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.807 0.669 . . . . 1.79 112.807 -175.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -156.27 154.74 31.17 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.053 0.761 . . . . 1.1 113.053 -174.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.427 HG13 HD13 ' A' ' 332' ' ' ILE . 90.6 t -107.37 110.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 114.964 -1.017 . . . . 0.32 108.732 172.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 21.7 ptp -109.02 133.7 52.64 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.12 0.486 . . . . 1.08 111.43 -174.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.622 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 36.9 mtm180 -89.68 98.59 11.85 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.9 -0.591 . . . . 1.55 109.929 176.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.71 HG21 ' HE1' ' A' ' 312' ' ' PHE . 62.2 t -88.98 130.03 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.202 0.525 . . . . 0.31 110.473 -178.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.795 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.3 t0 -71.68 128.01 34.42 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.637 -0.71 . . . . 0.77 110.719 -178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -80.3 -14.4 58.41 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.739 0.78 . . . . 1.51 109.74 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.24 -59.95 2.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.022 -0.99 . . . . 3.06 110.833 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 345' ' ' LYS . 1.7 m -96.12 -14.98 22.43 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.363 0.505 . . . . 0.92 112.363 -176.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 74.1 mmtt 68.89 25.93 5.98 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 122.803 0.441 . . . . 1.5 111.398 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.12 161.83 13.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 110.084 -0.339 . . . . 2.46 110.084 176.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 47.3 t -88.6 116.33 30.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.587 -0.523 . . . . 0.58 109.587 176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 66.3 mt -81.49 -54.93 8.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.324 -0.398 . . . . 0.35 110.94 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -145.15 133.3 21.53 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.909 -0.587 . . . . 1.65 109.84 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.39 129.19 51.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.924 0.392 . . . . 0.65 110.909 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 5.3 m-90 -113.55 123.86 50.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.456 -0.338 . . . . 0.52 111.065 178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 31.6 t -65.34 143.64 57.62 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.392 -0.596 . . . . 1.27 109.392 172.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 84.7 mt -61.89 -22.59 65.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.15 0.5 . . . . 0.31 110.481 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 53.1 p -75.32 -9.03 58.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.276 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.34 5.12 37.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.969 0.414 . . . . 0.83 110.786 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 59.9 mt -90.48 143.9 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.921 -0.581 . . . . 0.38 110.068 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -107.07 -48.32 3.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.176 0.512 . . . . 1.75 110.419 178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.767 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 3.7 ptp180 -164.09 159.94 21.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.37 -0.832 . . . . 1.75 109.693 -177.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.668 ' HB3' HD23 ' A' ' 368' ' ' LEU . 48.2 p90 -144.79 152.89 41.02 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.043 0.449 . . . . 0.4 110.996 175.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -117.49 124.28 48.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.539 -0.755 . . . . 0.31 110.224 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -105.11 122.76 46.57 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.879 -0.601 . . . . 0.38 110.759 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 45.3 m -140.56 151.84 64.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 116.482 -0.326 . . . . 1.0 110.146 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.36 -9.62 26.49 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.825 2.35 . . . . 0.66 113.356 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -100.6 -36.81 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.934 0.397 . . . . 2.08 110.943 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 53.1 m -158.11 155.84 29.9 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.12 0.486 . . . . 1.32 111.016 -174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.514 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.4 t80 -118.14 135.99 53.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.681 -0.859 . . . . 0.3 108.681 175.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.591 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 38.6 m -131.27 123.38 28.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.081 0.467 . . . . 0.34 111.803 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.668 HD23 ' HB3' ' A' ' 359' ' ' TRP . 63.3 mt -97.21 143.88 27.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.525 -0.761 . . . . 0.33 110.481 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.532 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.0 t70 -128.69 129.1 45.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.024 -0.535 . . . . 1.52 109.754 173.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.468 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 76.2 m-85 -110.81 6.82 21.67 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.477 -176.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 64.4 -103.29 0.71 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.614 -0.721 . . . . 0.58 113.422 174.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -100.47 9.24 42.86 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.871 0.367 . . . . 2.38 110.758 -173.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.468 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 90.7 t80 -86.04 -29.83 23.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.157 -0.474 . . . . 0.79 110.188 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -156.24 159.21 38.7 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.855 0.359 . . . . 1.09 110.696 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -86.11 144.82 27.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.864 -0.607 . . . . 2.3 109.927 175.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 83.32 -174.44 52.22 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.747 -0.74 . . . . 0.7 111.693 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -122.26 -176.85 3.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.88 -0.415 . . . . 1.06 109.88 177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.591 ' O ' ' HA ' ' A' ' 367' ' ' THR . 29.8 t80 -122.2 93.28 3.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.87 -0.419 . . . . 0.47 109.87 175.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 47.3 m -104.63 119.21 38.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.14 -0.482 . . . . 1.06 110.801 -177.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.574 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -123.32 133.79 68.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.967 -0.56 . . . . 0.33 110.749 177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 63.9 tt0 -74.75 118.75 18.06 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.292 -0.632 . . . . 1.47 109.292 175.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.411 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.6 t -160.02 140.7 12.04 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.227 0.537 . . . . 0.42 110.498 -178.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 7.4 p -89.64 -1.41 58.01 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.596 -0.729 . . . . 0.55 110.928 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -115.18 17.15 16.81 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 1.39 110.696 -179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' A' ' 388' ' ' ILE . . . -57.57 -31.39 63.43 Favored Glycine 0 C--N 1.331 0.261 0 CA-C-N 116.01 -0.541 . . . . 0.27 112.936 -178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -62.43 -41.6 98.83 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.238 0.542 . . . . 2.28 110.397 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -70.12 -36.73 75.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.622 -0.717 . . . . 2.27 110.447 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.436 HD12 ' HA2' ' A' ' 385' ' ' GLY . 60.1 mt -60.53 -47.39 92.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.021 -0.536 . . . . 0.29 110.271 178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.514 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -61.59 -43.5 98.75 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.692 -0.686 . . . . 0.28 111.437 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -65.96 -33.53 76.03 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.821 -0.627 . . . . 1.99 110.354 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.481 HD23 ' HB ' ' A' ' 332' ' ' ILE . 37.5 tp -70.72 -45.18 65.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.897 -0.592 . . . . 0.63 110.95 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 69.5 mt -59.19 -48.6 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-O 120.893 0.377 . . . . 0.21 110.362 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.1 -28.47 69.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.967 -0.56 . . . . 0.29 110.718 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.99 -48.5 53.75 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.984 -0.553 . . . . 0.35 112.527 178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.483 ' CE2' HG22 ' A' ' 332' ' ' ILE . 38.6 m-85 -63.47 -42.1 98.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.24 0.543 . . . . 0.7 110.2 177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.484 HG12 HD11 ' B' ' 379' ' ' ILE . 41.0 mt -57.95 -38.05 64.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.27 -0.877 . . . . 0.45 111.182 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -59.91 -31.58 69.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.212 -0.449 . . . . 0.99 110.991 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 57.0 mt -72.67 -34.88 48.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.097 0.475 . . . . 0.81 110.467 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 55.2 mt -75.34 -35.27 32.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.901 -0.591 . . . . 0.72 110.736 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.411 HD21 HG23 ' B' ' 379' ' ' ILE . 96.4 mt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.57 -0.729 . . . . 1.56 110.853 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.682 0 N-CA-C 111.743 -0.543 . . . . 12.98 111.743 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.12 73.16 0.45 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.218 0.532 . . . . 14.53 111.313 -179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 10.9 t -112.04 100.79 9.15 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.853 -0.612 . . . . 10.62 110.467 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 4.5 mmmt -125.33 80.54 1.89 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.177 -1.416 . . . . 9.78 107.177 174.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -87.16 109.54 19.53 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.608 -0.724 . . . . 8.94 110.546 -171.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 43.0 m -80.45 113.33 18.56 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 5.29 110.638 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -74.34 -48.61 13.88 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.233 -0.747 . . . . 2.37 111.233 177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -104.58 130.82 52.51 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.904 0.383 . . . . 1.42 110.232 175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.8 122.68 64.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.878 -0.786 . . . . 1.07 108.878 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.767 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 40.4 mt-10 -109.16 146.32 34.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.921 -0.581 . . . . 2.28 111.964 -168.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -96.28 155.97 16.54 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.081 -0.963 . . . . 1.83 110.893 178.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -107.54 25.81 11.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.14 -0.482 . . . . 1.88 111.642 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.484 HD11 HG12 ' A' ' 396' ' ' ILE . 23.5 pt -120.35 36.04 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.124 0.487 . . . . 1.17 110.772 172.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -88.54 104.81 17.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.054 -0.721 . . . . 0.58 109.054 176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.782 -0.627 . . . . 3.2 111.116 -174.054 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.819 0 N-CA-C 112.48 -0.248 . . . . 4.12 112.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 21.8 t -77.09 110.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.789 0.295 . . . . 2.92 110.452 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 16.5 m -97.36 122.27 40.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.426 -0.352 . . . . 1.06 110.214 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.455 ' HE1' HG21 ' A' ' 340' ' ' VAL . 97.0 m-85 -98.88 130.86 45.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.998 0.427 . . . . 0.52 111.376 -177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.447 ' CG ' HG12 ' A' ' 388' ' ' ILE . 97.4 m-85 -114.9 139.86 49.45 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.191 -0.67 . . . . 0.41 109.191 172.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 36.1 tp -95.02 98.68 10.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.239 0.542 . . . . 0.72 110.392 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 34.5 m -100.15 162.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.823 -0.626 . . . . 0.3 110.341 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 24.0 mtpp -114.45 119.68 37.71 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.547 -0.297 . . . . 1.44 110.348 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 61.7 mt-10 -80.06 119.43 22.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.638 -0.256 . . . . 0.7 111.055 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.723 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -98.77 92.52 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.621 -0.511 . . . . 1.74 109.621 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.1 mmt -104.67 176.82 5.03 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.688 -0.687 . . . . 1.68 110.615 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.99 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.1 OUTLIER -72.22 158.76 35.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.853 -0.612 . . . . 2.3 110.703 177.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 107.25 -42.29 1.97 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.731 -0.747 . . . . 1.93 113.009 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.6 pttm -152.76 163.85 38.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.627 0.727 . . . . 1.68 110.937 -177.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.723 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 23.6 p-10 -95.78 4.8 52.59 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.567 -1.197 . . . . 2.79 110.407 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.507 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 64.1 tttm -92.21 123.82 35.84 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.127 -0.694 . . . . 2.01 109.127 175.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 5.9 mp -88.87 139.27 30.63 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.22 -0.445 . . . . 0.69 110.829 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.438 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.2 t -87.62 124.41 67.66 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.034 -0.53 . . . . 0.51 111.111 -176.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 26.8 Cg_exo -64.1 121.67 9.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.897 2.398 . . . . 0.46 111.69 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.793 HH11 ' HA ' ' A' ' 341' ' ' ASP . 18.7 tpp180 -126.43 130.37 50.57 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.98 -0.555 . . . . 0.78 110.308 -177.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.726 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 93.9 mt -84.26 106.65 16.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.934 0.397 . . . . 0.37 110.011 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 30.6 tp -92.18 109.09 20.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.071 -0.513 . . . . 0.57 109.707 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.09 120.2 6.13 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.938 -0.649 . . . . 0.29 111.943 -178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 45.9 mm -107.64 126.4 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 110.041 -0.355 . . . . 0.36 110.041 178.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 72.3 p -125.77 -175.74 3.43 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.489 -0.323 . . . . 0.38 110.451 177.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 60.4 pttt -87.2 21.04 2.51 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.358 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -158.05 -31.62 0.07 Allowed 'General case' 0 C--O 1.234 0.248 0 N-CA-C 112.503 0.557 . . . . 1.79 112.503 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 8.0 p -145.2 166.99 23.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.447 0.642 . . . . 1.1 112.545 -175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 94.9 t -124.33 111.48 28.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.008 -0.996 . . . . 0.32 109.268 176.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -107.74 142.65 37.43 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.028 0.442 . . . . 1.08 110.909 -178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 339' ' ' ARG . 20.9 mtm180 -106.48 113.71 27.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.274 -0.421 . . . . 1.55 110.207 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.726 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 57.7 t -100.86 137.63 27.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.034 -0.53 . . . . 0.31 110.574 -178.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.793 ' HA ' HH11 ' A' ' 328' ' ' ARG . 37.6 t70 -75.37 135.91 40.8 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.77 110.155 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 327' ' ' PRO . 0.1 OUTLIER -77.86 -17.93 56.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.745 0.307 . . . . 1.51 111.425 -175.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -95.13 -50.12 5.21 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.023 0.439 . . . . 3.06 111.032 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.7 m -86.67 -19.46 29.21 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.224 -0.444 . . . . 0.92 110.994 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 45.9 mmtm 63.68 29.21 15.03 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.203 0.525 . . . . 1.5 110.855 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -112.35 155.81 23.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.797 -0.638 . . . . 2.46 110.724 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 340' ' ' VAL . 59.4 t -85.12 124.77 40.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.156 -0.474 . . . . 0.58 110.443 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.9 mt -90.16 -61.11 2.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.088 -0.506 . . . . 0.35 110.833 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -135.0 146.34 48.95 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.967 -0.561 . . . . 1.65 110.471 -175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -135.97 132.8 36.84 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.149 -0.478 . . . . 0.65 110.005 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -117.88 152.56 35.16 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.243 -0.28 . . . . 0.52 110.243 176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 39.6 t -86.47 145.29 26.88 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.58 -0.526 . . . . 1.27 109.58 174.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 86.7 mt -63.0 -25.88 68.59 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.355 0.598 . . . . 0.31 110.252 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 62.0 p -74.97 -5.6 44.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.216 -0.902 . . . . 0.44 111.408 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -112.22 10.27 20.12 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.954 0.407 . . . . 0.83 110.714 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.429 HG21 ' HE3' ' A' ' 359' ' ' TRP . 59.0 mt -88.57 132.62 33.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.091 -0.504 . . . . 0.38 109.785 177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.532 ' CD ' ' HA3' ' A' ' 371' ' ' GLY . 83.6 tttt -93.29 -46.81 7.21 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.84 -0.43 . . . . 1.75 109.84 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -171.87 157.78 4.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.592 -0.731 . . . . 1.75 109.873 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.429 ' HE3' HG21 ' A' ' 356' ' ' ILE . 35.6 p90 -133.42 162.37 32.03 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.103 0.477 . . . . 0.4 111.42 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -125.65 129.13 48.98 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.416 -0.811 . . . . 0.31 110.105 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.484 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -131.25 128.81 40.63 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.097 -0.502 . . . . 0.38 110.935 -177.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 21.4 m -141.25 161.48 52.82 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.937 -0.574 . . . . 1.0 109.535 178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.99 34.63 0.4 Allowed 'Trans proline' 0 CA--C 1.531 0.329 0 C-N-CA 122.677 2.252 . . . . 0.66 112.102 177.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttp -154.5 -36.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.03 -0.532 . . . . 2.08 110.611 -176.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 77.4 p -149.64 170.13 19.4 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.98 0.419 . . . . 1.32 111.225 -178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.479 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 77.6 t80 -139.33 143.85 37.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.603 -0.726 . . . . 0.3 109.098 177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.624 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.2 m -142.94 134.68 26.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.806 0.336 . . . . 0.34 111.325 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.603 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 80.0 mt -112.25 133.19 54.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.178 -0.465 . . . . 0.33 110.343 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -118.87 119.54 34.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.141 0.496 . . . . 1.52 110.137 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.418 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 78.5 m-85 -103.39 1.79 33.07 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.505 178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.532 ' HA3' ' CD ' ' A' ' 357' ' ' LYS . . . 55.34 -97.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 114.721 -1.127 . . . . 0.58 114.892 171.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -97.29 4.26 50.94 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.934 0.397 . . . . 2.38 110.655 -170.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.418 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 75.7 t80 -86.49 -35.42 19.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.038 -0.528 . . . . 0.79 111.006 -178.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -153.77 174.3 14.73 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.93 -0.308 . . . . 1.09 110.697 179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -90.24 119.67 30.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.273 -176.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.42 179.45 28.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.996 -0.621 . . . . 0.7 112.78 174.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -112.44 -179.44 3.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.353 -0.61 . . . . 1.06 109.353 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.624 ' O ' ' HA ' ' A' ' 367' ' ' THR . 45.3 t80 -122.0 97.83 5.66 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.644 -0.502 . . . . 0.47 109.644 174.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 20.0 m -107.67 119.2 38.76 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.056 -0.52 . . . . 1.06 110.799 -176.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . . . . . . . . . 13.1 m -132.46 164.75 34.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.176 -0.465 . . . . 0.33 110.691 177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 6.1 tp60 -101.2 135.26 42.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.118 -0.492 . . . . 1.47 109.781 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 7.2 t 179.25 133.45 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.174 0.511 . . . . 0.42 110.966 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 18.3 p -77.57 -11.41 59.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.969 -0.56 . . . . 0.55 110.597 176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.538 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -97.05 16.86 18.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.925 -0.579 . . . . 1.39 110.748 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.7 -41.11 81.81 Favored Glycine 0 C--N 1.333 0.363 0 CA-C-N 115.952 -0.567 . . . . 0.27 113.028 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.484 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.7 tt0 -68.38 -38.83 81.74 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.732 -0.275 . . . . 2.28 110.34 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -62.08 -36.7 82.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.383 -0.371 . . . . 2.27 110.664 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 384' ' ' GLU . 58.7 mt -64.8 -53.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.129 0.49 . . . . 0.29 110.224 176.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.479 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -60.93 -41.26 95.85 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.542 -0.754 . . . . 0.28 111.529 -178.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -62.65 -35.42 79.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.033 -0.531 . . . . 1.99 110.353 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 40.4 tp -70.79 -43.25 69.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.143 -0.481 . . . . 0.63 110.141 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 68.8 mt -59.05 -50.96 77.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 CA-C-N 116.219 -0.446 . . . . 0.21 110.124 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.73 -35.85 79.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.945 -0.571 . . . . 0.29 110.775 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -60.92 -51.8 56.32 Favored Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 116.113 -0.494 . . . . 0.35 112.443 178.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.7 m-85 -64.51 -43.67 93.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.91 0.386 . . . . 0.7 110.879 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 21.0 mt -59.87 -41.41 85.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.45 111.44 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -59.91 -28.53 67.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.905 0.383 . . . . 0.99 110.853 177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 81.2 mt -74.88 -31.21 25.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.81 110.547 176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.434 HG13 ' O ' ' A' ' 395' ' ' TYR . 56.2 mt -70.18 -37.5 71.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.244 -0.434 . . . . 0.72 111.285 -176.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 396' ' ' ILE . 1.6 mm? . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.666 -0.683 . . . . 1.56 110.426 178.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.764 -0.134 . . . . 12.98 112.764 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 19.2 tpt180 -113.7 122.68 47.87 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.282 -0.266 . . . . 14.53 110.282 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 14.4 m -64.08 119.51 10.29 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.085 0.469 . . . . 10.62 110.221 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -158.01 41.17 0.28 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.888 0.852 . . . . 9.78 109.654 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -81.79 139.69 34.65 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.406 -1.27 . . . . 8.94 110.099 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 8.3 t 71.19 152.64 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 123.761 0.663 . . . . 5.29 110.531 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 86.54 -65.57 3.78 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.853 -0.689 . . . . 2.37 112.143 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -142.76 142.9 32.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 1.42 110.945 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.2 t -115.35 124.64 72.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.552 -0.749 . . . . 1.07 109.474 176.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -98.7 126.66 44.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.255 -0.429 . . . . 2.28 111.032 -175.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -101.4 163.78 12.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.094 -0.503 . . . . 1.83 110.734 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -103.26 7.61 38.41 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 112.84 0.681 . . . . 1.88 112.84 -172.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.481 ' O ' HG13 ' B' ' 379' ' ' ILE . 21.8 pt -122.75 92.4 2.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.014 -0.539 . . . . 1.17 111.349 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -133.77 100.72 4.85 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.336 -0.616 . . . . 0.58 109.336 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . 0.438 ' N ' ' HD1' ' B' ' 381' ' ' TYR . 2.1 m-30 . . . . . 0 C--O 1.247 0.926 0 CA-C-O 118.395 -0.812 . . . . 3.2 110.713 -174.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 111.745 -0.542 . . . . 4.12 111.745 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 5.1 m -90.05 97.54 7.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.485 0.659 . . . . 2.92 110.219 177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 6.6 m -84.07 108.94 17.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.727 -0.669 . . . . 1.06 110.748 -176.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -101.32 124.33 46.84 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.078 -0.51 . . . . 0.52 110.437 178.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -106.93 137.44 44.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.147 -0.479 . . . . 0.41 109.834 177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 52.5 tp -88.31 99.66 12.41 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.077 0.465 . . . . 0.72 110.145 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 35.8 m -109.77 172.49 2.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.919 -0.582 . . . . 0.3 110.439 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 27.9 mtpp -125.86 124.01 39.95 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.021 -0.363 . . . . 1.44 110.021 178.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.448 ' HG2' HG12 ' A' ' 380' ' ' VAL . 53.2 mt-10 -98.87 122.66 42.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.449 -0.341 . . . . 0.7 111.418 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.582 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.5 tptm -80.2 93.76 5.92 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.211 -0.663 . . . . 1.74 109.211 170.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 78.9 mtp -98.98 158.05 15.91 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.103 -0.499 . . . . 1.68 110.802 -175.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.791 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.55 158.78 20.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 2.3 111.011 178.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 101.2 -40.66 2.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.752 -0.737 . . . . 1.93 112.524 177.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.624 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.9 pttm -143.99 166.47 24.88 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.536 0.684 . . . . 1.68 111.026 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.582 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 18.6 p-10 -97.89 24.63 6.72 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.788 -1.096 . . . . 2.79 110.379 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.624 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.9 tttp -111.1 133.52 53.4 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.552 -0.749 . . . . 2.01 109.964 -177.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.3 mp -90.47 120.36 31.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.604 -0.517 . . . . 0.69 109.604 178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 25.9 t -87.65 131.39 43.78 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.031 -0.531 . . . . 0.51 110.96 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_exo -62.49 128.28 23.15 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.847 2.364 . . . . 0.46 111.811 175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 341' ' ' ASP . 14.0 tpp180 -133.71 143.05 48.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.116 -0.493 . . . . 0.78 110.222 -178.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.42 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 64.1 mt -91.43 100.35 13.13 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.127 -0.488 . . . . 0.37 110.047 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 42.8 tp -84.6 106.1 15.91 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.894 -0.594 . . . . 0.57 109.733 179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -96.74 122.95 7.58 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.859 -0.686 . . . . 0.29 112.024 -178.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.512 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.7 mm -106.16 117.25 51.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.96 -0.385 . . . . 0.36 109.96 178.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 25.5 p -119.63 175.71 5.73 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.378 -0.374 . . . . 0.38 110.74 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 24.2 pttm -67.89 -18.51 64.81 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.758 0.651 . . . . 1.61 112.758 -171.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -124.68 -21.95 4.69 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.87 0.693 . . . . 1.79 112.87 -174.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.1 p -153.51 171.9 17.99 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.925 0.713 . . . . 1.1 112.925 -177.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 76.0 t -123.97 117.17 50.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 114.919 -1.037 . . . . 0.32 109.394 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -113.31 135.03 54.29 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.085 0.469 . . . . 1.08 111.746 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.459 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -88.7 101.97 14.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.151 174.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 347' ' ' VAL . 60.0 t -93.75 125.04 46.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.843 0.354 . . . . 0.31 110.051 178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 328' ' ' ARG . 16.4 t0 -65.86 124.45 22.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.372 -0.377 . . . . 0.77 110.312 178.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -64.17 -27.62 69.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.346 0.593 . . . . 1.51 110.211 179.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -75.85 -67.07 0.71 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.834 -0.621 . . . . 3.06 111.254 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.6 m -87.76 -13.39 42.49 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.811 0.3 . . . . 0.92 111.811 -173.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.91 25.11 9.52 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.007 0.523 . . . . 1.5 111.345 -177.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -104.91 144.51 31.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.299 -0.409 . . . . 2.46 111.065 179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.552 HG22 HG22 ' A' ' 340' ' ' VAL . 47.2 t -75.63 109.46 9.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.965 -0.561 . . . . 0.58 110.183 178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 52.4 mt -72.61 -48.76 45.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.116 -0.493 . . . . 0.35 110.319 -178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -153.03 138.86 17.99 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.119 -0.491 . . . . 1.65 110.193 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -117.3 138.43 51.76 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.046 -0.524 . . . . 0.65 110.268 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -118.42 130.59 56.06 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.185 -0.461 . . . . 0.52 110.363 175.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -69.26 146.76 52.02 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.232 -0.655 . . . . 1.27 109.232 171.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.462 HD22 HG23 ' A' ' 392' ' ' ILE . 89.5 mt -62.59 -22.97 66.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.303 0.573 . . . . 0.31 110.264 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.4 p -69.42 -14.45 62.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.349 -0.841 . . . . 0.44 111.836 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -93.32 -6.99 46.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.927 0.394 . . . . 0.83 111.208 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 70.0 mt -86.5 133.95 28.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.293 -0.412 . . . . 0.38 111.313 -174.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -96.95 -55.06 2.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.002 0.429 . . . . 1.75 110.237 177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' B' ' 376' ' ' GLU . 0.9 OUTLIER -155.39 162.82 40.71 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.863 -0.608 . . . . 1.75 110.014 179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.622 ' HB3' HD23 ' A' ' 368' ' ' LEU . 33.2 p90 -137.96 140.87 40.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.117 0.484 . . . . 0.4 111.018 177.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -101.35 109.0 20.77 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.478 -0.783 . . . . 0.31 110.3 178.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.425 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -92.89 116.56 29.15 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.297 -0.865 . . . . 0.38 110.907 -178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 365' ' ' SER . 34.3 m -140.98 144.88 36.9 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.013 -0.539 . . . . 1.0 109.695 176.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.573 ' O ' ' HA ' ' A' ' 383' ' ' THR . 59.0 Cg_endo -71.9 -3.71 13.72 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.895 2.397 . . . . 0.66 112.759 -178.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -104.6 -35.07 7.96 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.276 -0.42 . . . . 2.08 110.74 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 362' ' ' SER . 23.2 p -162.28 139.99 8.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.058 -0.519 . . . . 1.32 110.519 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.431 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 83.1 t80 -107.63 134.93 49.91 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.336 -0.616 . . . . 0.3 109.336 179.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 32.9 m -128.15 117.94 22.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.835 0.35 . . . . 0.34 111.4 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 36.0 mt -90.34 136.51 33.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.187 -0.461 . . . . 0.33 110.477 174.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.485 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.9 t0 -118.03 126.56 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.125 -0.489 . . . . 1.52 110.062 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.698 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 90.4 m-85 -107.89 10.57 28.5 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.863 -0.608 . . . . 0.44 110.056 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.32 -99.74 0.26 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.525 -0.761 . . . . 0.58 113.366 174.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -111.66 17.38 19.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.447 0.642 . . . . 2.38 110.189 -176.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.698 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 83.9 t80 -86.38 -59.05 2.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.732 -0.667 . . . . 0.79 110.666 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -123.67 155.63 37.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.973 0.416 . . . . 1.09 111.172 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -78.49 126.97 31.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.518 -0.764 . . . . 2.3 110.395 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 90.07 176.53 45.07 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.801 -0.714 . . . . 0.7 112.393 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -108.24 177.43 4.8 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.102 0.477 . . . . 1.06 110.718 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.679 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 70.9 t80 -120.63 85.47 2.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.752 -0.658 . . . . 0.47 109.272 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 3.2 p -101.31 119.13 38.29 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.524 -0.762 . . . . 1.06 110.84 -178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.675 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.7 m -126.95 142.94 42.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.127 -0.488 . . . . 0.33 110.973 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.566 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 62.8 tt0 -77.69 123.32 26.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.017 -0.538 . . . . 1.47 109.986 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.625 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.7 t -165.32 146.63 7.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.069 -0.514 . . . . 0.42 110.237 -178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 72.3 p -93.34 -7.88 43.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.061 0.457 . . . . 0.55 110.418 177.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.0 mt-10 -112.77 24.87 11.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.904 -0.589 . . . . 1.39 110.792 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -59.09 -33.97 77.13 Favored Glycine 0 C--N 1.331 0.277 0 CA-C-N 115.794 -0.639 . . . . 0.27 112.96 -178.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.425 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 43.9 tt0 -64.71 -41.61 95.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.81 0.338 . . . . 2.28 110.491 179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.76 -37.28 84.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.294 -0.412 . . . . 2.27 110.67 178.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 384' ' ' GLU . 63.2 mt -60.67 -49.05 86.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.22 0.533 . . . . 0.29 110.051 176.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.431 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.0 -48.93 78.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.426 -0.807 . . . . 0.28 111.388 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -63.77 -32.49 74.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.731 -0.668 . . . . 1.99 110.629 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.512 HD23 ' HB ' ' A' ' 332' ' ' ILE . 25.4 tp -70.05 -43.49 71.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.905 -0.589 . . . . 0.63 110.7 -178.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.462 HG23 HD22 ' A' ' 353' ' ' LEU . 70.1 mt -60.93 -49.25 85.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 N-CA-C 110.064 -0.347 . . . . 0.21 110.064 177.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -58.93 -36.51 74.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.956 -0.565 . . . . 0.29 110.847 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.416 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -65.6 -49.21 61.37 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.875 -0.602 . . . . 0.35 112.555 179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.466 ' HB3' ' HA ' ' A' ' 334' ' ' LYS . 22.9 m-85 -64.87 -41.05 95.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.905 0.383 . . . . 0.7 110.572 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 23.0 mt -58.43 -46.2 89.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.754 -0.657 . . . . 0.45 111.241 178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . 0.492 ' HA ' HD23 ' A' ' 400' ' ' LEU . 18.4 t70 -59.56 -30.03 68.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.902 0.382 . . . . 0.99 110.75 -177.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 394' ' ' GLY . 67.0 mt -68.6 -29.68 44.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.81 110.79 177.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.39 -32.09 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.479 -0.328 . . . . 0.72 110.952 -177.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 397' ' ' ASP . 2.2 mm? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.619 -0.705 . . . . 1.56 110.505 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.906 0 N-CA-C 111.815 -0.514 . . . . 12.98 111.815 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 10.9 tpp180 -145.5 -26.52 0.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.941 0.371 . . . . 14.53 111.838 -175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.7 m -91.35 71.7 6.1 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.925 -0.31 . . . . 10.62 111.074 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? 36.14 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 124.362 1.039 . . . . 9.78 112.222 -178.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -68.88 98.68 0.96 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.055 -0.975 . . . . 8.94 112.041 -174.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 45.9 m -100.68 96.9 7.64 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.358 0.599 . . . . 5.29 109.875 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.562 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -100.63 18.63 54.82 Favored Glycine 0 C--N 1.315 -0.629 0 CA-C-N 115.227 -0.897 . . . . 2.37 111.289 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 72.8 m95 -116.56 104.55 11.52 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.15 0.5 . . . . 1.42 110.407 -174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.476 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.5 t -88.28 125.72 41.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.597 -1.26 . . . . 1.07 107.597 176.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 358' ' ' ARG . 13.0 pt-20 -111.79 174.4 5.89 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 113.44 0.904 . . . . 2.28 113.44 -169.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.581 HD21 HG13 ' B' ' 379' ' ' ILE . 21.4 t30 -123.13 132.1 53.95 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.214 -1.357 . . . . 1.83 111.572 -162.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -83.7 -2.45 56.25 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.551 0.574 . . . . 1.88 112.551 -175.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.581 HG13 HD21 ' B' ' 377' ' ' ASN . 29.6 pt -118.62 26.98 3.68 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 120.452 -0.499 . . . . 1.17 111.246 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -70.42 119.24 14.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.141 -0.482 . . . . 0.58 110.211 174.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.947 -0.549 . . . . 3.2 110.286 177.429 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.779 0 N-CA-C 112.324 -0.31 . . . . 4.12 112.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.493 HG13 HG22 ' A' ' 333' ' ' THR . 46.3 t 68.95 84.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 121.273 0.559 . . . . 2.92 110.963 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . 0.419 ' HB2' HD21 ' A' ' 391' ' ' LEU . 40.7 m -105.19 148.9 26.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.764 -0.653 . . . . 1.06 111.141 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 330' ' ' LEU . 61.0 m-85 -116.84 135.55 53.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.52 110.862 178.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -122.84 141.75 51.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.897 -0.592 . . . . 0.41 110.046 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 64.6 tp -91.39 102.49 15.18 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.854 -0.425 . . . . 0.72 109.854 176.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 382' ' ' THR . 32.0 m -114.12 174.91 2.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.988 -0.551 . . . . 0.3 110.844 -177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.596 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 27.0 mtpp -126.28 112.01 15.21 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.325 -0.398 . . . . 1.44 110.422 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.483 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 83.8 mt-10 -75.6 118.51 18.52 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.746 0.308 . . . . 0.7 110.865 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -88.45 103.63 16.04 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.39 -0.596 . . . . 1.74 109.39 173.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 10.4 mmt -118.82 167.39 11.75 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.462 -0.79 . . . . 1.68 109.745 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.712 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -76.51 -176.97 3.94 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.385 -0.598 . . . . 2.3 109.385 171.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 93.45 -25.65 19.65 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.483 -0.865 . . . . 1.93 111.383 -178.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.707 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 21.6 pttm -167.23 -177.9 3.87 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.647 -0.501 . . . . 1.68 109.647 176.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -110.15 2.44 19.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.064 0.459 . . . . 2.79 110.586 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.707 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 40.6 ttmt -86.91 123.15 31.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.809 -0.632 . . . . 2.01 110.056 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.578 ' HB2' ' HE3' ' A' ' 316' ' ' LYS . 6.3 mp -78.67 120.06 22.81 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.59 -0.522 . . . . 0.69 109.59 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 21.1 t -74.83 119.8 78.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.802 -0.636 . . . . 0.51 111.468 -172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.61 121.06 8.69 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.567 2.178 . . . . 0.46 111.219 175.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -130.68 148.26 52.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.78 110.25 -177.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 97.2 mt -95.63 108.35 20.62 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.773 -0.455 . . . . 0.37 109.773 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -80.97 119.77 23.91 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.923 -0.581 . . . . 0.57 110.036 -178.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -106.58 106.79 2.59 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.206 -0.997 . . . . 0.29 112.205 177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 310' ' ' VAL . 29.9 mm -100.54 110.25 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 109.663 -0.495 . . . . 0.36 109.663 177.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.493 HG22 HG13 ' A' ' 310' ' ' VAL . 49.4 p -106.58 -177.75 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.752 -0.462 . . . . 0.38 109.752 178.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.503 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 24.8 pttm -78.49 0.24 26.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.923 0.392 . . . . 1.61 111.032 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -140.43 -30.87 0.65 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.655 0.613 . . . . 1.79 112.655 -172.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 26.6 p -145.26 154.47 42.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.615 0.722 . . . . 1.1 112.711 -175.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 87.1 t -105.88 114.92 46.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 114.834 -1.075 . . . . 0.32 108.853 172.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.3 ptp -114.45 138.43 50.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.925 0.393 . . . . 1.08 111.319 -175.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.517 ' HD3' ' CE1' ' A' ' 378' ' ' TYR . 46.8 mtm180 -94.95 99.61 11.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.55 110.528 177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 347' ' ' VAL . 45.6 t -92.8 120.42 42.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.346 -0.613 . . . . 0.31 109.346 176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 345' ' ' LYS . 24.6 t0 -65.07 136.45 56.75 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.776 -0.37 . . . . 0.77 110.477 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 8.2 tm-20 -72.95 -39.76 65.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.97 0.414 . . . . 1.51 109.955 -178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -75.13 -57.09 4.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 3.06 111.605 -175.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.04 -11.42 44.23 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.233 -0.44 . . . . 0.92 111.684 -174.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 341' ' ' ASP . 30.9 mmtp 59.15 33.02 22.58 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 121.065 0.46 . . . . 1.5 111.307 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -107.89 135.41 49.33 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.865 -0.607 . . . . 2.46 110.879 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.633 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -74.93 104.28 3.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.076 -0.713 . . . . 0.58 109.076 174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.2 -60.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.945 -0.57 . . . . 0.35 111.06 -174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -138.21 144.65 40.73 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.089 -0.505 . . . . 1.65 110.161 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -134.15 134.28 41.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.638 -175.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 4.3 m-90 -125.29 129.58 50.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.551 -0.295 . . . . 0.52 110.634 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 19.7 m -65.04 148.51 51.51 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.833 -0.432 . . . . 1.27 109.833 172.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 392' ' ' ILE . 87.9 mt -60.67 -23.99 65.26 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.476 0.655 . . . . 0.31 110.594 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 72.6 p -71.42 -10.13 59.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.114 -0.948 . . . . 0.44 111.597 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -100.17 -0.09 39.48 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.432 -0.349 . . . . 0.83 110.944 -177.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.3 mt -83.1 142.75 13.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.176 -0.466 . . . . 0.38 110.043 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.458 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 86.7 tttt -108.46 -40.72 5.04 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.0 0.429 . . . . 1.75 110.674 177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.482 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 3.1 ptp180 -170.73 155.69 4.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.947 -0.57 . . . . 1.75 109.85 -178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.768 ' HB3' HD23 ' A' ' 368' ' ' LEU . 41.4 p90 -138.37 150.02 46.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.162 0.506 . . . . 0.4 111.273 176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' B' ' 373' ' ' GLY . . . -112.48 112.65 24.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.414 -0.812 . . . . 0.31 110.702 178.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -94.29 102.92 14.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.306 -0.861 . . . . 0.38 110.55 179.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 41.6 m -124.05 155.27 67.77 Favored Pre-proline 0 C--N 1.321 -0.667 0 N-CA-C 109.934 -0.395 . . . . 1.0 109.934 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.03 -3.13 13.29 Favored 'Trans proline' 0 CA--C 1.53 0.277 0 C-N-CA 122.55 2.167 . . . . 0.66 112.751 -179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -110.75 -36.48 5.7 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.715 0.293 . . . . 2.08 111.233 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 10.9 p -156.59 150.77 25.21 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.104 0.478 . . . . 1.32 111.358 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . . . . . . . . . 80.2 t80 -116.29 125.49 52.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.3 109.238 177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . . . . . . . . . 85.1 m -117.59 121.38 40.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.578 -0.283 . . . . 0.34 111.619 -177.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 359' ' ' TRP . 46.2 mt -100.22 135.05 42.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.417 -0.356 . . . . 0.33 110.195 172.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.482 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.3 t0 -114.83 136.51 53.01 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.581 -0.525 . . . . 1.52 109.581 173.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 66.0 m-85 -114.59 1.66 14.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.422 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.458 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 58.33 -103.4 0.34 Allowed Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.562 -0.745 . . . . 0.58 113.798 174.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -93.13 6.85 46.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.684 -0.258 . . . . 2.38 111.176 -173.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 53.3 t80 -86.68 -35.34 19.36 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.037 -0.265 . . . . 0.79 110.738 -178.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -157.12 171.07 21.09 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.155 -0.313 . . . . 1.09 110.155 177.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -93.59 134.68 35.62 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.472 -0.331 . . . . 2.3 110.462 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.48 -174.73 27.38 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.657 -0.782 . . . . 0.7 111.983 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -122.24 176.81 5.65 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.089 0.471 . . . . 1.06 110.396 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.635 ' HD2' HD12 ' A' ' 368' ' ' LEU . 28.8 t80 -122.06 86.93 2.66 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.371 -0.603 . . . . 0.47 109.371 176.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 39.4 m -105.41 120.34 41.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.786 -0.643 . . . . 1.06 110.805 -177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.477 HG12 ' HG2' ' A' ' 317' ' ' GLU . 18.5 m -122.99 142.82 38.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.773 -0.649 . . . . 0.33 110.535 178.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.596 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.8 tt0 -76.46 123.9 26.73 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.138 -0.483 . . . . 1.47 109.83 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.519 ' HB ' HG12 ' A' ' 315' ' ' VAL . 3.4 t -167.36 144.95 4.63 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.009 -0.541 . . . . 0.42 110.444 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 -6.37 56.13 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.002 -0.545 . . . . 0.55 110.155 175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.481 ' O ' HG13 ' A' ' 388' ' ' ILE . 43.7 mt-10 -104.81 29.7 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.731 -0.668 . . . . 1.39 110.882 -176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -56.96 -43.52 92.9 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.279 -0.486 . . . . 0.27 112.843 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.46 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 13.4 tp10 -67.41 -38.16 84.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.035 0.445 . . . . 2.28 110.24 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 17.2 mp0 -60.05 -45.99 91.01 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.824 -0.625 . . . . 2.27 110.383 177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 384' ' ' GLU . 65.5 mt -63.69 -42.12 94.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.09 -0.505 . . . . 0.29 110.322 178.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.487 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -59.32 -49.65 77.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.861 -0.609 . . . . 0.28 111.097 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -58.26 -38.82 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.934 -0.575 . . . . 1.99 110.726 177.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.419 HD21 ' HB2' ' A' ' 311' ' ' SER . 21.8 tp -64.78 -50.76 65.53 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.815 -0.629 . . . . 0.63 110.576 -177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.469 HG23 HD22 ' A' ' 353' ' ' LEU . 67.7 mt -61.22 -48.83 87.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.436 -0.347 . . . . 0.21 110.543 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -60.75 -33.8 73.49 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.133 -0.485 . . . . 0.29 111.007 -179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -63.5 -47.73 84.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.118 -0.563 . . . . 0.35 112.416 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.503 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.7 m-85 -67.11 -40.46 86.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.973 0.416 . . . . 0.7 110.504 178.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 44.8 mt -58.51 -40.94 80.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 0.45 110.9 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.03 -35.98 74.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.145 -0.479 . . . . 0.99 111.059 177.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.58 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.81 110.58 178.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 58.0 mt -70.7 -34.64 57.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.071 -0.513 . . . . 0.72 110.773 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.427 HD21 HG23 ' B' ' 379' ' ' ILE . 85.9 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.542 -0.742 . . . . 1.56 110.953 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.638 0 N-CA-C 111.661 -0.575 . . . . 12.98 111.661 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.3 tpp180 -152.03 -60.24 0.16 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.926 0.393 . . . . 14.53 110.106 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.8 p -145.12 41.05 1.26 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.769 -0.65 . . . . 10.62 110.542 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.41 ' HE2' ' HD1' ' B' ' 374' ' ' TRP . 27.8 mtpp -119.96 103.58 9.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.983 -0.553 . . . . 9.78 110.795 -178.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -63.66 -55.37 24.04 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.213 -0.449 . . . . 8.94 110.748 170.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 27.6 m -98.24 169.17 9.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.138 0.494 . . . . 5.29 110.544 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 85.06 -64.59 4.2 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.359 -0.696 . . . . 2.37 111.359 -177.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.41 ' HD1' ' HE2' ' B' ' 370' ' ' LYS . 66.7 m95 -115.63 99.6 7.45 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 109.024 -0.732 . . . . 1.42 109.024 172.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 41.5 t -103.15 122.76 56.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-N 115.164 -0.925 . . . . 1.07 110.225 -171.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 140.27 38.37 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.767 -0.651 . . . . 2.28 110.116 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 31.1 p-10 -95.75 161.22 14.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.927 -0.579 . . . . 1.83 111.094 -175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -111.33 18.56 19.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.38 -0.373 . . . . 1.88 111.795 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.427 HG23 HD21 ' A' ' 400' ' ' LEU . 28.3 pt -121.59 28.86 2.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.208 -0.451 . . . . 1.17 111.14 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -84.3 105.25 15.0 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.127 -0.488 . . . . 0.58 110.07 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.731 -0.652 . . . . 3.2 110.529 178.508 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.749 0 N-CA-C 112.535 -0.226 . . . . 4.12 112.535 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 23.0 t -94.28 88.83 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 109.529 -0.545 . . . . 2.92 109.529 178.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 13.9 m -97.52 122.48 40.63 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.869 -0.605 . . . . 1.06 111.148 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.672 ' HE1' HG21 ' A' ' 340' ' ' VAL . 79.7 m-85 -101.66 123.06 45.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 0.52 110.29 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.0 130.96 55.46 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.915 -0.402 . . . . 0.41 109.915 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 51.6 tp -85.25 95.5 9.2 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.046 0.45 . . . . 0.72 109.916 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.4 m -103.42 156.69 5.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.918 -0.583 . . . . 0.3 110.826 -177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 24.4 mtpp -108.41 105.34 14.97 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.79 -0.448 . . . . 1.44 109.79 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.537 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 75.9 mt-10 -76.98 117.93 19.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.37 -0.377 . . . . 0.7 111.174 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 23.7 tptp -92.51 95.59 9.72 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.582 -0.525 . . . . 1.74 109.582 173.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.4 mmt -98.1 160.78 14.07 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.665 . . . . 1.68 110.356 178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 1.013 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -72.9 159.68 33.33 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.661 -0.699 . . . . 2.3 111.051 -178.356 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.05 -37.11 3.93 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.902 -0.666 . . . . 1.93 112.346 177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.509 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.6 pttm -144.14 156.87 44.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.729 0.299 . . . . 1.68 110.313 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.483 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 27.9 p30 -88.73 8.04 30.79 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.096 -0.502 . . . . 2.79 111.05 -179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 60.8 tttp -88.93 130.83 35.36 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.063 -0.517 . . . . 2.01 110.47 178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.2 mp -92.53 134.34 35.07 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.902 -0.59 . . . . 0.69 109.663 176.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 40.7 t -98.96 125.19 42.83 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 116.14 -0.482 . . . . 0.51 110.765 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 20.3 Cg_exo -66.79 125.4 13.68 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 122.855 2.37 . . . . 0.46 111.974 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.432 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 18.2 tpp180 -129.01 146.05 51.09 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.071 -0.513 . . . . 0.78 110.211 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.659 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.7 mt -92.51 97.67 10.98 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.303 -0.628 . . . . 0.37 109.303 174.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.9 tp -83.87 107.37 16.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.96 -178.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -98.49 116.74 5.64 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.929 -0.653 . . . . 0.29 111.865 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' A' ' 391' ' ' LEU . 42.5 mm -98.4 119.68 46.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.986 -0.376 . . . . 0.36 109.986 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 66.9 p -113.49 -170.97 1.8 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.371 -0.377 . . . . 0.38 110.433 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -81.46 1.04 35.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.405 -0.362 . . . . 1.61 111.46 -177.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.405 ' O ' ' HG ' ' A' ' 353' ' ' LEU . 8.9 pt-20 -144.69 -30.88 0.44 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.762 0.653 . . . . 1.79 112.762 -173.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 23.3 p -142.43 149.44 39.28 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.681 0.753 . . . . 1.1 113.018 -174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 61.7 t -97.45 105.14 16.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.686 -1.143 . . . . 0.32 108.623 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 19.0 ptp -103.64 126.35 50.72 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.017 0.437 . . . . 1.08 111.286 -172.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.537 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 41.9 mtm180 -91.05 101.13 13.89 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.324 -0.398 . . . . 1.55 110.828 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.672 HG21 ' HE1' ' A' ' 312' ' ' PHE . 61.1 t -88.79 123.53 41.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.189 -0.46 . . . . 0.31 110.234 177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -65.3 132.88 50.17 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.075 -0.512 . . . . 0.77 110.219 177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.04 -37.22 86.64 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.055 0.455 . . . . 1.51 110.185 -177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -77.84 -59.74 2.66 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.013 -0.54 . . . . 3.06 111.787 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.83 -15.65 41.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.508 -0.315 . . . . 0.92 111.819 -172.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 66.17 18.36 10.95 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 116.171 -0.468 . . . . 1.5 111.789 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -106.22 157.29 17.68 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.285 -0.635 . . . . 2.46 109.285 176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.462 HG12 HG22 ' A' ' 340' ' ' VAL . 30.3 m -87.13 134.36 27.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 119.748 -0.781 . . . . 0.58 111.238 179.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.3 mt -90.95 -33.29 5.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.162 -0.926 . . . . 0.35 110.179 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . 0.523 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 37.3 tt0 -156.38 148.02 22.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 1.65 109.937 -176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -137.18 125.1 22.67 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.589 -0.278 . . . . 0.65 110.402 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 9.1 m-90 -105.46 122.26 45.62 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.894 -0.139 . . . . 0.52 110.855 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.48 ' HB2' ' ND2' ' A' ' 355' ' ' ASN . 14.7 m -68.95 140.06 55.07 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.883 -0.784 . . . . 1.27 108.883 171.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 399' ' ' ILE . 82.9 mt -57.79 -21.86 44.12 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.066 0.395 . . . . 0.31 112.066 -175.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 63.9 p -69.98 -13.65 62.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.905 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' A' ' 352' ' ' SER . 37.3 m-80 -99.4 3.54 45.9 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.054 0.454 . . . . 0.83 110.585 -178.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 56.2 mt -86.97 126.49 40.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.954 -0.566 . . . . 0.38 109.965 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -95.66 -58.49 2.1 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.106 0.479 . . . . 1.75 110.12 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.425 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 10.9 ptp180 -156.64 151.32 25.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.819 -0.628 . . . . 1.75 109.812 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.517 ' HB3' HD23 ' A' ' 368' ' ' LEU . 45.1 p90 -128.06 140.0 52.2 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.212 0.529 . . . . 0.4 111.149 178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.89 104.15 13.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.511 -0.768 . . . . 0.31 109.764 177.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -103.07 124.68 48.99 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.94 -0.573 . . . . 0.38 110.715 -178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.45 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 54.4 p -142.06 162.64 44.66 Favored Pre-proline 0 C--N 1.319 -0.748 0 N-CA-C 109.529 -0.545 . . . . 1.0 109.529 175.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 37.4 Cg_endo -67.0 -4.87 12.23 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.492 2.128 . . . . 0.66 111.965 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -101.52 -36.04 8.94 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.715 -0.675 . . . . 2.08 110.96 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.4 p -166.41 167.32 15.88 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.13 0.49 . . . . 1.32 111.553 -175.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.462 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 64.3 t80 -129.42 124.14 33.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.703 -0.681 . . . . 0.3 109.201 176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 23.8 m -121.44 119.54 32.35 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.547 -0.297 . . . . 0.34 111.341 -176.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.613 HD12 ' HD2' ' A' ' 378' ' ' TYR . 46.8 mt -98.81 125.34 44.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.335 -0.393 . . . . 0.33 111.095 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.425 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 19.8 t0 -106.7 128.22 54.01 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.197 -0.668 . . . . 1.52 109.197 173.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -112.12 5.0 18.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.798 -175.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.42 -121.95 27.75 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.918 -0.658 . . . . 0.58 112.408 179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -91.74 66.81 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.68 0.752 . . . . 2.38 110.409 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -125.74 -44.89 1.79 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.378 -0.828 . . . . 0.79 110.107 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -151.05 169.78 20.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.044 -0.526 . . . . 1.09 110.389 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -81.07 125.76 30.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.06 -0.518 . . . . 2.3 110.331 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 86.82 -175.25 46.8 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.802 -0.713 . . . . 0.7 112.285 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -117.05 -170.78 1.91 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.971 0.415 . . . . 1.06 109.994 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.613 ' HD2' HD12 ' A' ' 368' ' ' LEU . 31.3 t80 -121.63 95.91 4.86 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.379 -0.6 . . . . 0.47 109.379 174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 11.0 m -108.2 118.92 38.02 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.915 -0.584 . . . . 1.06 110.832 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.511 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 22.3 m -120.59 140.73 43.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.899 -0.591 . . . . 0.33 110.508 177.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -87.13 124.05 32.84 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.786 -0.82 . . . . 1.47 108.786 176.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -163.48 157.4 19.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.875 0.369 . . . . 0.42 110.917 -175.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 12.8 p -100.49 -4.63 28.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.897 -0.592 . . . . 0.55 110.747 178.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -116.29 21.91 13.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.917 -0.583 . . . . 1.39 110.983 -175.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.54 -32.48 69.0 Favored Glycine 0 C--N 1.33 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.27 112.471 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.15 -45.92 89.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.802 0.334 . . . . 2.28 110.628 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -63.19 -35.5 80.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 2.27 110.754 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 53.8 mt -64.49 -51.67 65.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.213 0.53 . . . . 0.29 110.225 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.535 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -60.06 -48.7 80.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.316 -0.857 . . . . 0.28 111.797 -178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -66.71 -24.28 66.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.055 -0.521 . . . . 1.99 110.65 -177.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.578 HD23 ' HB ' ' A' ' 332' ' ' ILE . 32.6 tp -74.76 -47.7 29.65 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.169 -0.469 . . . . 0.63 110.142 177.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.449 HG22 HD12 ' A' ' 396' ' ' ILE . 68.7 mt -59.83 -48.72 86.58 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 CA-C-N 116.314 -0.403 . . . . 0.21 110.26 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.436 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -57.55 -35.8 70.8 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.994 -0.548 . . . . 0.29 111.065 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . 0.446 ' O ' HG13 ' A' ' 398' ' ' ILE . . . -64.28 -53.64 34.96 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.158 -0.544 . . . . 0.35 112.256 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 399' ' ' ILE . 38.8 m-85 -62.18 -40.02 94.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.955 0.407 . . . . 0.7 110.691 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 392' ' ' ILE . 15.7 mt -59.94 -39.31 79.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.783 -0.644 . . . . 0.45 111.395 178.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -68.77 -25.37 64.68 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.952 0.406 . . . . 0.99 110.57 178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 394' ' ' GLY . 65.6 mt -77.28 -36.83 24.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.202 -0.454 . . . . 0.81 110.436 177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 395' ' ' TYR . 69.3 mt -66.8 -30.93 51.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.047 -0.524 . . . . 0.72 110.741 179.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.523 -0.751 . . . . 1.56 110.918 179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.6 0 N-CA-C 111.444 -0.662 . . . . 12.98 111.444 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -114.4 131.62 56.51 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.384 -0.599 . . . . 14.53 109.384 178.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.4 m -118.23 90.97 3.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.855 0.359 . . . . 10.62 110.323 179.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -169.49 48.17 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.702 -0.681 . . . . 9.78 109.379 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -79.34 90.63 4.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.212 -0.904 . . . . 8.94 111.27 -171.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.2 m -84.32 117.72 23.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.823 -0.626 . . . . 5.29 110.807 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 169.67 65.66 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.512 -0.852 . . . . 2.37 112.605 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 85.4 m95 62.61 94.72 0.04 OUTLIER 'General case' 0 CA--C 1.518 -0.288 0 CA-C-O 121.693 0.758 . . . . 1.42 111.745 178.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.452 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 59.0 t -91.05 120.35 39.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 114.915 -1.039 . . . . 1.07 108.391 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -109.84 150.71 27.99 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.949 -0.569 . . . . 2.28 110.384 -172.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.629 ' OD1' HG12 ' B' ' 379' ' ' ILE . 4.7 p30 -120.84 -179.45 4.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.052 -0.522 . . . . 1.83 110.652 -173.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -121.28 24.92 9.78 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.475 0.546 . . . . 1.88 112.475 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.629 HG12 ' OD1' ' B' ' 377' ' ' ASN . 10.3 pt -119.18 15.34 6.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.637 -0.425 . . . . 1.17 111.871 174.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -77.3 118.52 19.87 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.684 -0.406 . . . . 0.58 110.132 178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.519 -0.753 . . . . 3.2 110.677 178.056 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.433 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.737 0 N-CA-C 111.654 -0.579 . . . . 4.12 111.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.412 ' HA ' HG22 ' A' ' 333' ' ' THR . 10.4 m -60.08 96.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-O 121.501 0.667 . . . . 2.92 111.284 178.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 4.9 m -103.91 114.76 29.25 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.893 -0.594 . . . . 1.06 109.922 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -98.67 122.7 42.22 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.161 0.505 . . . . 0.52 111.473 -175.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -107.44 145.44 32.99 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.713 -0.676 . . . . 0.41 109.678 176.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 62.6 tp -86.37 106.98 17.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.884 0.373 . . . . 0.72 110.073 -178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.677 HG23 ' HB3' ' A' ' 328' ' ' ARG . 34.3 m -119.26 159.86 19.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 116.169 -0.469 . . . . 0.3 110.826 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 54.2 mtpt -120.74 110.49 16.43 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.204 -0.453 . . . . 1.44 110.181 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.529 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 83.3 mt-10 -80.98 120.4 24.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.212 -0.449 . . . . 0.7 111.114 -178.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.634 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 20.8 tptm -93.18 91.62 7.37 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.458 -0.571 . . . . 1.74 109.458 172.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 52.9 mtt -104.93 158.57 16.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.84 -0.618 . . . . 1.68 110.388 179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.955 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.53 158.33 21.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.612 -0.722 . . . . 2.3 110.914 177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 115.64 -31.37 6.17 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.685 -0.689 . . . . 1.93 111.468 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.499 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.2 pttm -159.53 -177.53 6.47 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.972 -0.381 . . . . 1.68 109.972 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.634 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 0.0 OUTLIER -104.88 -16.54 14.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.079 0.466 . . . . 2.79 110.489 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 39.5 ttmt -73.66 134.46 43.62 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.922 -0.581 . . . . 2.01 111.06 176.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.7 mp -86.73 142.14 28.38 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.842 -0.617 . . . . 0.69 109.953 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 33.0 t -95.31 129.74 34.31 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.43 -0.35 . . . . 0.51 111.005 -175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -65.58 121.38 8.76 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.91 2.407 . . . . 0.46 111.753 176.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.865 HH11 ' HA ' ' A' ' 341' ' ' ASP . 11.4 tpp180 -124.77 141.02 52.4 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.633 -177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 54.5 mt -93.71 98.99 11.48 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.355 -0.609 . . . . 0.37 109.355 171.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.466 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -83.59 104.02 13.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.57 109.554 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -93.9 107.6 3.56 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.991 -0.623 . . . . 0.29 112.342 -177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.622 ' HB ' HD23 ' A' ' 391' ' ' LEU . 33.8 mm -93.63 123.9 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.449 -0.574 . . . . 0.36 109.449 177.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.412 HG22 ' HA ' ' A' ' 310' ' ' VAL . 69.7 p -116.0 -171.12 1.92 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 110.255 -0.276 . . . . 0.38 110.255 178.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.494 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 23.3 pttp -75.93 9.79 2.22 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.23 0.456 . . . . 1.61 112.23 -175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -168.84 -17.89 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.639 0.607 . . . . 1.79 112.639 -177.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 81.2 m -130.05 160.32 34.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.458 0.647 . . . . 1.1 112.289 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 332' ' ' ILE . 96.0 t -125.98 103.64 11.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 114.917 -1.038 . . . . 0.32 109.023 176.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 23.4 ptp -106.72 137.31 45.0 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.131 0.491 . . . . 1.08 111.788 -173.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.528 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.2 mtm180 -97.03 103.25 15.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.656 -0.702 . . . . 1.55 110.214 177.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 347' ' ' VAL . 61.2 t -99.77 130.54 48.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.14 -0.318 . . . . 0.31 110.14 178.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.865 ' HA ' HH11 ' A' ' 328' ' ' ARG . 24.9 t70 -67.17 126.78 30.29 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.968 -0.382 . . . . 0.77 109.968 178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -67.09 -34.34 77.43 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.206 -0.452 . . . . 1.51 110.616 -174.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -85.5 -52.92 5.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.108 -0.496 . . . . 3.06 111.732 -174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.98 -14.54 31.29 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.329 -0.396 . . . . 0.92 111.6 -173.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.0 mmtm 65.29 29.2 11.73 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.018 -0.537 . . . . 1.5 111.55 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -96.19 136.87 36.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.504 -0.316 . . . . 2.46 110.624 177.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 340' ' ' VAL . 49.1 t -78.09 108.27 11.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.268 -0.642 . . . . 0.58 109.268 173.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.5 mt -81.08 -48.02 19.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.985 -0.552 . . . . 0.35 111.448 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -155.13 148.93 25.51 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.92 -0.4 . . . . 1.65 109.92 -175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -131.7 136.93 48.03 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.756 0.312 . . . . 0.65 110.591 -178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . 0.447 ' HD1' ' CE2' ' A' ' 373' ' ' TYR . 6.3 m-90 -112.75 167.59 10.37 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.121 -0.491 . . . . 0.52 110.273 175.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 46.7 t -114.66 148.04 38.74 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.933 -0.766 . . . . 1.27 108.933 174.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.57 HD22 HG23 ' A' ' 392' ' ' ILE . 79.9 mt -62.53 -27.73 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.23 0.538 . . . . 0.31 110.037 178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 69.4 p -69.3 -11.99 61.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.669 -0.696 . . . . 0.44 111.506 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -103.62 4.59 35.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.447 -0.342 . . . . 0.83 110.935 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 65.7 mt -86.33 130.36 36.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 120.943 0.401 . . . . 0.38 110.752 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -93.34 -52.01 4.72 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.107 -0.497 . . . . 1.75 109.678 177.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -168.27 157.62 9.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.801 -0.636 . . . . 1.75 110.195 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.456 ' HB3' HD23 ' A' ' 368' ' ' LEU . 47.9 p90 -135.31 145.06 47.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.159 0.504 . . . . 0.4 111.37 178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.561 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -105.57 116.86 32.66 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.715 -0.675 . . . . 0.31 109.939 176.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -102.99 116.86 33.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.023 -0.535 . . . . 0.38 111.233 -176.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 35.1 m -131.89 150.44 76.18 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.371 -0.603 . . . . 1.0 109.371 174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.38 5.33 2.38 Favored 'Trans proline' 0 CA--C 1.531 0.372 0 C-N-CA 122.783 2.322 . . . . 0.66 113.128 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 364' ' ' LYS . 4.2 ttmp? -124.65 -25.68 3.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.668 0.27 . . . . 2.08 110.89 176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 12.1 p -154.77 149.39 26.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.175 0.512 . . . . 1.32 111.434 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.481 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 66.2 t80 -122.82 129.64 51.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.589 -0.732 . . . . 0.3 109.091 177.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.561 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 38.4 m -119.21 115.11 23.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.609 0.242 . . . . 0.34 111.414 -177.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.7 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.4 mt -94.92 129.21 42.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.328 -0.396 . . . . 0.33 110.697 175.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -117.15 126.7 53.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.165 -0.47 . . . . 1.52 109.842 175.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.571 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 98.6 m-85 -113.64 8.36 17.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.031 -0.531 . . . . 0.44 110.998 -175.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 58.5 -102.2 0.25 Allowed Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.902 -0.59 . . . . 0.58 114.215 173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -96.1 4.48 52.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.822 0.344 . . . . 2.38 110.915 -173.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.571 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 89.5 t80 -86.48 -26.93 24.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.932 -0.307 . . . . 0.79 111.004 -177.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.554 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -155.54 160.77 40.78 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.925 0.393 . . . . 1.09 111.276 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -89.42 122.42 32.6 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.522 -0.763 . . . . 2.3 110.09 174.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 97.06 -176.52 31.88 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.884 -0.674 . . . . 0.7 111.669 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -120.82 -178.79 3.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.366 -0.605 . . . . 1.06 109.366 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.7 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 26.1 t80 -121.76 88.56 2.96 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.59 -0.522 . . . . 0.47 109.59 175.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 13.1 m -100.14 120.91 40.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.491 -0.777 . . . . 1.06 110.156 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.568 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 14.9 m -128.5 137.62 56.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.174 -0.466 . . . . 0.33 111.112 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.414 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 36.1 tt0 -78.49 125.02 28.77 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.32 -0.622 . . . . 1.47 109.32 175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.6 t -168.44 145.58 3.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.006 0.431 . . . . 0.42 110.933 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -88.27 -2.99 58.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.839 -0.619 . . . . 0.55 110.514 176.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.573 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 39.1 mt-10 -102.88 15.25 29.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.006 -0.543 . . . . 1.39 110.657 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.01 -46.11 78.86 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.937 -0.574 . . . . 0.27 113.63 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -70.22 -28.64 65.43 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.907 0.384 . . . . 2.28 110.735 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.573 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.1 mp0 -70.71 -38.74 73.66 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.406 -0.361 . . . . 2.27 110.258 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 384' ' ' GLU . 54.3 mt -61.18 -49.21 85.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.073 -0.512 . . . . 0.29 109.891 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.481 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -57.69 -46.54 84.17 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.383 -0.826 . . . . 0.28 111.362 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -60.32 -44.37 95.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.864 -0.607 . . . . 1.99 111.142 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.622 HD23 ' HB ' ' A' ' 332' ' ' ILE . 29.4 tp -64.47 -45.57 86.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.63 110.942 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.57 HG23 HD22 ' A' ' 353' ' ' LEU . 74.1 mt -59.86 -49.56 83.44 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.408 -0.36 . . . . 0.21 110.533 179.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.65 -32.26 70.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.29 111.09 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -67.34 -46.04 74.27 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.911 -0.661 . . . . 0.35 112.358 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.494 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 31.5 m-85 -70.06 -35.45 74.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.763 0.316 . . . . 0.7 110.75 178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.496 HG12 HD11 ' B' ' 379' ' ' ILE . 33.6 mt -57.88 -40.18 75.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.45 110.804 175.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.63 -32.73 74.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.63 0.252 . . . . 0.99 111.28 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 68.7 mt -70.1 -40.06 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.015 0.436 . . . . 0.81 110.938 179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 60.7 mt -79.3 -29.56 13.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.218 0.532 . . . . 0.72 110.819 -178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 28.7 tp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.515 -0.755 . . . . 1.56 110.78 -175.574 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' B' ' 370' ' ' LYS . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 112.128 -0.389 . . . . 12.98 112.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 3.0 tpp180 -145.16 -54.33 0.3 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.157 -0.312 . . . . 14.53 110.157 177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 4.9 m -97.96 19.54 13.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 122.041 0.924 . . . . 10.62 109.551 177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.427 ' O ' ' HA3' ' B' ' 367' ' ' GLY . 30.4 ttpt 170.25 118.11 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.338 -1.755 . . . . 9.78 107.705 -178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -54.7 -61.83 2.05 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 123.289 0.368 . . . . 8.94 111.397 -177.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 2.0 m 62.39 102.25 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.813 0.696 . . . . 5.29 110.639 -178.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 121.32 -146.13 17.22 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.232 -0.985 . . . . 2.37 111.812 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 97.1 m95 63.58 86.21 0.12 Allowed 'General case' 0 CA--C 1.51 -0.594 0 CA-C-O 121.792 0.806 . . . . 1.42 110.602 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' A' ' 359' ' ' TRP . 46.9 t -101.02 117.01 45.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 CA-C-N 114.425 -1.261 . . . . 1.07 108.983 -178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.4 ' H ' ' CD ' ' B' ' 376' ' ' GLU . 0.7 OUTLIER -97.61 145.5 26.22 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.829 -0.623 . . . . 2.28 111.074 -176.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.535 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -112.26 167.49 10.38 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.715 -0.675 . . . . 1.83 109.998 174.641 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -115.68 24.31 11.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.04 0.447 . . . . 1.88 111.939 -178.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.496 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -108.92 20.69 5.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 121.176 0.512 . . . . 1.17 110.239 171.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -84.81 105.78 15.85 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.544 -0.753 . . . . 0.58 109.097 175.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 . . . . . 0 C--O 1.246 0.887 0 CA-C-N 115.783 -0.644 . . . . 3.2 111.105 -176.043 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.843 0 N-CA-C 111.91 -0.476 . . . . 4.12 111.91 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.425 ' HB ' ' CE2' ' A' ' 312' ' ' PHE . 61.3 t -105.23 138.14 31.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 110.338 -0.245 . . . . 2.92 110.338 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 18.5 m -81.47 107.55 14.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.777 0.322 . . . . 1.06 110.169 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.425 ' CE2' ' HB ' ' A' ' 310' ' ' VAL . 89.3 m-85 -99.61 146.37 26.53 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.52 110.986 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -128.49 143.64 51.01 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.796 -0.638 . . . . 0.41 109.655 174.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 57.6 tp -87.27 99.37 11.92 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.09 0.471 . . . . 0.72 110.868 -177.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.2 m -112.72 163.11 10.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.917 -0.583 . . . . 0.3 110.541 -179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.632 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.9 mtpt -127.1 116.9 21.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.757 0.313 . . . . 1.44 110.452 177.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.502 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.7 mt-10 -85.81 116.45 24.07 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.032 -0.531 . . . . 0.7 111.068 -178.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.524 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 22.9 tptm -85.75 93.8 8.96 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.509 -0.552 . . . . 1.74 109.509 174.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 29.9 mtt -107.99 177.05 4.93 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.876 -0.602 . . . . 1.68 110.708 -178.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.899 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -74.07 162.46 28.99 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.903 -0.589 . . . . 2.3 110.575 178.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 113.3 -45.79 1.27 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.987 -0.625 . . . . 1.93 112.819 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.1 pttt -148.86 174.11 12.57 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.772 0.32 . . . . 1.68 110.729 -177.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -81.31 -19.58 42.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.048 -0.524 . . . . 2.79 110.622 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.1 tttp -79.05 136.32 37.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.053 -0.521 . . . . 2.01 111.537 -174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.632 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 4.9 mp -82.67 129.43 34.95 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.945 -0.761 . . . . 0.69 108.945 172.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 27.8 t -80.46 120.71 80.14 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.249 -0.432 . . . . 0.51 110.802 -175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 24.4 Cg_exo -63.13 126.92 18.91 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.639 2.226 . . . . 0.46 111.621 177.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.502 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 15.9 tpp180 -132.06 148.12 52.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.91 0.386 . . . . 0.78 110.495 -178.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . . . . . . . . . 89.1 mt -98.28 99.39 10.6 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.422 -0.584 . . . . 0.37 109.422 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.568 HD23 HD13 ' A' ' 388' ' ' ILE . 28.6 tp -82.03 110.41 17.25 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.147 -0.479 . . . . 0.57 110.019 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -94.94 124.43 7.96 Favored Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.868 -0.682 . . . . 0.29 111.901 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.433 HG22 ' HE2' ' A' ' 395' ' ' TYR . 31.5 mm -111.91 112.28 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 120.711 0.291 . . . . 0.36 110.366 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 74.0 p -110.17 177.85 4.58 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.109 -0.33 . . . . 0.38 110.109 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.544 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 18.4 pttp -75.3 5.19 5.89 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.923 0.342 . . . . 1.61 111.923 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.405 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 7.8 pt-20 -146.37 -28.63 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.38 0.511 . . . . 1.79 112.38 -175.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 5.9 p -145.17 157.39 44.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.632 0.729 . . . . 1.1 112.734 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 74.1 t -116.25 114.53 46.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 114.979 -1.009 . . . . 0.32 109.433 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -111.7 135.48 52.24 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.125 0.488 . . . . 1.08 111.613 -176.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.469 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 44.2 mtm180 -90.97 100.97 13.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.888 -0.596 . . . . 1.55 110.085 174.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 347' ' ' VAL . 67.0 t -92.79 129.57 43.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.763 -0.458 . . . . 0.31 109.763 177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -64.74 127.95 33.7 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.675 -0.491 . . . . 0.77 109.675 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.09 -44.98 95.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.398 -0.364 . . . . 1.51 110.802 -175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -83.39 -48.93 9.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.271 -0.422 . . . . 3.06 111.208 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.0 m -83.09 -18.96 37.75 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.008 -0.542 . . . . 0.92 111.688 -172.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm 67.66 14.58 9.56 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 122.988 0.515 . . . . 1.5 111.718 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -90.03 137.15 32.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.547 -0.297 . . . . 2.46 111.247 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.447 HG22 HG22 ' A' ' 340' ' ' VAL . 41.5 t -75.66 105.47 4.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 109.589 -0.523 . . . . 0.58 109.589 175.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.1 mt -78.92 -56.39 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.125 -0.489 . . . . 0.35 111.807 -173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -147.22 134.91 21.09 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.12 -0.326 . . . . 1.65 110.12 -174.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -125.23 135.16 52.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.34 . . . . 0.65 110.711 -176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -121.87 131.83 54.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.448 -0.342 . . . . 0.52 110.93 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 40.3 t -68.78 149.15 49.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.875 -0.417 . . . . 1.27 109.875 172.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.459 HD22 HG23 ' A' ' 392' ' ' ILE . 79.5 mt -61.11 -27.05 68.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.06 0.457 . . . . 0.31 110.438 178.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 73.3 p -70.22 -11.39 60.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.35 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.21 -2.37 31.44 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.196 -0.456 . . . . 0.83 110.446 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -84.93 133.98 28.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.945 -0.57 . . . . 0.38 109.906 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.442 ' O ' ' HG3' ' B' ' 376' ' ' GLU . 84.9 tttt -102.58 -73.29 0.66 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.974 0.416 . . . . 1.75 110.052 178.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.45 ' HG3' ' HB3' ' A' ' 369' ' ' ASP . 12.7 ptp180 -137.21 148.32 46.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.812 -0.631 . . . . 1.75 109.857 -178.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.52 ' HZ2' ' HB2' ' A' ' 393' ' ' ALA . 35.4 p90 -128.88 147.12 50.8 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.134 0.492 . . . . 0.4 110.976 178.108 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.622 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -108.67 110.77 22.28 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.55 -0.75 . . . . 0.31 110.452 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -103.69 121.74 43.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.38 110.932 -178.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 364' ' ' LYS . 69.8 p -142.65 156.99 62.85 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.704 -0.48 . . . . 1.0 109.704 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.68 30.16 0.35 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.907 2.405 . . . . 0.66 112.334 178.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . 0.4 ' H ' ' C ' ' A' ' 362' ' ' SER . 63.9 tttm -147.32 -35.76 0.23 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.92 -0.582 . . . . 2.08 110.403 -174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 19.2 t -155.02 158.66 39.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.102 -0.499 . . . . 1.32 110.548 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.523 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 72.9 t80 -131.42 125.21 31.96 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.306 -0.627 . . . . 0.3 109.306 176.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 85.9 m -120.36 118.15 29.62 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.413 -0.358 . . . . 0.34 111.34 -176.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.477 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 41.1 mt -95.23 132.76 39.84 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.318 -0.401 . . . . 0.33 110.642 175.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.45 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 21.1 t0 -117.48 129.94 56.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.194 -0.457 . . . . 1.52 109.961 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.556 ' HB2' ' HG2' ' A' ' 374' ' ' GLN . 88.8 m-85 -114.99 10.94 16.37 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.013 -179.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 61.99 -110.33 3.13 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.423 -0.808 . . . . 0.58 113.316 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -98.27 10.76 39.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.816 0.341 . . . . 2.38 110.855 -174.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.404 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 67.8 t80 -85.74 -31.28 22.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.486 -0.325 . . . . 0.79 110.308 -178.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . 0.556 ' HG2' ' HB2' ' A' ' 370' ' ' PHE . 3.7 pt20 -146.02 167.93 22.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.552 -0.294 . . . . 1.09 110.616 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.26 122.35 31.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.8 -0.637 . . . . 2.3 111.195 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 85.97 -165.63 38.22 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.997 -0.62 . . . . 0.7 112.642 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -110.21 176.97 4.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.072 0.463 . . . . 1.06 110.349 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.477 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 32.7 t80 -122.37 91.3 3.47 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.683 -0.689 . . . . 0.47 109.175 172.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.3 m -105.42 118.96 37.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.976 -0.557 . . . . 1.06 111.048 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.484 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 17.2 m -119.33 148.96 21.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.906 -0.588 . . . . 0.33 110.705 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -87.6 127.08 35.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.697 -0.483 . . . . 1.47 109.697 176.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 9.8 t -176.39 148.53 0.76 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.243 -0.435 . . . . 0.42 110.271 -179.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 29.5 p -88.55 -3.27 58.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.109 0.481 . . . . 0.55 110.312 176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.489 ' O ' HG13 ' A' ' 388' ' ' ILE . 32.1 mt-10 -99.98 17.15 21.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.776 -0.647 . . . . 1.39 111.084 -175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.78 -44.5 94.17 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 121.276 -0.488 . . . . 0.27 112.805 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -61.84 -41.3 97.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.937 0.399 . . . . 2.28 110.379 178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -62.84 -45.41 92.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.648 . . . . 2.27 110.962 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 330' ' ' LEU . 66.7 mt -63.24 -48.71 86.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.051 -0.522 . . . . 0.29 110.478 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.523 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.26 -48.86 80.06 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.703 -0.681 . . . . 0.28 111.57 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -65.94 -28.62 69.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.023 -0.535 . . . . 1.99 110.598 -177.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.8 tp -73.46 -45.6 53.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.395 -0.366 . . . . 0.63 110.444 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.508 HG22 HD12 ' A' ' 396' ' ' ILE . 74.4 mt -59.74 -50.21 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 N-CA-C 109.834 -0.432 . . . . 0.21 109.834 176.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.52 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -62.57 -25.29 67.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.94 -0.573 . . . . 0.29 110.71 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.38 -46.32 56.9 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 116.155 -0.475 . . . . 0.35 112.053 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.544 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 35.1 m-85 -67.61 -38.41 83.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.308 0.575 . . . . 0.7 110.067 176.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.508 HD12 HG22 ' A' ' 392' ' ' ILE . 64.9 mt -64.09 -34.58 69.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.312 -0.858 . . . . 0.45 110.584 176.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -62.65 -24.09 67.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.084 -0.507 . . . . 0.99 110.825 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 59.9 mt -84.18 -49.74 15.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.279 -0.419 . . . . 0.81 110.776 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.1 mt -66.18 -42.8 91.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.72 110.936 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 C--O 1.247 0.941 0 CA-C-N 115.262 -0.881 . . . . 1.56 110.776 -175.482 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.837 0 N-CA-C 111.848 -0.501 . . . . 12.98 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . 0.411 ' HD2' ' H ' ' B' ' 368' ' ' ARG . 0.3 OUTLIER -136.41 -0.93 2.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.131 0.491 . . . . 14.53 110.083 177.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.09 -177.72 3.33 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.4 -0.963 . . . . 10.62 108.4 -179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -79.22 94.18 5.37 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.638 -0.505 . . . . 9.78 109.638 173.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.9 166.3 19.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.853 -0.612 . . . . 8.94 111.209 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 25.9 t -101.86 147.82 26.06 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.101 -0.703 . . . . 5.29 109.101 174.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 113.16 -72.6 0.22 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 111.154 -0.779 . . . . 2.37 111.154 -175.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 88.4 m95 -114.78 107.87 16.01 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.175 0.512 . . . . 1.42 110.293 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.427 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 42.9 t -111.12 116.54 52.79 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 CA-C-N 115.45 -0.795 . . . . 1.07 109.537 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.442 ' HG3' ' O ' ' A' ' 357' ' ' LYS . 37.9 tt0 -111.41 133.98 53.32 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.267 -0.424 . . . . 2.28 110.75 -176.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.439 ' OD1' HG12 ' B' ' 379' ' ' ILE . 0.1 OUTLIER -94.57 171.47 8.78 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.077 -0.51 . . . . 1.83 110.807 -179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -115.74 25.41 10.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.304 0.483 . . . . 1.88 112.304 -172.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.473 HD11 HG12 ' A' ' 396' ' ' ILE . 9.9 pt -116.22 21.03 6.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.023 0.44 . . . . 1.17 111.019 172.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -79.48 112.95 17.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.105 -0.702 . . . . 0.58 109.105 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.681 -0.676 . . . . 3.2 111.021 -177.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.756 0 N-CA-C 111.921 -0.472 . . . . 4.12 111.921 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 66.4 t 70.55 116.26 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 C-N-CA 123.09 0.556 . . . . 2.92 111.043 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.0 t -74.19 119.38 18.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.09 -0.505 . . . . 1.06 110.277 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -104.72 127.36 52.47 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.905 -0.589 . . . . 0.52 110.753 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -107.03 137.47 45.03 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.055 -0.52 . . . . 0.41 109.617 175.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 37.5 tp -90.14 99.21 12.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.279 0.561 . . . . 0.72 110.068 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 33.7 m -105.9 153.13 7.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.509 -0.769 . . . . 0.3 110.585 -177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 52.4 mtpt -106.24 105.04 14.88 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.829 -0.434 . . . . 1.44 109.829 176.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.499 ' CD ' ' HE ' ' A' ' 328' ' ' ARG . 94.0 mt-10 -74.18 124.68 26.8 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.147 -0.478 . . . . 0.7 111.236 -178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.691 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 24.6 tptp -108.79 103.49 12.58 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.534 -0.543 . . . . 1.74 109.534 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 73.2 mtm -121.02 173.73 7.08 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.684 -0.689 . . . . 1.68 109.748 178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.754 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -63.61 158.84 20.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.173 -0.467 . . . . 2.3 110.33 176.681 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 114.5 -49.39 0.85 Allowed Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.584 -0.817 . . . . 1.93 112.557 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -153.76 157.61 39.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.827 0.346 . . . . 1.68 110.774 -177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.691 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 33.8 m-80 -84.32 -1.96 56.25 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.991 -0.549 . . . . 2.79 111.186 178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.46 128.38 34.46 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.936 -0.394 . . . . 2.01 109.936 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 7.0 mp -87.49 142.13 28.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.732 -0.47 . . . . 0.69 109.732 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 43.2 t -102.15 120.47 53.53 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 116.604 -0.271 . . . . 0.51 111.028 -175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.51 116.45 3.64 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.687 2.258 . . . . 0.46 111.309 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.499 ' HE ' ' CD ' ' A' ' 317' ' ' GLU . 20.3 tpp180 -120.28 142.75 48.79 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.033 -0.531 . . . . 0.78 109.942 -178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.452 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 77.8 mt -88.22 98.48 11.59 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.483 -0.562 . . . . 0.37 109.483 174.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.0 tp -82.58 105.37 13.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.898 -0.592 . . . . 0.57 109.801 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -91.27 110.42 3.83 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 121.073 -0.584 . . . . 0.29 111.963 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.482 ' HB ' HD23 ' A' ' 391' ' ' LEU . 36.6 mm -98.9 113.98 35.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.438 -0.208 . . . . 0.36 110.438 -179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.6 p -111.56 177.94 4.49 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.598 -0.519 . . . . 0.38 109.598 176.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 65.6 pttt -84.32 14.45 4.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.874 0.368 . . . . 1.61 111.175 -179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -140.65 -31.65 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.375 -0.375 . . . . 1.79 112.007 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 25.1 p -150.89 158.08 43.7 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.594 0.711 . . . . 1.1 112.66 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.471 HG13 HD13 ' A' ' 332' ' ' ILE . 86.7 t -111.9 114.38 46.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 114.962 -1.017 . . . . 0.32 109.062 173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 24.2 ptp -112.39 142.25 45.14 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.96 0.41 . . . . 1.08 111.474 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.478 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 43.6 mtm180 -99.01 104.4 16.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.995 -0.548 . . . . 1.55 110.308 177.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 347' ' ' VAL . 48.5 t -97.62 127.11 50.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.235 -0.439 . . . . 0.31 110.169 178.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.16 132.09 50.64 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.409 -0.589 . . . . 0.77 109.409 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.83 -51.3 62.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.767 0.318 . . . . 1.51 110.491 -174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -73.24 -48.51 34.25 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.406 -0.361 . . . . 3.06 111.707 -174.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 2.2 m -83.63 -20.89 32.83 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.301 -0.408 . . . . 0.92 111.577 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 64.85 29.12 12.67 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.135 -0.484 . . . . 1.5 111.362 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -105.21 136.77 44.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.303 -0.408 . . . . 2.46 111.203 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.729 HG22 HG22 ' A' ' 340' ' ' VAL . 47.7 t -78.03 104.46 6.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.79 -0.448 . . . . 0.58 109.79 176.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.61 -42.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 116.255 -0.43 . . . . 0.35 111.382 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -151.55 148.61 28.22 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.094 -0.503 . . . . 1.65 110.041 -175.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -134.65 136.44 42.84 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.318 -0.401 . . . . 0.65 110.357 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . 0.413 ' CH2' ' HD3' ' A' ' 339' ' ' ARG . 5.0 m-90 -119.03 126.28 51.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.276 -0.42 . . . . 0.52 110.345 176.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.451 ' HB3' ' OD1' ' A' ' 355' ' ' ASN . 36.0 t -68.86 148.18 50.63 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.435 -0.58 . . . . 1.27 109.435 173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.55 -25.36 68.21 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.035 0.445 . . . . 0.31 110.92 -179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 35.9 p -73.41 -6.52 46.76 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.412 0.625 . . . . 0.44 110.921 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 352' ' ' SER . 2.0 m-20 -102.36 0.32 33.86 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.535 -0.757 . . . . 0.83 109.748 -174.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 74.8 mt -91.12 130.94 39.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.471 -0.786 . . . . 0.38 110.414 -178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -94.26 -51.38 4.83 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.707 -0.479 . . . . 1.75 109.707 176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.566 ' HB3' ' HB3' ' B' ' 376' ' ' GLU . 2.0 ptp180 -164.49 157.49 17.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.901 -0.59 . . . . 1.75 110.375 -178.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.572 ' HB3' HD23 ' A' ' 368' ' ' LEU . 36.6 p90 -134.46 152.43 51.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.917 0.389 . . . . 0.4 111.203 177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -111.51 120.7 42.99 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.707 -0.679 . . . . 0.31 109.833 177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -115.53 129.64 56.6 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.123 0.487 . . . . 0.38 111.364 -176.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.476 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 74.4 p -141.58 163.8 38.83 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.12 -0.696 . . . . 1.0 109.12 175.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 61.8 Cg_endo -74.8 0.31 8.96 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.141 1.894 . . . . 0.66 111.972 177.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -116.06 -32.59 5.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.823 -0.626 . . . . 2.08 110.998 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 33.7 p -154.25 171.57 19.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.187 0.518 . . . . 1.32 111.852 -175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.434 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 73.9 t80 -140.06 142.0 36.19 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.97 -0.752 . . . . 0.3 108.97 177.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 28.4 m -137.91 132.09 31.91 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.686 0.279 . . . . 0.34 111.134 -179.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 53.9 mt -108.88 138.5 45.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.485 -0.325 . . . . 0.33 111.214 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -123.13 131.5 53.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.833 -0.621 . . . . 1.52 109.658 172.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.502 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 80.7 m-85 -114.34 11.62 17.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.046 -0.525 . . . . 0.44 110.691 -175.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 62.48 -112.1 4.61 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.012 -0.613 . . . . 0.58 112.966 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -94.09 13.78 22.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.847 0.355 . . . . 2.38 111.027 -175.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.502 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 91.0 t80 -85.93 -31.94 21.87 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.491 -0.322 . . . . 0.79 110.747 -178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -158.42 161.93 37.54 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.535 -0.302 . . . . 1.09 110.423 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -92.03 131.73 37.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 2.3 110.185 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 99.54 -175.78 28.24 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.796 -0.716 . . . . 0.7 111.694 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -122.71 178.4 5.03 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.874 0.369 . . . . 1.06 110.181 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.587 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 33.1 t80 -121.22 88.48 2.95 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.328 -0.619 . . . . 0.47 109.328 175.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 16.2 m -97.67 118.8 35.0 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.657 -0.702 . . . . 1.06 110.865 -178.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.531 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 28.9 m -123.98 141.43 44.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.979 -0.555 . . . . 0.33 110.529 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -92.65 123.3 35.84 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.427 -0.583 . . . . 1.47 109.427 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.498 HG21 HG12 ' A' ' 315' ' ' VAL . 7.8 t -171.54 143.98 1.84 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.141 -0.482 . . . . 0.42 110.357 -176.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 2.3 p -80.87 -6.78 59.06 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.188 -0.46 . . . . 0.55 111.018 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.601 ' HA ' ' NE2' ' A' ' 387' ' ' GLN . 5.5 mp0 -99.03 11.45 38.96 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.96 -0.564 . . . . 1.39 110.888 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -55.25 -44.41 84.31 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 121.368 -0.444 . . . . 0.27 113.036 -177.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -65.37 -35.05 79.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.183 0.516 . . . . 2.28 110.66 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . 0.601 ' NE2' ' HA ' ' A' ' 384' ' ' GLU . 1.0 OUTLIER -72.82 -37.21 67.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.027 -0.533 . . . . 2.27 110.62 -178.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 384' ' ' GLU . 73.0 mt -59.11 -48.28 87.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.456 . . . . 0.29 109.871 176.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.434 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.53 -43.21 93.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.479 -0.782 . . . . 0.28 110.882 178.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -60.89 -38.39 85.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.772 -0.649 . . . . 1.99 110.836 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . 0.52 ' HG ' ' CE2' ' A' ' 395' ' ' TYR . 18.3 tp -73.36 -44.52 58.51 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.527 . . . . 0.63 110.651 -177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.491 HG22 HD12 ' A' ' 396' ' ' ILE . 70.6 mt -60.87 -50.26 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.834 0.35 . . . . 0.21 110.064 177.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.62 74.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.028 -0.533 . . . . 0.29 110.647 178.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.09 -45.97 83.66 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.106 -0.569 . . . . 0.35 112.351 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.52 ' CE2' ' HG ' ' A' ' 391' ' ' LEU . 18.7 m-85 -66.95 -43.26 83.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.0 0.429 . . . . 0.7 110.717 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.491 HD12 HG22 ' A' ' 392' ' ' ILE . 50.2 mt -63.69 -34.75 69.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.734 -0.666 . . . . 0.45 110.94 178.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -58.94 -25.91 63.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.852 -0.613 . . . . 0.99 111.053 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.0 mt -83.0 -23.63 8.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.093 -0.503 . . . . 0.81 110.775 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 54.4 mt -81.51 -37.01 15.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.463 -0.335 . . . . 0.72 111.358 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.86 0 CA-C-O 118.435 -0.793 . . . . 1.56 110.708 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.714 0 N-CA-C 111.791 -0.524 . . . . 12.98 111.791 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 20.9 mmt180 -116.27 -55.16 2.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 14.53 110.146 176.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 58.7 p -118.6 13.8 13.45 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.628 0.727 . . . . 10.62 110.663 178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 32.8 mtmm -153.56 111.74 3.61 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.458 -1.246 . . . . 9.78 109.148 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -102.4 160.78 14.25 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.843 0.354 . . . . 8.94 110.96 -177.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 16.0 m -95.9 157.66 15.8 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.914 -0.585 . . . . 5.29 109.923 177.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -83.03 -169.44 44.64 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.623 -0.799 . . . . 2.37 111.729 178.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.407 ' HB3' ' HB2' ' A' ' 358' ' ' ARG . 66.8 m95 -122.15 140.34 52.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.425 0.631 . . . . 1.42 112.157 -172.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.65 118.41 56.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 107.587 -1.264 . . . . 1.07 107.587 170.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 358' ' ' ARG . 9.6 pt-20 -117.02 137.75 52.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.995 0.426 . . . . 2.28 111.087 -173.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.487 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -88.7 164.61 15.22 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.701 -0.682 . . . . 1.83 111.391 -178.195 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -99.77 26.73 5.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.965 -0.561 . . . . 1.88 111.76 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . . . . . . . . . 25.6 pt -124.1 30.22 2.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 C-N-CA 120.762 -0.375 . . . . 1.17 111.551 175.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.57 108.41 14.18 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 120.507 -0.477 . . . . 0.58 110.069 177.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.413 -0.803 . . . . 3.2 110.284 178.471 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.974 -0.45 . . . . 4.12 111.974 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 8.7 t 57.42 41.63 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-O 121.614 0.721 . . . . 2.92 110.633 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 57.3 m -101.83 87.05 3.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.94 -0.573 . . . . 1.06 109.706 175.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -115.43 141.22 48.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.505 -0.771 . . . . 0.52 110.668 -177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -124.47 122.89 38.88 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.69 -0.686 . . . . 0.41 109.949 178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 59.3 tp -73.39 99.96 3.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.126 0.488 . . . . 0.72 110.08 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 34.1 m -109.22 165.89 5.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.671 -0.695 . . . . 0.3 110.386 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.787 ' HB3' ' HB3' ' A' ' 325' ' ' LEU . 53.6 mtpt -117.97 110.87 18.23 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.202 -0.454 . . . . 1.44 110.047 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.549 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 66.7 mt-10 -77.82 122.09 24.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.053 0.454 . . . . 0.7 111.839 -175.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 23.8 tptm -105.25 101.61 11.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.677 -0.692 . . . . 1.74 109.322 173.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 62.1 mtp -128.29 172.67 10.84 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.251 -0.431 . . . . 1.68 110.097 -175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.84 158.93 31.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 2.3 111.271 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 106.25 -29.7 10.7 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.818 -0.706 . . . . 1.93 112.264 177.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 24.7 pttm -163.29 174.36 12.15 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.047 -0.353 . . . . 1.68 110.047 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.425 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 33.1 m-80 -103.11 -15.46 16.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.715 0.293 . . . . 2.79 110.635 178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -64.44 121.0 13.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.886 -0.597 . . . . 2.01 110.893 -179.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.787 ' HB3' ' HB3' ' A' ' 316' ' ' LYS . 6.5 mp -83.13 119.63 24.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.115 -0.493 . . . . 0.69 109.948 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 48.7 t -84.71 129.06 58.42 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.032 -0.531 . . . . 0.51 111.152 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 23.7 Cg_exo -64.25 120.29 7.57 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.883 2.389 . . . . 0.46 111.744 176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.916 HH11 ' HA ' ' A' ' 341' ' ' ASP . 16.4 tpp180 -127.75 144.54 51.08 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.118 -0.492 . . . . 0.78 110.593 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.49 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 94.8 mt -95.93 100.71 12.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.292 -0.632 . . . . 0.37 109.292 173.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.24 107.95 13.45 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.182 -0.463 . . . . 0.57 109.825 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -95.84 111.0 4.13 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.009 -0.615 . . . . 0.29 112.197 -178.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.41 HD13 HG13 ' A' ' 337' ' ' VAL . 42.7 mm -95.83 127.39 47.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 110.053 -0.351 . . . . 0.36 110.053 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 71.2 p -122.28 -178.47 3.89 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.366 -0.379 . . . . 0.38 110.11 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -79.22 10.86 3.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.577 -0.283 . . . . 1.61 111.6 -176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.434 ' HG3' ' SG ' ' A' ' 336' ' ' CYS . 9.3 pt-20 -157.7 -31.13 0.08 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.051 0.389 . . . . 1.79 112.051 -174.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 352' ' ' SER . 60.6 m -133.23 168.45 18.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.296 0.569 . . . . 1.1 112.285 -173.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.41 HG13 HD13 ' A' ' 332' ' ' ILE . 80.4 t -132.6 105.76 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.339 -0.846 . . . . 0.32 109.338 177.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.449 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.3 ptp -104.93 138.32 41.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.048 0.452 . . . . 1.08 111.738 -173.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.549 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 46.3 mtm180 -93.46 104.09 16.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.861 -0.609 . . . . 1.55 110.205 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 347' ' ' VAL . 56.2 t -98.09 130.47 46.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.177 -0.305 . . . . 0.31 110.177 179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.916 ' HA ' HH11 ' A' ' 328' ' ' ARG . 17.9 t70 -63.23 129.63 41.12 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.111 -0.329 . . . . 0.77 110.111 177.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . 0.445 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 3.3 tm-20 -55.95 -52.55 63.77 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.251 -0.432 . . . . 1.51 111.202 -175.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 32.0 tttp -88.84 -40.82 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.318 -0.401 . . . . 3.06 111.751 -171.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.83 -14.7 36.34 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.852 0.315 . . . . 0.92 111.852 -173.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm 65.35 23.64 12.06 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 122.713 0.405 . . . . 1.5 111.892 177.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -92.97 132.64 36.89 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.629 0.252 . . . . 2.46 111.083 -179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.62 HG22 HG22 ' A' ' 340' ' ' VAL . 48.1 t -79.2 110.1 14.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.211 -0.663 . . . . 0.58 109.211 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 64.0 mt -84.91 -47.67 16.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.03 -0.532 . . . . 0.35 111.596 -174.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . 0.436 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 44.6 tt0 -151.33 133.44 15.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.412 -0.358 . . . . 1.65 110.067 -176.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 32.0 tt0 -118.8 125.23 49.11 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.12 -0.491 . . . . 0.65 110.6 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -100.15 179.09 4.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.047 -0.524 . . . . 0.52 110.026 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 336' ' ' CYS . 13.3 m -124.51 149.08 47.29 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.203 -0.666 . . . . 1.27 109.203 177.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.502 HD22 HG23 ' A' ' 392' ' ' ILE . 76.3 mt -61.1 -32.68 72.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.031 0.443 . . . . 0.31 110.618 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 43.0 p -71.8 -3.85 24.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.957 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -106.7 3.87 27.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 122.051 -0.406 . . . . 0.83 110.437 -178.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 61.9 mt -91.16 125.83 43.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.995 -0.548 . . . . 0.38 110.016 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.466 ' HD2' ' HA3' ' A' ' 371' ' ' GLY . 46.7 tttp -93.61 -45.34 7.77 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.311 0.577 . . . . 1.75 109.94 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.556 ' HG3' ' HB2' ' A' ' 369' ' ' ASP . 2.2 ptp180 -161.96 155.8 21.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.315 -0.857 . . . . 1.75 109.398 -177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.472 ' NE1' ' HB ' ' B' ' 375' ' ' VAL . 32.7 p90 -140.67 153.96 46.2 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.012 0.434 . . . . 0.4 111.331 177.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -116.65 117.99 31.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.632 -0.713 . . . . 0.31 110.619 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.479 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -102.82 114.43 28.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.587 -0.733 . . . . 0.38 111.252 -177.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.444 ' HB2' ' H ' ' A' ' 365' ' ' SER . 10.1 m -121.16 159.82 47.98 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 116.037 -0.529 . . . . 1.0 109.627 177.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.466 ' O ' ' HA ' ' A' ' 383' ' ' THR . 72.1 Cg_endo -78.54 -5.24 14.74 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.235 1.957 . . . . 0.66 112.22 176.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -125.27 -17.61 5.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.058 -0.519 . . . . 2.08 111.066 -179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.444 ' H ' ' HB2' ' A' ' 362' ' ' SER . 20.0 p -150.58 171.17 17.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.32 111.345 -177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.627 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 76.1 t80 -149.23 143.96 26.24 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.016 -0.735 . . . . 0.3 109.016 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 32.4 m -136.74 126.82 26.1 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.69 0.281 . . . . 0.34 111.552 -177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 52.7 mt -106.62 118.84 37.72 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.076 -0.511 . . . . 0.33 110.336 175.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.556 ' HB2' ' HG3' ' A' ' 358' ' ' ARG . 0.8 OUTLIER -103.95 120.56 41.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.271 -0.422 . . . . 1.52 110.245 177.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.497 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 73.4 m-85 -100.9 9.96 41.68 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.063 -0.517 . . . . 0.44 111.23 -175.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 357' ' ' LYS . . . 61.85 -109.62 2.66 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.988 -0.551 . . . . 0.58 112.956 176.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -109.64 24.89 12.45 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.099 0.476 . . . . 2.38 110.63 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.497 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 72.5 t80 -85.36 -30.01 24.01 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.906 -0.588 . . . . 0.79 109.534 177.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -163.65 153.53 15.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.786 -0.643 . . . . 1.09 109.828 175.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.89 119.94 25.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.782 -0.451 . . . . 2.3 109.782 177.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.65 139.63 10.74 Favored Glycine 0 N--CA 1.444 -0.832 0 N-CA-C 110.913 -0.875 . . . . 0.7 110.913 -174.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -106.78 -169.04 1.49 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.925 0.393 . . . . 1.06 110.922 -174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.533 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 23.7 t80 -120.78 94.95 4.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.921 -0.582 . . . . 0.47 109.961 -178.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 15.8 m -107.12 119.36 39.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.845 -0.616 . . . . 1.06 110.467 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.503 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 30.8 m -125.18 154.74 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.056 -0.52 . . . . 0.33 110.986 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.61 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 64.7 tt0 -93.84 128.77 40.28 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.796 -0.816 . . . . 1.47 108.796 172.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.424 ' HB ' HG12 ' A' ' 315' ' ' VAL . 5.1 t -169.03 138.37 2.14 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.255 0.55 . . . . 0.42 111.033 -176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 363' ' ' PRO . 1.2 p -82.49 -6.3 59.23 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.875 -0.602 . . . . 0.55 110.897 177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.573 ' O ' HG13 ' A' ' 388' ' ' ILE . 11.9 mp0 -105.77 16.34 25.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 1.39 110.556 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -54.91 -40.57 73.19 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.305 -0.474 . . . . 0.27 113.029 -178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.479 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 35.1 tt0 -64.09 -39.84 94.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.147 0.498 . . . . 2.28 110.316 178.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -69.63 -36.9 76.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.614 -0.721 . . . . 2.27 111.274 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 384' ' ' GLU . 60.3 mt -61.2 -51.63 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.954 0.407 . . . . 0.29 110.26 178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.627 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.82 -46.2 88.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.578 -0.737 . . . . 0.28 111.557 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -67.7 -31.8 72.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.904 -0.589 . . . . 1.99 110.742 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.87 -43.39 71.93 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.49 -0.323 . . . . 0.63 110.488 178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.502 HG23 HD22 ' A' ' 353' ' ' LEU . 78.2 mt -60.1 -49.68 83.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.179 -0.464 . . . . 0.21 110.444 177.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -63.5 -24.04 67.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.078 -0.51 . . . . 0.29 110.913 178.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -69.15 -37.7 82.12 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.99 -0.55 . . . . 0.35 112.429 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -79.12 -37.55 38.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.97 0.414 . . . . 0.7 110.307 178.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . . . . . . . . . 45.0 mt -55.74 -41.96 67.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.565 -0.743 . . . . 0.45 111.227 178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -59.97 -31.98 70.4 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.078 -0.51 . . . . 0.99 111.508 179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 63.5 mt -74.8 -31.9 27.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.328 -0.396 . . . . 0.81 111.023 -178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 46.1 mt -76.27 -32.64 22.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.222 -0.444 . . . . 0.72 111.086 -177.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.454 HD21 HG23 ' B' ' 379' ' ' ILE . 92.9 mt . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.828 -0.606 . . . . 1.56 111.515 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.788 0 N-CA-C 111.429 -0.668 . . . . 12.98 111.429 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 40.6 mtp180 -77.96 88.63 4.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.242 -0.651 . . . . 14.53 109.242 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 34.7 t -155.62 109.22 2.79 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 120.816 0.341 . . . . 10.62 110.711 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.83 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -91.3 107.62 19.33 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.05 -1.092 . . . . 9.78 108.05 168.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -55.5 109.68 0.59 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.189 -0.914 . . . . 8.94 113.313 -167.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 30.7 t -129.82 138.89 51.26 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.315 -0.857 . . . . 5.29 109.134 171.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . -176.27 -162.48 27.15 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.692 -0.766 . . . . 2.37 111.841 -176.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -106.51 127.84 53.63 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.354 0.597 . . . . 1.42 112.318 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.472 ' HB ' ' NE1' ' A' ' 359' ' ' TRP . 43.1 t -113.37 122.18 67.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.012 -0.995 . . . . 1.07 108.372 173.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -93.44 156.59 16.68 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.108 0.48 . . . . 2.28 111.091 -174.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.443 HD21 HG13 ' B' ' 379' ' ' ILE . 24.5 t30 -114.29 138.92 49.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.577 -0.738 . . . . 1.83 110.505 -174.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -96.52 3.79 52.46 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 112.23 0.456 . . . . 1.88 112.23 -173.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.49 ' O ' HG13 ' B' ' 379' ' ' ILE . 22.2 pt -124.41 86.37 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 115.999 -0.546 . . . . 1.17 110.56 175.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . 0.49 ' HA ' ' O ' ' A' ' 354' ' ' THR . 64.9 t80 -128.16 124.2 36.25 Favored 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.779 -0.575 . . . . 0.58 110.377 -178.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.508 -0.758 . . . . 3.2 110.464 176.834 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.653 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 112.125 -0.39 . . . . 4.12 112.125 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 3.5 p -107.87 95.24 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.902 0.858 . . . . 2.92 110.176 177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 17.3 m -93.1 131.87 37.74 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.435 -0.802 . . . . 1.06 110.88 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.537 ' HE1' HG21 ' A' ' 340' ' ' VAL . 71.8 m-85 -107.52 122.86 47.51 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.949 0.404 . . . . 0.52 110.366 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.43 125.65 51.5 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.795 -0.639 . . . . 0.41 110.205 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 48.9 tp -82.98 90.96 7.07 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.616 -0.513 . . . . 0.72 109.616 178.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . . . . . . . . . 33.6 m -101.71 171.57 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.718 -0.674 . . . . 0.3 110.794 -176.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -121.52 110.66 16.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.18 -0.464 . . . . 1.44 110.466 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 380' ' ' VAL . 65.0 mt-10 -84.32 112.22 20.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.24 -0.436 . . . . 0.7 110.205 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.702 ' HE2' ' HA ' ' A' ' 323' ' ' ASN . 27.1 tptp -85.97 100.99 12.5 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.242 0.544 . . . . 1.74 110.34 176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 34.8 mtt -97.17 166.58 11.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.676 -0.693 . . . . 1.68 110.193 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.877 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -77.82 175.44 9.99 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.227 -0.442 . . . . 2.3 110.283 178.324 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 90.87 -41.07 2.93 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.697 -0.763 . . . . 1.93 112.186 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 24.0 pttm -143.31 167.11 22.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.931 0.396 . . . . 1.68 110.31 179.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.702 ' HA ' ' HE2' ' A' ' 318' ' ' LYS . 90.2 m-20 -95.09 -9.71 32.86 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.933 -0.576 . . . . 2.79 110.609 -178.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 41.5 ttmt -77.76 121.47 24.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.896 -0.593 . . . . 2.01 110.449 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 6.3 mp -79.8 147.87 31.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.035 -0.53 . . . . 0.69 110.336 179.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 39.9 t -99.22 125.36 41.72 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.312 -0.404 . . . . 0.51 110.618 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -66.63 123.11 10.65 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.795 2.33 . . . . 0.46 111.607 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . 0.678 HH11 ' HA ' ' A' ' 341' ' ' ASP . 20.7 tpp180 -127.93 140.61 51.9 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.418 -0.356 . . . . 0.78 110.514 -177.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.576 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 97.5 mt -94.56 99.3 11.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.624 -0.51 . . . . 0.37 109.624 174.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 388' ' ' ILE . 22.7 tp -86.14 110.1 19.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.088 -0.505 . . . . 0.57 109.83 -178.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.85 123.7 7.44 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.945 -0.645 . . . . 0.29 112.121 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . 0.492 HD13 HG13 ' A' ' 337' ' ' VAL . 33.6 mm -110.7 116.6 52.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 110.107 -0.331 . . . . 0.36 110.107 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . . . . . . . . . 63.7 p -117.22 -175.25 2.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.798 -0.445 . . . . 0.38 109.798 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.466 ' HA ' ' HB3' ' A' ' 395' ' ' TYR . 51.6 pttt -86.07 8.6 20.11 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 121.111 -0.235 . . . . 1.61 111.531 -176.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -141.46 -30.51 0.6 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.399 0.518 . . . . 1.79 112.399 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 11.0 p -148.15 159.85 43.52 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.516 0.674 . . . . 1.1 112.801 -175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . 0.492 HG13 HD13 ' A' ' 332' ' ' ILE . 90.2 t -116.11 112.44 39.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.957 -1.02 . . . . 0.32 109.642 175.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -107.17 138.53 43.18 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.08 0.467 . . . . 1.08 111.516 -176.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.435 ' HD3' ' HH2' ' A' ' 351' ' ' TRP . 46.7 mtm180 -94.26 106.65 18.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.176 -0.466 . . . . 1.55 110.281 174.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.576 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 88.3 t -94.33 131.48 41.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.177 -0.465 . . . . 0.31 110.038 178.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.678 ' HA ' HH11 ' A' ' 328' ' ' ARG . 33.9 t70 -71.15 135.73 47.77 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.212 -0.449 . . . . 0.77 110.177 178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -64.34 -47.59 78.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.91 0.386 . . . . 1.51 110.349 -176.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 33.7 tptt -73.58 -53.38 10.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.143 -0.48 . . . . 3.06 111.709 -174.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.26 -19.11 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.357 -0.383 . . . . 0.92 111.77 -171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm 65.99 19.53 11.22 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.118 -0.492 . . . . 1.5 112.318 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -100.76 163.22 12.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.715 0.293 . . . . 2.46 110.504 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 50.4 t -86.94 125.86 40.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.275 -0.42 . . . . 0.58 110.04 177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 62.5 mt -89.07 -56.12 5.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.35 110.386 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -143.46 145.02 32.26 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.041 -0.527 . . . . 1.65 109.652 -178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -129.11 134.4 48.05 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.182 0.301 . . . . 0.65 110.335 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . 0.435 ' HH2' ' HD3' ' A' ' 339' ' ' ARG . 13.5 m-90 -110.86 123.86 50.93 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.332 -0.395 . . . . 0.52 110.754 178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 15.6 m -65.51 142.24 58.2 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.123 -0.695 . . . . 1.27 109.123 169.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.422 HD22 HG23 ' A' ' 392' ' ' ILE . 80.9 mt -62.33 -23.81 66.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.03 0.443 . . . . 0.31 110.598 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 68.4 p -69.38 -18.49 63.78 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.706 -0.679 . . . . 0.44 111.32 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -92.54 -0.81 57.28 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.805 0.336 . . . . 0.83 111.406 -175.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 69.7 mt -81.07 144.4 10.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 110.056 -0.35 . . . . 0.38 110.056 179.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -109.66 -51.0 2.92 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 1.75 110.213 177.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.538 ' HD3' ' CE3' ' B' ' 374' ' ' TRP . 1.7 ptp180 -163.1 147.93 11.42 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.648 -0.706 . . . . 1.75 109.775 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 44.0 p90 -124.87 148.7 48.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.209 0.528 . . . . 0.4 111.362 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.662 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -114.25 119.79 38.22 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.148 -0.933 . . . . 0.31 109.971 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 389' ' ' ALA . . . -114.83 131.58 56.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.717 -0.674 . . . . 0.38 111.197 -175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . 0.632 ' HB2' ' HD2' ' A' ' 363' ' ' PRO . 94.4 p -141.1 169.86 10.59 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 108.844 -0.799 . . . . 1.0 108.844 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . 0.632 ' HD2' ' HB2' ' A' ' 362' ' ' SER . 73.1 Cg_endo -76.08 9.69 2.33 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.223 1.949 . . . . 0.66 112.725 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -134.81 -35.07 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.953 0.353 . . . . 2.08 111.953 -177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 13.1 p -142.32 151.33 41.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.403 0.621 . . . . 1.32 111.806 -179.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.472 ' O ' ' HA ' ' A' ' 379' ' ' SER . 71.9 t80 -123.44 126.85 47.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.657 -0.701 . . . . 0.3 109.577 176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.662 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 90.0 m -119.85 124.42 46.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.398 -0.364 . . . . 0.34 111.486 -176.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.4 mt -104.57 124.42 49.27 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.64 174.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.446 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 13.4 t0 -110.88 128.46 55.8 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.512 -0.551 . . . . 1.52 109.512 173.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -110.65 1.78 18.18 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.534 -176.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.39 -113.8 5.56 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.761 -0.654 . . . . 0.58 112.771 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.52 66.48 8.24 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.535 0.683 . . . . 2.38 110.314 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -134.83 -56.92 0.83 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.807 -0.633 . . . . 0.79 110.304 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -142.84 178.88 7.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.906 0.384 . . . . 1.09 111.189 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.8 125.65 34.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.602 -0.726 . . . . 2.3 111.113 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 80.05 161.76 24.4 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.066 -0.587 . . . . 0.7 113.125 176.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -81.7 177.8 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.904 0.383 . . . . 1.06 109.996 177.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.473 ' HD2' HD12 ' A' ' 368' ' ' LEU . 37.2 t80 -122.56 99.78 6.58 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.741 -0.466 . . . . 0.47 109.741 173.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 366' ' ' PHE . 21.8 m -116.16 122.57 45.45 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.359 -0.382 . . . . 1.06 110.843 -177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 317' ' ' GLU . 16.4 m -119.09 145.97 24.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.074 -0.512 . . . . 0.33 110.332 176.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -86.7 121.33 29.06 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.434 -0.58 . . . . 1.47 109.434 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 3.4 t -169.19 140.59 2.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.975 -0.557 . . . . 0.42 110.846 -174.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 50.0 p -81.78 -12.0 58.74 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 0.55 109.946 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 388' ' ' ILE . 37.6 mt-10 -94.68 9.22 39.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.479 -0.782 . . . . 1.39 110.43 -178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -58.68 -34.9 78.84 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 121.147 -0.549 . . . . 0.27 111.833 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -56.44 -47.3 79.39 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.209 0.528 . . . . 2.28 110.37 174.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -62.42 -48.57 79.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.329 -0.85 . . . . 2.27 110.716 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.445 HD13 HD23 ' A' ' 330' ' ' LEU . 57.9 mt -56.29 -47.15 81.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.739 -0.664 . . . . 0.29 111.16 -177.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.418 ' HB2' ' HB2' ' A' ' 361' ' ' ALA . . . -56.69 -54.92 40.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.779 -0.646 . . . . 0.28 111.761 -177.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.31 -23.73 60.3 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.222 -0.445 . . . . 1.99 110.945 -176.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 31.9 tp -68.38 -46.81 69.05 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.847 -0.427 . . . . 0.63 109.847 176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 396' ' ' ILE . 73.6 mt -60.41 -47.32 93.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.328 -0.396 . . . . 0.21 110.045 176.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -59.81 -34.81 73.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.064 -0.516 . . . . 0.29 111.067 178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -66.47 -46.74 75.05 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 116.094 -0.503 . . . . 0.35 112.378 178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.653 ' HH ' ' N ' ' A' ' 309' ' ' GLY . 25.2 m-85 -65.88 -42.08 90.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.963 0.411 . . . . 0.7 110.594 177.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.433 HD12 HG22 ' A' ' 392' ' ' ILE . 41.4 mt -58.1 -36.8 58.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.81 -0.632 . . . . 0.45 110.977 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.16 -28.62 69.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.012 -0.54 . . . . 0.99 110.717 178.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 64.1 mt -76.58 -37.04 28.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.81 110.368 178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 57.4 mt -68.81 -38.23 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.932 -0.576 . . . . 0.72 110.513 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.439 HD21 HG23 ' B' ' 379' ' ' ILE . 84.8 mt . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.699 -0.667 . . . . 1.56 110.926 179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.919 0 N-CA-C 111.843 -0.503 . . . . 12.98 111.843 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 51.9 mmm-85 -68.96 -37.69 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.326 0.584 . . . . 14.53 109.886 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -128.23 175.43 8.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.261 -1.014 . . . . 10.62 108.261 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -75.75 79.32 2.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.921 -0.77 . . . . 9.78 108.921 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -86.2 64.97 8.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.915 -1.039 . . . . 8.94 110.425 -176.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . 0.457 ' OG ' ' HB3' ' A' ' 362' ' ' SER . 9.9 m -147.28 128.05 14.34 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.407 -0.815 . . . . 5.29 110.044 -177.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . -80.22 177.45 54.32 Favored Glycine 0 N--CA 1.441 -0.996 0 C-N-CA 120.215 -0.993 . . . . 2.37 111.135 174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.538 ' CE3' ' HD3' ' A' ' 358' ' ' ARG . 66.0 m95 -123.29 129.26 51.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.297 0.57 . . . . 1.42 111.155 -171.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.4 113.81 44.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.201 -0.909 . . . . 1.07 108.843 178.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' B' ' 376' ' ' GLU . 0.4 OUTLIER -98.19 145.75 26.3 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.304 0.573 . . . . 2.28 111.45 -175.828 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -97.83 155.46 17.04 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.185 -0.916 . . . . 1.83 110.561 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -106.68 19.67 20.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.172 0.511 . . . . 1.88 111.356 -179.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.439 HG23 HD21 ' A' ' 400' ' ' LEU . 22.8 pt -117.89 18.54 6.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.803 -0.635 . . . . 1.17 111.244 173.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -75.44 121.68 22.67 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.783 -0.451 . . . . 0.58 109.783 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.863 -0.589 . . . . 3.2 110.86 -179.902 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.69 -0.564 . . . . 4.12 111.69 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.473 HG22 HG22 ' A' ' 333' ' ' THR . 19.5 t 52.9 67.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-O 121.623 0.725 . . . . 2.92 109.731 -177.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 10.2 m -103.46 129.31 50.57 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.31 -0.859 . . . . 1.06 110.722 -174.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -104.41 122.65 45.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.155 0.502 . . . . 0.52 110.67 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -110.0 136.95 48.46 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.614 -0.721 . . . . 0.41 109.371 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 40.4 tp -85.46 95.24 9.21 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.122 0.487 . . . . 0.72 109.807 -179.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.417 ' HB ' ' HB ' ' A' ' 380' ' ' VAL . 27.5 m -95.21 153.13 3.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.895 -0.593 . . . . 0.3 110.139 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.85 ' HE2' ' HB2' ' A' ' 325' ' ' LEU . 52.0 mtpt -109.11 105.41 14.87 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.914 0.388 . . . . 1.44 110.516 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.47 ' HG2' HG12 ' A' ' 380' ' ' VAL . 86.4 mt-10 -78.62 109.51 12.9 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.82 -0.627 . . . . 0.7 110.039 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.419 ' HD3' ' HG ' ' A' ' 325' ' ' LEU . 26.3 tptp -81.37 98.98 8.44 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.448 -0.575 . . . . 1.74 109.448 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 32.5 mtt -104.59 171.85 7.11 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.528 -0.76 . . . . 1.68 110.316 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.93 ' HD3' ' H ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -75.23 162.05 28.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.786 -0.643 . . . . 2.3 110.171 177.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 110.28 -35.38 4.87 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.519 -0.848 . . . . 1.93 112.563 176.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . 0.456 ' HD2' ' HB3' ' A' ' 324' ' ' LYS . 23.1 pttm -153.01 167.93 27.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.745 0.307 . . . . 1.68 110.592 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 31.0 p30 -87.13 -11.98 48.43 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.128 -0.487 . . . . 2.79 111.232 179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . 0.456 ' HB3' ' HD2' ' A' ' 322' ' ' LYS . 38.5 ttmt -83.16 139.62 33.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.473 -0.331 . . . . 2.01 110.507 178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.85 ' HB2' ' HE2' ' A' ' 316' ' ' LYS . 5.6 mp -89.74 141.83 28.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.988 -0.551 . . . . 0.69 109.726 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 28.7 t -87.26 118.74 70.34 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.368 -0.378 . . . . 0.51 110.976 -175.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 326' ' ' VAL . 12.5 Cg_exo -69.84 119.63 6.54 Favored 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.848 2.365 . . . . 0.46 111.654 177.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -123.8 144.29 49.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.108 -0.496 . . . . 0.78 109.675 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 340' ' ' VAL . 95.1 mt -86.68 101.25 13.1 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.76 -0.459 . . . . 0.37 109.76 176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . . . . . . . . . 21.8 tp -85.46 103.94 14.8 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.911 -0.586 . . . . 0.57 109.647 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.44 121.15 6.35 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.834 -0.698 . . . . 0.29 112.144 -177.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 32.2 mm -103.45 118.38 50.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.83 -0.433 . . . . 0.36 109.83 177.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.473 HG22 HG22 ' A' ' 310' ' ' VAL . 34.4 p -118.55 -173.64 2.51 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.421 -0.354 . . . . 0.38 110.294 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 395' ' ' TYR . 58.3 pttt -72.03 -21.39 61.55 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.059 0.392 . . . . 1.61 112.059 -173.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . 0.417 ' C ' ' HG ' ' A' ' 353' ' ' LEU . 0.2 OUTLIER -131.37 -12.68 3.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.918 0.71 . . . . 1.79 112.918 -174.524 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 6.0 p -151.8 163.64 38.74 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 113.266 0.839 . . . . 1.1 113.266 -174.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 96.8 t -121.95 111.83 32.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 114.64 -1.164 . . . . 0.32 109.116 175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -106.96 138.66 42.71 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.192 0.52 . . . . 1.08 111.721 -175.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 45.8 mtm180 -94.07 106.07 18.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.841 -0.618 . . . . 1.55 110.004 173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.562 ' HB ' ' HB2' ' A' ' 329' ' ' LEU . 63.8 t -98.64 129.45 48.94 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 116.3 -0.409 . . . . 0.31 110.075 178.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . 0.495 ' HB3' ' H ' ' A' ' 346' ' ' GLU . 12.5 t70 -61.93 130.38 45.37 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.58 -0.526 . . . . 0.77 109.58 176.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -67.57 -32.6 73.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.088 -174.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -91.69 -53.06 4.46 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.408 -0.36 . . . . 3.06 111.323 -174.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 7.8 m -90.88 -16.99 27.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.92 111.715 -173.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 65.04 40.63 5.02 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.179 0.514 . . . . 1.5 111.387 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . 0.495 ' H ' ' HB3' ' A' ' 341' ' ' ASP . 69.0 mm-40 -97.82 137.51 36.57 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.918 -0.583 . . . . 2.46 110.758 177.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . . . . . . . . . 46.0 t -80.2 93.17 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.017 -0.735 . . . . 0.58 109.017 174.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 61.0 mt -71.03 -42.97 76.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.08 -174.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . . . . . . . . . 6.5 tp60 -153.16 132.62 12.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.273 -0.421 . . . . 1.65 110.528 -176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.38 119.39 33.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.69 -0.485 . . . . 0.65 109.69 177.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 6.1 m-90 -102.56 121.99 43.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.566 -0.288 . . . . 0.52 110.341 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . 0.45 ' HB3' HD22 ' A' ' 355' ' ' ASN . 32.0 t -72.64 144.83 47.65 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.931 -0.766 . . . . 1.27 108.931 173.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 335' ' ' GLU . 70.7 mt -59.43 -22.11 60.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.138 0.494 . . . . 0.31 110.944 -177.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' B' ' 380' ' ' TYR . 58.9 p -69.97 -16.07 63.13 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.942 -0.572 . . . . 0.44 111.573 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.45 HD22 ' HB3' ' A' ' 352' ' ' SER . 45.4 m-80 -101.95 2.56 38.06 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.836 0.351 . . . . 0.83 110.825 -177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . 0.407 ' O ' ' HB2' ' B' ' 380' ' ' TYR . 62.9 mt -80.76 124.87 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 109.471 -0.566 . . . . 0.38 109.471 176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.433 ' HD3' ' OD2' ' A' ' 369' ' ' ASP . 87.8 tttt -95.03 -50.12 5.23 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.258 0.551 . . . . 1.75 109.627 178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.924 ' HB3' ' HG2' ' B' ' 376' ' ' GLU . 4.3 ptp180 -157.56 154.45 28.57 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.559 -0.746 . . . . 1.75 109.925 179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.527 ' HB3' HD23 ' A' ' 368' ' ' LEU . 31.9 p90 -139.62 147.06 40.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.07 0.462 . . . . 0.4 110.307 175.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -113.51 124.01 51.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.754 -0.657 . . . . 0.31 111.07 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . . . . . . . . . . . -107.19 120.73 42.93 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.209 -0.905 . . . . 0.38 110.668 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 65.9 p -141.28 155.48 67.86 Favored Pre-proline 0 C--N 1.321 -0.648 0 N-CA-C 109.674 -0.491 . . . . 1.0 109.674 176.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -67.57 -11.29 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.421 2.081 . . . . 0.66 112.794 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -101.67 -35.56 9.06 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.751 0.278 . . . . 2.08 111.751 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 47.1 p -157.16 178.34 10.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.265 0.555 . . . . 1.32 112.076 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.513 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 71.6 t80 -137.05 140.55 42.12 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.518 -0.764 . . . . 0.3 109.274 178.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 378' ' ' TYR . 93.5 m -134.44 129.23 34.98 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.799 0.333 . . . . 0.34 111.546 -178.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.527 HD23 ' HB3' ' A' ' 359' ' ' TRP . 61.0 mt -109.81 141.48 42.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.944 -0.571 . . . . 0.33 110.597 176.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.433 ' OD2' ' HD3' ' A' ' 357' ' ' LYS . 10.0 t0 -125.9 135.29 51.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.667 -0.494 . . . . 1.52 109.667 173.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . 0.427 ' HB3' ' HB3' ' A' ' 373' ' ' TYR . 74.8 m-85 -120.63 8.57 10.67 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.037 -0.529 . . . . 0.44 110.789 -175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 56.05 -101.3 0.13 Allowed Glycine 0 C--N 1.332 0.313 0 CA-C-N 115.658 -0.701 . . . . 0.58 113.984 174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -91.63 4.54 52.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.076 0.465 . . . . 2.38 111.405 -172.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . 0.427 ' HB3' ' HB3' ' A' ' 370' ' ' PHE . 85.5 t80 -85.84 -40.03 16.42 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.79 111.53 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -147.85 172.74 13.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.634 0.254 . . . . 1.09 110.701 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -93.89 112.58 24.44 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.178 -0.465 . . . . 2.3 111.124 -176.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 101.24 -170.56 21.59 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.862 -0.685 . . . . 0.7 112.273 177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -108.49 177.66 4.72 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.946 0.403 . . . . 1.06 110.217 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 37.1 t80 -122.39 96.73 5.16 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.938 -0.574 . . . . 0.47 109.495 174.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 49.4 m -108.3 123.92 49.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.144 -0.48 . . . . 1.06 110.735 -177.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.47 HG12 ' HG2' ' A' ' 317' ' ' GLU . 17.9 m -130.61 144.98 36.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.846 -0.615 . . . . 0.33 110.193 178.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -88.19 130.68 34.99 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.838 -0.43 . . . . 1.47 109.838 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . . . . . . . . . 5.5 t -170.25 138.75 1.65 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.807 -0.633 . . . . 0.42 109.813 -178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 3.3 p -84.88 -3.39 58.67 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.108 0.48 . . . . 0.55 111.079 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.94 30.64 7.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.836 -0.62 . . . . 1.39 110.634 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -61.59 -33.19 84.05 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.633 -0.712 . . . . 0.27 112.907 -179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -65.87 -44.36 85.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.752 0.31 . . . . 2.28 110.352 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 19.6 mp0 -57.19 -44.28 83.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 2.27 110.217 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 61.5 mt -62.85 -49.53 83.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.796 -0.638 . . . . 0.29 110.684 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.513 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -59.98 -49.72 76.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.8 -0.636 . . . . 0.28 111.813 -177.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -67.15 -27.51 67.36 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.123 -0.489 . . . . 1.99 110.835 -177.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 30.1 tp -72.46 -43.36 63.85 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.174 -0.306 . . . . 0.63 110.174 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . . . . . . . . . 74.3 mt -62.08 -50.6 79.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-N 116.31 -0.404 . . . . 0.21 109.943 176.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 359' ' ' TRP . . . -60.7 -30.48 69.97 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.059 -0.518 . . . . 0.29 110.763 179.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -65.33 -45.24 91.61 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 121.206 -0.521 . . . . 0.35 112.344 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.404 ' CG ' ' HA ' ' A' ' 334' ' ' LYS . 25.4 m-85 -74.51 -31.13 62.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.727 0.299 . . . . 0.7 110.84 177.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.52 HD13 ' HB3' ' B' ' 377' ' ' ASN . 48.8 mt -59.89 -39.66 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.355 -0.384 . . . . 0.45 109.983 172.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.41 -21.89 65.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.906 -0.588 . . . . 0.99 111.084 177.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 9.0 mm -85.98 -47.68 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.954 0.407 . . . . 0.81 110.43 179.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 59.2 mt -70.12 -36.02 66.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.103 -0.499 . . . . 0.72 110.831 -178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.413 HD13 HG23 ' B' ' 379' ' ' ILE . 29.8 tp . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.739 -0.648 . . . . 1.56 110.437 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.711 0 N-CA-C 111.947 -0.461 . . . . 12.98 111.947 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 7.9 mmt180 -106.03 -1.32 24.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.699 0.285 . . . . 14.53 111.02 -178.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 19.5 m -106.75 44.79 1.02 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.054 0.454 . . . . 10.62 110.964 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.884 ' HE3' ' HB2' ' B' ' 376' ' ' GLU . 60.9 mttm -121.44 148.73 44.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 9.78 109.969 176.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -70.45 157.79 37.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.057 -0.52 . . . . 8.94 111.477 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.5 p -80.91 123.44 28.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.252 -0.431 . . . . 5.29 110.294 178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . . . . . . . . . . . 123.33 -43.6 1.41 Allowed Glycine 0 N--CA 1.45 -0.387 0 N-CA-C 111.289 -0.724 . . . . 2.37 111.289 -176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . . . . . . . . . 66.3 m95 -124.47 103.95 8.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.357 -0.609 . . . . 1.42 109.357 175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . 0.456 HG13 ' CE2' ' A' ' 359' ' ' TRP . 3.8 p -136.78 132.97 48.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.532 -0.758 . . . . 1.07 111.04 -169.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.924 ' HG2' ' HB3' ' A' ' 358' ' ' ARG . 26.6 mt-10 -115.73 151.41 35.17 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.49 -0.777 . . . . 2.28 109.798 -178.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . 0.572 HD22 ' C ' ' B' ' 377' ' ' ASN . 0.2 OUTLIER -104.76 173.94 6.09 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.164 -0.214 . . . . 1.83 110.949 176.702 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -119.54 23.32 11.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.079 0.4 . . . . 1.88 112.079 -179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.474 HD11 HG12 ' A' ' 396' ' ' ILE . 4.8 pt -101.29 11.11 7.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.499 . . . . 1.17 110.222 171.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . 0.54 ' HA ' ' O ' ' A' ' 354' ' ' THR . 73.4 t80 -79.84 89.22 5.25 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.579 -0.737 . . . . 0.58 109.632 177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 . . . . . 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 3.2 109.318 177.442 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . 0.691 ' N ' ' HH ' ' A' ' 395' ' ' TYR . . . . . . . . 0 N--CA 1.481 1.645 0 N-CA-C 111.647 -0.581 . . . . 4.12 111.647 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . 0.865 HG12 HG22 ' A' ' 333' ' ' THR . 15.4 m -62.66 101.44 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.608 0.718 . . . . 2.92 111.372 -177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' SER . . . . . . . . . . . . . 11.3 m -104.26 126.26 51.22 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.748 -0.66 . . . . 1.06 110.021 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.611 ' HE2' HG21 ' A' ' 340' ' ' VAL . 78.9 m-85 -108.0 121.21 44.34 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.065 0.459 . . . . 0.52 110.605 -178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -108.41 125.76 52.12 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.87 -0.605 . . . . 0.41 110.067 179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 44.2 tp -78.55 95.94 5.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.3 0.571 . . . . 0.72 109.767 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 327' ' ' PRO . 35.9 m -103.97 162.91 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.542 -0.754 . . . . 0.3 110.431 -176.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.62 ' HB2' ' HB3' ' A' ' 381' ' ' GLN . 26.0 mtpp -112.06 104.98 13.25 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.344 -0.389 . . . . 1.44 110.095 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' GLU . . . . . 0.535 ' OE2' ' HD2' ' A' ' 339' ' ' ARG . 56.8 mt-10 -77.76 122.16 25.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.454 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' LYS . . . . . 0.727 ' HE3' ' HA ' ' A' ' 323' ' ' ASN . 21.6 tptm -90.69 101.14 13.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.096 0.474 . . . . 1.74 110.039 175.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' MET . . . . . . . . . . . . . 6.3 mmt -100.28 157.11 16.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.878 -0.601 . . . . 1.68 110.098 176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LYS . . . . . 0.48 ' HE3' ' N ' ' A' ' 320' ' ' LYS . 0.0 OUTLIER -73.29 162.64 29.12 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.922 -0.581 . . . . 2.3 110.62 179.642 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 104.74 -32.49 7.46 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.957 -0.64 . . . . 1.93 112.166 179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' LYS . . . . . . . . . . . . . 25.7 pttm -153.73 157.98 40.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.318 -0.623 . . . . 1.68 109.318 178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.727 ' HA ' ' HE3' ' A' ' 318' ' ' LYS . 55.1 m-80 -86.48 -14.31 43.51 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 121.003 -0.279 . . . . 2.79 111.246 -178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -68.05 125.1 25.29 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.485 -0.325 . . . . 2.01 110.16 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.34 150.32 26.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.786 -0.45 . . . . 0.69 109.786 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 327' ' ' PRO . 21.7 t -105.56 119.35 52.99 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.46 -0.336 . . . . 0.51 110.621 -177.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' PRO . . . . . 0.469 ' HA ' ' O ' ' A' ' 315' ' ' VAL . 23.6 Cg_exo -65.5 127.66 18.57 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.757 2.305 . . . . 0.46 111.923 177.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -134.92 155.21 51.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.068 -0.514 . . . . 0.78 109.795 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 342' ' ' GLU . 94.7 mt -96.2 101.85 13.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.901 0.381 . . . . 0.37 110.099 178.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 388' ' ' ILE . 29.1 tp -83.01 104.52 13.27 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.64 -0.504 . . . . 0.57 109.64 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -92.23 108.75 3.67 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.92 -0.657 . . . . 0.29 112.205 -177.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ILE . . . . . . . . . . . . . 42.1 mm -95.09 121.85 46.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.902 -0.406 . . . . 0.36 109.902 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' THR . . . . . 0.865 HG22 HG12 ' A' ' 310' ' ' VAL . 66.6 p -111.97 -170.88 1.74 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.615 -0.513 . . . . 0.38 109.615 177.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.473 ' HA ' ' CD2' ' A' ' 395' ' ' TYR . 24.7 pttm -86.35 12.48 10.0 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.831 0.348 . . . . 1.61 110.597 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -155.39 -30.65 0.1 Allowed 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.246 0.462 . . . . 1.79 112.246 -172.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' CYS . . . . . . . . . . . . . 65.3 m -136.2 166.21 23.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.368 0.604 . . . . 1.1 112.043 -173.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' VAL . . . . . . . . . . . . . 99.7 t -126.77 102.27 9.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.223 -0.899 . . . . 0.32 109.072 176.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 350' ' ' GLU . 22.6 ptp -104.88 128.82 53.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.114 0.483 . . . . 1.08 111.834 -172.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.535 ' HD2' ' OE2' ' A' ' 317' ' ' GLU . 42.7 mtm180 -83.74 99.48 10.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.061 -0.518 . . . . 1.55 109.948 173.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' VAL . . . . . 0.611 HG21 ' HE2' ' A' ' 312' ' ' PHE . 98.9 t -95.35 129.13 45.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 116.135 -0.484 . . . . 0.31 110.019 179.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -62.12 134.42 56.55 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.751 0.31 . . . . 0.77 110.586 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' GLU . . . . . 0.565 ' HA ' ' HG ' ' A' ' 329' ' ' LEU . 13.1 tm-20 -57.47 -46.35 83.76 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.575 -0.739 . . . . 1.51 110.625 -175.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -87.62 -55.55 3.73 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.321 -0.399 . . . . 3.06 111.925 -173.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' THR . . . . . . . . . . . . . 1.2 m -85.81 -10.47 55.4 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.436 0.532 . . . . 0.92 112.436 -170.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp 65.57 21.65 11.73 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 122.623 0.369 . . . . 1.5 111.551 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -79.36 128.66 33.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.344 -0.389 . . . . 2.46 111.21 -179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.444 HG22 HG22 ' A' ' 340' ' ' VAL . 48.8 t -79.19 97.12 2.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.27 -0.641 . . . . 0.58 109.27 175.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 60.0 mt -74.5 -42.41 49.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.712 -0.676 . . . . 0.35 111.317 -174.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' GLN . . . . . 0.479 ' HB3' ' HE ' ' A' ' 339' ' ' ARG . 35.1 tt0 -153.76 115.91 4.32 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.436 -0.347 . . . . 1.65 110.393 -175.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 338' ' ' MET . 38.1 tt0 -106.86 114.44 28.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.228 -0.442 . . . . 0.65 110.733 -179.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -92.86 168.13 11.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.146 -0.479 . . . . 0.52 110.344 175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 45.5 t -116.6 148.52 40.86 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.119 -0.697 . . . . 1.27 109.119 174.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' LEU . . . . . 0.618 HD22 HG23 ' A' ' 392' ' ' ILE . 75.7 mt -61.28 -27.18 68.29 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.378 0.609 . . . . 0.31 110.327 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' THR . . . . . . . . . . . . . 81.9 p -73.3 -17.89 61.26 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.149 -0.932 . . . . 0.44 111.822 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -99.13 -0.89 40.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.317 0.58 . . . . 0.83 110.409 -175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' ILE . . . . . . . . . . . . . 78.7 mt -87.52 150.06 3.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.219 -0.9 . . . . 0.38 109.662 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 51.1 tttp -112.59 -56.68 2.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.092 0.472 . . . . 1.75 110.482 171.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.611 ' HB3' ' OE1' ' B' ' 376' ' ' GLU . 2.9 ptp180 -144.17 149.67 36.81 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.055 -0.52 . . . . 1.75 110.488 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' TRP . . . . . 0.489 ' HB3' HD23 ' A' ' 368' ' ' LEU . 42.0 p90 -132.95 137.64 46.64 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.921 -0.581 . . . . 0.4 110.508 176.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 367' ' ' THR . . . -102.04 115.93 31.59 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.485 -0.78 . . . . 0.31 110.433 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 386' ' ' GLU . . . -105.01 125.78 51.35 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.516 -0.766 . . . . 0.38 110.821 -179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' SER . . . . . . . . . . . . . 79.4 p -142.2 159.17 59.53 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.297 -0.631 . . . . 1.0 109.297 175.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.31 5.04 3.88 Favored 'Trans proline' 0 CA--C 1.528 0.191 0 C-N-CA 122.4 2.066 . . . . 0.66 112.163 176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' LYS . . . . . . . . . . . . . 13.9 tptp -113.94 -37.53 4.46 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.187 -0.46 . . . . 2.08 110.778 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . 0.527 ' HA ' ' H ' ' A' ' 382' ' ' THR . 67.6 m -157.35 176.79 12.22 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.171 0.51 . . . . 1.32 111.27 -176.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' PHE . . . . . 0.498 ' HE1' ' HB2' ' A' ' 389' ' ' ALA . 69.8 t80 -136.15 138.64 42.19 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.136 -0.69 . . . . 0.3 109.136 176.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 360' ' ' ALA . 87.0 m -131.43 118.99 20.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.732 0.301 . . . . 0.34 111.687 -176.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 378' ' ' TYR . 54.1 mt -98.48 136.32 38.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.497 -0.319 . . . . 0.33 110.765 175.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' ASP . . . . . 0.578 ' HB3' ' HG3' ' A' ' 358' ' ' ARG . 11.5 t0 -122.96 132.57 54.21 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.27 -0.423 . . . . 1.52 109.92 173.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -115.53 6.34 14.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.939 -0.573 . . . . 0.44 110.702 -175.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' GLY . . . . . . . . . . . . . . . 59.84 -104.77 0.62 Allowed Glycine 0 N--CA 1.45 -0.399 0 CA-C-N 115.87 -0.604 . . . . 0.58 113.658 175.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -96.97 8.93 43.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.684 0.253 . . . . 2.38 111.684 -173.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -85.68 -27.76 25.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.915 0.388 . . . . 0.79 110.134 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -168.42 161.78 12.02 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.13 -0.486 . . . . 1.09 110.109 177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -85.6 136.27 33.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.807 0.337 . . . . 2.3 111.124 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . 95.01 165.99 35.61 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.461 175.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -94.99 177.39 5.9 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.218 0.532 . . . . 1.06 110.155 177.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' TYR . . . . . 0.611 ' HB3' ' HB2' ' A' ' 368' ' ' LEU . 36.6 t80 -122.36 86.63 2.61 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.565 -0.902 . . . . 0.47 108.565 168.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' SER . . . . . . . . . . . . . 6.1 p -100.98 118.35 36.81 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.714 -0.675 . . . . 1.06 110.993 -178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' VAL . . . . . 0.45 ' HB ' ' HB ' ' A' ' 315' ' ' VAL . 16.6 m -120.99 144.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.426 -0.807 . . . . 0.33 110.171 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLN . . . . . 0.62 ' HB3' ' HB2' ' A' ' 316' ' ' LYS . 35.4 tt0 -82.23 121.03 26.12 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 116.085 -0.507 . . . . 1.47 109.869 178.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 365' ' ' SER . 2.8 t -166.64 134.42 2.67 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.987 -0.552 . . . . 0.42 110.836 -178.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' THR . . . . . . . . . . . . . 25.2 p -80.57 -14.4 58.24 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.525 0.678 . . . . 0.55 110.064 176.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -96.29 13.85 26.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.106 -0.952 . . . . 1.39 110.173 -177.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLY . . . . . . . . . . . . . . . -57.47 -38.23 86.1 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.936 -0.575 . . . . 0.27 112.917 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . 0.451 ' HA ' ' HB1' ' A' ' 361' ' ' ALA . 38.2 tt0 -63.42 -38.7 92.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.775 0.321 . . . . 2.28 110.681 178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -61.52 -41.72 97.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.075 -0.511 . . . . 2.27 110.085 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.437 HD13 HD23 ' A' ' 330' ' ' LEU . 52.1 mt -60.69 -50.76 79.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.709 -0.678 . . . . 0.29 110.204 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ALA . . . . . 0.498 ' HB2' ' HE1' ' A' ' 366' ' ' PHE . . . -58.88 -45.85 89.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.493 -0.776 . . . . 0.28 111.72 -178.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -64.56 -34.01 77.25 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.978 -0.556 . . . . 1.99 110.611 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 29.2 tp -71.64 -45.62 61.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.163 -0.471 . . . . 0.63 110.345 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ILE . . . . . 0.618 HG23 HD22 ' A' ' 353' ' ' LEU . 80.0 mt -58.93 -49.39 83.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.043 0.449 . . . . 0.21 110.229 176.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ALA . . . . . . . . . . . . . . . -62.23 -30.08 70.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.833 -0.621 . . . . 0.29 111.059 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLY . . . . . . . . . . . . . . . -68.62 -49.04 46.37 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 121.167 -0.539 . . . . 0.35 112.412 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' TYR . . . . . 0.691 ' HH ' ' N ' ' A' ' 309' ' ' GLY . 20.8 m-85 -71.16 -34.88 71.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.736 0.303 . . . . 0.7 110.938 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' ILE . . . . . 0.485 HD12 HG22 ' A' ' 392' ' ' ILE . 23.6 mt -64.53 -36.44 77.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.145 -0.48 . . . . 0.45 110.738 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -59.28 -31.4 69.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.006 -0.543 . . . . 0.99 111.022 178.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' ILE . . . . . . . . . . . . . 69.0 mt -69.54 -37.98 75.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.076 -0.511 . . . . 0.81 110.917 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ILE . . . . . . . . . . . . . 40.6 mt -74.53 -20.92 17.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.72 110.826 -177.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' LEU . . . . . 0.674 HD21 HG23 ' B' ' 379' ' ' ILE . 97.6 mt . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.285 -0.864 . . . . 1.56 111.488 -175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.765 -0.534 . . . . 12.98 111.765 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -151.15 179.94 7.86 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 110.018 -0.364 . . . . 14.53 110.018 -179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' SER . . . . . . . . . . . . . 5.2 m -98.5 94.19 6.57 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.201 -0.666 . . . . 10.62 109.201 175.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' LYS . . . . . 0.565 ' HD2' ' H ' ' B' ' 370' ' ' LYS . 0.0 OUTLIER -62.88 139.74 58.75 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.679 -0.489 . . . . 9.78 109.679 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' GLU . . . . . 0.555 ' HB3' ' HB2' ' B' ' 374' ' ' TRP . 7.4 mp0 -45.72 -61.27 1.78 Allowed 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.978 0.799 . . . . 8.94 112.431 -171.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' SER . . . . . . . . . . . . . 7.3 m 59.62 103.5 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.579 0 O-C-N 123.767 0.667 . . . . 5.29 111.361 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 360' ' ' ALA . . . 98.39 -39.67 2.69 Favored Glycine 0 C--N 1.316 -0.531 0 C-N-CA 120.689 -0.767 . . . . 2.37 111.265 -176.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' TRP . . . . . 0.555 ' HB2' ' HB3' ' B' ' 371' ' ' GLU . 94.3 m95 -92.05 121.24 33.42 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.171 0.51 . . . . 1.42 109.944 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' VAL . . . . . . . . . . . . . 38.5 t -113.18 111.89 38.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.671 -0.695 . . . . 1.07 110.304 -177.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 358' ' ' ARG . 7.8 mm-40 -80.26 139.29 36.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.687 -0.688 . . . . 2.28 109.94 178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -100.54 172.37 7.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.845 0.355 . . . . 1.83 110.44 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 378' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -127.16 23.78 6.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.316 -0.402 . . . . 1.88 111.722 176.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 379' ' ' ILE . . . . . 0.674 HG23 HD21 ' A' ' 400' ' ' LEU . 23.1 pt -130.29 37.37 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.932 0.396 . . . . 1.17 110.685 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 380' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -83.28 115.7 22.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.04 -0.527 . . . . 0.58 110.996 -177.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 . . . . . 0 N--CA 1.439 -1.004 0 CA-C-N 115.706 -0.679 . . . . 3.2 110.349 177.342 . . . . . . . . 0 0 . 1 stop_ save_